data_2jtr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jtr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.12 142.68 42.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 108.34 171.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.15 119.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.6 mt -125.5 109.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.93 132.52 45.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 167.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.56 10.83 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.528 0.731 . . . . 0.0 111.695 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -67.83 170.58 7.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.26 1.391 . . . . 0.0 108.708 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.78 150.41 48.07 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.28 -0.887 . . . . 0.0 110.921 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.79 -34.33 61.84 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.479 2.119 . . . . 0.0 112.76 -167.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.68 -27.48 68.38 Favored 'General case' 0 C--O 1.227 -0.131 0 O-C-N 121.301 -0.875 . . . . 0.0 111.224 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -88.35 -30.74 19.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.417 -0.802 . . . . 0.0 112.949 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -53.71 -47.37 70.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 170.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.76 -20.07 66.16 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.081 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.2 -49.32 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -178.88 134.43 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -148.11 160.78 42.53 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.566 1.146 . . . . 0.0 110.067 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.98 131.15 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -56.6 140.76 45.66 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.192 2.197 . . . . 0.0 109.967 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.36 83.91 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.8 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 172.8 7.8 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.527 1.164 . . . . 0.0 109.639 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 tt -112.87 170.87 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 2.9 t-20 -124.12 127.67 48.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.24 86.86 19.06 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.82 149.34 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.704 2.269 . . . . 0.0 111.959 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.8 tp -46.84 -37.64 9.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.99 0.916 . . . . 0.0 112.68 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -62.23 -28.19 69.52 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -113.21 -16.94 12.47 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.426 1.891 . . . . 0.0 108.665 -166.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -41.71 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.675 0.79 . . . . 0.0 110.477 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -57.44 -34.23 68.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.161 0.984 . . . . 0.0 113.578 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.54 -6.87 58.15 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -148.68 -25.11 0.32 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -153.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.85 -35.98 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.93 66.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.707 0.803 . . . . 0.0 112.342 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 -39.36 14.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.798 0.839 . . . . 0.0 109.805 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.47 60.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.782 0.833 . . . . 0.0 112.265 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 t -139.95 75.3 30.2 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.303 1.841 . . . . 0.0 106.867 -173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.92 -17.62 36.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.824 2.35 . . . . 0.0 112.882 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -113.21 123.49 50.31 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 mtpt -71.08 -26.73 63.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 125.201 1.401 . . . . 0.0 113.239 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.55 -14.55 62.13 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 126.07 2.106 . . . . 0.0 108.634 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.78 146.37 52.97 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.748 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -81.55 117.89 22.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.68 1.228 . . . . 0.0 110.845 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -104.85 110.67 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 O-C-N 120.771 -1.205 . . . . 0.0 107.756 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -95.55 119.45 34.07 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.65 141.12 29.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -149.35 171.93 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.435 ' HG ' ' HB2' ' A' ' 53' ' ' GLN . 31.5 p -165.86 -170.99 1.91 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.734 1.214 . . . . 0.0 108.606 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.07 104.93 1.24 Allowed 'General case' 0 C--O 1.26 1.645 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 85.5 5.67 0.48 Allowed 'General case' 0 C--N 1.404 2.953 1 O-C-N 129.974 4.546 . . . . 0.0 111.282 156.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.92 63.15 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.171 0.891 . . . . 0.0 112.731 162.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -52.16 43.76 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 121.646 -0.914 . . . . 0.0 113.351 -165.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.435 ' HB2' ' HG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -61.16 -29.48 69.82 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.88 -45.92 55.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.582 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.64 95.92 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.55 -45.75 91.49 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.406 1.482 . . . . 0.0 111.788 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.34 88.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 69' ' ' VAL . 61.0 tttt -58.6 -42.2 87.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.604 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.57 -56.34 23.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.529 1.059 . . . . 0.0 110.091 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.1 pt -66.77 -31.96 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.155 -0.34 . . . . 0.0 110.359 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -71.59 -41.73 68.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.138 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.8 m -57.18 -41.29 79.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.943 0.792 . . . . 0.0 109.54 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -67.11 -39.04 86.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.611 0.641 . . . . 0.0 110.646 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.94 -10.18 51.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.846 -1.159 . . . . 0.0 111.281 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.4 ' HA3' ' HZ2' ' A' ' 40' ' ' LYS . . . 96.92 13.19 47.34 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.608 1.575 . . . . 0.0 113.345 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 40' ' ' LYS . 80.9 m-85 -70.22 130.12 41.19 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.709 1.754 . . . . 0.0 107.492 166.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 -2.07 18.3 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.06 0.544 . . . . 0.0 111.61 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -131.76 34.35 3.89 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 110.241 -169.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.493 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 37.2 t -85.67 139.12 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -141.12 129.14 21.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.39 1.076 . . . . 0.0 108.464 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.06 109.4 10.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.76 69.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.272 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.07 -153.01 25.01 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 162.39 12.63 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 166.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.446 HD12 ' HE2' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -37.3 -51.49 1.06 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.846 2.058 . . . . 0.0 110.823 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -68.58 -40.72 80.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.4 -33.38 32.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.943 -1.935 . . . . 0.0 107.176 -168.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.39 123.76 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -8.78 58.68 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mtp -66.47 152.76 94.28 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.473 0.709 . . . . 0.0 110.925 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.58 162.08 22.32 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.168 2.579 . . . . 0.0 112.191 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HE2' HD12 ' A' ' 75' ' ' LEU . 9.9 mptt -130.46 156.39 44.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.096 0.958 . . . . 0.0 108.659 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--N 1.324 -0.51 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.83 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 C--O 1.236 0.386 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.59 140.45 27.41 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 108.953 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -80.26 102.96 9.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 168.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -112.27 94.69 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.424 ' CG ' ' HE ' ' A' ' 8' ' ' ARG . 6.6 t0 -65.84 156.2 34.0 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.53 16.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.325 1.05 . . . . 0.0 111.688 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.424 ' HE ' ' CG ' ' A' ' 6' ' ' ASP . 20.8 ptp180 -54.97 159.71 2.26 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.871 1.268 . . . . 0.0 111.795 172.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.13 145.96 32.38 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.64 -37.75 86.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.648 2.232 . . . . 0.0 113.996 -166.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.16 -17.58 64.59 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -88.54 -10.35 49.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.838 0.745 . . . . 0.0 110.959 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -72.52 -20.61 61.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.531 1.514 . . . . 0.0 110.962 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.05 -12.48 60.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.773 0.829 . . . . 0.0 111.213 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -114.79 -172.49 2.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.724 1.61 . . . . 0.0 108.567 -167.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.58 117.53 4.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.203 1.001 . . . . 0.0 111.345 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -147.66 160.9 42.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.693 1.197 . . . . 0.0 109.456 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.48 139.17 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.617 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -50.84 120.13 4.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.934 1.294 . . . . 0.0 110.101 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.82 4.25 81.79 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.666 -1.075 . . . . 0.0 114.536 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 151.11 47.93 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.475 1.638 . . . . 0.0 110.654 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.63 159.5 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -125.61 133.0 52.39 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 169.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.67 88.74 18.93 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.24 144.61 29.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.029 2.486 . . . . 0.0 113.378 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.6 tp -52.23 -32.17 35.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.636 0.774 . . . . 0.0 112.561 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -68.21 -15.48 63.59 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -131.42 -14.96 3.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.317 1.447 . . . . 0.0 112.087 -169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p -50.81 -43.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 125.675 1.59 . . . . 0.0 114.038 -167.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.86 -21.91 66.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.423 1.011 . . . . 0.0 112.362 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.35 -18.05 40.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.746 0.818 . . . . 0.0 112.033 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -135.22 -16.78 1.86 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -166.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.29 -34.24 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.552 1.069 . . . . 0.0 111.166 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.36 77.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.469 0.577 . . . . 0.0 111.719 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -68.66 -42.82 77.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.343 0.657 . . . . 0.0 109.663 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.31 -29.02 61.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.85 81.67 45.81 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.79 -5.76 17.56 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.369 2.712 . . . . 0.0 114.541 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -142.44 136.32 29.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.58 1.082 . . . . 0.0 109.044 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.66 -22.32 66.63 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -19.4 60.28 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.261 0.937 . . . . 0.0 112.162 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.1 143.91 50.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.972 0.805 . . . . 0.0 110.674 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.84 152.94 33.17 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -138.37 137.77 43.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.22 103.35 12.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.03 141.26 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -154.32 173.74 15.78 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.43 -177.0 5.68 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.414 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -48.02 -43.93 30.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 0.0 112.132 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 16.97 5.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.195 0.998 . . . . 0.0 112.907 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.39 -31.4 0.99 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.11 1.338 . . . . 0.0 114.927 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.8 -43.28 99.23 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.395 1.597 . . . . 0.0 113.54 -173.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.48 -36.68 83.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.027 1.285 . . . . 0.0 109.453 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.44 -36.6 60.7 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.642 -0.695 . . . . 0.0 112.844 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.54 97.67 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 171.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -48.79 79.37 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 175.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -39.75 94.19 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.196 0.599 . . . . 0.0 111.589 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.2 -42.25 76.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.271 0.941 . . . . 0.0 110.066 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.14 -53.13 54.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.87 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.96 -35.69 75.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 CA-C-N 119.413 1.006 . . . . 0.0 110.996 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.0 -34.46 68.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.964 0.802 . . . . 0.0 110.534 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.4 m -63.63 -40.84 97.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.448 0.567 . . . . 0.0 110.093 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.05 -37.66 88.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.581 0.628 . . . . 0.0 110.76 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.69 -3.01 16.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.899 1.28 . . . . 0.0 112.317 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.03 4.45 60.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.495 -1.169 . . . . 0.0 113.928 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -75.1 86.26 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.591 1.695 . . . . 0.0 108.221 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 p -71.27 9.69 0.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.319 1.447 . . . . 0.0 113.904 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -136.34 27.98 3.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 111.717 -170.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.33 137.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -136.75 144.09 43.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -85.16 110.77 19.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.99 73.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.744 0.418 . . . . 0.0 111.73 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.79 -154.39 25.52 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.16 162.25 12.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.8 tp -43.48 -48.56 7.3 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 114.503 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.83 -18.49 60.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.58 -22.46 21.24 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.884 0.874 . . . . 0.0 111.958 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 mm -63.32 132.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.81 58.77 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.5 mmm -66.36 156.22 85.96 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.198 0.999 . . . . 0.0 111.612 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.24 161.67 16.02 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.497 2.798 . . . . 0.0 112.088 168.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -130.0 160.37 33.86 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.951 0.9 . . . . 0.0 110.446 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.538 0.491 0 C-N-CA 127.504 2.321 . . . . 0.0 107.772 179.003 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.237 0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -139.98 122.03 15.7 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 169.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -78.92 118.94 21.41 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.45 104.23 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.89 124.69 24.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.17 6.48 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.009 0.924 . . . . 0.0 111.076 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -63.76 160.32 17.46 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.005 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 148.01 51.94 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.47 -32.94 70.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.922 1.748 . . . . 0.0 113.161 -167.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.06 -27.72 64.87 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.568 -0.707 . . . . 0.0 111.844 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -84.23 -34.87 23.79 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -46.24 76.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.196 0.598 . . . . 0.0 110.616 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.05 -22.6 66.97 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -65.23 -45.02 86.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.765 0.712 . . . . 0.0 110.706 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -172.63 138.2 0.85 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.887 1.675 . . . . 0.0 106.988 171.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -147.18 160.54 42.33 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.294 1.038 . . . . 0.0 110.752 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.41 127.69 22.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -61.54 145.61 51.43 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.884 0.374 . . . . 0.0 110.929 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.1 -7.37 52.44 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.214 0.911 . . . . 0.0 114.094 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.62 7.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.012 1.406 . . . . 0.0 111.332 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.76 166.52 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.051 1.741 . . . . 0.0 106.409 168.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -123.74 128.83 50.15 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 109.187 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 mt -139.12 84.43 16.84 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.1 153.77 11.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.397 2.731 . . . . 0.0 112.815 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -51.59 -35.98 43.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.768 0.827 . . . . 0.0 112.613 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.56 -22.61 66.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.428 0.691 . . . . 0.0 112.46 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -114.66 -27.68 7.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.112 1.365 . . . . 0.0 111.772 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -56.7 -38.92 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 124.4 1.08 . . . . 0.0 112.898 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -63.11 -19.46 64.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.238 0.926 . . . . 0.0 112.446 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -103.86 -5.4 22.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.642 1.177 . . . . 0.0 111.918 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -134.95 -21.25 1.67 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -60.43 -38.67 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 120.012 1.278 . . . . 0.0 111.524 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.6 75.14 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.969 0.804 . . . . 0.0 111.868 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 m -71.67 -45.12 62.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.635 0.774 . . . . 0.0 109.633 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.55 -30.71 66.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.17 0.588 . . . . 0.0 112.402 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.0 t -136.06 86.26 26.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.17 -1.78 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.205 2.604 . . . . 0.0 113.661 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -138.28 114.88 10.54 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.615 1.166 . . . . 0.0 108.692 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.62 -15.51 51.99 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.115 0.966 . . . . 0.0 112.871 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -66.22 -22.77 66.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.02 142.64 53.6 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.04 0.536 . . . . 0.0 111.182 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -78.2 97.87 5.66 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.55 88.19 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -82.21 89.78 6.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.14 139.97 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.857 0.463 . . . . 0.0 109.832 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -149.61 168.15 24.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.211 1.005 . . . . 0.0 108.514 169.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.39 -154.29 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -47.71 84.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.9 0.773 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.74 -23.22 0.72 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -25.83 1.46 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.739 1.154 . . . . 0.0 114.81 172.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -64.56 -45.49 86.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.639 1.72 . . . . 0.0 112.927 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.5 -31.29 72.44 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.75 1.159 . . . . 0.0 109.438 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -65.01 -49.53 69.86 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.899 0.88 . . . . 0.0 111.02 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.77 -42.09 95.36 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.07 -42.7 95.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.475 0.71 . . . . 0.0 110.664 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.53 92.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.017 0.527 . . . . 0.0 110.368 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.5 -37.83 73.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.985 0.811 . . . . 0.0 111.144 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -62.13 -53.09 60.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.957 0.799 . . . . 0.0 110.72 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt -69.4 -30.38 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.295 0.952 . . . . 0.0 111.566 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.21 -37.01 82.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 119.471 1.032 . . . . 0.0 110.143 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -66.29 -38.4 87.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.019 0.372 . . . . 0.0 110.199 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.19 -38.76 92.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.633 0.651 . . . . 0.0 110.538 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -75.09 6.24 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.287 1.435 . . . . 0.0 112.274 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.42 13.5 83.33 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.324 -1.265 . . . . 0.0 114.418 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -69.43 147.62 50.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.756 1.778 . . . . 0.0 108.433 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 p -132.67 8.58 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.591 1.157 . . . . 0.0 111.336 -171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -134.02 30.47 3.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.524 1.53 . . . . 0.0 110.026 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -77.08 140.21 17.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -138.66 129.73 26.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.22 108.79 16.7 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -31.4 72.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.259 0.223 . . . . 0.0 111.315 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.95 -139.34 8.12 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.98 163.68 24.51 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -48.69 -48.07 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.363 1.465 . . . . 0.0 112.396 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -68.73 -38.05 79.9 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.709 0.404 . . . . 0.0 111.49 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -78.19 -36.71 47.04 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.643 0.777 . . . . 0.0 111.992 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.31 132.55 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.462 1.105 . . . . 0.0 108.977 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.49 -13.84 56.01 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.2 mmm -61.98 154.21 69.62 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.757 0.823 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.22 162.3 42.34 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.134 2.556 . . . . 0.0 112.003 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -133.4 159.96 38.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.2 1.0 . . . . 0.0 110.811 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.237 0.432 0 C-N-CA 125.632 1.573 . . . . 0.0 108.75 171.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.236 0.353 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -138.31 152.18 48.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.267 1.427 . . . . 0.0 107.744 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.47 120.53 37.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -125.46 110.25 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -68.21 133.47 48.9 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.36 6.15 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.679 0.672 . . . . 0.0 110.332 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -57.41 157.41 6.67 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.31 -0.869 . . . . 0.0 111.066 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -53.94 148.26 21.5 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 167.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.33 -26.94 63.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.171 1.914 . . . . 0.0 113.368 -166.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.32 -28.85 61.35 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.396 -0.815 . . . . 0.0 112.023 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -82.54 -33.93 28.02 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.128 0.876 . . . . 0.0 109.18 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -50.13 -50.6 48.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.774 0.83 . . . . 0.0 111.492 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -66.19 -19.83 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -63.74 -45.04 91.65 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.083 0.856 . . . . 0.0 110.324 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.79 147.82 0.82 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.002 2.521 . . . . 0.0 105.381 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.11 158.16 43.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.608 1.094 . . . . 0.0 109.28 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.71 134.69 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -58.09 143.08 44.94 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.198 0.999 . . . . 0.0 110.137 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.15 45.32 20.26 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.266 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.23 176.1 9.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.097 1.359 . . . . 0.0 110.072 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 tt -121.31 171.13 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.09 1.756 . . . . 0.0 106.406 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -124.97 131.9 53.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 mt -139.0 100.64 7.91 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.34 159.07 6.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.778 2.985 . . . . 0.0 114.078 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -55.63 -35.85 66.34 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.359 -0.838 . . . . 0.0 112.092 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.11 -2.92 29.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.692 0.797 . . . . 0.0 112.821 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.72 -17.68 2.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.0 1.32 . . . . 0.0 112.311 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.82 -37.13 77.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.027 0.931 . . . . 0.0 111.967 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.03 -31.45 68.85 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.868 0.758 . . . . 0.0 111.354 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -77.88 -14.14 59.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.581 0.752 . . . . 0.0 112.472 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -130.58 -22.06 2.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.31 -36.24 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.606 1.094 . . . . 0.0 111.066 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.1 -25.01 28.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.061 1.344 . . . . 0.0 114.143 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -122.83 -29.99 3.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.641 1.176 . . . . 0.0 110.906 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.43 72.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.782 0.833 . . . . 0.0 111.046 171.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -134.6 91.29 21.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -6.3 18.77 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.089 2.526 . . . . 0.0 115.727 -166.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -146.71 139.1 24.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.102 1.319 . . . . 0.0 109.318 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.16 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -76.15 -23.76 54.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.061 0.846 . . . . 0.0 111.673 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -69.66 144.08 53.0 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.112 -0.367 . . . . 0.0 110.736 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.59 144.72 37.3 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 109.733 -169.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.73 141.23 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -123.95 137.35 54.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.67 142.61 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -154.59 155.01 33.96 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.966 1.306 . . . . 0.0 108.135 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 66.6 m -155.95 -174.03 4.78 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.25 1.82 . . . . 0.0 109.462 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.45 128.84 37.91 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.69 18.2 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.718 1.607 . . . . 0.0 114.28 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.4 11.91 11.25 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.144 -1.364 . . . . 0.0 115.061 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -67.64 -57.95 5.52 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 120.858 2.329 . . . . 0.0 113.379 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.26 -30.33 70.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.19 0.904 . . . . 0.0 109.716 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -74.71 -42.95 57.41 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.366 1.066 . . . . 0.0 112.196 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.49 -40.58 86.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.11 -42.24 85.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.356 1.063 . . . . 0.0 110.214 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.84 -39.62 79.86 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.732 0.696 . . . . 0.0 111.883 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.32 -38.84 66.43 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.27 1.395 . . . . 0.0 110.213 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.92 -58.59 7.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.668 0.667 . . . . 0.0 110.784 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.41 -37.1 79.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 119.611 1.096 . . . . 0.0 110.604 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.03 -37.68 75.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.234 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.8 m -62.55 -40.14 95.85 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.712 0.687 . . . . 0.0 110.356 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.19 -37.59 81.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.528 0.604 . . . . 0.0 111.182 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.4 mtp -64.46 -31.49 72.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.467 0.707 . . . . 0.0 110.945 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.26 -9.45 3.25 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.567 1.08 . . . . 0.0 113.565 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -77.21 72.75 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.095 1.447 . . . . 0.0 109.951 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 p -70.67 18.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.348 1.459 . . . . 0.0 112.895 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -132.2 24.76 4.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.316 1.846 . . . . 0.0 110.911 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -92.21 141.37 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.38 133.51 40.66 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.27 109.88 10.32 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 -30.66 70.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 111.611 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.4 -154.03 25.23 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.31 164.9 12.46 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.1 tp -46.18 -49.8 16.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 113.639 -169.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.24 -20.13 22.26 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 119.23 -0.414 . . . . 0.0 112.014 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.21 -37.62 69.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.448 0.567 . . . . 0.0 110.421 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.54 124.73 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -9.79 59.41 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mtp -61.14 154.59 60.72 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 110.608 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.4 164.23 34.97 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.961 2.44 . . . . 0.0 111.712 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -126.49 157.66 38.13 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.101 0.961 . . . . 0.0 110.044 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.238 0.473 0 C-N-CA 126.03 1.732 . . . . 0.0 107.569 172.822 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -136.29 132.02 35.17 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -94.77 115.34 27.39 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.49 107.24 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -65.97 142.54 57.82 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.1 11.6 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.809 0.731 . . . . 0.0 112.081 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -66.38 162.76 19.69 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 172.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.94 148.94 68.15 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.96 -32.94 64.87 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.896 1.73 . . . . 0.0 114.074 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.04 -30.18 67.4 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.497 -0.752 . . . . 0.0 111.408 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.04 -33.97 29.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -48.71 70.33 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.384 0.674 . . . . 0.0 111.251 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -61.99 -21.03 64.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.091 0.556 . . . . 0.0 112.35 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.98 -24.09 64.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.514 -1.231 . . . . 0.0 112.573 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 167.06 135.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.415 2.686 . . . . 0.0 106.848 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.31 162.8 38.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.847 1.203 . . . . 0.0 110.307 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.22 137.6 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -60.37 142.82 54.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.811 0.844 . . . . 0.0 109.91 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.78 44.09 39.85 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.185 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.83 179.34 6.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.111 1.364 . . . . 0.0 110.22 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -130.37 177.15 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.462 1.905 . . . . 0.0 106.48 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.37 137.33 50.89 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.349 -0.844 . . . . 0.0 108.781 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -140.79 97.38 7.23 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.19 157.2 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.527 2.818 . . . . 0.0 113.152 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -52.98 -35.88 59.67 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.618 -0.676 . . . . 0.0 112.248 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.28 -13.7 62.54 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -116.68 -36.02 4.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.189 1.395 . . . . 0.0 110.197 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.13 -33.06 45.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 C-N-CA 124.399 1.079 . . . . 0.0 111.705 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.36 -22.72 65.2 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.82 -30.94 7.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 110.534 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -84.6 -26.13 28.13 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.683 -0.636 . . . . 0.0 112.208 -169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.18 -33.65 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.568 1.076 . . . . 0.0 110.857 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.48 -9.01 10.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 -37.09 4.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.572 1.149 . . . . 0.0 109.905 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.96 -37.9 72.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.741 0.701 . . . . 0.0 112.143 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.96 73.47 33.05 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.34 -27.35 34.33 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.247 1.965 . . . . 0.0 111.976 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -76.75 102.13 6.11 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.38 -4.79 24.07 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -111.51 39.54 2.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.592 1.157 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.35 149.93 50.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.921 1.289 . . . . 0.0 108.159 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.01 153.67 43.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.237 0.615 . . . . 0.0 111.207 -168.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.17 137.54 51.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -110.87 126.76 55.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.3 141.89 39.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.63 169.01 24.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.55 1.14 . . . . 0.0 108.036 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -154.11 -155.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.43 -47.15 76.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.222 0.609 . . . . 0.0 111.213 177.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.86 -37.08 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.04 -23.13 0.6 Allowed Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.659 1.118 . . . . 0.0 115.615 172.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -58.58 -52.06 67.26 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.252 2.026 . . . . 0.0 112.48 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -58.99 -32.33 69.6 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.358 0.526 . . . . 0.0 110.113 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -72.92 -44.9 60.68 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 124.505 1.122 . . . . 0.0 112.59 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -45.39 93.43 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -57.23 -43.63 83.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.96 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.94 85.99 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.804 -0.56 . . . . 0.0 110.89 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -59.39 -38.15 79.78 Favored 'General case' 0 C--O 1.231 0.101 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.91 -52.63 64.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.105 0.866 . . . . 0.0 110.67 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.4 pt -68.04 -33.32 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.363 0.983 . . . . 0.0 111.335 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.51 -40.02 92.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.51 1.05 . . . . 0.0 110.289 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -64.4 -41.4 96.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.747 0.419 . . . . 0.0 109.903 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.02 -39.84 93.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.379 0.671 . . . . 0.0 111.012 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.3 mtp -68.26 -14.66 63.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.596 1.158 . . . . 0.0 111.947 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.81 28.32 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.219 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -64.22 120.05 11.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.1 p -68.66 -28.03 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -167.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.18 126.04 8.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.44 1.096 . . . . 0.0 109.665 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -144.56 149.82 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -139.64 135.08 32.89 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -79.39 110.68 14.9 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.45 70.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.814 0.446 . . . . 0.0 111.932 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.7 -141.44 9.74 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.23 168.41 24.62 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 tp -54.31 -36.07 63.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.866 1.266 . . . . 0.0 112.267 -173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.32 -9.04 58.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.049 0.94 . . . . 0.0 113.083 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.37 -31.11 2.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.459 1.027 . . . . 0.0 113.253 -168.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.43 129.94 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.93 -13.55 55.83 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.24 158.6 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.08 0.952 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.36 164.83 29.1 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.977 2.451 . . . . 0.0 111.51 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -132.83 158.16 43.19 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.054 0.942 . . . . 0.0 110.267 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 126.346 1.859 . . . . 0.0 108.216 176.602 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -139.84 149.62 43.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.672 1.589 . . . . 0.0 107.179 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -119.04 112.95 20.2 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.14 107.44 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.42 142.55 58.15 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.86 7.05 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.093 0.957 . . . . 0.0 111.766 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -63.88 165.81 8.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.661 1.119 . . . . 0.0 110.472 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.36 147.82 66.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.36 -38.15 76.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.043 1.829 . . . . 0.0 113.125 -167.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.89 -26.48 66.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.185 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.04 -34.92 32.46 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -45.61 85.66 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.994 0.518 . . . . 0.0 110.861 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -61.31 -22.34 64.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -67.26 -35.46 79.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.63 -171.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 176.78 141.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.144 2.578 . . . . 0.0 106.8 169.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.61 155.27 40.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.492 1.117 . . . . 0.0 109.723 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.11 134.09 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.059 0.943 . . . . 0.0 109.27 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.72 141.32 49.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.368 0.667 . . . . 0.0 110.177 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.87 55.42 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.674 1.13 . . . . 0.0 114.236 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.59 177.44 6.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.97 1.385 . . . . 0.0 111.509 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.02 175.7 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.647 1.979 . . . . 0.0 105.752 168.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -138.64 133.11 31.97 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.851 -1.156 . . . . 0.0 109.994 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -140.53 101.78 6.64 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.35 150.88 31.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.375 2.05 . . . . 0.0 111.821 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -46.69 -45.75 19.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.429 1.091 . . . . 0.0 112.968 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -67.73 -10.14 49.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -119.17 -13.69 9.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.707 2.003 . . . . 0.0 111.129 -170.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -49.31 -56.65 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.828 1.651 . . . . 0.0 111.326 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.65 -31.02 65.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.38 -25.11 60.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.188 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.23 -30.31 4.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.883 0.765 . . . . 0.0 112.394 -168.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.95 -34.37 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.609 1.095 . . . . 0.0 111.52 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -8.75 6.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 m -120.92 -34.37 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.797 1.239 . . . . 0.0 110.036 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -35.57 80.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.878 0.763 . . . . 0.0 111.496 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.63 79.24 41.25 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.6 18.54 0.7 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.956 3.104 . . . . 0.0 113.581 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -142.99 113.17 7.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.052 1.341 . . . . 0.0 108.173 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -20.02 57.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.86 -20.33 49.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.761 0.709 . . . . 0.0 111.7 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -75.3 148.37 39.42 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.744 0.702 . . . . 0.0 111.24 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.78 145.04 45.34 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.73 0.812 . . . . 0.0 109.858 -175.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.34 141.44 37.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -120.9 135.93 55.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -129.05 144.39 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -150.77 166.13 31.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.893 1.277 . . . . 0.0 107.829 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.7 p -169.52 -174.58 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.329 1.052 . . . . 0.0 109.242 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -65.36 125.3 24.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.68 17.7 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.491 2.317 . . . . 0.0 115.676 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.07 -8.31 8.56 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 118.563 -1.132 . . . . 0.0 115.176 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -56.66 -53.36 58.54 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.108 1.954 . . . . 0.0 111.191 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.13 -28.5 68.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.38 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 m -75.42 -46.37 33.17 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 110.792 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.8 -43.32 86.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 172.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -66.85 -41.9 86.62 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.637 0.375 . . . . 0.0 111.456 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.65 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.47 0.708 . . . . 0.0 111.134 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -57.14 -37.34 71.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.654 1.115 . . . . 0.0 110.869 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.14 -54.58 23.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.373 0.988 . . . . 0.0 109.939 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 pt -65.31 -35.18 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.418 0.554 . . . . 0.0 110.492 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.76 -35.46 72.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.656 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 m -64.28 -38.6 91.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.812 0.733 . . . . 0.0 110.599 173.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.69 -37.77 82.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.403 0.547 . . . . 0.0 110.885 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -65.94 -33.8 76.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.545 0.611 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.17 -2.53 5.48 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.164 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.45 142.2 57.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.445 1.622 . . . . 0.0 109.124 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -130.88 10.47 5.05 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.751 0.82 . . . . 0.0 111.987 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -136.49 32.71 2.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.938 1.295 . . . . 0.0 110.12 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -88.98 141.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.1 141.69 44.23 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.393 1.077 . . . . 0.0 108.139 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.25 112.33 20.19 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.67 -30.24 70.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.479 0.311 . . . . 0.0 111.698 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.46 -147.37 17.86 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.5 168.29 19.6 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -43.85 -50.33 7.96 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.549 1.539 . . . . 0.0 114.617 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -91.49 -23.89 19.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 119.295 -0.384 . . . . 0.0 111.679 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.37 -38.02 74.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.017 0.527 . . . . 0.0 110.391 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.05 113.59 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.03 58.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.6 mtp -60.67 151.31 72.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.668 0.787 . . . . 0.0 110.547 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.22 160.02 49.49 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.082 2.522 . . . . 0.0 111.141 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 156.63 45.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.963 0.905 . . . . 0.0 110.737 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.236 0.366 0 C-N-CA 126.69 1.996 . . . . 0.0 108.307 -176.414 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.236 0.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -134.35 157.14 47.14 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.31 1.444 . . . . 0.0 108.34 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -118.98 119.96 35.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -131.32 109.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.76 144.44 56.32 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.8 11.59 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.028 0.831 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -68.6 163.8 22.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.254 -0.903 . . . . 0.0 109.844 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -56.57 147.65 49.41 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.28 -39.44 57.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.818 1.678 . . . . 0.0 113.484 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.51 -25.95 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.528 -0.732 . . . . 0.0 112.011 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.74 -34.66 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -45.28 89.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.825 0.739 . . . . 0.0 110.605 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -52.06 -28.96 19.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.666 0.786 . . . . 0.0 112.754 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.8 -23.44 65.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.252 -1.356 . . . . 0.0 112.73 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 156.26 147.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.968 3.307 . . . . 0.0 110.373 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -151.73 169.44 22.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 109.168 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.13 137.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 110.06 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.34 125.94 22.92 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.176 0.991 . . . . 0.0 109.802 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.28 -1.2 89.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.215 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.57 -173.73 3.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.106 1.453 . . . . 0.0 111.025 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.87 178.52 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.791 2.036 . . . . 0.0 106.232 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -133.97 136.46 44.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.109 -0.994 . . . . 0.0 109.367 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.4 95.99 11.24 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.4 152.34 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.328 2.685 . . . . 0.0 111.946 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 tp -48.11 -40.3 23.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.763 0.825 . . . . 0.0 112.824 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.46 -34.85 77.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 111.944 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -88.14 -25.67 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.615 1.566 . . . . 0.0 111.166 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.0 t -46.62 -47.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.428 1.091 . . . . 0.0 110.336 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -56.62 -20.61 22.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.16 -1.96 5.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.137 0.975 . . . . 0.0 112.305 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -135.63 -20.39 1.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.036 0.835 . . . . 0.0 113.246 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -61.75 -34.88 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.843 1.202 . . . . 0.0 112.14 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.96 68.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.376 0.534 . . . . 0.0 112.321 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 m -66.73 -35.23 79.62 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 0.0 110.462 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.56 -20.98 21.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.751 0.82 . . . . 0.0 112.227 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.1 74.61 79.13 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.34 -7.97 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.327 2.684 . . . . 0.0 113.505 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -138.56 122.76 18.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -59.28 -18.75 40.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.24 -18.83 57.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.233 0.924 . . . . 0.0 112.019 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.84 145.51 54.57 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.441 -0.787 . . . . 0.0 110.59 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -80.48 139.0 36.62 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.93 93.14 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.29 124.78 26.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.83 143.73 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.91 161.26 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.94 0.896 . . . . 0.0 108.692 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 p -164.1 179.71 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.243 1.017 . . . . 0.0 108.396 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.49 135.61 56.22 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 54.56 15.76 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.562 1.945 . . . . 0.0 116.026 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.2 -22.53 0.61 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.857 1.217 . . . . 0.0 116.029 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -53.79 -52.62 59.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.129 1.964 . . . . 0.0 113.139 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.98 -26.25 68.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.357 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -76.4 -44.93 33.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.426 1.012 . . . . 0.0 111.692 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -44.55 96.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.69 -35.5 80.76 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.376 1.07 . . . . 0.0 111.397 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.82 -42.43 70.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 110.571 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -59.98 -40.64 89.82 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 121.19 -0.944 . . . . 0.0 110.704 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.0 -44.01 77.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.694 1.134 . . . . 0.0 111.816 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 pt -67.27 -36.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 120.725 1.602 . . . . 0.0 110.15 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -67.86 -36.66 80.67 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.779 0.718 . . . . 0.0 110.766 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.6 m -63.13 -38.65 92.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.649 0.379 . . . . 0.0 110.416 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.02 -41.06 78.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.995 0.518 . . . . 0.0 110.554 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.7 mtp -64.93 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.394 1.078 . . . . 0.0 111.116 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.36 1.2 6.18 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.355 0.979 . . . . 0.0 114.302 169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -71.58 145.75 48.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.24 1.52 . . . . 0.0 108.817 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -132.31 7.77 4.26 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -137.11 30.71 2.71 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.521 1.128 . . . . 0.0 110.457 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.0 t -87.9 136.31 23.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -144.9 131.86 20.28 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.38 112.27 10.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.85 -30.76 70.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.298 0.639 . . . . 0.0 111.649 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.62 -136.2 6.55 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.46 170.2 25.64 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.92 -41.1 64.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.836 1.254 . . . . 0.0 113.34 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -80.14 -9.04 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.71 -32.83 5.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.769 0.828 . . . . 0.0 111.817 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.6 125.04 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.97 -10.86 59.66 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mtp -63.83 155.6 76.57 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.749 0.82 . . . . 0.0 111.061 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.08 162.0 9.97 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.697 2.931 . . . . 0.0 112.961 170.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.58 160.07 36.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.02 0.928 . . . . 0.0 110.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.239 0.53 0 C-N-CA 126.422 1.889 . . . . 0.0 107.989 175.173 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.236 0.362 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -141.74 124.57 16.08 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -86.07 117.11 24.7 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.24 107.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -66.45 134.81 53.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -119.01 10.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.888 0.767 . . . . 0.0 111.189 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -61.62 161.32 10.0 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.796 0.725 . . . . 0.0 109.147 167.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.47 150.7 43.18 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.38 -31.21 43.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.267 1.312 . . . . 0.0 112.396 -168.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.73 -10.78 60.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 112.218 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.66 -32.95 10.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.636 1.107 . . . . 0.0 110.282 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -57.49 -40.4 78.54 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.721 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.24 -34.03 76.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.751 0.42 . . . . 0.0 111.264 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -72.23 -41.86 66.37 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.462 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -164.92 141.8 5.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.447 1.021 . . . . 0.0 109.507 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -155.31 164.74 38.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.06 . . . . 0.0 109.21 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.47 137.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -59.08 117.19 4.43 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 -170.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.81 90.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.314 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.2 141.86 57.91 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.703 1.752 . . . . 0.0 109.73 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.82 169.26 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.6 t-20 -131.8 128.65 39.2 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.955 -1.09 . . . . 0.0 109.845 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.71 90.45 19.59 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.2 152.84 7.57 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.452 2.768 . . . . 0.0 111.845 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -46.87 -44.17 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.86 -30.34 71.44 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.309 0.504 . . . . 0.0 112.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.67 -21.56 23.86 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.082 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.1 t -49.1 -48.41 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.619 1.167 . . . . 0.0 110.129 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.39 -16.14 21.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.39 -3.17 8.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.226 0.921 . . . . 0.0 112.249 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -142.55 -13.75 0.77 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.96 -35.11 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.167 1.348 . . . . 0.0 111.984 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.65 67.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.397 0.544 . . . . 0.0 112.419 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 m -68.9 -38.98 79.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.952 0.796 . . . . 0.0 110.127 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.33 -23.26 35.19 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.222 0.609 . . . . 0.0 112.168 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.9 75.92 78.92 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.31 -14.73 37.99 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.195 2.597 . . . . 0.0 113.663 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -145.56 138.4 26.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -57.53 -23.94 53.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -67.42 -26.22 66.31 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.281 0.946 . . . . 0.0 112.067 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -68.56 143.95 54.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.335 0.516 . . . . 0.0 110.752 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.07 145.71 35.67 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.53 136.63 48.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -123.5 121.04 34.66 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 m -114.77 141.85 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -152.04 170.84 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.98 -165.6 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.442 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.2 OUTLIER -52.64 -52.29 56.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.809 0.844 . . . . 0.0 111.719 -177.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.7 31.48 2.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.135 1.374 . . . . 0.0 111.352 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.33 -24.1 2.18 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.666 -1.075 . . . . 0.0 115.321 170.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.9 mmt-85 -66.39 -44.59 82.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.285 2.043 . . . . 0.0 113.624 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -64.16 -33.98 77.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.825 1.193 . . . . 0.0 109.283 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.69 37.61 Favored 'General case' 0 N--CA 1.46 0.07 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.5 -46.64 91.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -56.89 -44.01 81.9 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.712 0.805 . . . . 0.0 111.323 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.07 87.84 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.707 -0.62 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.11 -40.31 84.96 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.281 -0.887 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.79 -53.1 59.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.098 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -65.22 -34.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-N 120.226 1.375 . . . . 0.0 110.781 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.43 -36.22 76.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.066 0.848 . . . . 0.0 110.77 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 m -63.01 -39.16 93.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.191 0.451 . . . . 0.0 110.366 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -68.2 -42.47 79.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.352 0.661 . . . . 0.0 110.346 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.74 -30.12 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.084 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.52 6.04 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.726 -1.041 . . . . 0.0 114.181 169.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -70.69 148.12 48.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.507 1.653 . . . . 0.0 109.163 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 p -133.78 10.03 3.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.846 0.858 . . . . 0.0 112.068 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -133.75 33.08 3.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.073 1.349 . . . . 0.0 110.213 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.42 138.7 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.02 146.25 40.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.12 112.27 19.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.34 68.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.6 -150.41 22.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.47 156.09 15.83 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 168.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.5 tp -53.41 -39.37 64.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.179 . . . . 0.0 113.439 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.51 -31.82 63.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.954 0.343 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.36 -35.49 27.74 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.469 0.708 . . . . 0.0 111.345 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.73 128.9 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.899 1.279 . . . . 0.0 108.77 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -7.54 59.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.998 0.919 . . . . 0.0 113.274 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mmm -60.28 154.55 52.09 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.524 0.73 . . . . 0.0 110.5 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.53 167.31 21.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.757 2.304 . . . . 0.0 110.989 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -128.73 173.63 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.449 1.1 . . . . 0.0 110.104 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.236 0.363 0 C-N-CA 125.442 1.497 . . . . 0.0 107.05 167.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -135.79 126.68 27.59 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -90.18 121.54 32.31 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.66 111.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -71.19 125.31 26.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.01 12.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 123.082 0.553 . . . . 0.0 110.828 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -54.66 156.84 3.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.873 0.76 . . . . 0.0 111.444 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.19 143.74 24.15 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 166.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -60.17 -33.76 94.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.622 1.548 . . . . 0.0 113.849 -166.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.74 -36.99 81.56 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.566 -0.709 . . . . 0.0 111.16 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.22 -32.93 56.21 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.59 -50.5 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.598 0.759 . . . . 0.0 110.633 170.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -63.61 -24.9 67.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.48 -38.81 92.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.538 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -179.96 135.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.39 2.276 . . . . 0.0 106.307 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -145.5 162.92 36.26 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.535 1.134 . . . . 0.0 110.589 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.72 127.34 27.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.74 151.85 28.4 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 111.841 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.72 -12.85 45.69 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.585 1.088 . . . . 0.0 114.006 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 172.15 11.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.717 1.259 . . . . 0.0 111.578 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -113.39 166.83 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.337 1.855 . . . . 0.0 106.017 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -122.74 126.34 47.3 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 119.238 0.927 . . . . 0.0 109.638 172.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 mt -136.23 87.52 22.87 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 143.14 41.55 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.184 2.589 . . . . 0.0 112.812 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.06 -21.33 30.71 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.379 1.072 . . . . 0.0 111.586 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.36 -32.38 70.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.023 1.329 . . . . 0.0 113.334 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -134.95 -2.77 2.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.43 1.092 . . . . 0.0 113.508 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.4 p -52.66 -38.2 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 113.957 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.92 -27.15 63.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.249 0.932 . . . . 0.0 112.293 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.18 -7.97 49.92 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 112.153 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -139.18 -15.75 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.0 -40.18 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.698 1.136 . . . . 0.0 111.135 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.38 74.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.375 0.534 . . . . 0.0 111.53 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 m -68.75 -43.72 75.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.7 . . . . 0.0 109.862 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -38.22 57.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.881 0.472 . . . . 0.0 112.229 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.29 79.05 32.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.83 -30.31 17.52 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.932 1.755 . . . . 0.0 111.825 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -84.3 101.99 12.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.259 0.624 . . . . 0.0 109.757 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.71 -16.33 56.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -77.21 -20.16 55.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.037 0.835 . . . . 0.0 111.775 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.92 147.42 36.98 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 m -70.88 147.64 48.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.321 0.648 . . . . 0.0 110.599 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.84 141.56 38.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -126.9 121.19 31.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.7 m -114.23 140.1 36.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -147.01 165.12 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.342 1.057 . . . . 0.0 108.265 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 p -148.75 -147.31 0.22 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.93 76.61 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.985 0.812 . . . . 0.0 110.361 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.25 -22.37 0.44 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.01 -29.91 0.48 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.434 1.47 . . . . 0.0 116.233 171.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.99 -57.69 11.68 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.3 2.05 . . . . 0.0 112.481 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -33.52 72.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.632 0.651 . . . . 0.0 109.629 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -52.53 58.54 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.554 0.742 . . . . 0.0 111.654 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.0 91.0 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -54.93 -47.52 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.155 0.982 . . . . 0.0 110.331 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -48.28 76.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 111.08 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.21 -42.93 82.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.809 0.731 . . . . 0.0 109.926 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.27 -53.34 56.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.987 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -67.25 -34.88 71.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.779 1.172 . . . . 0.0 111.333 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.42 -35.58 75.85 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.898 1.226 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -62.05 -43.06 99.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.059 0.39 . . . . 0.0 109.958 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -65.21 -38.15 89.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.421 0.689 . . . . 0.0 111.26 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -69.84 -7.06 36.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.987 1.315 . . . . 0.0 112.309 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 4.52 47.47 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.737 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.26 143.23 52.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.432 1.616 . . . . 0.0 106.92 168.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.404 ' HG1' ' CD2' ' A' ' 68' ' ' HIS . 2.1 p -122.47 7.38 9.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.907 0.483 . . . . 0.0 112.171 -171.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.404 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 70.3 m-70 -140.8 36.6 1.79 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.658 1.183 . . . . 0.0 110.148 -170.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -105.35 130.89 55.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.38 148.0 40.62 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -78.76 115.91 18.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.29 70.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.807 0.443 . . . . 0.0 111.798 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.24 5.97 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.31 168.83 30.9 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -36.49 62.47 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.721 1.608 . . . . 0.0 110.329 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -54.92 -23.07 17.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 113.599 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -131.12 -32.35 1.6 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.66 125.99 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.216 0.917 . . . . 0.0 108.628 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.97 -4.55 56.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.05 0.94 . . . . 0.0 113.287 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.12 154.49 69.51 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.923 0.889 . . . . 0.0 111.062 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.95 153.03 21.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.793 2.995 . . . . 0.0 113.631 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -127.75 156.88 41.74 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.824 0.85 . . . . 0.0 110.904 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 125.598 1.559 . . . . 0.0 108.022 168.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -144.34 153.45 42.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.984 1.714 . . . . 0.0 107.125 169.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -111.21 108.55 18.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.06 112.07 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -81.97 125.45 30.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.85 -0.36 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -63.28 167.63 5.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.193 1.36 . . . . 0.0 109.644 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.36 152.77 30.61 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.02 -27.93 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 121.807 1.671 . . . . 0.0 112.175 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.14 -0.65 12.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.613 1.165 . . . . 0.0 112.561 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -112.6 -33.2 6.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.856 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -53.53 -46.61 70.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.692 1.133 . . . . 0.0 110.407 168.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -61.84 -25.35 67.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -70.16 -50.45 40.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.635 0.652 . . . . 0.0 109.92 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -168.55 143.18 3.32 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -145.5 151.43 38.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.627 1.171 . . . . 0.0 110.041 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.18 125.33 8.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -52.76 113.16 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.024 0.93 . . . . 0.0 111.133 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 2.94 80.34 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.975 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.31 141.13 58.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.555 1.678 . . . . 0.0 109.709 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.73 132.15 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.56 108.87 4.54 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.532 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.2 78.69 14.83 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 167.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.37 156.86 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.813 3.676 . . . . 0.0 113.426 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -52.57 -35.68 54.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.705 0.802 . . . . 0.0 112.617 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -70.04 -16.49 63.16 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -116.27 -28.01 6.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.224 1.41 . . . . 0.0 111.332 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.11 -41.21 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 125.103 1.361 . . . . 0.0 113.277 -167.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -59.65 -29.35 67.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.091 0.86 . . . . 0.0 112.287 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.13 -24.95 40.13 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 0.0 111.718 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.84 -17.37 4.48 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -166.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 tp -60.67 -35.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.601 1.546 . . . . 0.0 111.496 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.78 -8.92 12.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -118.96 -35.15 3.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.955 1.302 . . . . 0.0 109.562 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.71 83.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 111.068 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -140.02 76.43 27.78 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.199 1.399 . . . . 0.0 107.565 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.56 -35.77 94.67 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.433 2.088 . . . . 0.0 112.723 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -78.84 102.25 8.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.544 0.737 . . . . 0.0 110.052 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -64.07 -14.09 52.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -79.53 -16.7 55.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.371 0.987 . . . . 0.0 112.034 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.51 148.21 49.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.065 -1.022 . . . . 0.0 111.017 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -78.46 100.55 6.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.095 0.558 . . . . 0.0 109.679 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -80.81 89.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -66.57 130.08 42.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -128.85 143.25 41.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.44 166.73 29.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -158.09 -140.7 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -123.64 133.96 53.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 60.24 15.69 5.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.03 1.732 . . . . 0.0 114.968 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.7 -31.11 1.25 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.234 1.397 . . . . 0.0 115.672 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -53.03 -49.33 66.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.293 1.547 . . . . 0.0 113.934 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.52 -33.34 73.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.743 1.156 . . . . 0.0 110.98 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -74.7 -40.21 61.48 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.591 1.087 . . . . 0.0 112.79 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.27 -44.86 96.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -59.99 -42.93 95.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.662 1.185 . . . . 0.0 111.369 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.15 90.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.757 0.708 . . . . 0.0 110.523 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -60.61 -37.9 82.94 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.96 -1.087 . . . . 0.0 110.844 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.65 -49.84 69.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.866 0.867 . . . . 0.0 110.61 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.86 -36.24 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.883 1.22 . . . . 0.0 111.009 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.05 -34.79 71.57 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.008 0.822 . . . . 0.0 110.906 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -67.87 -34.76 77.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.732 0.696 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.57 -38.31 89.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.99 0.814 . . . . 0.0 110.475 172.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -69.82 -8.98 52.87 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.383 1.073 . . . . 0.0 112.385 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.03 6.39 51.97 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.192 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.3 144.5 51.71 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.603 1.701 . . . . 0.0 108.298 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 p -126.14 4.68 7.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.126 0.57 . . . . 0.0 112.376 -171.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -139.28 31.53 2.14 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.532 1.133 . . . . 0.0 110.251 -173.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.1 133.69 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.95 122.7 15.29 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.19 110.83 11.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.58 67.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.092 0.557 . . . . 0.0 111.817 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.33 -142.92 10.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.35 162.87 19.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 168.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 tp -42.03 -48.43 4.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.995 1.318 . . . . 0.0 114.081 -168.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.57 -13.5 62.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.95 -12.26 10.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.273 1.029 . . . . 0.0 112.467 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.61 134.01 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -20.07 61.43 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mmm -62.64 156.29 64.87 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 110.885 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.45 156.88 64.29 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.336 2.024 . . . . 0.0 110.283 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 149.12 36.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.054 0.942 . . . . 0.0 109.081 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.236 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 108.923 -173.213 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -143.29 145.69 32.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.716 1.606 . . . . 0.0 106.695 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -105.07 122.89 46.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.76 119.55 53.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -75.38 128.02 34.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.55 12.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 119.461 1.028 . . . . 0.0 111.087 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -62.66 162.71 10.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.39 -0.818 . . . . 0.0 110.571 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.6 147.74 49.24 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.309 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.81 -31.69 67.98 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.905 1.736 . . . . 0.0 112.969 -167.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.8 -28.89 66.1 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.599 -0.688 . . . . 0.0 111.828 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -80.9 -38.62 27.67 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -41.52 76.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.738 0.415 . . . . 0.0 111.049 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -58.91 -30.03 67.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.113 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -67.14 -50.31 61.72 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.815 0.734 . . . . 0.0 110.269 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.06 156.22 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.898 1.279 . . . . 0.0 108.351 168.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -153.53 160.34 42.47 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.829 1.252 . . . . 0.0 108.807 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.88 142.61 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.718 0.807 . . . . 0.0 109.215 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.34 157.84 8.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.904 0.482 . . . . 0.0 111.664 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.36 41.17 91.47 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.676 0.655 . . . . 0.0 112.681 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.41 178.1 7.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.696 1.198 . . . . 0.0 110.996 -174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.79 169.91 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.309 2.244 . . . . 0.0 106.42 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -126.2 131.15 52.04 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 110.107 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.37 89.03 9.61 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.51 153.89 16.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.347 2.698 . . . . 0.0 113.03 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -52.8 -34.69 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.589 0.756 . . . . 0.0 112.747 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.31 -14.39 62.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -122.84 -24.32 4.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.246 1.418 . . . . 0.0 111.345 -169.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.44 -38.69 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 124.451 1.101 . . . . 0.0 112.429 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -57.33 -27.93 62.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.751 0.705 . . . . 0.0 112.118 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -99.47 -6.18 28.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 0.0 112.11 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -137.59 -23.32 1.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -167.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.58 -35.82 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 121.131 1.787 . . . . 0.0 110.903 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.3 -30.67 69.64 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.335 0.516 . . . . 0.0 111.814 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -79.28 -45.36 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.908 0.883 . . . . 0.0 109.764 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.36 66.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.241 0.617 . . . . 0.0 112.495 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.41 76.56 36.85 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.019 1.728 . . . . 0.0 106.508 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 -20.65 30.74 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.75 101.75 2.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 109.331 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.12 -9.93 35.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.737 0.815 . . . . 0.0 112.7 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -109.44 12.81 24.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.701 1.2 . . . . 0.0 111.19 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.62 148.74 51.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 169.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -78.89 83.46 5.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.34 109.07 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -98.5 127.69 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.1 141.58 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 123.118 0.567 . . . . 0.0 109.488 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -149.05 172.47 14.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.9 p -157.8 -162.61 1.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -46.26 91.18 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.05 -0.407 . . . . 0.0 112.082 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 18.54 3.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.209 1.404 . . . . 0.0 112.762 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.69 -17.53 44.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.987 -1.071 . . . . 0.0 114.874 172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -67.62 -50.65 57.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.7 1.75 . . . . 0.0 111.903 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.97 -33.28 71.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 110.076 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -76.5 -40.84 48.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.78 0.718 . . . . 0.0 112.808 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.55 -43.35 99.14 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -58.87 -47.16 85.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.133 1.373 . . . . 0.0 110.793 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.24 86.25 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.661 -0.649 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.38 -34.05 68.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.527 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.6 -54.73 31.26 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.319 0.963 . . . . 0.0 109.83 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -68.31 -30.93 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 121.538 -0.726 . . . . 0.0 111.616 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.9 -40.47 95.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.446 1.021 . . . . 0.0 110.101 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -66.22 -41.32 90.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.561 0.344 . . . . 0.0 110.242 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -65.24 -36.44 84.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.625 0.648 . . . . 0.0 111.109 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.5 mtm -73.39 -2.81 23.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.168 0.987 . . . . 0.0 112.266 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.36 17.2 59.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.354 -1.248 . . . . 0.0 114.261 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -63.99 129.98 42.23 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.692 1.746 . . . . 0.0 107.077 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 p -65.21 -33.55 76.27 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.717 0.407 . . . . 0.0 111.904 -168.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.36 154.34 33.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 109.319 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -148.13 146.51 17.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -129.46 122.12 28.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.43 104.91 7.19 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.15 69.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.917 0.487 . . . . 0.0 111.811 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.95 -148.29 19.4 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.64 165.1 21.62 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -49.5 -49.28 46.45 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.677 1.191 . . . . 0.0 112.41 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.7 -36.24 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.674 0.39 . . . . 0.0 111.38 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.91 -37.31 62.11 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.458 0.703 . . . . 0.0 111.751 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.16 125.27 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -19.85 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 61.4 mtm -63.91 155.25 78.57 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.384 0.674 . . . . 0.0 111.165 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.78 165.8 28.42 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.612 2.874 . . . . 0.0 112.563 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -126.84 156.59 41.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.588 1.155 . . . . 0.0 110.151 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.236 0.387 0 C-N-CA 126.476 1.91 . . . . 0.0 108.345 175.077 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.236 0.368 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -139.48 137.29 35.41 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -89.87 118.72 29.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.38 104.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -168.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.46 145.07 56.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.86 15.44 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.335 -0.853 . . . . 0.0 112.496 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.89 160.98 5.28 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.432 -0.793 . . . . 0.0 110.545 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -54.6 146.92 32.48 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.86 -31.4 91.6 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.191 1.927 . . . . 0.0 113.778 -166.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.59 -29.75 63.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.657 -0.652 . . . . 0.0 111.999 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -84.29 -31.69 24.76 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.04 0.836 . . . . 0.0 109.127 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -49.27 64.97 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.767 0.827 . . . . 0.0 111.204 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.15 -18.65 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.882 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -69.32 -31.53 70.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.806 -171.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 176.23 133.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.833 2.453 . . . . 0.0 105.973 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -147.68 161.97 40.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.911 1.232 . . . . 0.0 109.782 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.86 136.33 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.54 142.86 54.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.581 0.752 . . . . 0.0 109.812 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 46.02 42.1 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.004 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.55 178.76 6.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.129 1.371 . . . . 0.0 110.277 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.94 176.22 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.561 1.944 . . . . 0.0 106.924 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.19 139.71 50.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.927 0.891 . . . . 0.0 109.181 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -139.92 85.2 14.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.21 145.86 84.72 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.189 1.926 . . . . 0.0 112.772 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.6 tp -54.69 -25.39 26.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.015 0.526 . . . . 0.0 111.509 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.7 -22.71 65.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.232 1.013 . . . . 0.0 113.511 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -131.24 -10.05 3.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.484 1.038 . . . . 0.0 112.83 -169.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -46.26 -42.57 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.59 1.956 . . . . 0.0 113.387 -169.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.29 -25.18 61.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.285 0.948 . . . . 0.0 112.98 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -114.87 5.84 15.26 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.017 1.327 . . . . 0.0 110.983 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -136.85 -25.2 1.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.14 -167.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -34.66 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 120.261 1.391 . . . . 0.0 112.086 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.89 67.14 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.553 0.615 . . . . 0.0 112.104 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -66.19 -35.98 81.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.659 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 -25.28 20.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.302 0.641 . . . . 0.0 112.096 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.02 78.05 41.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.57 -8.48 20.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.142 2.561 . . . . 0.0 113.652 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.94 134.77 30.44 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.204 1.001 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.29 -16.46 64.29 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -19.67 60.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.737 1.153 . . . . 0.0 112.334 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 146.54 44.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.034 0.834 . . . . 0.0 110.809 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -78.37 138.13 38.37 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.007 -0.433 . . . . 0.0 110.092 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.1 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -84.16 93.21 8.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -83.85 142.8 12.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -150.47 165.24 33.81 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.668 0.787 . . . . 0.0 109.473 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.8 p -158.86 -160.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.434 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.2 OUTLIER -57.58 -51.5 69.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.301 0.5 . . . . 0.0 111.157 -177.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.18 23.52 2.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.574 1.149 . . . . 0.0 112.319 -169.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.92 -3.65 64.18 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.364 -1.242 . . . . 0.0 114.96 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -68.6 -53.59 21.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.707 2.254 . . . . 0.0 111.108 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -61.13 -31.85 71.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -66.7 -48.23 69.9 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.268 1.027 . . . . 0.0 112.452 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.61 91.45 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -55.67 -46.37 77.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.332 1.053 . . . . 0.0 110.927 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.25 80.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.079 0.552 . . . . 0.0 111.214 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.82 -39.76 90.19 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 120.03 1.286 . . . . 0.0 110.516 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -58.05 -53.08 62.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.32 0.964 . . . . 0.0 110.483 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.76 -39.69 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 118.495 0.589 . . . . 0.0 110.492 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.55 -35.86 70.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.175 0.898 . . . . 0.0 110.857 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -63.92 -41.49 97.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.57 -39.25 88.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.168 0.587 . . . . 0.0 111.008 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.0 mtp -66.34 -18.39 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.52 1.128 . . . . 0.0 111.765 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.92 8.0 24.6 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.717 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -71.68 97.85 1.82 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.508 1.654 . . . . 0.0 107.627 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.414 ' HG1' ' CD2' ' A' ' 68' ' ' HIS . 1.3 p -79.02 6.32 9.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.541 1.136 . . . . 0.0 113.185 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 47.1 m-70 -136.33 31.2 2.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.471 1.108 . . . . 0.0 111.504 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.9 140.93 15.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 170.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.19 145.01 28.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -85.38 114.59 22.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -33.82 76.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.433 0.293 . . . . 0.0 111.482 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.75 -156.42 26.68 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.33 160.88 18.27 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -43.01 -56.06 3.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.182 1.793 . . . . 0.0 113.431 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.82 -16.39 32.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.667 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.33 -34.64 65.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.588 0.631 . . . . 0.0 110.919 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.8 126.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 55.55 3.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.471 1.508 . . . . 0.0 111.161 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.2 mtp -136.51 160.62 66.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 125.455 1.502 . . . . 0.0 108.67 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 163.2 34.73 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.546 2.164 . . . . 0.0 111.284 173.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -131.91 156.53 45.96 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.13 0.972 . . . . 0.0 109.646 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.237 0.424 0 C-N-CA 126.246 1.819 . . . . 0.0 107.986 177.46 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -144.17 129.27 18.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.582 1.153 . . . . 0.0 108.192 171.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.65 117.51 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.39 105.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -68.37 149.25 49.6 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.46 12.98 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.591 0.756 . . . . 0.0 111.58 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -53.72 156.39 2.74 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 121.649 -0.657 . . . . 0.0 111.16 171.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.26 149.25 38.07 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 167.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.81 -34.44 95.74 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.331 2.02 . . . . 0.0 114.048 -166.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.11 -27.37 61.66 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.301 -0.875 . . . . 0.0 111.815 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -82.36 -34.48 28.41 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.29 -48.81 73.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.08 0.952 . . . . 0.0 110.726 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.86 2.62 3.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -75.02 -61.3 1.93 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.952 1.251 . . . . 0.0 108.716 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.61 149.26 8.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.277 1.831 . . . . 0.0 107.006 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -151.01 166.82 29.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.873 0.76 . . . . 0.0 110.401 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -60.03 137.18 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.127 0.971 . . . . 0.0 109.497 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.76 135.0 56.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.117 0.567 . . . . 0.0 109.593 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.71 2.96 53.27 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 118.833 -0.982 . . . . 0.0 114.744 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.91 -178.75 3.89 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.207 1.503 . . . . 0.0 111.101 174.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.04 171.2 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.424 1.89 . . . . 0.0 106.699 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -132.56 139.69 47.96 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.134 0.879 . . . . 0.0 110.924 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mt -142.37 82.14 13.21 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.26 143.87 62.52 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.49 2.126 . . . . 0.0 112.78 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.16 -30.02 47.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.74 -13.93 61.44 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -129.5 -14.86 4.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.608 1.163 . . . . 0.0 112.107 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.77 -39.51 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.913 1.685 . . . . 0.0 113.196 -169.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 -20.63 62.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.236 0.925 . . . . 0.0 112.653 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -111.81 7.13 20.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 111.115 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -137.58 -30.41 0.83 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -167.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.48 -38.56 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.747 1.158 . . . . 0.0 110.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.15 90.4 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.315 0.507 . . . . 0.0 111.562 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 -38.54 55.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.236 0.615 . . . . 0.0 111.068 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.51 72.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.393 0.542 . . . . 0.0 111.749 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.43 79.25 20.96 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.289 1.436 . . . . 0.0 107.644 -172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.82 -36.05 97.64 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.335 2.023 . . . . 0.0 112.856 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -83.77 104.38 13.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.608 0.763 . . . . 0.0 110.515 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.03 -14.45 60.46 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.46 -14.14 59.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.492 1.042 . . . . 0.0 111.971 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.6 143.84 57.5 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.171 -0.955 . . . . 0.0 110.991 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -81.99 97.58 8.18 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.3 94.69 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.05 79.43 5.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.66 139.27 19.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -147.89 165.59 30.18 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.015 0.926 . . . . 0.0 109.462 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.5 p -169.0 -160.46 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.211 1.004 . . . . 0.0 109.145 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.53 128.34 34.01 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.45 13.83 0.5 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.536 1.934 . . . . 0.0 115.433 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.1 3.78 46.39 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.194 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.0 -39.63 61.11 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.353 2.076 . . . . 0.0 112.806 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.82 -30.56 69.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.603 1.092 . . . . 0.0 109.221 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -69.14 -48.41 62.47 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.03 0.932 . . . . 0.0 111.727 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.7 -43.57 98.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -57.95 -47.86 81.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.575 0.75 . . . . 0.0 111.241 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.53 88.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.171 0.588 . . . . 0.0 111.354 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -57.52 -35.93 70.9 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.213 -0.929 . . . . 0.0 111.445 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.94 -55.03 33.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.235 0.925 . . . . 0.0 110.428 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt -68.95 -34.73 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 O-C-N 121.766 -0.584 . . . . 0.0 111.069 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.1 mt -69.33 -37.03 77.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.307 0.958 . . . . 0.0 110.605 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -64.26 -39.96 95.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.472 0.578 . . . . 0.0 109.942 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.69 -39.87 94.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.468 0.577 . . . . 0.0 110.901 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.01 -16.92 64.26 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.255 1.022 . . . . 0.0 111.985 174.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.36 27.82 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.847 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -73.13 106.15 4.87 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.564 1.682 . . . . 0.0 107.586 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.402 ' HG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER -86.09 3.26 43.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 113.058 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 24.4 m-70 -137.95 31.49 2.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.208 1.003 . . . . 0.0 111.382 -169.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.25 130.53 36.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 172.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -142.34 129.24 20.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -75.1 111.46 10.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.88 71.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.826 0.451 . . . . 0.0 111.542 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.52 -153.98 25.36 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.74 165.53 12.34 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 170.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -45.15 -50.32 11.37 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.37 1.468 . . . . 0.0 113.222 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -77.56 -36.76 51.84 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.672 0.389 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.46 -36.25 73.81 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.541 0.736 . . . . 0.0 111.713 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.64 129.18 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.373 1.069 . . . . 0.0 108.497 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 -10.57 59.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.2 mmm -61.26 154.23 63.7 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.663 0.785 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.82 161.01 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.749 2.299 . . . . 0.0 111.09 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -129.26 167.15 18.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.609 1.164 . . . . 0.0 109.18 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 125.517 1.527 . . . . 0.0 106.905 170.213 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -138.92 147.38 42.22 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.651 1.58 . . . . 0.0 106.802 169.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.55 125.45 48.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.61 108.95 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -74.79 119.13 18.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.6 m -105.29 14.23 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 122.946 0.498 . . . . 0.0 111.305 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -55.67 157.24 4.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 118.641 0.655 . . . . 0.0 110.644 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.3 145.69 25.24 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 166.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.62 -30.89 70.55 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.72 1.613 . . . . 0.0 112.825 -166.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -71.26 -21.79 62.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.341 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.67 -34.36 16.29 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.737 1.153 . . . . 0.0 109.347 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -51.87 -46.19 64.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.96 0.504 . . . . 0.0 110.941 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.38 -21.22 66.15 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -73.62 -49.89 23.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.574 1.079 . . . . 0.0 110.508 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -162.66 132.43 4.44 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -151.11 160.78 43.68 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.485 1.493 . . . . 0.0 111.73 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.4 107.06 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -44.05 134.85 4.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.839 1.255 . . . . 0.0 111.753 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.12 -17.94 55.44 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.62 -1.1 . . . . 0.0 112.869 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.45 129.57 40.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.392 1.596 . . . . 0.0 109.259 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.66 156.38 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -111.46 121.29 44.79 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.596 -0.69 . . . . 0.0 109.66 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.2 mt -135.11 84.27 37.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.51 151.46 7.19 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.102 2.535 . . . . 0.0 111.658 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.1 tp -44.95 -44.0 9.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.89 -41.88 97.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.522 0.601 . . . . 0.0 111.336 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -75.07 -22.6 58.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.825 1.65 . . . . 0.0 111.249 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.84 -44.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.539 1.063 . . . . 0.0 109.713 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -61.81 -15.59 43.03 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.24 -20.28 9.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 111.696 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -129.5 -12.38 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.94 -39.24 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 121.362 1.892 . . . . 0.0 111.206 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.79 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.305 0.502 . . . . 0.0 111.787 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 m -68.3 -44.97 74.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.678 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 -39.41 68.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.236 0.614 . . . . 0.0 112.015 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.77 87.64 12.74 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.134 1.889 . . . . 0.0 111.974 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.0 152.68 44.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.364 1.066 . . . . 0.0 109.989 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.73 35.27 4.2 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.569 0.622 . . . . 0.0 112.113 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -142.78 -34.67 0.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.81 150.72 44.09 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.747 0.819 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 m -62.23 132.47 52.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 110.528 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -132.43 139.27 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.56 138.52 53.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.31 141.93 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -147.05 163.51 36.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.3 p -159.82 -154.26 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.277 0.231 . . . . 0.0 111.01 174.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.48 130.21 38.21 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 170.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 55.12 17.68 2.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.298 1.839 . . . . 0.0 114.558 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.13 -13.03 1.04 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.876 1.227 . . . . 0.0 115.188 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -64.55 -44.9 89.31 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 120.056 1.928 . . . . 0.0 111.985 -171.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.44 -30.36 71.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.798 0.726 . . . . 0.0 110.007 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -75.12 -43.41 52.9 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.615 1.098 . . . . 0.0 112.195 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -49.35 78.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -58.26 -40.76 82.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.069 . . . . 0.0 111.977 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.91 -44.17 77.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.483 0.583 . . . . 0.0 109.97 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.06 -35.77 79.61 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.787 1.176 . . . . 0.0 110.498 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.71 -52.97 63.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.557 1.071 . . . . 0.0 110.379 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.0 pt -68.07 -39.43 81.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 119.442 1.019 . . . . 0.0 110.525 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.1 -40.42 94.54 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.394 0.543 . . . . 0.0 110.91 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.87 -39.55 94.8 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.609 0.64 . . . . 0.0 110.136 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.27 -33.93 73.98 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.806 -0.559 . . . . 0.0 111.019 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.6 mtp -73.96 -1.0 17.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.804 1.242 . . . . 0.0 112.08 173.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.35 90.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.848 -1.157 . . . . 0.0 113.136 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.48 55.02 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.364 1.466 . . . . 0.0 108.686 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -67.75 -25.09 65.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.171 1.388 . . . . 0.0 111.869 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.513 ' CD2' ' H ' ' A' ' 68' ' ' HIS . 18.8 p80 -77.5 33.67 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.23 2.612 . . . . 0.0 112.736 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.5 t -120.99 140.41 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.08 1.752 . . . . 0.0 106.427 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.43 141.68 41.64 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.48 114.37 19.33 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.37 -29.97 67.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.904 0.482 . . . . 0.0 112.005 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.28 -139.46 8.12 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.75 169.7 24.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.35 -53.95 7.88 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.391 1.477 . . . . 0.0 112.427 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.79 -37.83 67.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.481 0.313 . . . . 0.0 111.272 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.64 -37.37 68.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.339 0.655 . . . . 0.0 111.787 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.05 131.86 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.288 1.035 . . . . 0.0 108.574 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.52 -8.37 59.55 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.87 151.31 74.02 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.7 0.682 . . . . 0.0 110.676 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 163.83 11.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.123 2.549 . . . . 0.0 111.877 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -136.3 166.54 23.21 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.235 0.309 0 C-N-CA 125.819 1.647 . . . . 0.0 106.556 168.108 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -133.88 128.2 34.11 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -88.74 122.61 32.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mt -128.55 115.18 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -69.54 129.01 38.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.68 7.59 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.626 0.648 . . . . 0.0 111.615 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -65.59 162.82 17.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.046 0.839 . . . . 0.0 110.206 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.88 146.76 35.89 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.4 -38.6 73.28 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.968 1.778 . . . . 0.0 113.303 -167.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.09 -27.9 68.41 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.557 -0.714 . . . . 0.0 112.045 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -82.74 -33.05 27.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -46.42 79.92 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.178 0.591 . . . . 0.0 110.671 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -61.32 -22.75 65.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -66.19 -44.27 84.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.449 0.568 . . . . 0.0 111.022 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.37 137.9 0.3 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.741 2.017 . . . . 0.0 106.912 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -149.3 164.0 36.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.471 1.109 . . . . 0.0 110.256 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.13 134.86 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.577 0.751 . . . . 0.0 109.798 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -55.14 130.66 42.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.0 88.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.333 171.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.13 -178.74 4.0 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.762 1.281 . . . . 0.0 111.623 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.0 tt -125.88 172.22 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 127.418 2.287 . . . . 0.0 106.531 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -129.8 124.21 32.8 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.484 1.038 . . . . 0.0 110.483 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.2 mt -134.76 87.5 30.61 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 170.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.83 153.94 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.673 2.916 . . . . 0.0 111.366 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.02 -39.0 18.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.655 0.782 . . . . 0.0 112.333 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -65.0 -21.48 66.86 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.129 0.971 . . . . 0.0 113.275 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' CD ' HH12 ' A' ' 32' ' ' ARG . 26.7 mt-10 -111.1 -13.73 14.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.4 1.48 . . . . 0.0 111.752 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -48.78 -52.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.809 1.186 . . . . 0.0 110.489 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -64.26 -10.59 24.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.72 -10.58 12.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.031 0.933 . . . . 0.0 112.141 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.415 HH12 ' CD ' ' A' ' 28' ' ' GLU . 29.8 ttp180 -141.14 -14.91 0.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.98 -36.62 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 120.531 1.514 . . . . 0.0 111.751 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.99 69.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.487 0.585 . . . . 0.0 112.124 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.0 m -68.53 -39.63 81.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.636 0.653 . . . . 0.0 110.06 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.48 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.938 0.495 . . . . 0.0 112.151 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.34 81.18 44.13 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.6 -0.74 10.78 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.213 2.609 . . . . 0.0 114.451 -169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -142.33 137.08 30.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.789 1.177 . . . . 0.0 110.06 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -62.0 -25.89 67.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.537 1.135 . . . . 0.0 113.513 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -13.81 53.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.63 0.65 . . . . 0.0 112.324 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.82 145.88 44.63 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.145 0.884 . . . . 0.0 110.826 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.4 146.51 32.78 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.751 0.42 . . . . 0.0 109.999 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.24 139.14 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.57 95.62 4.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.22 143.11 12.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -147.83 160.39 42.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 p -162.21 -166.37 1.39 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.45 135.69 33.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 56.41 17.12 2.75 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.252 1.821 . . . . 0.0 115.391 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.17 -26.27 1.02 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.853 1.216 . . . . 0.0 115.378 170.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -54.49 -51.5 64.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.737 1.769 . . . . 0.0 112.625 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.57 -29.72 70.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.887 0.767 . . . . 0.0 110.471 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 m -74.46 -43.87 54.18 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.965 0.802 . . . . 0.0 112.138 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 -46.11 94.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.56 -45.04 85.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.83 1.252 . . . . 0.0 110.981 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.42 86.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.622 0.647 . . . . 0.0 110.955 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.04 -40.34 84.73 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.446 -0.784 . . . . 0.0 110.113 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.64 -54.18 43.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.977 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -66.08 -32.93 60.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.881 1.219 . . . . 0.0 111.015 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.12 -34.78 71.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.157 0.89 . . . . 0.0 110.938 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.8 m -63.77 -38.91 92.86 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.261 0.482 . . . . 0.0 110.166 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.02 -40.95 82.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.054 0.542 . . . . 0.0 110.8 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.12 -30.14 71.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.042 0.937 . . . . 0.0 111.004 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.26 0.44 7.46 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.182 -1.343 . . . . 0.0 114.528 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -65.82 151.02 47.6 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.874 1.837 . . . . 0.0 109.217 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -131.42 4.98 4.36 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.32 0.648 . . . . 0.0 112.421 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -136.25 30.3 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.471 1.108 . . . . 0.0 110.823 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.07 136.48 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.25 149.99 42.04 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -85.36 117.13 24.1 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.73 -32.47 74.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.627 0.371 . . . . 0.0 111.503 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.91 -163.92 28.86 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.596 1.57 . . . . 0.0 109.686 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.25 154.28 21.77 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.9 -44.54 63.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.791 0.836 . . . . 0.0 112.422 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.44 -37.26 82.72 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.751 0.42 . . . . 0.0 111.472 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.21 -35.14 61.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.283 0.633 . . . . 0.0 111.497 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.94 128.17 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 108.651 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.53 -8.5 59.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.6 mmm -61.18 153.86 65.03 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.903 0.881 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.86 162.39 42.32 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.058 2.505 . . . . 0.0 111.153 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -129.42 158.71 38.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.767 0.827 . . . . 0.0 110.935 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.238 0.471 0 C-N-CA 126.552 1.941 . . . . 0.0 107.869 172.429 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -147.84 154.88 41.01 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.52 1.528 . . . . 0.0 107.733 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -99.98 112.16 24.45 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.74 102.95 14.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.11 144.84 55.86 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.49 9.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.499 -0.751 . . . . 0.0 111.583 -172.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -61.28 157.78 15.65 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.89 145.92 40.18 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.14 -32.08 90.87 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.944 1.763 . . . . 0.0 113.708 -165.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.43 -15.43 56.81 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.494 -0.754 . . . . 0.0 112.498 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -88.1 -31.45 19.21 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.757 1.162 . . . . 0.0 108.859 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -50.61 72.72 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.393 0.677 . . . . 0.0 111.385 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -62.26 -23.9 66.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -169.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -63.99 -37.98 89.41 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.664 -0.684 . . . . 0.0 111.725 -172.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -174.49 135.99 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.325 1.45 . . . . 0.0 107.438 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -152.56 157.89 41.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.001 1.273 . . . . 0.0 111.026 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.54 123.11 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.77 158.7 6.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.154 0.982 . . . . 0.0 111.366 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.5 39.22 42.58 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.56 174.28 10.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.292 1.437 . . . . 0.0 110.039 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.62 164.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -121.66 135.4 54.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.01 92.92 10.65 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.53 149.89 37.23 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.963 2.442 . . . . 0.0 113.158 -171.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 tp -56.37 -28.8 60.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.229 0.612 . . . . 0.0 112.364 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -70.18 -22.35 62.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 112.763 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -116.86 -24.76 7.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.145 1.378 . . . . 0.0 112.098 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.1 p -54.81 -35.69 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.363 1.465 . . . . 0.0 113.392 -168.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.6 -18.18 58.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.658 0.663 . . . . 0.0 112.774 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -110.18 4.17 20.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 111.414 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.92 -21.7 0.72 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -62.73 -36.6 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 110.952 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.07 94.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.283 0.492 . . . . 0.0 111.631 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -37.96 63.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.252 0.478 . . . . 0.0 111.116 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.66 -39.41 64.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.36 0.527 . . . . 0.0 111.951 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.01 81.68 15.8 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.93 -26.48 26.74 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.878 1.718 . . . . 0.0 112.242 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -84.36 103.28 13.4 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.422 0.689 . . . . 0.0 110.195 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.41 -14.4 60.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.55 -17.9 62.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.326 0.966 . . . . 0.0 111.769 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.45 141.89 58.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.874 0.761 . . . . 0.0 111.557 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -83.49 82.12 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.53 100.17 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.74 130.57 38.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.59 138.61 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.54 153.3 32.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.584 1.154 . . . . 0.0 108.488 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -154.58 -174.35 4.94 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.862 1.665 . . . . 0.0 109.691 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.78 125.39 23.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.01 17.49 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.912 1.685 . . . . 0.0 114.172 -170.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.35 10.64 23.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 117.668 -1.629 . . . . 0.0 115.632 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -70.35 -44.1 68.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 121.768 2.784 . . . . 0.0 113.781 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.18 -30.53 69.65 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.899 1.227 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -41.27 48.6 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.772 0.829 . . . . 0.0 112.069 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -41.98 97.8 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.43 -45.96 84.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.586 0.754 . . . . 0.0 110.896 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.36 75.43 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.588 -0.695 . . . . 0.0 112.719 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.85 -36.98 68.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.682 1.128 . . . . 0.0 110.463 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.33 -55.41 18.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.135 0.425 . . . . 0.0 110.571 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -66.88 -35.13 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.21 0.914 . . . . 0.0 110.592 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.79 -36.09 62.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.757 -0.589 . . . . 0.0 110.863 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 p -66.66 -35.92 81.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.107 0.867 . . . . 0.0 110.328 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.58 -36.48 82.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.128 0.876 . . . . 0.0 111.472 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.5 mmm -66.44 -16.57 64.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.901 0.88 . . . . 0.0 111.847 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.04 4.99 27.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.32 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -74.89 93.22 2.63 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.409 1.604 . . . . 0.0 107.692 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -75.65 4.7 7.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.371 1.069 . . . . 0.0 113.585 -172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -138.52 24.75 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.316 0.962 . . . . 0.0 112.646 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.76 140.71 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -143.79 138.64 28.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.43 105.57 9.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.7 68.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.318 0.647 . . . . 0.0 111.977 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.12 -150.13 21.55 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.24 168.12 22.7 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 169.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.3 tp -50.16 -46.06 53.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 113.217 -169.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.25 -28.63 34.69 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.782 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -76.05 -38.34 57.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.323 0.649 . . . . 0.0 111.121 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -66.48 123.94 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.08 -7.66 58.99 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -62.06 156.57 57.57 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.94 0.896 . . . . 0.0 110.757 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.24 169.06 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.759 2.306 . . . . 0.0 110.915 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -140.0 164.7 29.32 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.45 1.1 . . . . 0.0 110.196 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 126.092 1.757 . . . . 0.0 108.209 172.576 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.236 0.374 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -142.71 129.92 20.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -90.17 115.63 27.56 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mt -125.38 108.19 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.91 138.01 55.67 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 168.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.2 6.88 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.971 0.805 . . . . 0.0 111.66 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -60.26 162.35 6.11 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.934 0.788 . . . . 0.0 110.437 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.47 149.53 60.12 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -64.23 -31.55 63.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.59 1.526 . . . . 0.0 112.636 -168.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.56 -24.63 64.64 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.337 0.655 . . . . 0.0 111.842 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -86.37 -37.14 18.74 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.165 0.893 . . . . 0.0 108.862 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -36.97 78.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.523 0.601 . . . . 0.0 110.894 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.87 -20.52 66.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.415 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.37 -54.23 7.05 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.515 1.052 . . . . 0.0 108.701 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -164.79 153.29 12.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 110.41 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -163.17 176.12 10.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.933 1.693 . . . . 0.0 109.099 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.37 145.0 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.189 -0.944 . . . . 0.0 108.579 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -63.31 146.06 54.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.033 0.933 . . . . 0.0 110.187 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.65 46.51 75.36 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.26 177.16 8.19 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.259 1.424 . . . . 0.0 110.174 -175.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 tt -126.26 176.58 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.012 1.725 . . . . 0.0 107.173 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -132.65 134.23 44.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.366 -0.833 . . . . 0.0 109.45 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.18 89.37 14.42 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.29 151.98 21.03 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.139 2.559 . . . . 0.0 112.896 -172.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.6 tp -51.48 -34.06 33.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.651 0.78 . . . . 0.0 112.177 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.41 -15.95 63.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -125.21 -24.06 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.482 1.113 . . . . 0.0 111.969 -169.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.1 -34.88 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.639 1.176 . . . . 0.0 113.116 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -56.45 -25.38 50.44 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.008 0.822 . . . . 0.0 112.799 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.56 -0.69 20.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.178 0.991 . . . . 0.0 111.659 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -136.67 -24.44 1.17 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -167.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.3 -35.68 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.089 1.768 . . . . 0.0 110.295 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -17.6 41.9 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.269 1.027 . . . . 0.0 113.638 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -117.94 -30.16 5.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.57 1.148 . . . . 0.0 110.969 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.88 85.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.797 0.726 . . . . 0.0 110.914 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.69 77.13 22.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -25.77 38.62 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.215 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -77.04 102.05 6.31 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.36 0.664 . . . . 0.0 110.052 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.46 -13.3 60.6 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.28 -14.85 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.225 0.921 . . . . 0.0 111.735 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.67 147.54 53.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.195 -0.941 . . . . 0.0 111.486 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -77.53 78.71 4.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.949 0.9 . . . . 0.0 109.344 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.09 100.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -92.45 128.73 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.7 m -122.19 142.8 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.265 0.626 . . . . 0.0 109.571 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.92 167.35 30.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.013 1.325 . . . . 0.0 107.588 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.09 -171.14 2.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.417 HD21 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -51.53 -47.59 63.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 112.052 -178.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.32 26.11 2.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 112.41 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.17 -18.15 1.25 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.742 1.163 . . . . 0.0 115.523 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -67.41 -40.45 85.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 120.424 2.112 . . . . 0.0 113.028 -173.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -65.75 -30.3 70.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.714 1.143 . . . . 0.0 109.275 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -73.39 -45.55 54.09 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 124.258 1.023 . . . . 0.0 112.293 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.74 97.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -58.25 -46.33 86.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.88 0.872 . . . . 0.0 111.167 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -37.41 87.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.303 0.641 . . . . 0.0 111.575 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.03 -36.35 74.84 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.986 0.812 . . . . 0.0 111.028 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.53 -54.93 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.853 0.752 . . . . 0.0 110.011 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.3 pt -66.18 -34.79 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.469 0.577 . . . . 0.0 111.195 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.41 -39.79 92.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 0.0 110.339 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -64.53 -42.44 95.74 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.01 -35.93 81.89 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.548 0.613 . . . . 0.0 111.317 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.59 -10.5 59.44 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.254 1.021 . . . . 0.0 111.994 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.89 11.0 47.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.56 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -71.83 135.17 46.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.352 1.576 . . . . 0.0 107.364 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -118.37 4.6 11.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.648 0.779 . . . . 0.0 112.378 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -136.98 29.39 2.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.711 1.204 . . . . 0.0 110.075 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.66 142.32 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -144.03 128.32 17.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.46 110.32 14.65 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.72 71.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.454 0.301 . . . . 0.0 111.248 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.59 -157.95 27.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.29 159.59 14.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 167.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.26 -44.83 65.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.262 1.025 . . . . 0.0 111.791 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -68.74 -11.28 60.11 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.73 -30.19 5.51 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.307 1.043 . . . . 0.0 111.867 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 131.21 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.032 0.933 . . . . 0.0 108.619 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.73 56.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.4 mmm -61.18 154.2 63.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.916 0.886 . . . . 0.0 110.667 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.92 163.46 35.51 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 111.534 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -123.92 165.83 16.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.341 1.056 . . . . 0.0 109.641 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 125.872 1.669 . . . . 0.0 106.518 171.037 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.293 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -137.61 147.31 44.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.318 1.447 . . . . 0.0 107.482 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.09 110.07 21.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.24 107.0 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.1 138.25 49.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.27 8.66 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.084 0.856 . . . . 0.0 111.783 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -62.45 159.02 16.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.899 0.772 . . . . 0.0 110.683 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.5 m -54.67 147.89 28.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.726 0.81 . . . . 0.0 109.337 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.37 -33.0 71.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.867 1.711 . . . . 0.0 112.291 -169.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 -23.82 64.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.17 -34.1 16.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.177 0.898 . . . . 0.0 108.652 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -57.31 -41.11 79.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.416 0.687 . . . . 0.0 110.831 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -62.08 -28.24 69.47 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.695 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.88 -50.51 23.37 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.413 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -167.03 152.33 7.56 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.369 0.986 . . . . 0.0 110.204 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -153.64 167.51 29.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.503 1.521 . . . . 0.0 109.683 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 t -65.85 139.85 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.3 161.76 18.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.089 0.556 . . . . 0.0 112.003 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.99 38.61 84.78 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.886 0.755 . . . . 0.0 111.825 172.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.95 179.37 7.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.299 1.039 . . . . 0.0 111.924 -169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.44 175.9 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.745 2.018 . . . . 0.0 105.994 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.25 133.08 45.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.167 -0.958 . . . . 0.0 108.67 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 mt -136.47 84.04 29.52 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -55.59 146.88 62.11 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.087 2.525 . . . . 0.0 113.026 -172.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -48.72 -34.46 12.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.888 0.875 . . . . 0.0 112.389 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -55.09 -28.48 52.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.631 1.172 . . . . 0.0 112.957 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -140.04 2.81 1.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.093 0.957 . . . . 0.0 113.016 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.36 -39.66 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.7 -29.11 66.39 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.979 0.809 . . . . 0.0 112.122 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.32 -16.78 57.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 111.641 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -125.62 -36.91 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.173 -0.918 . . . . 0.0 113.04 -169.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.67 -36.49 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 120.047 1.294 . . . . 0.0 111.34 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.8 -7.68 5.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.721 1.209 . . . . 0.0 114.103 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.7 m -125.98 -32.59 2.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.787 1.235 . . . . 0.0 109.927 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.92 82.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.687 0.795 . . . . 0.0 111.053 172.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.42 75.66 32.5 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.6 -35.74 16.37 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 111.976 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.69 113.86 11.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.091 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -65.42 -20.95 66.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -21.71 58.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.356 0.662 . . . . 0.0 111.804 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.29 146.51 43.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.558 1.072 . . . . 0.0 110.67 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -75.26 146.57 40.98 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.011 -0.431 . . . . 0.0 110.184 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.7 98.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.74 123.11 23.49 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 m -126.55 140.77 47.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 123.537 0.735 . . . . 0.0 109.097 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -164.14 157.68 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.4 -170.7 1.72 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.644 0.778 . . . . 0.0 109.774 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -68.22 132.41 47.09 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.2 16.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.771 2.028 . . . . 0.0 115.51 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.1 -14.2 0.44 Allowed Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.723 1.154 . . . . 0.0 115.385 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mmt-85 -63.86 -40.09 95.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.352 2.076 . . . . 0.0 112.785 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -27.41 68.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.393 0.542 . . . . 0.0 110.609 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.0 m -79.41 -43.61 23.04 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.862 0.756 . . . . 0.0 111.031 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.28 -43.19 93.74 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -65.73 -42.56 90.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.105 0.562 . . . . 0.0 111.292 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.12 91.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.121 0.568 . . . . 0.0 111.157 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -55.1 -39.02 68.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.352 0.978 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.72 -53.73 30.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.809 0.731 . . . . 0.0 110.204 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 pt -68.14 -33.74 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.793 -0.567 . . . . 0.0 110.964 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.07 -35.89 74.55 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.897 0.772 . . . . 0.0 110.171 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -62.44 -39.63 93.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 110.208 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.43 -38.88 91.2 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.477 0.58 . . . . 0.0 110.748 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.0 mtp -70.43 -9.93 57.76 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.205 1.002 . . . . 0.0 112.41 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 1.74 46.24 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.058 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.29 145.98 54.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.495 1.648 . . . . 0.0 109.153 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 p -131.19 7.88 4.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.992 0.917 . . . . 0.0 111.824 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -137.06 31.05 2.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.848 1.259 . . . . 0.0 110.444 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -75.2 141.54 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -142.12 124.77 15.88 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.49 108.72 8.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -28.96 68.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.62 0.368 . . . . 0.0 111.355 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.76 -144.07 12.22 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.46 175.48 21.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.84 -52.46 8.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.195 1.398 . . . . 0.0 113.064 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.24 -36.35 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.29 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.71 -38.58 62.3 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 111.615 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.8 128.32 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.1 54.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.46 156.42 70.59 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.717 0.807 . . . . 0.0 111.277 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.42 161.64 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.077 3.185 . . . . 0.0 113.722 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -135.48 159.36 41.85 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.672 1.189 . . . . 0.0 109.966 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.235 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.924 176.86 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -143.11 153.36 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -108.47 117.75 34.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.4 113.11 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -172.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.87 132.62 45.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 165.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.261 4.3 p -127.27 9.52 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.791 0.837 . . . . 0.0 111.145 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -64.57 161.39 17.58 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.961 -1.087 . . . . 0.0 110.121 170.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.48 151.86 58.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.46 -37.32 72.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.94 1.76 . . . . 0.0 112.038 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.3 -6.58 30.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -105.29 -31.23 9.18 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.139 0.881 . . . . 0.0 110.269 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.32 -41.01 88.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.702 1.137 . . . . 0.0 110.266 169.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -64.19 -8.24 11.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.9 0.88 . . . . 0.0 112.644 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.0 -59.9 1.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.3 169.97 16.8 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.836 1.198 . . . . 0.0 111.556 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -154.28 172.91 16.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 108.69 168.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.4 144.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -61.66 159.88 12.58 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.823 -0.548 . . . . 0.0 111.699 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.36 41.93 99.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.435 0.54 . . . . 0.0 112.573 171.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.97 177.69 7.66 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.969 1.308 . . . . 0.0 110.769 -172.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.8 tt -131.97 140.85 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.367 1.467 . . . . 0.0 108.571 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -82.62 121.28 26.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.059 0.944 . . . . 0.0 110.28 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -144.26 75.05 15.54 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -53.71 150.66 28.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.58 2.854 . . . . 0.0 112.147 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.63 -27.14 67.56 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.568 -0.708 . . . . 0.0 111.829 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.11 -10.47 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -129.33 -21.33 3.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.304 1.442 . . . . 0.0 112.082 -168.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.52 -41.38 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.917 1.287 . . . . 0.0 112.706 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.19 -23.4 62.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.792 0.724 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -110.29 2.89 19.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.917 1.287 . . . . 0.0 111.267 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -133.63 -37.4 0.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.536 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.59 -36.83 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.392 1.451 . . . . 0.0 111.395 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.71 -10.53 19.92 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 m -116.18 -35.75 4.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.13 0.972 . . . . 0.0 109.867 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.67 85.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.388 0.675 . . . . 0.0 111.968 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.6 76.6 47.89 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.51 10.45 1.87 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.723 2.949 . . . . 0.0 114.202 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.52 133.74 29.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.53 1.059 . . . . 0.0 108.996 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.64 -15.11 62.23 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -17.54 59.65 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.932 1.242 . . . . 0.0 112.611 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.41 144.47 55.81 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.44 0.564 . . . . 0.0 111.506 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 m -79.65 87.91 5.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.52 82.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.446 1.098 . . . . 0.0 108.37 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.7 132.43 46.14 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.76 143.75 39.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.601 0.761 . . . . 0.0 109.526 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.29 160.02 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.363 0.665 . . . . 0.0 110.664 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.8 p -168.9 -178.94 3.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.771 1.628 . . . . 0.0 108.489 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -58.82 127.53 32.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.642 -0.661 . . . . 0.0 109.483 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.56 16.9 0.7 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.552 1.941 . . . . 0.0 115.311 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.04 1.1 6.24 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 119.628 1.104 . . . . 0.0 115.209 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.6 mmt-85 -69.32 -39.79 78.0 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 120.131 1.965 . . . . 0.0 112.503 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -69.0 -30.17 68.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.319 0.963 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -70.13 -47.65 60.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.341 1.057 . . . . 0.0 111.646 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.16 99.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -57.5 -49.42 76.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.184 0.994 . . . . 0.0 110.948 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.6 81.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.941 0.496 . . . . 0.0 111.903 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.24 -35.39 69.65 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.178 0.899 . . . . 0.0 111.379 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -53.8 46.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.152 0.887 . . . . 0.0 110.254 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 pt -69.44 -33.16 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.805 -0.559 . . . . 0.0 111.083 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.75 -40.22 88.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.125 0.875 . . . . 0.0 110.153 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -63.66 -38.65 91.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.019 0.372 . . . . 0.0 110.348 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.65 -41.27 88.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.131 0.572 . . . . 0.0 110.908 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -64.25 -33.16 75.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.664 0.786 . . . . 0.0 110.965 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 -1.31 5.27 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.419 -1.212 . . . . 0.0 114.189 169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -68.0 125.38 26.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.542 1.671 . . . . 0.0 108.036 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -114.06 9.25 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.91 0.884 . . . . 0.0 112.305 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -133.32 29.01 4.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.654 1.181 . . . . 0.0 110.134 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.41 140.9 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.65 143.29 25.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 115.13 17.17 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.98 74.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.567 0.347 . . . . 0.0 111.015 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.52 -170.86 32.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.737 1.637 . . . . 0.0 109.242 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.52 155.96 38.3 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 168.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.8 -49.84 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.494 1.117 . . . . 0.0 111.642 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -76.97 -33.56 57.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.974 0.509 . . . . 0.0 111.525 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.92 -34.96 76.24 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.526 0.73 . . . . 0.0 111.674 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.2 mt -58.08 126.17 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.4 59.58 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.88 141.35 89.55 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.613 1.165 . . . . 0.0 110.655 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.23 161.58 26.35 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.679 2.919 . . . . 0.0 114.398 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -110.9 161.79 15.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.071 0.948 . . . . 0.0 109.733 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.238 0.484 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 168.243 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.326 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -143.47 157.97 44.02 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.332 1.453 . . . . 0.0 108.71 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -99.04 128.03 45.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.67 116.04 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 104.376 -2.454 . . . . 0.0 104.376 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -77.37 129.56 35.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.21 -1.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.829 1.652 . . . . 0.0 109.696 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.41 161.58 11.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.891 1.223 . . . . 0.0 109.515 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -55.81 148.89 34.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.82 0.448 . . . . 0.0 109.803 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.77 -31.19 39.95 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.48 1.453 . . . . 0.0 111.823 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -69.16 -17.61 63.83 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.841 . . . . 0.0 111.725 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -89.77 -40.16 12.66 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 109.416 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -54.0 -43.45 70.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.477 1.035 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.47 -32.71 72.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.908 0.483 . . . . 0.0 111.683 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -83.96 -32.23 25.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.229 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -166.4 127.04 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.379 1.072 . . . . 0.0 108.833 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -158.44 164.49 36.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.106 0.866 . . . . 0.0 110.604 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.88 137.01 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -52.51 119.93 5.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 110.834 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.22 1.59 86.22 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.568 -1.129 . . . . 0.0 114.887 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.29 41.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.599 1.699 . . . . 0.0 111.746 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.86 155.64 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -99.11 105.03 17.08 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 mm -138.17 77.03 37.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.6 159.98 5.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.985 3.124 . . . . 0.0 113.102 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -53.09 -42.65 66.11 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.082 0.553 . . . . 0.0 112.105 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -61.1 -29.83 69.99 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.515 0.726 . . . . 0.0 111.743 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -91.9 -31.44 15.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.868 1.267 . . . . 0.0 110.618 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -44.96 -51.64 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.766 1.167 . . . . 0.0 110.95 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -57.57 -23.34 50.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.38 -2.18 6.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.835 0.854 . . . . 0.0 112.336 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -135.48 -20.73 1.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.494 -169.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.5 -29.27 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.803 1.638 . . . . 0.0 112.401 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.29 61.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.915 0.78 . . . . 0.0 112.717 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -36.12 82.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.851 0.75 . . . . 0.0 110.377 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.65 -27.09 16.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.411 1.084 . . . . 0.0 111.739 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.41 76.6 49.15 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 -14.12 30.48 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.906 2.404 . . . . 0.0 114.063 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.8 152.39 38.69 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -56.31 -27.35 55.34 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.633 1.573 . . . . 0.0 114.222 -171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.14 -32.29 73.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.327 0.651 . . . . 0.0 112.703 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.36 136.06 52.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.036 0.446 . . . . 0.0 109.896 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -84.71 138.24 32.76 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.2 96.21 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 89.58 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.7 m -81.71 138.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -149.49 171.85 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.084 0.954 . . . . 0.0 108.467 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 p -151.97 -153.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 170.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.416 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.1 -47.99 74.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.498 1.045 . . . . 0.0 111.028 -178.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.32 -18.88 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.34 -27.26 1.69 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.542 1.064 . . . . 0.0 114.583 172.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -56.85 -58.32 8.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.363 1.581 . . . . 0.0 113.789 -170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.52 77.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.203 0.911 . . . . 0.0 110.976 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.73 -41.22 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.027 0.531 . . . . 0.0 112.094 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.61 95.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.31 -43.85 79.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.654 1.182 . . . . 0.0 110.567 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.13 70.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.477 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -59.37 -32.29 70.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.209 1.368 . . . . 0.0 111.462 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.1 -53.45 30.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.041 0.837 . . . . 0.0 109.712 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.66 -35.94 76.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.498 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.65 -37.07 84.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.363 0.983 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 m -63.96 -42.07 97.38 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.177 0.444 . . . . 0.0 110.043 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.49 -38.94 91.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.987 0.515 . . . . 0.0 110.836 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 85.1 mtp -70.48 -11.21 60.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.145 1.378 . . . . 0.0 111.945 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.03 48.87 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.822 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -73.89 151.18 40.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.352 1.576 . . . . 0.0 109.336 171.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -139.1 9.13 2.53 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.301 1.041 . . . . 0.0 111.781 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -134.79 38.87 3.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.392 1.477 . . . . 0.0 109.522 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -109.95 138.23 38.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.2 145.21 28.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -79.76 106.03 11.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.91 -28.18 67.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.28 -144.72 11.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.43 165.71 25.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.79 -47.04 51.46 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.333 1.453 . . . . 0.0 110.992 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.65 -2.15 16.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.029 0.932 . . . . 0.0 113.123 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.69 -30.54 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.509 1.124 . . . . 0.0 112.596 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.89 134.54 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.267 1.027 . . . . 0.0 108.512 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.3 -16.56 54.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.6 mtp -63.68 158.81 57.57 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.416 0.686 . . . . 0.0 111.776 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.93 161.13 8.86 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.611 2.874 . . . . 0.0 113.189 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.43 163.8 23.28 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.614 1.166 . . . . 0.0 108.797 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.1 m . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 171.039 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.236 0.392 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.51 152.89 41.24 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.068 1.747 . . . . 0.0 106.799 169.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -114.3 112.7 23.51 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.75 111.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -69.46 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 166.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.81 7.43 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.785 0.721 . . . . 0.0 111.406 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -64.6 162.15 16.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.038 -1.039 . . . . 0.0 110.462 170.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 m -54.69 144.99 42.67 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.51 -33.67 77.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.104 1.203 . . . . 0.0 111.524 -168.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.84 -29.98 70.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.24 -37.86 16.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.66 -44.68 77.48 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.952 0.501 . . . . 0.0 110.224 176.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -60.48 -25.8 66.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.62 0.768 . . . . 0.0 112.506 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -71.06 -49.1 48.3 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.563 0.62 . . . . 0.0 110.424 -173.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -166.0 133.4 2.79 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -146.46 162.04 39.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.488 1.04 . . . . 0.0 111.36 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.03 135.99 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -60.33 144.9 49.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 110.074 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.18 20.28 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.96 174.57 10.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.042 1.337 . . . . 0.0 110.36 -177.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.05 169.97 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.557 1.943 . . . . 0.0 106.688 170.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -127.67 127.91 44.54 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.186 172.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -136.99 92.38 14.24 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 171.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.8 153.05 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.538 2.825 . . . . 0.0 111.984 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -46.09 -47.83 17.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.548 1.139 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -57.26 -31.35 65.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.697 1.199 . . . . 0.0 112.289 177.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -101.54 -9.34 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.342 1.857 . . . . 0.0 111.943 -169.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -51.43 -53.37 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.036 1.289 . . . . 0.0 110.127 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -61.41 -22.11 64.71 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -82.83 -21.36 34.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.557 -176.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -136.22 -28.02 1.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.99 -36.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 121.195 1.816 . . . . 0.0 111.361 -169.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -6.36 4.44 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 m -126.31 -33.52 2.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.894 -178.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.09 78.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.702 0.801 . . . . 0.0 111.098 172.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 t -139.57 75.73 31.52 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.38 -23.59 32.37 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.238 1.959 . . . . 0.0 112.202 -175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.96 104.99 3.13 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.757 0.823 . . . . 0.0 109.826 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -63.58 -13.05 38.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.26 11.95 34.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.196 0.998 . . . . 0.0 111.369 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.73 146.99 53.22 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.071 -1.018 . . . . 0.0 109.265 168.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -80.24 77.84 6.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.67 111.88 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -92.26 136.74 32.94 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.12 143.78 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.73 168.27 24.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 p -156.33 -159.32 0.88 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.2 OUTLIER -63.64 -49.79 71.87 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.625 -0.672 . . . . 0.0 110.898 179.426 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.67 35.09 1.43 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.679 1.191 . . . . 0.0 112.5 -168.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 -20.63 1.63 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.962 1.268 . . . . 0.0 115.986 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -64.11 -52.19 60.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.352 2.076 . . . . 0.0 111.831 -174.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -59.16 -30.65 68.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.906 177.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 -47.16 59.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.726 1.148 . . . . 0.0 112.768 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.28 -42.64 97.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.59 -34.72 76.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.414 1.085 . . . . 0.0 111.573 174.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -37.87 64.44 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 176.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -58.88 -39.51 81.64 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.277 -0.889 . . . . 0.0 111.247 -178.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.98 -43.93 81.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.595 1.089 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.2 pt -69.81 -32.8 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.312 1.414 . . . . 0.0 111.01 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -37.95 85.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.246 0.93 . . . . 0.0 110.268 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.3 m -64.21 -40.24 95.65 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.94 -38.41 90.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.172 0.589 . . . . 0.0 110.715 176.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -71.24 -3.62 21.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.72 1.208 . . . . 0.0 112.464 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.76 14.85 64.44 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.304 -1.275 . . . . 0.0 113.883 169.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -62.55 129.19 39.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.613 1.707 . . . . 0.0 107.534 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -66.71 -29.41 69.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.54 0.336 . . . . 0.0 111.665 -169.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.95 158.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 108.741 178.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -149.19 147.36 16.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 175.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -131.99 124.94 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -77.02 112.19 13.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.07 72.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.761 0.424 . . . . 0.0 111.741 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.95 -149.45 21.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -177.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.87 163.11 16.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -50.15 -44.36 52.48 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.132 1.373 . . . . 0.0 111.732 -173.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -75.31 -5.87 46.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.954 0.902 . . . . 0.0 113.057 -175.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.52 -30.56 3.62 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.222 1.009 . . . . 0.0 112.266 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.32 130.5 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.59 -16.32 51.96 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mtp -62.05 156.5 57.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.998 0.919 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 165.16 30.72 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.154 2.57 . . . . 0.0 111.748 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.2 162.34 26.4 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.258 1.023 . . . . 0.0 109.907 -176.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.536 0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 107.604 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.61 163.57 39.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.12 142.68 42.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 108.34 171.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.15 119.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.6 mt -125.5 109.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.93 132.52 45.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 167.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.56 10.83 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.528 0.731 . . . . 0.0 111.695 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -67.83 170.58 7.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.26 1.391 . . . . 0.0 108.708 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.78 150.41 48.07 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.28 -0.887 . . . . 0.0 110.921 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.79 -34.33 61.84 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.479 2.119 . . . . 0.0 112.76 -167.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.68 -27.48 68.38 Favored 'General case' 0 C--O 1.227 -0.131 0 O-C-N 121.301 -0.875 . . . . 0.0 111.224 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -88.35 -30.74 19.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.417 -0.802 . . . . 0.0 112.949 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -53.71 -47.37 70.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 170.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.76 -20.07 66.16 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.081 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.2 -49.32 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -178.88 134.43 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -148.11 160.78 42.53 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.566 1.146 . . . . 0.0 110.067 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.98 131.15 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -56.6 140.76 45.66 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.192 2.197 . . . . 0.0 109.967 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.36 83.91 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.8 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 172.8 7.8 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.527 1.164 . . . . 0.0 109.639 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 tt -112.87 170.87 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 2.9 t-20 -124.12 127.67 48.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.24 86.86 19.06 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.82 149.34 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.704 2.269 . . . . 0.0 111.959 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.8 tp -46.84 -37.64 9.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.99 0.916 . . . . 0.0 112.68 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -62.23 -28.19 69.52 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -113.21 -16.94 12.47 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.426 1.891 . . . . 0.0 108.665 -166.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -41.71 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.675 0.79 . . . . 0.0 110.477 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -57.44 -34.23 68.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.161 0.984 . . . . 0.0 113.578 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.54 -6.87 58.15 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -148.68 -25.11 0.32 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -153.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.85 -35.98 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.93 66.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.707 0.803 . . . . 0.0 112.342 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 -39.36 14.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.798 0.839 . . . . 0.0 109.805 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.47 60.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.782 0.833 . . . . 0.0 112.265 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 t -139.95 75.3 30.2 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.303 1.841 . . . . 0.0 106.867 -173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.92 -17.62 36.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.824 2.35 . . . . 0.0 112.882 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -113.21 123.49 50.31 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 5.1 mtpt -71.08 -26.73 63.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 125.201 1.401 . . . . 0.0 113.239 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.55 -14.55 62.13 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 126.07 2.106 . . . . 0.0 108.634 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.78 146.37 52.97 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.748 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -81.55 117.89 22.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.68 1.228 . . . . 0.0 110.845 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -104.85 110.67 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 O-C-N 120.771 -1.205 . . . . 0.0 107.756 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -95.55 119.45 34.07 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.65 141.12 29.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -149.35 171.93 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.435 ' HG ' ' HB2' ' A' ' 53' ' ' GLN . 31.5 p -165.86 -170.99 1.91 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.734 1.214 . . . . 0.0 108.606 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.07 104.93 1.24 Allowed 'General case' 0 C--O 1.26 1.645 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 85.5 5.67 0.48 Allowed 'General case' 0 C--N 1.404 2.953 1 O-C-N 129.974 4.546 . . . . 0.0 111.282 156.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.92 63.15 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.171 0.891 . . . . 0.0 112.731 162.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -52.16 43.76 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 121.646 -0.914 . . . . 0.0 113.351 -165.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.435 ' HB2' ' HG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -61.16 -29.48 69.82 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.88 -45.92 55.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.582 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.64 95.92 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.55 -45.75 91.49 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.406 1.482 . . . . 0.0 111.788 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.34 88.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 69' ' ' VAL . 61.0 tttt -58.6 -42.2 87.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.604 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.57 -56.34 23.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.529 1.059 . . . . 0.0 110.091 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.1 pt -66.77 -31.96 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.155 -0.34 . . . . 0.0 110.359 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -71.59 -41.73 68.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.138 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.8 m -57.18 -41.29 79.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.943 0.792 . . . . 0.0 109.54 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -67.11 -39.04 86.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.611 0.641 . . . . 0.0 110.646 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.94 -10.18 51.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.846 -1.159 . . . . 0.0 111.281 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' HA3' ' HZ2' ' A' ' 40' ' ' LYS . . . 96.92 13.19 47.34 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.608 1.575 . . . . 0.0 113.345 171.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CD2' ' HA ' ' A' ' 40' ' ' LYS . 80.9 m-85 -70.22 130.12 41.19 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.709 1.754 . . . . 0.0 107.492 166.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 -2.07 18.3 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.06 0.544 . . . . 0.0 111.61 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -131.76 34.35 3.89 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 110.241 -169.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.493 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 37.2 t -85.67 139.12 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -141.12 129.14 21.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.39 1.076 . . . . 0.0 108.464 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.06 109.4 10.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.76 69.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.272 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.07 -153.01 25.01 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 162.39 12.63 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 166.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.446 HD12 ' HE2' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -37.3 -51.49 1.06 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.846 2.058 . . . . 0.0 110.823 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -68.58 -40.72 80.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.4 -33.38 32.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.943 -1.935 . . . . 0.0 107.176 -168.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.39 123.76 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -8.78 58.68 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mtp -66.47 152.76 94.28 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.473 0.709 . . . . 0.0 110.925 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.58 162.08 22.32 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.168 2.579 . . . . 0.0 112.191 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HE2' HD12 ' A' ' 75' ' ' LEU . 9.9 mptt -130.46 156.39 44.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.096 0.958 . . . . 0.0 108.659 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.47 162.45 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -95.97 157.92 15.68 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.347 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 165.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -149.14 162.81 39.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.899 1.28 . . . . 0.0 108.115 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.59 140.45 27.41 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 108.953 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -80.26 102.96 9.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 168.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -112.27 94.69 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.424 ' CG ' ' HE ' ' A' ' 8' ' ' ARG . 6.6 t0 -65.84 156.2 34.0 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.53 16.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.325 1.05 . . . . 0.0 111.688 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' HE ' ' CG ' ' A' ' 6' ' ' ASP . 20.8 ptp180 -54.97 159.71 2.26 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.871 1.268 . . . . 0.0 111.795 172.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.13 145.96 32.38 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.64 -37.75 86.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.648 2.232 . . . . 0.0 113.996 -166.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.16 -17.58 64.59 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -88.54 -10.35 49.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.838 0.745 . . . . 0.0 110.959 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -72.52 -20.61 61.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.531 1.514 . . . . 0.0 110.962 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.05 -12.48 60.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.773 0.829 . . . . 0.0 111.213 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -114.79 -172.49 2.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.724 1.61 . . . . 0.0 108.567 -167.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.58 117.53 4.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.203 1.001 . . . . 0.0 111.345 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -147.66 160.9 42.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.693 1.197 . . . . 0.0 109.456 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.48 139.17 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.617 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -50.84 120.13 4.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.934 1.294 . . . . 0.0 110.101 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.82 4.25 81.79 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.666 -1.075 . . . . 0.0 114.536 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 151.11 47.93 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.475 1.638 . . . . 0.0 110.654 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.63 159.5 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -125.61 133.0 52.39 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 169.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.67 88.74 18.93 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.24 144.61 29.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.029 2.486 . . . . 0.0 113.378 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.6 tp -52.23 -32.17 35.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.636 0.774 . . . . 0.0 112.561 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -68.21 -15.48 63.59 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -131.42 -14.96 3.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.317 1.447 . . . . 0.0 112.087 -169.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p -50.81 -43.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 125.675 1.59 . . . . 0.0 114.038 -167.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.86 -21.91 66.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.423 1.011 . . . . 0.0 112.362 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.35 -18.05 40.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.746 0.818 . . . . 0.0 112.033 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -135.22 -16.78 1.86 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -166.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.29 -34.24 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.552 1.069 . . . . 0.0 111.166 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.36 77.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.469 0.577 . . . . 0.0 111.719 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -68.66 -42.82 77.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.343 0.657 . . . . 0.0 109.663 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.31 -29.02 61.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.85 81.67 45.81 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.79 -5.76 17.56 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.369 2.712 . . . . 0.0 114.541 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -142.44 136.32 29.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.58 1.082 . . . . 0.0 109.044 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.66 -22.32 66.63 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -19.4 60.28 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.261 0.937 . . . . 0.0 112.162 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.1 143.91 50.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.972 0.805 . . . . 0.0 110.674 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.84 152.94 33.17 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -138.37 137.77 43.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.22 103.35 12.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.03 141.26 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -154.32 173.74 15.78 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.43 -177.0 5.68 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.414 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -48.02 -43.93 30.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 0.0 112.132 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 16.97 5.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.195 0.998 . . . . 0.0 112.907 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.39 -31.4 0.99 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.11 1.338 . . . . 0.0 114.927 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.8 -43.28 99.23 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.395 1.597 . . . . 0.0 113.54 -173.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.48 -36.68 83.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.027 1.285 . . . . 0.0 109.453 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.44 -36.6 60.7 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.642 -0.695 . . . . 0.0 112.844 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.54 97.67 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 171.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -48.79 79.37 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 175.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -39.75 94.19 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.196 0.599 . . . . 0.0 111.589 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.2 -42.25 76.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.271 0.941 . . . . 0.0 110.066 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.14 -53.13 54.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.87 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.96 -35.69 75.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 CA-C-N 119.413 1.006 . . . . 0.0 110.996 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.0 -34.46 68.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.964 0.802 . . . . 0.0 110.534 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.4 m -63.63 -40.84 97.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.448 0.567 . . . . 0.0 110.093 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.05 -37.66 88.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.581 0.628 . . . . 0.0 110.76 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.69 -3.01 16.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.899 1.28 . . . . 0.0 112.317 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.03 4.45 60.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.495 -1.169 . . . . 0.0 113.928 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -75.1 86.26 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.591 1.695 . . . . 0.0 108.221 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 p -71.27 9.69 0.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.319 1.447 . . . . 0.0 113.904 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -136.34 27.98 3.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 111.717 -170.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.33 137.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -136.75 144.09 43.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -85.16 110.77 19.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.99 73.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.744 0.418 . . . . 0.0 111.73 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.79 -154.39 25.52 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.16 162.25 12.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.8 tp -43.48 -48.56 7.3 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 114.503 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.83 -18.49 60.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.58 -22.46 21.24 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.884 0.874 . . . . 0.0 111.958 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 mm -63.32 132.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.81 58.77 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.5 mmm -66.36 156.22 85.96 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.198 0.999 . . . . 0.0 111.612 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.24 161.67 16.02 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.497 2.798 . . . . 0.0 112.088 168.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -130.0 160.37 33.86 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.951 0.9 . . . . 0.0 110.446 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m -141.19 178.59 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 127.504 2.321 . . . . 0.0 107.772 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -132.26 173.1 11.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.121 1.368 . . . . 0.0 108.625 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 174.541 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.27 157.55 44.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.768 0.827 . . . . 0.0 109.582 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -139.98 122.03 15.7 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 169.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -78.92 118.94 21.41 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.45 104.23 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.89 124.69 24.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.17 6.48 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.009 0.924 . . . . 0.0 111.076 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -63.76 160.32 17.46 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.005 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 148.01 51.94 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.47 -32.94 70.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.922 1.748 . . . . 0.0 113.161 -167.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.06 -27.72 64.87 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.568 -0.707 . . . . 0.0 111.844 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -84.23 -34.87 23.79 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -46.24 76.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.196 0.598 . . . . 0.0 110.616 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.05 -22.6 66.97 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -65.23 -45.02 86.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.765 0.712 . . . . 0.0 110.706 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -172.63 138.2 0.85 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.887 1.675 . . . . 0.0 106.988 171.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -147.18 160.54 42.33 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.294 1.038 . . . . 0.0 110.752 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.41 127.69 22.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -61.54 145.61 51.43 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.884 0.374 . . . . 0.0 110.929 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.1 -7.37 52.44 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.214 0.911 . . . . 0.0 114.094 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.62 7.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.012 1.406 . . . . 0.0 111.332 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.76 166.52 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.051 1.741 . . . . 0.0 106.409 168.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -123.74 128.83 50.15 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 109.187 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 mt -139.12 84.43 16.84 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.1 153.77 11.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.397 2.731 . . . . 0.0 112.815 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -51.59 -35.98 43.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.768 0.827 . . . . 0.0 112.613 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.56 -22.61 66.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.428 0.691 . . . . 0.0 112.46 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -114.66 -27.68 7.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.112 1.365 . . . . 0.0 111.772 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -56.7 -38.92 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 124.4 1.08 . . . . 0.0 112.898 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -63.11 -19.46 64.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.238 0.926 . . . . 0.0 112.446 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -103.86 -5.4 22.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.642 1.177 . . . . 0.0 111.918 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -134.95 -21.25 1.67 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -60.43 -38.67 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 120.012 1.278 . . . . 0.0 111.524 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.6 75.14 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.969 0.804 . . . . 0.0 111.868 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 m -71.67 -45.12 62.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.635 0.774 . . . . 0.0 109.633 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.55 -30.71 66.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.17 0.588 . . . . 0.0 112.402 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.0 t -136.06 86.26 26.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.17 -1.78 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.205 2.604 . . . . 0.0 113.661 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -138.28 114.88 10.54 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.615 1.166 . . . . 0.0 108.692 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.62 -15.51 51.99 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.115 0.966 . . . . 0.0 112.871 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -66.22 -22.77 66.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.02 142.64 53.6 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.04 0.536 . . . . 0.0 111.182 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -78.2 97.87 5.66 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.55 88.19 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -82.21 89.78 6.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.14 139.97 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.857 0.463 . . . . 0.0 109.832 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -149.61 168.15 24.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.211 1.005 . . . . 0.0 108.514 169.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.39 -154.29 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -47.71 84.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.9 0.773 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.74 -23.22 0.72 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -25.83 1.46 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.739 1.154 . . . . 0.0 114.81 172.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -64.56 -45.49 86.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.639 1.72 . . . . 0.0 112.927 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.5 -31.29 72.44 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.75 1.159 . . . . 0.0 109.438 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -65.01 -49.53 69.86 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.899 0.88 . . . . 0.0 111.02 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.77 -42.09 95.36 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.07 -42.7 95.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.475 0.71 . . . . 0.0 110.664 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.53 92.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.017 0.527 . . . . 0.0 110.368 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.5 -37.83 73.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.985 0.811 . . . . 0.0 111.144 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -62.13 -53.09 60.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.957 0.799 . . . . 0.0 110.72 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt -69.4 -30.38 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.295 0.952 . . . . 0.0 111.566 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.21 -37.01 82.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 119.471 1.032 . . . . 0.0 110.143 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -66.29 -38.4 87.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.019 0.372 . . . . 0.0 110.199 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.19 -38.76 92.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.633 0.651 . . . . 0.0 110.538 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -75.09 6.24 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.287 1.435 . . . . 0.0 112.274 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.42 13.5 83.33 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.324 -1.265 . . . . 0.0 114.418 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -69.43 147.62 50.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.756 1.778 . . . . 0.0 108.433 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 p -132.67 8.58 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.591 1.157 . . . . 0.0 111.336 -171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -134.02 30.47 3.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.524 1.53 . . . . 0.0 110.026 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -77.08 140.21 17.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -138.66 129.73 26.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.22 108.79 16.7 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -31.4 72.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.259 0.223 . . . . 0.0 111.315 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.95 -139.34 8.12 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.98 163.68 24.51 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -48.69 -48.07 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.363 1.465 . . . . 0.0 112.396 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -68.73 -38.05 79.9 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.709 0.404 . . . . 0.0 111.49 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -78.19 -36.71 47.04 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.643 0.777 . . . . 0.0 111.992 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.31 132.55 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.462 1.105 . . . . 0.0 108.977 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.49 -13.84 56.01 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.2 mmm -61.98 154.21 69.62 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.757 0.823 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.22 162.3 42.34 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.134 2.556 . . . . 0.0 112.003 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -133.4 159.96 38.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.2 1.0 . . . . 0.0 110.811 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.53 161.95 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.632 1.573 . . . . 0.0 108.75 171.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.35 156.44 29.17 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 170.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.093 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.33 149.37 28.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.141 1.376 . . . . 0.0 107.456 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -138.31 152.18 48.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.267 1.427 . . . . 0.0 107.744 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.47 120.53 37.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -125.46 110.25 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -68.21 133.47 48.9 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.36 6.15 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.679 0.672 . . . . 0.0 110.332 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -57.41 157.41 6.67 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.31 -0.869 . . . . 0.0 111.066 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -53.94 148.26 21.5 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 167.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.33 -26.94 63.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.171 1.914 . . . . 0.0 113.368 -166.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.32 -28.85 61.35 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.396 -0.815 . . . . 0.0 112.023 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -82.54 -33.93 28.02 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.128 0.876 . . . . 0.0 109.18 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -50.13 -50.6 48.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.774 0.83 . . . . 0.0 111.492 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -66.19 -19.83 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -63.74 -45.04 91.65 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.083 0.856 . . . . 0.0 110.324 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.79 147.82 0.82 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.002 2.521 . . . . 0.0 105.381 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.11 158.16 43.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.608 1.094 . . . . 0.0 109.28 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.71 134.69 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -58.09 143.08 44.94 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.198 0.999 . . . . 0.0 110.137 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.15 45.32 20.26 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.266 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.23 176.1 9.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.097 1.359 . . . . 0.0 110.072 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 tt -121.31 171.13 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.09 1.756 . . . . 0.0 106.406 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -124.97 131.9 53.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 mt -139.0 100.64 7.91 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.34 159.07 6.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.778 2.985 . . . . 0.0 114.078 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -55.63 -35.85 66.34 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.359 -0.838 . . . . 0.0 112.092 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.11 -2.92 29.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.692 0.797 . . . . 0.0 112.821 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.72 -17.68 2.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.0 1.32 . . . . 0.0 112.311 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.82 -37.13 77.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.027 0.931 . . . . 0.0 111.967 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.03 -31.45 68.85 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.868 0.758 . . . . 0.0 111.354 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -77.88 -14.14 59.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.581 0.752 . . . . 0.0 112.472 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -130.58 -22.06 2.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.31 -36.24 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.606 1.094 . . . . 0.0 111.066 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.1 -25.01 28.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.061 1.344 . . . . 0.0 114.143 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -122.83 -29.99 3.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.641 1.176 . . . . 0.0 110.906 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.43 72.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.782 0.833 . . . . 0.0 111.046 171.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -134.6 91.29 21.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -6.3 18.77 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.089 2.526 . . . . 0.0 115.727 -166.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -146.71 139.1 24.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.102 1.319 . . . . 0.0 109.318 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.16 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -76.15 -23.76 54.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.061 0.846 . . . . 0.0 111.673 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -69.66 144.08 53.0 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.112 -0.367 . . . . 0.0 110.736 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.59 144.72 37.3 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 109.733 -169.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.73 141.23 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -123.95 137.35 54.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.67 142.61 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -154.59 155.01 33.96 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.966 1.306 . . . . 0.0 108.135 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 66.6 m -155.95 -174.03 4.78 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.25 1.82 . . . . 0.0 109.462 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.45 128.84 37.91 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.69 18.2 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.718 1.607 . . . . 0.0 114.28 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.4 11.91 11.25 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.144 -1.364 . . . . 0.0 115.061 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -67.64 -57.95 5.52 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 120.858 2.329 . . . . 0.0 113.379 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.26 -30.33 70.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.19 0.904 . . . . 0.0 109.716 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -74.71 -42.95 57.41 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.366 1.066 . . . . 0.0 112.196 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.49 -40.58 86.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.11 -42.24 85.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.356 1.063 . . . . 0.0 110.214 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.84 -39.62 79.86 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.732 0.696 . . . . 0.0 111.883 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.32 -38.84 66.43 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.27 1.395 . . . . 0.0 110.213 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.92 -58.59 7.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.668 0.667 . . . . 0.0 110.784 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.41 -37.1 79.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 119.611 1.096 . . . . 0.0 110.604 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.03 -37.68 75.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.234 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.8 m -62.55 -40.14 95.85 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.712 0.687 . . . . 0.0 110.356 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.19 -37.59 81.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.528 0.604 . . . . 0.0 111.182 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.4 mtp -64.46 -31.49 72.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.467 0.707 . . . . 0.0 110.945 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.26 -9.45 3.25 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.567 1.08 . . . . 0.0 113.565 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -77.21 72.75 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.095 1.447 . . . . 0.0 109.951 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 p -70.67 18.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.348 1.459 . . . . 0.0 112.895 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -132.2 24.76 4.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.316 1.846 . . . . 0.0 110.911 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -92.21 141.37 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.38 133.51 40.66 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.27 109.88 10.32 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 -30.66 70.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 111.611 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.4 -154.03 25.23 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.31 164.9 12.46 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.1 tp -46.18 -49.8 16.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 113.639 -169.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.24 -20.13 22.26 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 119.23 -0.414 . . . . 0.0 112.014 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.21 -37.62 69.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.448 0.567 . . . . 0.0 110.421 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.54 124.73 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -9.79 59.41 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mtp -61.14 154.59 60.72 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 110.608 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.4 164.23 34.97 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.961 2.44 . . . . 0.0 111.712 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -126.49 157.66 38.13 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.101 0.961 . . . . 0.0 110.044 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.05 158.58 36.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.03 1.732 . . . . 0.0 107.569 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -110.79 161.4 15.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.898 0.879 . . . . 0.0 110.382 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 175.278 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.12 172.45 15.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.08 -1.013 . . . . 0.0 109.54 170.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -136.29 132.02 35.17 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -94.77 115.34 27.39 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.49 107.24 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -65.97 142.54 57.82 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.1 11.6 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.809 0.731 . . . . 0.0 112.081 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -66.38 162.76 19.69 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 172.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.94 148.94 68.15 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.96 -32.94 64.87 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.896 1.73 . . . . 0.0 114.074 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.04 -30.18 67.4 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.497 -0.752 . . . . 0.0 111.408 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.04 -33.97 29.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -48.71 70.33 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.384 0.674 . . . . 0.0 111.251 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -61.99 -21.03 64.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.091 0.556 . . . . 0.0 112.35 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.98 -24.09 64.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.514 -1.231 . . . . 0.0 112.573 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 167.06 135.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.415 2.686 . . . . 0.0 106.848 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.31 162.8 38.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.847 1.203 . . . . 0.0 110.307 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.22 137.6 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -60.37 142.82 54.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.811 0.844 . . . . 0.0 109.91 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.78 44.09 39.85 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.185 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.83 179.34 6.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.111 1.364 . . . . 0.0 110.22 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -130.37 177.15 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.462 1.905 . . . . 0.0 106.48 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.37 137.33 50.89 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.349 -0.844 . . . . 0.0 108.781 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -140.79 97.38 7.23 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.19 157.2 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.527 2.818 . . . . 0.0 113.152 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -52.98 -35.88 59.67 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.618 -0.676 . . . . 0.0 112.248 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.28 -13.7 62.54 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -116.68 -36.02 4.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.189 1.395 . . . . 0.0 110.197 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.13 -33.06 45.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 C-N-CA 124.399 1.079 . . . . 0.0 111.705 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.36 -22.72 65.2 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.82 -30.94 7.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 110.534 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -84.6 -26.13 28.13 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.683 -0.636 . . . . 0.0 112.208 -169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.18 -33.65 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.568 1.076 . . . . 0.0 110.857 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.48 -9.01 10.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 -37.09 4.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.572 1.149 . . . . 0.0 109.905 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.96 -37.9 72.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.741 0.701 . . . . 0.0 112.143 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.96 73.47 33.05 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.34 -27.35 34.33 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.247 1.965 . . . . 0.0 111.976 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -76.75 102.13 6.11 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.38 -4.79 24.07 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -111.51 39.54 2.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.592 1.157 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.35 149.93 50.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.921 1.289 . . . . 0.0 108.159 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.01 153.67 43.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.237 0.615 . . . . 0.0 111.207 -168.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.17 137.54 51.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -110.87 126.76 55.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.3 141.89 39.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.63 169.01 24.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.55 1.14 . . . . 0.0 108.036 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -154.11 -155.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.43 -47.15 76.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.222 0.609 . . . . 0.0 111.213 177.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.86 -37.08 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.04 -23.13 0.6 Allowed Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.659 1.118 . . . . 0.0 115.615 172.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -58.58 -52.06 67.26 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.252 2.026 . . . . 0.0 112.48 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -58.99 -32.33 69.6 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.358 0.526 . . . . 0.0 110.113 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -72.92 -44.9 60.68 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 124.505 1.122 . . . . 0.0 112.59 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -45.39 93.43 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -57.23 -43.63 83.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.96 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.94 85.99 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.804 -0.56 . . . . 0.0 110.89 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -59.39 -38.15 79.78 Favored 'General case' 0 C--O 1.231 0.101 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.91 -52.63 64.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.105 0.866 . . . . 0.0 110.67 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.4 pt -68.04 -33.32 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.363 0.983 . . . . 0.0 111.335 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.51 -40.02 92.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.51 1.05 . . . . 0.0 110.289 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -64.4 -41.4 96.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.747 0.419 . . . . 0.0 109.903 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.02 -39.84 93.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.379 0.671 . . . . 0.0 111.012 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.3 mtp -68.26 -14.66 63.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.596 1.158 . . . . 0.0 111.947 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.81 28.32 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.219 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -64.22 120.05 11.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.1 p -68.66 -28.03 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -167.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.18 126.04 8.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.44 1.096 . . . . 0.0 109.665 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -144.56 149.82 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -139.64 135.08 32.89 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -79.39 110.68 14.9 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.45 70.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.814 0.446 . . . . 0.0 111.932 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.7 -141.44 9.74 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.23 168.41 24.62 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 tp -54.31 -36.07 63.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.866 1.266 . . . . 0.0 112.267 -173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.32 -9.04 58.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.049 0.94 . . . . 0.0 113.083 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.37 -31.11 2.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.459 1.027 . . . . 0.0 113.253 -168.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.43 129.94 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.93 -13.55 55.83 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.24 158.6 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.08 0.952 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.36 164.83 29.1 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.977 2.451 . . . . 0.0 111.51 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -132.83 158.16 43.19 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.054 0.942 . . . . 0.0 110.267 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.74 157.78 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.346 1.859 . . . . 0.0 108.216 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -66.08 161.64 21.29 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.381 -0.825 . . . . 0.0 110.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 170.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.56 151.83 31.14 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.396 1.478 . . . . 0.0 107.305 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -139.84 149.62 43.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.672 1.589 . . . . 0.0 107.179 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -119.04 112.95 20.2 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.14 107.44 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.42 142.55 58.15 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.86 7.05 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.093 0.957 . . . . 0.0 111.766 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -63.88 165.81 8.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.661 1.119 . . . . 0.0 110.472 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.36 147.82 66.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.36 -38.15 76.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.043 1.829 . . . . 0.0 113.125 -167.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.89 -26.48 66.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.185 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.04 -34.92 32.46 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -45.61 85.66 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.994 0.518 . . . . 0.0 110.861 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -61.31 -22.34 64.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -67.26 -35.46 79.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.63 -171.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 176.78 141.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.144 2.578 . . . . 0.0 106.8 169.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.61 155.27 40.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.492 1.117 . . . . 0.0 109.723 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.11 134.09 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.059 0.943 . . . . 0.0 109.27 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.72 141.32 49.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.368 0.667 . . . . 0.0 110.177 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.87 55.42 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.674 1.13 . . . . 0.0 114.236 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.59 177.44 6.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.97 1.385 . . . . 0.0 111.509 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.02 175.7 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.647 1.979 . . . . 0.0 105.752 168.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -138.64 133.11 31.97 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.851 -1.156 . . . . 0.0 109.994 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -140.53 101.78 6.64 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.35 150.88 31.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.375 2.05 . . . . 0.0 111.821 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -46.69 -45.75 19.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.429 1.091 . . . . 0.0 112.968 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -67.73 -10.14 49.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -119.17 -13.69 9.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.707 2.003 . . . . 0.0 111.129 -170.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -49.31 -56.65 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.828 1.651 . . . . 0.0 111.326 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.65 -31.02 65.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.38 -25.11 60.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.188 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.23 -30.31 4.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.883 0.765 . . . . 0.0 112.394 -168.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.95 -34.37 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.609 1.095 . . . . 0.0 111.52 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -8.75 6.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 m -120.92 -34.37 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.797 1.239 . . . . 0.0 110.036 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -35.57 80.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.878 0.763 . . . . 0.0 111.496 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.63 79.24 41.25 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.6 18.54 0.7 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.956 3.104 . . . . 0.0 113.581 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -142.99 113.17 7.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.052 1.341 . . . . 0.0 108.173 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -20.02 57.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.86 -20.33 49.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.761 0.709 . . . . 0.0 111.7 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -75.3 148.37 39.42 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.744 0.702 . . . . 0.0 111.24 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.78 145.04 45.34 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.73 0.812 . . . . 0.0 109.858 -175.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.34 141.44 37.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -120.9 135.93 55.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -129.05 144.39 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -150.77 166.13 31.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.893 1.277 . . . . 0.0 107.829 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.7 p -169.52 -174.58 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.329 1.052 . . . . 0.0 109.242 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -65.36 125.3 24.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.68 17.7 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.491 2.317 . . . . 0.0 115.676 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.07 -8.31 8.56 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 118.563 -1.132 . . . . 0.0 115.176 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -56.66 -53.36 58.54 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.108 1.954 . . . . 0.0 111.191 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.13 -28.5 68.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.38 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 m -75.42 -46.37 33.17 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 110.792 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.8 -43.32 86.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 172.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -66.85 -41.9 86.62 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.637 0.375 . . . . 0.0 111.456 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.65 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.47 0.708 . . . . 0.0 111.134 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -57.14 -37.34 71.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.654 1.115 . . . . 0.0 110.869 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.14 -54.58 23.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.373 0.988 . . . . 0.0 109.939 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 pt -65.31 -35.18 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.418 0.554 . . . . 0.0 110.492 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.76 -35.46 72.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.656 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 m -64.28 -38.6 91.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.812 0.733 . . . . 0.0 110.599 173.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.69 -37.77 82.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.403 0.547 . . . . 0.0 110.885 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -65.94 -33.8 76.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.545 0.611 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.17 -2.53 5.48 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.164 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.45 142.2 57.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.445 1.622 . . . . 0.0 109.124 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -130.88 10.47 5.05 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.751 0.82 . . . . 0.0 111.987 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -136.49 32.71 2.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.938 1.295 . . . . 0.0 110.12 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -88.98 141.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.1 141.69 44.23 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.393 1.077 . . . . 0.0 108.139 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.25 112.33 20.19 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.67 -30.24 70.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.479 0.311 . . . . 0.0 111.698 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.46 -147.37 17.86 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.5 168.29 19.6 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -43.85 -50.33 7.96 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.549 1.539 . . . . 0.0 114.617 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -91.49 -23.89 19.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 119.295 -0.384 . . . . 0.0 111.679 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.37 -38.02 74.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.017 0.527 . . . . 0.0 110.391 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.05 113.59 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.03 58.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.6 mtp -60.67 151.31 72.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.668 0.787 . . . . 0.0 110.547 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.22 160.02 49.49 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.082 2.522 . . . . 0.0 111.141 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 156.63 45.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.963 0.905 . . . . 0.0 110.737 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.6 159.43 24.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.69 1.996 . . . . 0.0 108.307 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -129.06 170.85 12.99 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.336 1.054 . . . . 0.0 111.272 -169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.528 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -147.51 149.33 32.42 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.77 1.228 . . . . 0.0 108.665 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -134.35 157.14 47.14 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.31 1.444 . . . . 0.0 108.34 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -118.98 119.96 35.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -131.32 109.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.76 144.44 56.32 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.8 11.59 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.028 0.831 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -68.6 163.8 22.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.254 -0.903 . . . . 0.0 109.844 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -56.57 147.65 49.41 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.28 -39.44 57.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.818 1.678 . . . . 0.0 113.484 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.51 -25.95 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.528 -0.732 . . . . 0.0 112.011 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.74 -34.66 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -45.28 89.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.825 0.739 . . . . 0.0 110.605 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -52.06 -28.96 19.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.666 0.786 . . . . 0.0 112.754 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.8 -23.44 65.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.252 -1.356 . . . . 0.0 112.73 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 156.26 147.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.968 3.307 . . . . 0.0 110.373 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -151.73 169.44 22.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 109.168 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.13 137.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 110.06 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.34 125.94 22.92 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.176 0.991 . . . . 0.0 109.802 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.28 -1.2 89.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.215 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.57 -173.73 3.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.106 1.453 . . . . 0.0 111.025 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.87 178.52 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.791 2.036 . . . . 0.0 106.232 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -133.97 136.46 44.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.109 -0.994 . . . . 0.0 109.367 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.4 95.99 11.24 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.4 152.34 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.328 2.685 . . . . 0.0 111.946 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 tp -48.11 -40.3 23.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.763 0.825 . . . . 0.0 112.824 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.46 -34.85 77.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 111.944 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -88.14 -25.67 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.615 1.566 . . . . 0.0 111.166 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.0 t -46.62 -47.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.428 1.091 . . . . 0.0 110.336 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -56.62 -20.61 22.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.16 -1.96 5.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.137 0.975 . . . . 0.0 112.305 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -135.63 -20.39 1.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.036 0.835 . . . . 0.0 113.246 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -61.75 -34.88 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.843 1.202 . . . . 0.0 112.14 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.96 68.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.376 0.534 . . . . 0.0 112.321 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 m -66.73 -35.23 79.62 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 0.0 110.462 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.56 -20.98 21.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.751 0.82 . . . . 0.0 112.227 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.1 74.61 79.13 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.34 -7.97 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.327 2.684 . . . . 0.0 113.505 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -138.56 122.76 18.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -59.28 -18.75 40.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.24 -18.83 57.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.233 0.924 . . . . 0.0 112.019 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.84 145.51 54.57 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.441 -0.787 . . . . 0.0 110.59 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -80.48 139.0 36.62 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.93 93.14 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.29 124.78 26.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.83 143.73 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.91 161.26 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.94 0.896 . . . . 0.0 108.692 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 p -164.1 179.71 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.243 1.017 . . . . 0.0 108.396 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.49 135.61 56.22 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 54.56 15.76 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.562 1.945 . . . . 0.0 116.026 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.2 -22.53 0.61 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.857 1.217 . . . . 0.0 116.029 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -53.79 -52.62 59.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.129 1.964 . . . . 0.0 113.139 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.98 -26.25 68.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.357 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -76.4 -44.93 33.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.426 1.012 . . . . 0.0 111.692 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -44.55 96.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.69 -35.5 80.76 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.376 1.07 . . . . 0.0 111.397 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.82 -42.43 70.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 110.571 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -59.98 -40.64 89.82 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 121.19 -0.944 . . . . 0.0 110.704 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.0 -44.01 77.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.694 1.134 . . . . 0.0 111.816 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 pt -67.27 -36.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 120.725 1.602 . . . . 0.0 110.15 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -67.86 -36.66 80.67 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.779 0.718 . . . . 0.0 110.766 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.6 m -63.13 -38.65 92.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.649 0.379 . . . . 0.0 110.416 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.02 -41.06 78.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.995 0.518 . . . . 0.0 110.554 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.7 mtp -64.93 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.394 1.078 . . . . 0.0 111.116 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.36 1.2 6.18 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.355 0.979 . . . . 0.0 114.302 169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -71.58 145.75 48.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.24 1.52 . . . . 0.0 108.817 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -132.31 7.77 4.26 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -137.11 30.71 2.71 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.521 1.128 . . . . 0.0 110.457 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.0 t -87.9 136.31 23.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -144.9 131.86 20.28 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.38 112.27 10.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.85 -30.76 70.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.298 0.639 . . . . 0.0 111.649 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.62 -136.2 6.55 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.46 170.2 25.64 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.92 -41.1 64.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.836 1.254 . . . . 0.0 113.34 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -80.14 -9.04 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.71 -32.83 5.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.769 0.828 . . . . 0.0 111.817 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.6 125.04 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.97 -10.86 59.66 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mtp -63.83 155.6 76.57 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.749 0.82 . . . . 0.0 111.061 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.08 162.0 9.97 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.697 2.931 . . . . 0.0 112.961 170.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.58 160.07 36.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.02 0.928 . . . . 0.0 110.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.61 152.93 21.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 126.422 1.889 . . . . 0.0 107.989 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -64.33 154.45 35.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 176.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.06 154.6 44.13 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.062 1.745 . . . . 0.0 107.191 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -141.74 124.57 16.08 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -86.07 117.11 24.7 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.24 107.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -66.45 134.81 53.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -119.01 10.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.888 0.767 . . . . 0.0 111.189 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -61.62 161.32 10.0 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.796 0.725 . . . . 0.0 109.147 167.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.47 150.7 43.18 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.38 -31.21 43.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.267 1.312 . . . . 0.0 112.396 -168.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.73 -10.78 60.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 112.218 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.66 -32.95 10.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.636 1.107 . . . . 0.0 110.282 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -57.49 -40.4 78.54 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.721 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.24 -34.03 76.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.751 0.42 . . . . 0.0 111.264 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -72.23 -41.86 66.37 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.462 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -164.92 141.8 5.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.447 1.021 . . . . 0.0 109.507 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -155.31 164.74 38.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.06 . . . . 0.0 109.21 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.47 137.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -59.08 117.19 4.43 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 -170.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.81 90.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.314 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.2 141.86 57.91 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.703 1.752 . . . . 0.0 109.73 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.82 169.26 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.6 t-20 -131.8 128.65 39.2 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.955 -1.09 . . . . 0.0 109.845 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.71 90.45 19.59 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.2 152.84 7.57 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.452 2.768 . . . . 0.0 111.845 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -46.87 -44.17 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.86 -30.34 71.44 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.309 0.504 . . . . 0.0 112.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.67 -21.56 23.86 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.082 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.1 t -49.1 -48.41 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.619 1.167 . . . . 0.0 110.129 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.39 -16.14 21.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.39 -3.17 8.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.226 0.921 . . . . 0.0 112.249 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -142.55 -13.75 0.77 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.96 -35.11 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.167 1.348 . . . . 0.0 111.984 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.65 67.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.397 0.544 . . . . 0.0 112.419 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 m -68.9 -38.98 79.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.952 0.796 . . . . 0.0 110.127 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.33 -23.26 35.19 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.222 0.609 . . . . 0.0 112.168 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.9 75.92 78.92 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.31 -14.73 37.99 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.195 2.597 . . . . 0.0 113.663 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -145.56 138.4 26.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -57.53 -23.94 53.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -67.42 -26.22 66.31 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.281 0.946 . . . . 0.0 112.067 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -68.56 143.95 54.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.335 0.516 . . . . 0.0 110.752 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.07 145.71 35.67 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.53 136.63 48.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -123.5 121.04 34.66 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 m -114.77 141.85 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -152.04 170.84 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.98 -165.6 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.442 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.2 OUTLIER -52.64 -52.29 56.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.809 0.844 . . . . 0.0 111.719 -177.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.7 31.48 2.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.135 1.374 . . . . 0.0 111.352 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.33 -24.1 2.18 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.666 -1.075 . . . . 0.0 115.321 170.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.9 mmt-85 -66.39 -44.59 82.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.285 2.043 . . . . 0.0 113.624 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -64.16 -33.98 77.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.825 1.193 . . . . 0.0 109.283 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.69 37.61 Favored 'General case' 0 N--CA 1.46 0.07 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.5 -46.64 91.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -56.89 -44.01 81.9 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.712 0.805 . . . . 0.0 111.323 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.07 87.84 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.707 -0.62 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.11 -40.31 84.96 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.281 -0.887 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.79 -53.1 59.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.098 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -65.22 -34.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-N 120.226 1.375 . . . . 0.0 110.781 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.43 -36.22 76.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.066 0.848 . . . . 0.0 110.77 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 m -63.01 -39.16 93.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.191 0.451 . . . . 0.0 110.366 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -68.2 -42.47 79.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.352 0.661 . . . . 0.0 110.346 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.74 -30.12 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.084 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.52 6.04 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.726 -1.041 . . . . 0.0 114.181 169.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -70.69 148.12 48.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.507 1.653 . . . . 0.0 109.163 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 p -133.78 10.03 3.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.846 0.858 . . . . 0.0 112.068 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -133.75 33.08 3.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.073 1.349 . . . . 0.0 110.213 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.42 138.7 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.02 146.25 40.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.12 112.27 19.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.34 68.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.6 -150.41 22.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.47 156.09 15.83 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 168.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.5 tp -53.41 -39.37 64.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.179 . . . . 0.0 113.439 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.51 -31.82 63.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.954 0.343 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.36 -35.49 27.74 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.469 0.708 . . . . 0.0 111.345 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.73 128.9 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.899 1.279 . . . . 0.0 108.77 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -7.54 59.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.998 0.919 . . . . 0.0 113.274 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mmm -60.28 154.55 52.09 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.524 0.73 . . . . 0.0 110.5 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.53 167.31 21.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.757 2.304 . . . . 0.0 110.989 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -128.73 173.63 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.449 1.1 . . . . 0.0 110.104 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.66 164.22 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.442 1.497 . . . . 0.0 107.05 167.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -146.13 156.5 43.48 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.943 1.697 . . . . 0.0 108.168 -169.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 176.134 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.27 165.47 30.0 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -135.79 126.68 27.59 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -90.18 121.54 32.31 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.66 111.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -71.19 125.31 26.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.01 12.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 123.082 0.553 . . . . 0.0 110.828 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -54.66 156.84 3.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.873 0.76 . . . . 0.0 111.444 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.19 143.74 24.15 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 166.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -60.17 -33.76 94.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.622 1.548 . . . . 0.0 113.849 -166.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.74 -36.99 81.56 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.566 -0.709 . . . . 0.0 111.16 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.22 -32.93 56.21 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.59 -50.5 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.598 0.759 . . . . 0.0 110.633 170.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -63.61 -24.9 67.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.48 -38.81 92.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.538 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -179.96 135.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.39 2.276 . . . . 0.0 106.307 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -145.5 162.92 36.26 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.535 1.134 . . . . 0.0 110.589 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.72 127.34 27.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.74 151.85 28.4 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 111.841 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.72 -12.85 45.69 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.585 1.088 . . . . 0.0 114.006 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 172.15 11.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.717 1.259 . . . . 0.0 111.578 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -113.39 166.83 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.337 1.855 . . . . 0.0 106.017 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -122.74 126.34 47.3 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 119.238 0.927 . . . . 0.0 109.638 172.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.7 mt -136.23 87.52 22.87 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 143.14 41.55 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.184 2.589 . . . . 0.0 112.812 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.06 -21.33 30.71 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.379 1.072 . . . . 0.0 111.586 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.36 -32.38 70.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.023 1.329 . . . . 0.0 113.334 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -134.95 -2.77 2.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.43 1.092 . . . . 0.0 113.508 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.4 p -52.66 -38.2 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 113.957 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.92 -27.15 63.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.249 0.932 . . . . 0.0 112.293 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.18 -7.97 49.92 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 112.153 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -139.18 -15.75 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.0 -40.18 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.698 1.136 . . . . 0.0 111.135 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.38 74.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.375 0.534 . . . . 0.0 111.53 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 m -68.75 -43.72 75.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.7 . . . . 0.0 109.862 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -38.22 57.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.881 0.472 . . . . 0.0 112.229 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.29 79.05 32.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.83 -30.31 17.52 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.932 1.755 . . . . 0.0 111.825 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -84.3 101.99 12.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.259 0.624 . . . . 0.0 109.757 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.71 -16.33 56.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -77.21 -20.16 55.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.037 0.835 . . . . 0.0 111.775 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.92 147.42 36.98 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 m -70.88 147.64 48.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.321 0.648 . . . . 0.0 110.599 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.84 141.56 38.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -126.9 121.19 31.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.7 m -114.23 140.1 36.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -147.01 165.12 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.342 1.057 . . . . 0.0 108.265 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 p -148.75 -147.31 0.22 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.93 76.61 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.985 0.812 . . . . 0.0 110.361 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.25 -22.37 0.44 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.01 -29.91 0.48 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.434 1.47 . . . . 0.0 116.233 171.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.99 -57.69 11.68 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.3 2.05 . . . . 0.0 112.481 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -33.52 72.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.632 0.651 . . . . 0.0 109.629 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -52.53 58.54 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.554 0.742 . . . . 0.0 111.654 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.0 91.0 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -54.93 -47.52 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.155 0.982 . . . . 0.0 110.331 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -48.28 76.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 111.08 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.21 -42.93 82.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.809 0.731 . . . . 0.0 109.926 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.27 -53.34 56.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.987 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -67.25 -34.88 71.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.779 1.172 . . . . 0.0 111.333 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.42 -35.58 75.85 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.898 1.226 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -62.05 -43.06 99.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.059 0.39 . . . . 0.0 109.958 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -65.21 -38.15 89.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.421 0.689 . . . . 0.0 111.26 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -69.84 -7.06 36.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.987 1.315 . . . . 0.0 112.309 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 4.52 47.47 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.737 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.26 143.23 52.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.432 1.616 . . . . 0.0 106.92 168.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.404 ' HG1' ' CD2' ' A' ' 68' ' ' HIS . 2.1 p -122.47 7.38 9.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.907 0.483 . . . . 0.0 112.171 -171.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.404 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 70.3 m-70 -140.8 36.6 1.79 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.658 1.183 . . . . 0.0 110.148 -170.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -105.35 130.89 55.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.38 148.0 40.62 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -78.76 115.91 18.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.29 70.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.807 0.443 . . . . 0.0 111.798 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.24 5.97 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.31 168.83 30.9 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -36.49 62.47 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.721 1.608 . . . . 0.0 110.329 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -54.92 -23.07 17.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 113.599 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -131.12 -32.35 1.6 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.66 125.99 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.216 0.917 . . . . 0.0 108.628 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.97 -4.55 56.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.05 0.94 . . . . 0.0 113.287 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.12 154.49 69.51 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.923 0.889 . . . . 0.0 111.062 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.95 153.03 21.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.793 2.995 . . . . 0.0 113.631 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -127.75 156.88 41.74 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.824 0.85 . . . . 0.0 110.904 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 164.94 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.598 1.559 . . . . 0.0 108.022 168.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -137.61 168.54 19.47 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.576 1.15 . . . . 0.0 110.157 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.748 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.98 161.49 38.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.371 1.068 . . . . 0.0 109.546 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -144.34 153.45 42.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.984 1.714 . . . . 0.0 107.125 169.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -111.21 108.55 18.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.06 112.07 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -81.97 125.45 30.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.85 -0.36 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -63.28 167.63 5.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.193 1.36 . . . . 0.0 109.644 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.36 152.77 30.61 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.02 -27.93 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 121.807 1.671 . . . . 0.0 112.175 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.14 -0.65 12.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.613 1.165 . . . . 0.0 112.561 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -112.6 -33.2 6.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.856 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -53.53 -46.61 70.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.692 1.133 . . . . 0.0 110.407 168.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -61.84 -25.35 67.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -70.16 -50.45 40.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.635 0.652 . . . . 0.0 109.92 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -168.55 143.18 3.32 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -145.5 151.43 38.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.627 1.171 . . . . 0.0 110.041 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.18 125.33 8.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -52.76 113.16 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.024 0.93 . . . . 0.0 111.133 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 2.94 80.34 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.975 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.31 141.13 58.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.555 1.678 . . . . 0.0 109.709 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.73 132.15 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.56 108.87 4.54 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.532 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.2 78.69 14.83 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 167.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.37 156.86 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.813 3.676 . . . . 0.0 113.426 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -52.57 -35.68 54.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.705 0.802 . . . . 0.0 112.617 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -70.04 -16.49 63.16 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -116.27 -28.01 6.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.224 1.41 . . . . 0.0 111.332 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.11 -41.21 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 125.103 1.361 . . . . 0.0 113.277 -167.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -59.65 -29.35 67.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.091 0.86 . . . . 0.0 112.287 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.13 -24.95 40.13 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 0.0 111.718 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.84 -17.37 4.48 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -166.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 tp -60.67 -35.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.601 1.546 . . . . 0.0 111.496 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.78 -8.92 12.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -118.96 -35.15 3.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.955 1.302 . . . . 0.0 109.562 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.71 83.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 111.068 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -140.02 76.43 27.78 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.199 1.399 . . . . 0.0 107.565 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.56 -35.77 94.67 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.433 2.088 . . . . 0.0 112.723 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -78.84 102.25 8.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.544 0.737 . . . . 0.0 110.052 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -64.07 -14.09 52.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -79.53 -16.7 55.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.371 0.987 . . . . 0.0 112.034 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.51 148.21 49.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.065 -1.022 . . . . 0.0 111.017 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -78.46 100.55 6.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.095 0.558 . . . . 0.0 109.679 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -80.81 89.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -66.57 130.08 42.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -128.85 143.25 41.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.44 166.73 29.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -158.09 -140.7 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -123.64 133.96 53.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 60.24 15.69 5.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.03 1.732 . . . . 0.0 114.968 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.7 -31.11 1.25 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.234 1.397 . . . . 0.0 115.672 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -53.03 -49.33 66.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.293 1.547 . . . . 0.0 113.934 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.52 -33.34 73.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.743 1.156 . . . . 0.0 110.98 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -74.7 -40.21 61.48 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.591 1.087 . . . . 0.0 112.79 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.27 -44.86 96.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -59.99 -42.93 95.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.662 1.185 . . . . 0.0 111.369 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.15 90.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.757 0.708 . . . . 0.0 110.523 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -60.61 -37.9 82.94 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.96 -1.087 . . . . 0.0 110.844 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.65 -49.84 69.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.866 0.867 . . . . 0.0 110.61 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.86 -36.24 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.883 1.22 . . . . 0.0 111.009 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.05 -34.79 71.57 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.008 0.822 . . . . 0.0 110.906 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -67.87 -34.76 77.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.732 0.696 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.57 -38.31 89.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.99 0.814 . . . . 0.0 110.475 172.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -69.82 -8.98 52.87 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.383 1.073 . . . . 0.0 112.385 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.03 6.39 51.97 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.192 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.3 144.5 51.71 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.603 1.701 . . . . 0.0 108.298 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 p -126.14 4.68 7.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.126 0.57 . . . . 0.0 112.376 -171.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -139.28 31.53 2.14 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.532 1.133 . . . . 0.0 110.251 -173.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.1 133.69 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.95 122.7 15.29 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.19 110.83 11.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.58 67.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.092 0.557 . . . . 0.0 111.817 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.33 -142.92 10.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.35 162.87 19.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 168.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 tp -42.03 -48.43 4.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.995 1.318 . . . . 0.0 114.081 -168.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.57 -13.5 62.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.95 -12.26 10.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.273 1.029 . . . . 0.0 112.467 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.61 134.01 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -20.07 61.43 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.5 mmm -62.64 156.29 64.87 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 110.885 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.45 156.88 64.29 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.336 2.024 . . . . 0.0 110.283 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 149.12 36.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.054 0.942 . . . . 0.0 109.081 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.9 m -147.24 162.83 7.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 108.923 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.5 148.47 15.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.359 0.664 . . . . 0.0 110.219 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 175.221 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -154.43 162.47 41.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.153 0.981 . . . . 0.0 109.466 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -143.29 145.69 32.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.716 1.606 . . . . 0.0 106.695 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -105.07 122.89 46.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.76 119.55 53.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -75.38 128.02 34.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.55 12.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 119.461 1.028 . . . . 0.0 111.087 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -62.66 162.71 10.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.39 -0.818 . . . . 0.0 110.571 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.6 147.74 49.24 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.309 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.81 -31.69 67.98 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.905 1.736 . . . . 0.0 112.969 -167.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.8 -28.89 66.1 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.599 -0.688 . . . . 0.0 111.828 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -80.9 -38.62 27.67 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -41.52 76.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.738 0.415 . . . . 0.0 111.049 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -58.91 -30.03 67.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.113 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -67.14 -50.31 61.72 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.815 0.734 . . . . 0.0 110.269 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.06 156.22 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.898 1.279 . . . . 0.0 108.351 168.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -153.53 160.34 42.47 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.829 1.252 . . . . 0.0 108.807 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.88 142.61 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.718 0.807 . . . . 0.0 109.215 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.34 157.84 8.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.904 0.482 . . . . 0.0 111.664 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.36 41.17 91.47 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.676 0.655 . . . . 0.0 112.681 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.41 178.1 7.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.696 1.198 . . . . 0.0 110.996 -174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.79 169.91 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.309 2.244 . . . . 0.0 106.42 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -126.2 131.15 52.04 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 110.107 172.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.37 89.03 9.61 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.51 153.89 16.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.347 2.698 . . . . 0.0 113.03 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -52.8 -34.69 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.589 0.756 . . . . 0.0 112.747 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.31 -14.39 62.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -122.84 -24.32 4.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.246 1.418 . . . . 0.0 111.345 -169.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.44 -38.69 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 124.451 1.101 . . . . 0.0 112.429 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -57.33 -27.93 62.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.751 0.705 . . . . 0.0 112.118 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -99.47 -6.18 28.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 0.0 112.11 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -137.59 -23.32 1.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -167.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.58 -35.82 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 121.131 1.787 . . . . 0.0 110.903 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.3 -30.67 69.64 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.335 0.516 . . . . 0.0 111.814 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -79.28 -45.36 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.908 0.883 . . . . 0.0 109.764 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.36 66.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.241 0.617 . . . . 0.0 112.495 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.41 76.56 36.85 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.019 1.728 . . . . 0.0 106.508 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 -20.65 30.74 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.75 101.75 2.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 109.331 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.12 -9.93 35.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.737 0.815 . . . . 0.0 112.7 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -109.44 12.81 24.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.701 1.2 . . . . 0.0 111.19 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.62 148.74 51.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 169.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -78.89 83.46 5.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.34 109.07 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -98.5 127.69 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.1 141.58 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 123.118 0.567 . . . . 0.0 109.488 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -149.05 172.47 14.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.9 p -157.8 -162.61 1.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -46.26 91.18 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.05 -0.407 . . . . 0.0 112.082 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 18.54 3.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.209 1.404 . . . . 0.0 112.762 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.69 -17.53 44.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.987 -1.071 . . . . 0.0 114.874 172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -67.62 -50.65 57.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.7 1.75 . . . . 0.0 111.903 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.97 -33.28 71.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 110.076 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -76.5 -40.84 48.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.78 0.718 . . . . 0.0 112.808 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.55 -43.35 99.14 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -58.87 -47.16 85.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.133 1.373 . . . . 0.0 110.793 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.24 86.25 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.661 -0.649 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.38 -34.05 68.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.527 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.6 -54.73 31.26 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.319 0.963 . . . . 0.0 109.83 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -68.31 -30.93 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 121.538 -0.726 . . . . 0.0 111.616 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.9 -40.47 95.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.446 1.021 . . . . 0.0 110.101 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -66.22 -41.32 90.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.561 0.344 . . . . 0.0 110.242 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -65.24 -36.44 84.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.625 0.648 . . . . 0.0 111.109 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.5 mtm -73.39 -2.81 23.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.168 0.987 . . . . 0.0 112.266 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.36 17.2 59.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.354 -1.248 . . . . 0.0 114.261 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -63.99 129.98 42.23 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.692 1.746 . . . . 0.0 107.077 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 p -65.21 -33.55 76.27 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.717 0.407 . . . . 0.0 111.904 -168.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.36 154.34 33.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 109.319 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -148.13 146.51 17.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -129.46 122.12 28.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.43 104.91 7.19 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.15 69.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.917 0.487 . . . . 0.0 111.811 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.95 -148.29 19.4 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.64 165.1 21.62 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -49.5 -49.28 46.45 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.677 1.191 . . . . 0.0 112.41 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.7 -36.24 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.674 0.39 . . . . 0.0 111.38 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.91 -37.31 62.11 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.458 0.703 . . . . 0.0 111.751 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.16 125.27 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -19.85 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 61.4 mtm -63.91 155.25 78.57 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.384 0.674 . . . . 0.0 111.165 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.78 165.8 28.42 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.612 2.874 . . . . 0.0 112.563 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -126.84 156.59 41.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.588 1.155 . . . . 0.0 110.151 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -143.54 160.74 16.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.476 1.91 . . . . 0.0 108.345 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -57.65 149.55 21.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.798 -0.564 . . . . 0.0 109.511 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 173.241 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.84 161.05 40.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.382 1.073 . . . . 0.0 109.662 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -139.48 137.29 35.41 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -89.87 118.72 29.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.38 104.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -168.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.46 145.07 56.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.86 15.44 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.335 -0.853 . . . . 0.0 112.496 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.89 160.98 5.28 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.432 -0.793 . . . . 0.0 110.545 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -54.6 146.92 32.48 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.86 -31.4 91.6 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.191 1.927 . . . . 0.0 113.778 -166.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.59 -29.75 63.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.657 -0.652 . . . . 0.0 111.999 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -84.29 -31.69 24.76 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.04 0.836 . . . . 0.0 109.127 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -49.27 64.97 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.767 0.827 . . . . 0.0 111.204 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.15 -18.65 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.882 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -69.32 -31.53 70.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.806 -171.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 176.23 133.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.833 2.453 . . . . 0.0 105.973 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -147.68 161.97 40.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.911 1.232 . . . . 0.0 109.782 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.86 136.33 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.54 142.86 54.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.581 0.752 . . . . 0.0 109.812 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 46.02 42.1 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.004 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.55 178.76 6.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.129 1.371 . . . . 0.0 110.277 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.94 176.22 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.561 1.944 . . . . 0.0 106.924 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.19 139.71 50.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.927 0.891 . . . . 0.0 109.181 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -139.92 85.2 14.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.21 145.86 84.72 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.189 1.926 . . . . 0.0 112.772 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.6 tp -54.69 -25.39 26.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.015 0.526 . . . . 0.0 111.509 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.7 -22.71 65.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.232 1.013 . . . . 0.0 113.511 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -131.24 -10.05 3.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.484 1.038 . . . . 0.0 112.83 -169.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -46.26 -42.57 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.59 1.956 . . . . 0.0 113.387 -169.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.29 -25.18 61.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.285 0.948 . . . . 0.0 112.98 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -114.87 5.84 15.26 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.017 1.327 . . . . 0.0 110.983 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -136.85 -25.2 1.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.14 -167.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -34.66 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 120.261 1.391 . . . . 0.0 112.086 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.89 67.14 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.553 0.615 . . . . 0.0 112.104 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -66.19 -35.98 81.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.659 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 -25.28 20.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.302 0.641 . . . . 0.0 112.096 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.02 78.05 41.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.57 -8.48 20.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.142 2.561 . . . . 0.0 113.652 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.94 134.77 30.44 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.204 1.001 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.29 -16.46 64.29 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -19.67 60.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.737 1.153 . . . . 0.0 112.334 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 146.54 44.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.034 0.834 . . . . 0.0 110.809 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -78.37 138.13 38.37 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.007 -0.433 . . . . 0.0 110.092 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.1 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -84.16 93.21 8.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -83.85 142.8 12.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -150.47 165.24 33.81 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.668 0.787 . . . . 0.0 109.473 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.8 p -158.86 -160.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.434 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.2 OUTLIER -57.58 -51.5 69.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.301 0.5 . . . . 0.0 111.157 -177.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.18 23.52 2.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.574 1.149 . . . . 0.0 112.319 -169.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.92 -3.65 64.18 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.364 -1.242 . . . . 0.0 114.96 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -68.6 -53.59 21.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.707 2.254 . . . . 0.0 111.108 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -61.13 -31.85 71.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -66.7 -48.23 69.9 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.268 1.027 . . . . 0.0 112.452 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.61 91.45 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -55.67 -46.37 77.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.332 1.053 . . . . 0.0 110.927 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.25 80.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.079 0.552 . . . . 0.0 111.214 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.82 -39.76 90.19 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 120.03 1.286 . . . . 0.0 110.516 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -58.05 -53.08 62.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.32 0.964 . . . . 0.0 110.483 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.76 -39.69 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 118.495 0.589 . . . . 0.0 110.492 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.55 -35.86 70.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.175 0.898 . . . . 0.0 110.857 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -63.92 -41.49 97.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.57 -39.25 88.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.168 0.587 . . . . 0.0 111.008 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.0 mtp -66.34 -18.39 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.52 1.128 . . . . 0.0 111.765 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.92 8.0 24.6 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.717 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -71.68 97.85 1.82 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.508 1.654 . . . . 0.0 107.627 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.414 ' HG1' ' CD2' ' A' ' 68' ' ' HIS . 1.3 p -79.02 6.32 9.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.541 1.136 . . . . 0.0 113.185 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 47.1 m-70 -136.33 31.2 2.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.471 1.108 . . . . 0.0 111.504 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.9 140.93 15.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 170.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.19 145.01 28.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -85.38 114.59 22.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -33.82 76.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.433 0.293 . . . . 0.0 111.482 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.75 -156.42 26.68 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.33 160.88 18.27 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -43.01 -56.06 3.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.182 1.793 . . . . 0.0 113.431 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.82 -16.39 32.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.667 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.33 -34.64 65.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.588 0.631 . . . . 0.0 110.919 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.8 126.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 55.55 3.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.471 1.508 . . . . 0.0 111.161 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.2 mtp -136.51 160.62 66.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 125.455 1.502 . . . . 0.0 108.67 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 163.2 34.73 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.546 2.164 . . . . 0.0 111.284 173.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -131.91 156.53 45.96 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.13 0.972 . . . . 0.0 109.646 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.12 160.3 20.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.246 1.819 . . . . 0.0 107.986 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -138.08 166.87 23.03 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.942 0.897 . . . . 0.0 110.931 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -174.391 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -155.41 161.01 41.09 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.948 0.899 . . . . 0.0 109.61 -171.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -144.17 129.27 18.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.582 1.153 . . . . 0.0 108.192 171.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.65 117.51 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.39 105.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -68.37 149.25 49.6 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.46 12.98 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.591 0.756 . . . . 0.0 111.58 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -53.72 156.39 2.74 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 121.649 -0.657 . . . . 0.0 111.16 171.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.26 149.25 38.07 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 167.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.81 -34.44 95.74 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.331 2.02 . . . . 0.0 114.048 -166.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.11 -27.37 61.66 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.301 -0.875 . . . . 0.0 111.815 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -82.36 -34.48 28.41 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.29 -48.81 73.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.08 0.952 . . . . 0.0 110.726 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.86 2.62 3.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -75.02 -61.3 1.93 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.952 1.251 . . . . 0.0 108.716 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.61 149.26 8.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.277 1.831 . . . . 0.0 107.006 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -151.01 166.82 29.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.873 0.76 . . . . 0.0 110.401 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -60.03 137.18 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.127 0.971 . . . . 0.0 109.497 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.76 135.0 56.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.117 0.567 . . . . 0.0 109.593 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.71 2.96 53.27 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 118.833 -0.982 . . . . 0.0 114.744 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.91 -178.75 3.89 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.207 1.503 . . . . 0.0 111.101 174.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.04 171.2 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.424 1.89 . . . . 0.0 106.699 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -132.56 139.69 47.96 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.134 0.879 . . . . 0.0 110.924 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mt -142.37 82.14 13.21 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.26 143.87 62.52 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.49 2.126 . . . . 0.0 112.78 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.16 -30.02 47.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.74 -13.93 61.44 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -129.5 -14.86 4.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.608 1.163 . . . . 0.0 112.107 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.77 -39.51 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.913 1.685 . . . . 0.0 113.196 -169.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 -20.63 62.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.236 0.925 . . . . 0.0 112.653 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -111.81 7.13 20.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 111.115 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -137.58 -30.41 0.83 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -167.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.48 -38.56 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.747 1.158 . . . . 0.0 110.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.15 90.4 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.315 0.507 . . . . 0.0 111.562 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 -38.54 55.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.236 0.615 . . . . 0.0 111.068 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.51 72.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.393 0.542 . . . . 0.0 111.749 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.43 79.25 20.96 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.289 1.436 . . . . 0.0 107.644 -172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.82 -36.05 97.64 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.335 2.023 . . . . 0.0 112.856 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -83.77 104.38 13.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.608 0.763 . . . . 0.0 110.515 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.03 -14.45 60.46 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.46 -14.14 59.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.492 1.042 . . . . 0.0 111.971 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.6 143.84 57.5 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.171 -0.955 . . . . 0.0 110.991 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -81.99 97.58 8.18 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.3 94.69 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.05 79.43 5.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.66 139.27 19.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -147.89 165.59 30.18 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.015 0.926 . . . . 0.0 109.462 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.5 p -169.0 -160.46 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.211 1.004 . . . . 0.0 109.145 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.53 128.34 34.01 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.45 13.83 0.5 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.536 1.934 . . . . 0.0 115.433 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.1 3.78 46.39 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.194 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.0 -39.63 61.11 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.353 2.076 . . . . 0.0 112.806 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.82 -30.56 69.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.603 1.092 . . . . 0.0 109.221 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -69.14 -48.41 62.47 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.03 0.932 . . . . 0.0 111.727 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.7 -43.57 98.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -57.95 -47.86 81.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.575 0.75 . . . . 0.0 111.241 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.53 88.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.171 0.588 . . . . 0.0 111.354 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -57.52 -35.93 70.9 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.213 -0.929 . . . . 0.0 111.445 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.94 -55.03 33.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.235 0.925 . . . . 0.0 110.428 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt -68.95 -34.73 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 O-C-N 121.766 -0.584 . . . . 0.0 111.069 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.1 mt -69.33 -37.03 77.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.307 0.958 . . . . 0.0 110.605 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -64.26 -39.96 95.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.472 0.578 . . . . 0.0 109.942 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.69 -39.87 94.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.468 0.577 . . . . 0.0 110.901 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.01 -16.92 64.26 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.255 1.022 . . . . 0.0 111.985 174.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.36 27.82 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.847 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -73.13 106.15 4.87 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.564 1.682 . . . . 0.0 107.586 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.402 ' HG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER -86.09 3.26 43.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 113.058 -172.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 24.4 m-70 -137.95 31.49 2.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.208 1.003 . . . . 0.0 111.382 -169.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.25 130.53 36.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 172.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -142.34 129.24 20.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -75.1 111.46 10.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.88 71.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.826 0.451 . . . . 0.0 111.542 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.52 -153.98 25.36 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.74 165.53 12.34 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 170.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -45.15 -50.32 11.37 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.37 1.468 . . . . 0.0 113.222 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -77.56 -36.76 51.84 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.672 0.389 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.46 -36.25 73.81 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.541 0.736 . . . . 0.0 111.713 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.64 129.18 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.373 1.069 . . . . 0.0 108.497 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 -10.57 59.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.2 mmm -61.26 154.23 63.7 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.663 0.785 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.82 161.01 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.749 2.299 . . . . 0.0 111.09 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -129.26 167.15 18.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.609 1.164 . . . . 0.0 109.18 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.2 151.27 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.517 1.527 . . . . 0.0 106.905 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -67.96 148.28 51.29 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -169.794 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -155.8 155.48 33.09 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.708 1.203 . . . . 0.0 108.208 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -138.92 147.38 42.22 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.651 1.58 . . . . 0.0 106.802 169.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.55 125.45 48.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.61 108.95 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -74.79 119.13 18.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.6 m -105.29 14.23 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 122.946 0.498 . . . . 0.0 111.305 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -55.67 157.24 4.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 118.641 0.655 . . . . 0.0 110.644 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.3 145.69 25.24 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 166.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.62 -30.89 70.55 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.72 1.613 . . . . 0.0 112.825 -166.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -71.26 -21.79 62.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.341 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.67 -34.36 16.29 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.737 1.153 . . . . 0.0 109.347 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -51.87 -46.19 64.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.96 0.504 . . . . 0.0 110.941 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.38 -21.22 66.15 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -73.62 -49.89 23.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.574 1.079 . . . . 0.0 110.508 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -162.66 132.43 4.44 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -151.11 160.78 43.68 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.485 1.493 . . . . 0.0 111.73 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.4 107.06 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -44.05 134.85 4.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.839 1.255 . . . . 0.0 111.753 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.12 -17.94 55.44 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.62 -1.1 . . . . 0.0 112.869 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.45 129.57 40.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.392 1.596 . . . . 0.0 109.259 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.66 156.38 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -111.46 121.29 44.79 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.596 -0.69 . . . . 0.0 109.66 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.2 mt -135.11 84.27 37.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.51 151.46 7.19 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.102 2.535 . . . . 0.0 111.658 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.1 tp -44.95 -44.0 9.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.89 -41.88 97.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.522 0.601 . . . . 0.0 111.336 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -75.07 -22.6 58.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.825 1.65 . . . . 0.0 111.249 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.84 -44.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.539 1.063 . . . . 0.0 109.713 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -61.81 -15.59 43.03 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.24 -20.28 9.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 111.696 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -129.5 -12.38 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.94 -39.24 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 121.362 1.892 . . . . 0.0 111.206 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.79 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.305 0.502 . . . . 0.0 111.787 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 m -68.3 -44.97 74.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.678 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 -39.41 68.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.236 0.614 . . . . 0.0 112.015 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.77 87.64 12.74 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.134 1.889 . . . . 0.0 111.974 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.0 152.68 44.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.364 1.066 . . . . 0.0 109.989 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.73 35.27 4.2 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.569 0.622 . . . . 0.0 112.113 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -142.78 -34.67 0.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.81 150.72 44.09 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.747 0.819 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 m -62.23 132.47 52.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 110.528 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -132.43 139.27 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.56 138.52 53.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.31 141.93 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -147.05 163.51 36.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.3 p -159.82 -154.26 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.277 0.231 . . . . 0.0 111.01 174.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.48 130.21 38.21 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 170.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 55.12 17.68 2.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.298 1.839 . . . . 0.0 114.558 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.13 -13.03 1.04 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.876 1.227 . . . . 0.0 115.188 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -64.55 -44.9 89.31 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 120.056 1.928 . . . . 0.0 111.985 -171.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.44 -30.36 71.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.798 0.726 . . . . 0.0 110.007 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -75.12 -43.41 52.9 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.615 1.098 . . . . 0.0 112.195 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -49.35 78.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -58.26 -40.76 82.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.069 . . . . 0.0 111.977 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.91 -44.17 77.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.483 0.583 . . . . 0.0 109.97 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.06 -35.77 79.61 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.787 1.176 . . . . 0.0 110.498 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.71 -52.97 63.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.557 1.071 . . . . 0.0 110.379 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.0 pt -68.07 -39.43 81.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 119.442 1.019 . . . . 0.0 110.525 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.1 -40.42 94.54 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.394 0.543 . . . . 0.0 110.91 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.87 -39.55 94.8 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.609 0.64 . . . . 0.0 110.136 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.27 -33.93 73.98 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.806 -0.559 . . . . 0.0 111.019 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.6 mtp -73.96 -1.0 17.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.804 1.242 . . . . 0.0 112.08 173.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.35 90.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.848 -1.157 . . . . 0.0 113.136 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.48 55.02 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.364 1.466 . . . . 0.0 108.686 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -67.75 -25.09 65.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.171 1.388 . . . . 0.0 111.869 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.513 ' CD2' ' H ' ' A' ' 68' ' ' HIS . 18.8 p80 -77.5 33.67 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.23 2.612 . . . . 0.0 112.736 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.5 t -120.99 140.41 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.08 1.752 . . . . 0.0 106.427 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.43 141.68 41.64 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.48 114.37 19.33 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.37 -29.97 67.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.904 0.482 . . . . 0.0 112.005 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.28 -139.46 8.12 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.75 169.7 24.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.35 -53.95 7.88 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.391 1.477 . . . . 0.0 112.427 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.79 -37.83 67.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.481 0.313 . . . . 0.0 111.272 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.64 -37.37 68.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.339 0.655 . . . . 0.0 111.787 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.05 131.86 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.288 1.035 . . . . 0.0 108.574 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.52 -8.37 59.55 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.87 151.31 74.02 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.7 0.682 . . . . 0.0 110.676 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 163.83 11.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.123 2.549 . . . . 0.0 111.877 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -136.3 166.54 23.21 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.14 155.85 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.819 1.647 . . . . 0.0 106.556 168.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -138.66 153.47 48.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.081 0.952 . . . . 0.0 109.899 -167.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.972 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.381 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.85 148.25 28.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -133.88 128.2 34.11 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -88.74 122.61 32.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mt -128.55 115.18 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -69.54 129.01 38.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.68 7.59 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.626 0.648 . . . . 0.0 111.615 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -65.59 162.82 17.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.046 0.839 . . . . 0.0 110.206 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.88 146.76 35.89 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.4 -38.6 73.28 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.968 1.778 . . . . 0.0 113.303 -167.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.09 -27.9 68.41 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.557 -0.714 . . . . 0.0 112.045 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -82.74 -33.05 27.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -46.42 79.92 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.178 0.591 . . . . 0.0 110.671 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -61.32 -22.75 65.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -66.19 -44.27 84.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.449 0.568 . . . . 0.0 111.022 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.37 137.9 0.3 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.741 2.017 . . . . 0.0 106.912 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -149.3 164.0 36.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.471 1.109 . . . . 0.0 110.256 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.13 134.86 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.577 0.751 . . . . 0.0 109.798 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -55.14 130.66 42.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.0 88.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.333 171.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.13 -178.74 4.0 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.762 1.281 . . . . 0.0 111.623 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.0 tt -125.88 172.22 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 127.418 2.287 . . . . 0.0 106.531 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -129.8 124.21 32.8 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.484 1.038 . . . . 0.0 110.483 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.2 mt -134.76 87.5 30.61 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 170.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.83 153.94 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.673 2.916 . . . . 0.0 111.366 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.02 -39.0 18.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.655 0.782 . . . . 0.0 112.333 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -65.0 -21.48 66.86 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.129 0.971 . . . . 0.0 113.275 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' CD ' HH12 ' A' ' 32' ' ' ARG . 26.7 mt-10 -111.1 -13.73 14.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.4 1.48 . . . . 0.0 111.752 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -48.78 -52.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.809 1.186 . . . . 0.0 110.489 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -64.26 -10.59 24.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.72 -10.58 12.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.031 0.933 . . . . 0.0 112.141 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.415 HH12 ' CD ' ' A' ' 28' ' ' GLU . 29.8 ttp180 -141.14 -14.91 0.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.98 -36.62 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 120.531 1.514 . . . . 0.0 111.751 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.99 69.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.487 0.585 . . . . 0.0 112.124 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.0 m -68.53 -39.63 81.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.636 0.653 . . . . 0.0 110.06 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.48 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.938 0.495 . . . . 0.0 112.151 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.34 81.18 44.13 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.6 -0.74 10.78 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.213 2.609 . . . . 0.0 114.451 -169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -142.33 137.08 30.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.789 1.177 . . . . 0.0 110.06 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -62.0 -25.89 67.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.537 1.135 . . . . 0.0 113.513 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -13.81 53.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.63 0.65 . . . . 0.0 112.324 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.82 145.88 44.63 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.145 0.884 . . . . 0.0 110.826 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.4 146.51 32.78 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.751 0.42 . . . . 0.0 109.999 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.24 139.14 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.57 95.62 4.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.22 143.11 12.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -147.83 160.39 42.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 p -162.21 -166.37 1.39 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.45 135.69 33.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 56.41 17.12 2.75 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.252 1.821 . . . . 0.0 115.391 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.17 -26.27 1.02 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.853 1.216 . . . . 0.0 115.378 170.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -54.49 -51.5 64.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.737 1.769 . . . . 0.0 112.625 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.57 -29.72 70.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.887 0.767 . . . . 0.0 110.471 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 m -74.46 -43.87 54.18 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.965 0.802 . . . . 0.0 112.138 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 -46.11 94.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.56 -45.04 85.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.83 1.252 . . . . 0.0 110.981 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.42 86.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.622 0.647 . . . . 0.0 110.955 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.04 -40.34 84.73 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.446 -0.784 . . . . 0.0 110.113 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.64 -54.18 43.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.977 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -66.08 -32.93 60.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.881 1.219 . . . . 0.0 111.015 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.12 -34.78 71.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.157 0.89 . . . . 0.0 110.938 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.8 m -63.77 -38.91 92.86 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.261 0.482 . . . . 0.0 110.166 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.02 -40.95 82.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.054 0.542 . . . . 0.0 110.8 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.12 -30.14 71.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.042 0.937 . . . . 0.0 111.004 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.26 0.44 7.46 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.182 -1.343 . . . . 0.0 114.528 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -65.82 151.02 47.6 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.874 1.837 . . . . 0.0 109.217 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -131.42 4.98 4.36 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.32 0.648 . . . . 0.0 112.421 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -136.25 30.3 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.471 1.108 . . . . 0.0 110.823 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.07 136.48 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.25 149.99 42.04 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -85.36 117.13 24.1 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.73 -32.47 74.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.627 0.371 . . . . 0.0 111.503 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.91 -163.92 28.86 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.596 1.57 . . . . 0.0 109.686 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.25 154.28 21.77 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.9 -44.54 63.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.791 0.836 . . . . 0.0 112.422 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.44 -37.26 82.72 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.751 0.42 . . . . 0.0 111.472 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.21 -35.14 61.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.283 0.633 . . . . 0.0 111.497 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.94 128.17 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 108.651 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.53 -8.5 59.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.6 mmm -61.18 153.86 65.03 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.903 0.881 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.86 162.39 42.32 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.058 2.505 . . . . 0.0 111.153 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -129.42 158.71 38.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.767 0.827 . . . . 0.0 110.935 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.68 163.5 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.552 1.941 . . . . 0.0 107.869 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -115.11 163.61 15.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.821 0.848 . . . . 0.0 110.389 -171.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 172.468 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -154.72 157.97 38.86 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.201 1.001 . . . . 0.0 109.33 -171.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -147.84 154.88 41.01 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.52 1.528 . . . . 0.0 107.733 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -99.98 112.16 24.45 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.74 102.95 14.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.11 144.84 55.86 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.49 9.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.499 -0.751 . . . . 0.0 111.583 -172.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -61.28 157.78 15.65 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.89 145.92 40.18 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.14 -32.08 90.87 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.944 1.763 . . . . 0.0 113.708 -165.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.43 -15.43 56.81 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.494 -0.754 . . . . 0.0 112.498 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -88.1 -31.45 19.21 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.757 1.162 . . . . 0.0 108.859 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -50.61 72.72 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.393 0.677 . . . . 0.0 111.385 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -62.26 -23.9 66.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -169.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -63.99 -37.98 89.41 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.664 -0.684 . . . . 0.0 111.725 -172.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -174.49 135.99 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.325 1.45 . . . . 0.0 107.438 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -152.56 157.89 41.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.001 1.273 . . . . 0.0 111.026 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.54 123.11 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.77 158.7 6.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.154 0.982 . . . . 0.0 111.366 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.5 39.22 42.58 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.56 174.28 10.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.292 1.437 . . . . 0.0 110.039 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.62 164.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -121.66 135.4 54.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.01 92.92 10.65 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.53 149.89 37.23 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.963 2.442 . . . . 0.0 113.158 -171.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 tp -56.37 -28.8 60.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.229 0.612 . . . . 0.0 112.364 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -70.18 -22.35 62.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 112.763 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -116.86 -24.76 7.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.145 1.378 . . . . 0.0 112.098 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.1 p -54.81 -35.69 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.363 1.465 . . . . 0.0 113.392 -168.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.6 -18.18 58.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.658 0.663 . . . . 0.0 112.774 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -110.18 4.17 20.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 111.414 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.92 -21.7 0.72 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -62.73 -36.6 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 110.952 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.07 94.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.283 0.492 . . . . 0.0 111.631 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -37.96 63.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.252 0.478 . . . . 0.0 111.116 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.66 -39.41 64.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.36 0.527 . . . . 0.0 111.951 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.01 81.68 15.8 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.93 -26.48 26.74 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.878 1.718 . . . . 0.0 112.242 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -84.36 103.28 13.4 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.422 0.689 . . . . 0.0 110.195 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.41 -14.4 60.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.55 -17.9 62.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.326 0.966 . . . . 0.0 111.769 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.45 141.89 58.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.874 0.761 . . . . 0.0 111.557 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -83.49 82.12 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.53 100.17 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.74 130.57 38.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.59 138.61 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.54 153.3 32.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.584 1.154 . . . . 0.0 108.488 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -154.58 -174.35 4.94 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.862 1.665 . . . . 0.0 109.691 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.78 125.39 23.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.01 17.49 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.912 1.685 . . . . 0.0 114.172 -170.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.35 10.64 23.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 117.668 -1.629 . . . . 0.0 115.632 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -70.35 -44.1 68.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 121.768 2.784 . . . . 0.0 113.781 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.18 -30.53 69.65 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.899 1.227 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -41.27 48.6 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.772 0.829 . . . . 0.0 112.069 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -41.98 97.8 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.43 -45.96 84.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.586 0.754 . . . . 0.0 110.896 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.36 75.43 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.588 -0.695 . . . . 0.0 112.719 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.85 -36.98 68.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.682 1.128 . . . . 0.0 110.463 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.33 -55.41 18.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.135 0.425 . . . . 0.0 110.571 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -66.88 -35.13 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.21 0.914 . . . . 0.0 110.592 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.79 -36.09 62.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.757 -0.589 . . . . 0.0 110.863 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 p -66.66 -35.92 81.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.107 0.867 . . . . 0.0 110.328 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.58 -36.48 82.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.128 0.876 . . . . 0.0 111.472 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.5 mmm -66.44 -16.57 64.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.901 0.88 . . . . 0.0 111.847 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.04 4.99 27.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.32 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -74.89 93.22 2.63 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.409 1.604 . . . . 0.0 107.692 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -75.65 4.7 7.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.371 1.069 . . . . 0.0 113.585 -172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -138.52 24.75 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.316 0.962 . . . . 0.0 112.646 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.76 140.71 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -143.79 138.64 28.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.43 105.57 9.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.7 68.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.318 0.647 . . . . 0.0 111.977 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.12 -150.13 21.55 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.24 168.12 22.7 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 169.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.3 tp -50.16 -46.06 53.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 113.217 -169.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.25 -28.63 34.69 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.782 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -76.05 -38.34 57.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.323 0.649 . . . . 0.0 111.121 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -66.48 123.94 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.08 -7.66 58.99 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -62.06 156.57 57.57 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.94 0.896 . . . . 0.0 110.757 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.24 169.06 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.759 2.306 . . . . 0.0 110.915 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -140.0 164.7 29.32 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.45 1.1 . . . . 0.0 110.196 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.65 158.87 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.092 1.757 . . . . 0.0 108.209 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.96 155.04 40.34 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.289 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 175.149 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.91 161.64 38.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.893 1.277 . . . . 0.0 108.618 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -142.71 129.92 20.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -90.17 115.63 27.56 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mt -125.38 108.19 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.91 138.01 55.67 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 168.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.2 6.88 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.971 0.805 . . . . 0.0 111.66 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -60.26 162.35 6.11 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.934 0.788 . . . . 0.0 110.437 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.47 149.53 60.12 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -64.23 -31.55 63.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.59 1.526 . . . . 0.0 112.636 -168.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.56 -24.63 64.64 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.337 0.655 . . . . 0.0 111.842 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -86.37 -37.14 18.74 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.165 0.893 . . . . 0.0 108.862 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -36.97 78.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.523 0.601 . . . . 0.0 110.894 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.87 -20.52 66.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.415 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.37 -54.23 7.05 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.515 1.052 . . . . 0.0 108.701 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -164.79 153.29 12.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 110.41 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -163.17 176.12 10.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.933 1.693 . . . . 0.0 109.099 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.37 145.0 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.189 -0.944 . . . . 0.0 108.579 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -63.31 146.06 54.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.033 0.933 . . . . 0.0 110.187 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.65 46.51 75.36 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.26 177.16 8.19 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.259 1.424 . . . . 0.0 110.174 -175.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 tt -126.26 176.58 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.012 1.725 . . . . 0.0 107.173 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -132.65 134.23 44.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.366 -0.833 . . . . 0.0 109.45 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.18 89.37 14.42 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.29 151.98 21.03 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.139 2.559 . . . . 0.0 112.896 -172.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.6 tp -51.48 -34.06 33.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.651 0.78 . . . . 0.0 112.177 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.41 -15.95 63.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -125.21 -24.06 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.482 1.113 . . . . 0.0 111.969 -169.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.1 -34.88 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.639 1.176 . . . . 0.0 113.116 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -56.45 -25.38 50.44 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.008 0.822 . . . . 0.0 112.799 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.56 -0.69 20.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.178 0.991 . . . . 0.0 111.659 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -136.67 -24.44 1.17 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -167.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.3 -35.68 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.089 1.768 . . . . 0.0 110.295 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -17.6 41.9 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.269 1.027 . . . . 0.0 113.638 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -117.94 -30.16 5.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.57 1.148 . . . . 0.0 110.969 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.88 85.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.797 0.726 . . . . 0.0 110.914 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.69 77.13 22.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -25.77 38.62 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.215 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -77.04 102.05 6.31 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.36 0.664 . . . . 0.0 110.052 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.46 -13.3 60.6 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.28 -14.85 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.225 0.921 . . . . 0.0 111.735 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.67 147.54 53.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.195 -0.941 . . . . 0.0 111.486 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -77.53 78.71 4.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.949 0.9 . . . . 0.0 109.344 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.09 100.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -92.45 128.73 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.7 m -122.19 142.8 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.265 0.626 . . . . 0.0 109.571 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.92 167.35 30.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.013 1.325 . . . . 0.0 107.588 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.09 -171.14 2.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.417 HD21 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -51.53 -47.59 63.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 112.052 -178.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.32 26.11 2.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 112.41 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.17 -18.15 1.25 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.742 1.163 . . . . 0.0 115.523 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -67.41 -40.45 85.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 120.424 2.112 . . . . 0.0 113.028 -173.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -65.75 -30.3 70.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.714 1.143 . . . . 0.0 109.275 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -73.39 -45.55 54.09 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 124.258 1.023 . . . . 0.0 112.293 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.74 97.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -58.25 -46.33 86.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.88 0.872 . . . . 0.0 111.167 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -37.41 87.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.303 0.641 . . . . 0.0 111.575 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.03 -36.35 74.84 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.986 0.812 . . . . 0.0 111.028 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.53 -54.93 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.853 0.752 . . . . 0.0 110.011 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.3 pt -66.18 -34.79 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.469 0.577 . . . . 0.0 111.195 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.41 -39.79 92.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 0.0 110.339 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -64.53 -42.44 95.74 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.01 -35.93 81.89 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.548 0.613 . . . . 0.0 111.317 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.59 -10.5 59.44 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.254 1.021 . . . . 0.0 111.994 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.89 11.0 47.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.56 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -71.83 135.17 46.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.352 1.576 . . . . 0.0 107.364 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -118.37 4.6 11.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.648 0.779 . . . . 0.0 112.378 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -136.98 29.39 2.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.711 1.204 . . . . 0.0 110.075 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.66 142.32 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -144.03 128.32 17.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.46 110.32 14.65 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.72 71.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.454 0.301 . . . . 0.0 111.248 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.59 -157.95 27.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.29 159.59 14.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 167.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.26 -44.83 65.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.262 1.025 . . . . 0.0 111.791 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -68.74 -11.28 60.11 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.73 -30.19 5.51 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.307 1.043 . . . . 0.0 111.867 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 131.21 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.032 0.933 . . . . 0.0 108.619 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.73 56.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.4 mmm -61.18 154.2 63.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.916 0.886 . . . . 0.0 110.667 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.92 163.46 35.51 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 111.534 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -123.92 165.83 16.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.341 1.056 . . . . 0.0 109.641 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.7 148.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.872 1.669 . . . . 0.0 106.518 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -149.23 151.14 33.75 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.308 1.043 . . . . 0.0 108.803 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 176.41 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.15 169.71 18.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.33 1.052 . . . . 0.0 109.916 175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -137.61 147.31 44.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.318 1.447 . . . . 0.0 107.482 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.09 110.07 21.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.24 107.0 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.1 138.25 49.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.27 8.66 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.084 0.856 . . . . 0.0 111.783 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -62.45 159.02 16.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.899 0.772 . . . . 0.0 110.683 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.5 m -54.67 147.89 28.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.726 0.81 . . . . 0.0 109.337 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.37 -33.0 71.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.867 1.711 . . . . 0.0 112.291 -169.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 -23.82 64.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.17 -34.1 16.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.177 0.898 . . . . 0.0 108.652 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -57.31 -41.11 79.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.416 0.687 . . . . 0.0 110.831 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -62.08 -28.24 69.47 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.695 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.88 -50.51 23.37 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.413 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -167.03 152.33 7.56 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.369 0.986 . . . . 0.0 110.204 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -153.64 167.51 29.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.503 1.521 . . . . 0.0 109.683 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 t -65.85 139.85 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.3 161.76 18.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.089 0.556 . . . . 0.0 112.003 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.99 38.61 84.78 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.886 0.755 . . . . 0.0 111.825 172.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.95 179.37 7.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.299 1.039 . . . . 0.0 111.924 -169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.44 175.9 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.745 2.018 . . . . 0.0 105.994 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.25 133.08 45.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.167 -0.958 . . . . 0.0 108.67 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 mt -136.47 84.04 29.52 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -55.59 146.88 62.11 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.087 2.525 . . . . 0.0 113.026 -172.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -48.72 -34.46 12.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.888 0.875 . . . . 0.0 112.389 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -55.09 -28.48 52.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.631 1.172 . . . . 0.0 112.957 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -140.04 2.81 1.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.093 0.957 . . . . 0.0 113.016 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.36 -39.66 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.7 -29.11 66.39 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.979 0.809 . . . . 0.0 112.122 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.32 -16.78 57.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 111.641 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -125.62 -36.91 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.173 -0.918 . . . . 0.0 113.04 -169.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.67 -36.49 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 120.047 1.294 . . . . 0.0 111.34 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.8 -7.68 5.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.721 1.209 . . . . 0.0 114.103 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.7 m -125.98 -32.59 2.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.787 1.235 . . . . 0.0 109.927 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.92 82.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.687 0.795 . . . . 0.0 111.053 172.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.42 75.66 32.5 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.6 -35.74 16.37 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 111.976 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.69 113.86 11.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.091 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -65.42 -20.95 66.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -21.71 58.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.356 0.662 . . . . 0.0 111.804 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.29 146.51 43.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.558 1.072 . . . . 0.0 110.67 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -75.26 146.57 40.98 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.011 -0.431 . . . . 0.0 110.184 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.7 98.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.74 123.11 23.49 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 m -126.55 140.77 47.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 123.537 0.735 . . . . 0.0 109.097 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -164.14 157.68 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.4 -170.7 1.72 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.644 0.778 . . . . 0.0 109.774 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -68.22 132.41 47.09 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.2 16.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.771 2.028 . . . . 0.0 115.51 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.1 -14.2 0.44 Allowed Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.723 1.154 . . . . 0.0 115.385 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mmt-85 -63.86 -40.09 95.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.352 2.076 . . . . 0.0 112.785 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -27.41 68.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.393 0.542 . . . . 0.0 110.609 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.0 m -79.41 -43.61 23.04 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.862 0.756 . . . . 0.0 111.031 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.28 -43.19 93.74 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -65.73 -42.56 90.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.105 0.562 . . . . 0.0 111.292 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.12 91.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.121 0.568 . . . . 0.0 111.157 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -55.1 -39.02 68.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.352 0.978 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.72 -53.73 30.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.809 0.731 . . . . 0.0 110.204 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 pt -68.14 -33.74 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.793 -0.567 . . . . 0.0 110.964 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.07 -35.89 74.55 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.897 0.772 . . . . 0.0 110.171 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -62.44 -39.63 93.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 110.208 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.43 -38.88 91.2 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.477 0.58 . . . . 0.0 110.748 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.0 mtp -70.43 -9.93 57.76 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.205 1.002 . . . . 0.0 112.41 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 1.74 46.24 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.058 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.29 145.98 54.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.495 1.648 . . . . 0.0 109.153 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 p -131.19 7.88 4.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.992 0.917 . . . . 0.0 111.824 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -137.06 31.05 2.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.848 1.259 . . . . 0.0 110.444 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -75.2 141.54 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -142.12 124.77 15.88 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.49 108.72 8.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -28.96 68.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.62 0.368 . . . . 0.0 111.355 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.76 -144.07 12.22 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.46 175.48 21.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.84 -52.46 8.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.195 1.398 . . . . 0.0 113.064 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.24 -36.35 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.29 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.71 -38.58 62.3 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 111.615 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.8 128.32 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.1 54.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.46 156.42 70.59 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.717 0.807 . . . . 0.0 111.277 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.42 161.64 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.077 3.185 . . . . 0.0 113.722 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -135.48 159.36 41.85 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.672 1.189 . . . . 0.0 109.966 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.45 164.75 11.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.924 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.7 161.73 25.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.355 1.462 . . . . 0.0 110.125 -169.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 174.849 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.72 160.05 40.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.78 0.832 . . . . 0.0 109.576 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -143.11 153.36 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -108.47 117.75 34.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.4 113.11 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -172.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.87 132.62 45.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 165.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.261 4.3 p -127.27 9.52 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.791 0.837 . . . . 0.0 111.145 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -64.57 161.39 17.58 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.961 -1.087 . . . . 0.0 110.121 170.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.48 151.86 58.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.46 -37.32 72.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.94 1.76 . . . . 0.0 112.038 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.3 -6.58 30.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -105.29 -31.23 9.18 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.139 0.881 . . . . 0.0 110.269 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.32 -41.01 88.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.702 1.137 . . . . 0.0 110.266 169.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -64.19 -8.24 11.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.9 0.88 . . . . 0.0 112.644 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.0 -59.9 1.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.3 169.97 16.8 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.836 1.198 . . . . 0.0 111.556 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -154.28 172.91 16.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 108.69 168.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.4 144.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -61.66 159.88 12.58 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.823 -0.548 . . . . 0.0 111.699 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.36 41.93 99.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.435 0.54 . . . . 0.0 112.573 171.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.97 177.69 7.66 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.969 1.308 . . . . 0.0 110.769 -172.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.8 tt -131.97 140.85 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.367 1.467 . . . . 0.0 108.571 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -82.62 121.28 26.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.059 0.944 . . . . 0.0 110.28 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -144.26 75.05 15.54 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -53.71 150.66 28.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.58 2.854 . . . . 0.0 112.147 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.63 -27.14 67.56 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.568 -0.708 . . . . 0.0 111.829 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.11 -10.47 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -129.33 -21.33 3.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.304 1.442 . . . . 0.0 112.082 -168.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.52 -41.38 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.917 1.287 . . . . 0.0 112.706 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.19 -23.4 62.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.792 0.724 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -110.29 2.89 19.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.917 1.287 . . . . 0.0 111.267 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -133.63 -37.4 0.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.536 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.59 -36.83 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.392 1.451 . . . . 0.0 111.395 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.71 -10.53 19.92 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 m -116.18 -35.75 4.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.13 0.972 . . . . 0.0 109.867 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.67 85.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.388 0.675 . . . . 0.0 111.968 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.6 76.6 47.89 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.51 10.45 1.87 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.723 2.949 . . . . 0.0 114.202 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.52 133.74 29.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.53 1.059 . . . . 0.0 108.996 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.64 -15.11 62.23 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -17.54 59.65 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.932 1.242 . . . . 0.0 112.611 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.41 144.47 55.81 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.44 0.564 . . . . 0.0 111.506 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 m -79.65 87.91 5.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.52 82.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.446 1.098 . . . . 0.0 108.37 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.7 132.43 46.14 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.76 143.75 39.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.601 0.761 . . . . 0.0 109.526 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.29 160.02 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.363 0.665 . . . . 0.0 110.664 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.8 p -168.9 -178.94 3.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.771 1.628 . . . . 0.0 108.489 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -58.82 127.53 32.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.642 -0.661 . . . . 0.0 109.483 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.56 16.9 0.7 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.552 1.941 . . . . 0.0 115.311 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.04 1.1 6.24 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 119.628 1.104 . . . . 0.0 115.209 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.6 mmt-85 -69.32 -39.79 78.0 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 120.131 1.965 . . . . 0.0 112.503 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -69.0 -30.17 68.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.319 0.963 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -70.13 -47.65 60.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.341 1.057 . . . . 0.0 111.646 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.16 99.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -57.5 -49.42 76.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.184 0.994 . . . . 0.0 110.948 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.6 81.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.941 0.496 . . . . 0.0 111.903 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.24 -35.39 69.65 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.178 0.899 . . . . 0.0 111.379 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -53.8 46.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.152 0.887 . . . . 0.0 110.254 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 pt -69.44 -33.16 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.805 -0.559 . . . . 0.0 111.083 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.75 -40.22 88.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.125 0.875 . . . . 0.0 110.153 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -63.66 -38.65 91.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.019 0.372 . . . . 0.0 110.348 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.65 -41.27 88.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.131 0.572 . . . . 0.0 110.908 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -64.25 -33.16 75.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.664 0.786 . . . . 0.0 110.965 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 -1.31 5.27 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.419 -1.212 . . . . 0.0 114.189 169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -68.0 125.38 26.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.542 1.671 . . . . 0.0 108.036 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -114.06 9.25 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.91 0.884 . . . . 0.0 112.305 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -133.32 29.01 4.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.654 1.181 . . . . 0.0 110.134 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.41 140.9 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.65 143.29 25.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 115.13 17.17 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.98 74.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.567 0.347 . . . . 0.0 111.015 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.52 -170.86 32.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.737 1.637 . . . . 0.0 109.242 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.52 155.96 38.3 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 168.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.8 -49.84 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.494 1.117 . . . . 0.0 111.642 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -76.97 -33.56 57.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.974 0.509 . . . . 0.0 111.525 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.92 -34.96 76.24 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.526 0.73 . . . . 0.0 111.674 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.2 mt -58.08 126.17 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.4 59.58 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.88 141.35 89.55 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.613 1.165 . . . . 0.0 110.655 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.23 161.58 26.35 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.679 2.919 . . . . 0.0 114.398 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -110.9 161.79 15.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.071 0.948 . . . . 0.0 109.733 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.61 138.84 42.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -65.42 154.46 38.39 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 173.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.02 158.32 44.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.464 0.706 . . . . 0.0 110.084 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -143.47 157.97 44.02 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.332 1.453 . . . . 0.0 108.71 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -99.04 128.03 45.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.67 116.04 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 104.376 -2.454 . . . . 0.0 104.376 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -77.37 129.56 35.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.21 -1.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.829 1.652 . . . . 0.0 109.696 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.41 161.58 11.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.891 1.223 . . . . 0.0 109.515 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -55.81 148.89 34.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.82 0.448 . . . . 0.0 109.803 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.77 -31.19 39.95 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.48 1.453 . . . . 0.0 111.823 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -69.16 -17.61 63.83 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.841 . . . . 0.0 111.725 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -89.77 -40.16 12.66 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 109.416 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -54.0 -43.45 70.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.477 1.035 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.47 -32.71 72.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.908 0.483 . . . . 0.0 111.683 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -83.96 -32.23 25.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.229 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -166.4 127.04 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.379 1.072 . . . . 0.0 108.833 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -158.44 164.49 36.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.106 0.866 . . . . 0.0 110.604 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.88 137.01 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -52.51 119.93 5.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 110.834 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.22 1.59 86.22 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.568 -1.129 . . . . 0.0 114.887 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.29 41.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.599 1.699 . . . . 0.0 111.746 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.86 155.64 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -99.11 105.03 17.08 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 mm -138.17 77.03 37.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.6 159.98 5.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.985 3.124 . . . . 0.0 113.102 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -53.09 -42.65 66.11 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.082 0.553 . . . . 0.0 112.105 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -61.1 -29.83 69.99 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.515 0.726 . . . . 0.0 111.743 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -91.9 -31.44 15.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.868 1.267 . . . . 0.0 110.618 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -44.96 -51.64 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.766 1.167 . . . . 0.0 110.95 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -57.57 -23.34 50.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.38 -2.18 6.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.835 0.854 . . . . 0.0 112.336 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -135.48 -20.73 1.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.494 -169.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.5 -29.27 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.803 1.638 . . . . 0.0 112.401 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.29 61.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.915 0.78 . . . . 0.0 112.717 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -36.12 82.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.851 0.75 . . . . 0.0 110.377 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.65 -27.09 16.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.411 1.084 . . . . 0.0 111.739 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.41 76.6 49.15 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 -14.12 30.48 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.906 2.404 . . . . 0.0 114.063 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.8 152.39 38.69 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -56.31 -27.35 55.34 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.633 1.573 . . . . 0.0 114.222 -171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.14 -32.29 73.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.327 0.651 . . . . 0.0 112.703 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.36 136.06 52.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.036 0.446 . . . . 0.0 109.896 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -84.71 138.24 32.76 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.2 96.21 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 89.58 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.7 m -81.71 138.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -149.49 171.85 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.084 0.954 . . . . 0.0 108.467 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 p -151.97 -153.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 170.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.416 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.1 -47.99 74.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.498 1.045 . . . . 0.0 111.028 -178.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.32 -18.88 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.34 -27.26 1.69 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.542 1.064 . . . . 0.0 114.583 172.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -56.85 -58.32 8.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.363 1.581 . . . . 0.0 113.789 -170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.52 77.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.203 0.911 . . . . 0.0 110.976 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.73 -41.22 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.027 0.531 . . . . 0.0 112.094 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.61 95.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.31 -43.85 79.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.654 1.182 . . . . 0.0 110.567 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.13 70.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.477 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -59.37 -32.29 70.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.209 1.368 . . . . 0.0 111.462 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.1 -53.45 30.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.041 0.837 . . . . 0.0 109.712 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.66 -35.94 76.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.498 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.65 -37.07 84.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.363 0.983 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 m -63.96 -42.07 97.38 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.177 0.444 . . . . 0.0 110.043 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.49 -38.94 91.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.987 0.515 . . . . 0.0 110.836 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 85.1 mtp -70.48 -11.21 60.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.145 1.378 . . . . 0.0 111.945 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.03 48.87 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.822 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -73.89 151.18 40.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.352 1.576 . . . . 0.0 109.336 171.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -139.1 9.13 2.53 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.301 1.041 . . . . 0.0 111.781 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -134.79 38.87 3.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.392 1.477 . . . . 0.0 109.522 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -109.95 138.23 38.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.2 145.21 28.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -79.76 106.03 11.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.91 -28.18 67.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.28 -144.72 11.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.43 165.71 25.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.79 -47.04 51.46 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.333 1.453 . . . . 0.0 110.992 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.65 -2.15 16.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.029 0.932 . . . . 0.0 113.123 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.69 -30.54 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.509 1.124 . . . . 0.0 112.596 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.89 134.54 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.267 1.027 . . . . 0.0 108.512 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.3 -16.56 54.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.6 mtp -63.68 158.81 57.57 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.416 0.686 . . . . 0.0 111.776 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.93 161.13 8.86 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.611 2.874 . . . . 0.0 113.189 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.43 163.8 23.28 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.614 1.166 . . . . 0.0 108.797 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.79 155.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -140.98 168.83 18.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.755 0.822 . . . . 0.0 110.168 -170.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 178.448 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 163.61 33.43 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.364 1.066 . . . . 0.0 109.279 176.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.51 152.89 41.24 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.068 1.747 . . . . 0.0 106.799 169.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -114.3 112.7 23.51 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.75 111.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -69.46 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 166.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.81 7.43 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.785 0.721 . . . . 0.0 111.406 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -64.6 162.15 16.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.038 -1.039 . . . . 0.0 110.462 170.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 m -54.69 144.99 42.67 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.51 -33.67 77.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.104 1.203 . . . . 0.0 111.524 -168.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.84 -29.98 70.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.24 -37.86 16.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.66 -44.68 77.48 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.952 0.501 . . . . 0.0 110.224 176.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -60.48 -25.8 66.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.62 0.768 . . . . 0.0 112.506 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -71.06 -49.1 48.3 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.563 0.62 . . . . 0.0 110.424 -173.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -166.0 133.4 2.79 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -146.46 162.04 39.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.488 1.04 . . . . 0.0 111.36 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.03 135.99 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -60.33 144.9 49.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 110.074 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.18 20.28 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.96 174.57 10.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.042 1.337 . . . . 0.0 110.36 -177.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.05 169.97 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.557 1.943 . . . . 0.0 106.688 170.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -127.67 127.91 44.54 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.186 172.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -136.99 92.38 14.24 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 171.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.8 153.05 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.538 2.825 . . . . 0.0 111.984 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -46.09 -47.83 17.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.548 1.139 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -57.26 -31.35 65.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.697 1.199 . . . . 0.0 112.289 177.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -101.54 -9.34 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.342 1.857 . . . . 0.0 111.943 -169.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -51.43 -53.37 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.036 1.289 . . . . 0.0 110.127 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -61.41 -22.11 64.71 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -82.83 -21.36 34.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.557 -176.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -136.22 -28.02 1.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.99 -36.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 121.195 1.816 . . . . 0.0 111.361 -169.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -6.36 4.44 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 m -126.31 -33.52 2.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.894 -178.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.09 78.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.702 0.801 . . . . 0.0 111.098 172.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 t -139.57 75.73 31.52 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.38 -23.59 32.37 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.238 1.959 . . . . 0.0 112.202 -175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.96 104.99 3.13 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.757 0.823 . . . . 0.0 109.826 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -63.58 -13.05 38.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.26 11.95 34.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.196 0.998 . . . . 0.0 111.369 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.73 146.99 53.22 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.071 -1.018 . . . . 0.0 109.265 168.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -80.24 77.84 6.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.67 111.88 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -92.26 136.74 32.94 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.12 143.78 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.73 168.27 24.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 p -156.33 -159.32 0.88 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.428 ' C ' HD21 ' A' ' 49' ' ' ASN . 0.2 OUTLIER -63.64 -49.79 71.87 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.625 -0.672 . . . . 0.0 110.898 179.426 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.67 35.09 1.43 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.679 1.191 . . . . 0.0 112.5 -168.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 -20.63 1.63 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.962 1.268 . . . . 0.0 115.986 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -64.11 -52.19 60.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.352 2.076 . . . . 0.0 111.831 -174.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -59.16 -30.65 68.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.906 177.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 -47.16 59.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.726 1.148 . . . . 0.0 112.768 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.28 -42.64 97.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.59 -34.72 76.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.414 1.085 . . . . 0.0 111.573 174.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -37.87 64.44 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 176.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -58.88 -39.51 81.64 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.277 -0.889 . . . . 0.0 111.247 -178.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.98 -43.93 81.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.595 1.089 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.2 pt -69.81 -32.8 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.312 1.414 . . . . 0.0 111.01 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -37.95 85.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.246 0.93 . . . . 0.0 110.268 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.3 m -64.21 -40.24 95.65 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.94 -38.41 90.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.172 0.589 . . . . 0.0 110.715 176.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -71.24 -3.62 21.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.72 1.208 . . . . 0.0 112.464 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.76 14.85 64.44 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.304 -1.275 . . . . 0.0 113.883 169.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -62.55 129.19 39.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.613 1.707 . . . . 0.0 107.534 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -66.71 -29.41 69.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.54 0.336 . . . . 0.0 111.665 -169.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.95 158.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 108.741 178.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -149.19 147.36 16.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 175.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -131.99 124.94 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -77.02 112.19 13.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.07 72.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.761 0.424 . . . . 0.0 111.741 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.95 -149.45 21.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -177.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.87 163.11 16.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -50.15 -44.36 52.48 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.132 1.373 . . . . 0.0 111.732 -173.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -75.31 -5.87 46.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.954 0.902 . . . . 0.0 113.057 -175.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.52 -30.56 3.62 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.222 1.009 . . . . 0.0 112.266 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.32 130.5 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.59 -16.32 51.96 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mtp -62.05 156.5 57.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.998 0.919 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 165.16 30.72 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.154 2.57 . . . . 0.0 111.748 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.2 162.34 26.4 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.258 1.023 . . . . 0.0 109.907 -176.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 m -137.04 164.25 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 107.604 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -135.11 162.16 33.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.19 0.996 . . . . 0.0 110.045 -171.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 169.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.12 142.68 42.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 108.34 171.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.15 119.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.406 HD12 HG13 ' A' ' 44' ' ' VAL . 8.6 mt -125.5 109.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.93 132.52 45.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 167.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.56 10.83 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.528 0.731 . . . . 0.0 111.695 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' HD23 ' A' ' 75' ' ' LEU . 4.0 ptp180 -67.83 170.58 7.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.26 1.391 . . . . 0.0 108.708 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.78 150.41 48.07 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.28 -0.887 . . . . 0.0 110.921 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.79 -34.33 61.84 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.479 2.119 . . . . 0.0 112.76 -167.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.68 -27.48 68.38 Favored 'General case' 0 C--O 1.227 -0.131 0 O-C-N 121.301 -0.875 . . . . 0.0 111.224 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -88.35 -30.74 19.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.417 -0.802 . . . . 0.0 112.949 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -53.71 -47.37 70.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 170.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.76 -20.07 66.16 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.081 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.2 -49.32 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -178.88 134.43 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -148.11 160.78 42.53 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.566 1.146 . . . . 0.0 110.067 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.98 131.15 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -56.6 140.76 45.66 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.192 2.197 . . . . 0.0 109.967 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.36 83.91 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.8 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 172.8 7.8 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.527 1.164 . . . . 0.0 109.639 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 tt -112.87 170.87 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 2.9 t-20 -124.12 127.67 48.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.24 86.86 19.06 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.82 149.34 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.704 2.269 . . . . 0.0 111.959 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.8 tp -46.84 -37.64 9.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.99 0.916 . . . . 0.0 112.68 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -62.23 -28.19 69.52 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -113.21 -16.94 12.47 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.426 1.891 . . . . 0.0 108.665 -166.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -41.71 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.675 0.79 . . . . 0.0 110.477 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -57.44 -34.23 68.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.161 0.984 . . . . 0.0 113.578 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.54 -6.87 58.15 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -148.68 -25.11 0.32 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -153.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.85 -35.98 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.93 66.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.707 0.803 . . . . 0.0 112.342 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 -39.36 14.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.798 0.839 . . . . 0.0 109.805 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.47 60.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.782 0.833 . . . . 0.0 112.265 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 t -139.95 75.3 30.2 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.303 1.841 . . . . 0.0 106.867 -173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.92 -17.62 36.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.824 2.35 . . . . 0.0 112.882 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -113.21 123.49 50.31 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 5.1 mtpt -71.08 -26.73 63.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 125.201 1.401 . . . . 0.0 113.239 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.55 -14.55 62.13 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 126.07 2.106 . . . . 0.0 108.634 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.78 146.37 52.97 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.748 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -81.55 117.89 22.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.68 1.228 . . . . 0.0 110.845 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 5' ' ' ILE . 6.7 t -104.85 110.67 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 O-C-N 120.771 -1.205 . . . . 0.0 107.756 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -95.55 119.45 34.07 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.65 141.12 29.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -149.35 171.93 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 31.5 p -165.86 -170.99 1.91 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.734 1.214 . . . . 0.0 108.606 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.07 104.93 1.24 Allowed 'General case' 0 C--O 1.26 1.645 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 85.5 5.67 0.48 Allowed 'General case' 0 C--N 1.404 2.953 1 O-C-N 129.974 4.546 . . . . 0.0 111.282 156.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.92 63.15 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.171 0.891 . . . . 0.0 112.731 162.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -52.16 43.76 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 121.646 -0.914 . . . . 0.0 113.351 -165.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -61.16 -29.48 69.82 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.88 -45.92 55.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.582 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.64 95.92 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.55 -45.75 91.49 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.406 1.482 . . . . 0.0 111.788 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.34 88.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 69' ' ' VAL . 61.0 tttt -58.6 -42.2 87.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.604 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.57 -56.34 23.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.529 1.059 . . . . 0.0 110.091 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.1 pt -66.77 -31.96 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.155 -0.34 . . . . 0.0 110.359 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -71.59 -41.73 68.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.138 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.8 m -57.18 -41.29 79.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.943 0.792 . . . . 0.0 109.54 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -67.11 -39.04 86.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.611 0.641 . . . . 0.0 110.646 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.94 -10.18 51.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.846 -1.159 . . . . 0.0 111.281 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.92 13.19 47.34 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.608 1.575 . . . . 0.0 113.345 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 80.9 m-85 -70.22 130.12 41.19 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.709 1.754 . . . . 0.0 107.492 166.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 -2.07 18.3 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.06 0.544 . . . . 0.0 111.61 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -131.76 34.35 3.89 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 110.241 -169.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 37.2 t -85.67 139.12 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -141.12 129.14 21.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.39 1.076 . . . . 0.0 108.464 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.06 109.4 10.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.76 69.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.272 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.07 -153.01 25.01 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 162.39 12.63 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 166.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.512 HD23 ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -37.3 -51.49 1.06 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.846 2.058 . . . . 0.0 110.823 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -68.58 -40.72 80.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.4 -33.38 32.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.943 -1.935 . . . . 0.0 107.176 -168.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.39 123.76 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -8.78 58.68 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mtp -66.47 152.76 94.28 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.473 0.709 . . . . 0.0 110.925 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.58 162.08 22.32 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.168 2.579 . . . . 0.0 112.191 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.486 ' HE2' HD13 ' A' ' 75' ' ' LEU . 9.9 mptt -130.46 156.39 44.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.096 0.958 . . . . 0.0 108.659 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--N 1.324 -0.51 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.83 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 C--O 1.236 0.386 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.59 140.45 27.41 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 108.953 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -80.26 102.96 9.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 168.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -112.27 94.69 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -65.84 156.2 34.0 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.53 16.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.325 1.05 . . . . 0.0 111.688 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -54.97 159.71 2.26 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.871 1.268 . . . . 0.0 111.795 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.13 145.96 32.38 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.64 -37.75 86.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.648 2.232 . . . . 0.0 113.996 -166.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.16 -17.58 64.59 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -88.54 -10.35 49.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.838 0.745 . . . . 0.0 110.959 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -72.52 -20.61 61.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.531 1.514 . . . . 0.0 110.962 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.05 -12.48 60.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.773 0.829 . . . . 0.0 111.213 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -114.79 -172.49 2.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.724 1.61 . . . . 0.0 108.567 -167.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.58 117.53 4.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.203 1.001 . . . . 0.0 111.345 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -147.66 160.9 42.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.693 1.197 . . . . 0.0 109.456 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.48 139.17 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.617 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -50.84 120.13 4.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.934 1.294 . . . . 0.0 110.101 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.82 4.25 81.79 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.666 -1.075 . . . . 0.0 114.536 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 151.11 47.93 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.475 1.638 . . . . 0.0 110.654 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.63 159.5 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -125.61 133.0 52.39 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 169.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 29' ' ' VAL . 8.7 mt -136.67 88.74 18.93 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.24 144.61 29.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.029 2.486 . . . . 0.0 113.378 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.6 tp -52.23 -32.17 35.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.636 0.774 . . . . 0.0 112.561 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -68.21 -15.48 63.59 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -131.42 -14.96 3.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.317 1.447 . . . . 0.0 112.087 -169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 24' ' ' ILE . 11.0 p -50.81 -43.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 125.675 1.59 . . . . 0.0 114.038 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.86 -21.91 66.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.423 1.011 . . . . 0.0 112.362 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.35 -18.05 40.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.746 0.818 . . . . 0.0 112.033 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -135.22 -16.78 1.86 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -166.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.29 -34.24 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.552 1.069 . . . . 0.0 111.166 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.36 77.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.469 0.577 . . . . 0.0 111.719 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -68.66 -42.82 77.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.343 0.657 . . . . 0.0 109.663 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.31 -29.02 61.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.85 81.67 45.81 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.79 -5.76 17.56 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.369 2.712 . . . . 0.0 114.541 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -142.44 136.32 29.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.58 1.082 . . . . 0.0 109.044 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.66 -22.32 66.63 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -19.4 60.28 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.261 0.937 . . . . 0.0 112.162 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.1 143.91 50.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.972 0.805 . . . . 0.0 110.674 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.84 152.94 33.17 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -138.37 137.77 43.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.22 103.35 12.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.03 141.26 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -154.32 173.74 15.78 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.43 -177.0 5.68 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -48.02 -43.93 30.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 0.0 112.132 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 16.97 5.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.195 0.998 . . . . 0.0 112.907 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.39 -31.4 0.99 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.11 1.338 . . . . 0.0 114.927 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.8 -43.28 99.23 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.395 1.597 . . . . 0.0 113.54 -173.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.48 -36.68 83.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.027 1.285 . . . . 0.0 109.453 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.44 -36.6 60.7 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.642 -0.695 . . . . 0.0 112.844 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.54 97.67 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 171.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -48.79 79.37 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 175.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -39.75 94.19 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.196 0.599 . . . . 0.0 111.589 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.2 -42.25 76.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.271 0.941 . . . . 0.0 110.066 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.14 -53.13 54.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.87 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.96 -35.69 75.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 CA-C-N 119.413 1.006 . . . . 0.0 110.996 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.0 -34.46 68.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.964 0.802 . . . . 0.0 110.534 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.4 m -63.63 -40.84 97.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.448 0.567 . . . . 0.0 110.093 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.05 -37.66 88.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.581 0.628 . . . . 0.0 110.76 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.69 -3.01 16.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.899 1.28 . . . . 0.0 112.317 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.03 4.45 60.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.495 -1.169 . . . . 0.0 113.928 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -75.1 86.26 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.591 1.695 . . . . 0.0 108.221 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 p -71.27 9.69 0.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.319 1.447 . . . . 0.0 113.904 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -136.34 27.98 3.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 111.717 -170.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.33 137.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -136.75 144.09 43.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -85.16 110.77 19.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.99 73.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.744 0.418 . . . . 0.0 111.73 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.79 -154.39 25.52 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.16 162.25 12.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.8 tp -43.48 -48.56 7.3 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 114.503 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.83 -18.49 60.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.58 -22.46 21.24 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.884 0.874 . . . . 0.0 111.958 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 mm -63.32 132.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.81 58.77 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.5 mmm -66.36 156.22 85.96 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.198 0.999 . . . . 0.0 111.612 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.24 161.67 16.02 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.497 2.798 . . . . 0.0 112.088 168.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -130.0 160.37 33.86 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.951 0.9 . . . . 0.0 110.446 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.538 0.491 0 C-N-CA 127.504 2.321 . . . . 0.0 107.772 179.003 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.237 0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -139.98 122.03 15.7 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 169.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -78.92 118.94 21.41 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.45 104.23 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.89 124.69 24.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.17 6.48 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.009 0.924 . . . . 0.0 111.076 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -63.76 160.32 17.46 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.005 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 148.01 51.94 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.47 -32.94 70.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.922 1.748 . . . . 0.0 113.161 -167.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.06 -27.72 64.87 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.568 -0.707 . . . . 0.0 111.844 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -84.23 -34.87 23.79 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -55.28 -46.24 76.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.196 0.598 . . . . 0.0 110.616 178.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.05 -22.6 66.97 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -65.23 -45.02 86.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.765 0.712 . . . . 0.0 110.706 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -172.63 138.2 0.85 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.887 1.675 . . . . 0.0 106.988 171.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -147.18 160.54 42.33 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.294 1.038 . . . . 0.0 110.752 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.41 127.69 22.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -61.54 145.61 51.43 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.884 0.374 . . . . 0.0 110.929 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.1 -7.37 52.44 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.214 0.911 . . . . 0.0 114.094 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.62 7.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.012 1.406 . . . . 0.0 111.332 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.76 166.52 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.051 1.741 . . . . 0.0 106.409 168.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.8 t-20 -123.74 128.83 50.15 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 109.187 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 29' ' ' VAL . 9.7 mt -139.12 84.43 16.84 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.1 153.77 11.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.397 2.731 . . . . 0.0 112.815 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -51.59 -35.98 43.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.768 0.827 . . . . 0.0 112.613 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.56 -22.61 66.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.428 0.691 . . . . 0.0 112.46 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -114.66 -27.68 7.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.112 1.365 . . . . 0.0 111.772 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 p -56.7 -38.92 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 124.4 1.08 . . . . 0.0 112.898 -168.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -63.11 -19.46 64.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.238 0.926 . . . . 0.0 112.446 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -103.86 -5.4 22.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.642 1.177 . . . . 0.0 111.918 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -134.95 -21.25 1.67 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -60.43 -38.67 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 120.012 1.278 . . . . 0.0 111.524 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.6 75.14 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.969 0.804 . . . . 0.0 111.868 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 m -71.67 -45.12 62.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.635 0.774 . . . . 0.0 109.633 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.55 -30.71 66.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.17 0.588 . . . . 0.0 112.402 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.0 t -136.06 86.26 26.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.17 -1.78 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.205 2.604 . . . . 0.0 113.661 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -138.28 114.88 10.54 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.615 1.166 . . . . 0.0 108.692 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.62 -15.51 51.99 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.115 0.966 . . . . 0.0 112.871 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -66.22 -22.77 66.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.02 142.64 53.6 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.04 0.536 . . . . 0.0 111.182 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -78.2 97.87 5.66 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.55 88.19 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -82.21 89.78 6.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.14 139.97 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.857 0.463 . . . . 0.0 109.832 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -149.61 168.15 24.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.211 1.005 . . . . 0.0 108.514 169.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.39 -154.29 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -59.27 -47.71 84.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.9 0.773 . . . . 0.0 110.728 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.74 -23.22 0.72 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -25.83 1.46 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.739 1.154 . . . . 0.0 114.81 172.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -64.56 -45.49 86.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.639 1.72 . . . . 0.0 112.927 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.5 -31.29 72.44 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.75 1.159 . . . . 0.0 109.438 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -65.01 -49.53 69.86 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.899 0.88 . . . . 0.0 111.02 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.77 -42.09 95.36 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.07 -42.7 95.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.475 0.71 . . . . 0.0 110.664 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.53 92.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.017 0.527 . . . . 0.0 110.368 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.5 -37.83 73.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.985 0.811 . . . . 0.0 111.144 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -62.13 -53.09 60.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.957 0.799 . . . . 0.0 110.72 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt -69.4 -30.38 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.295 0.952 . . . . 0.0 111.566 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.21 -37.01 82.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 119.471 1.032 . . . . 0.0 110.143 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -66.29 -38.4 87.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.019 0.372 . . . . 0.0 110.199 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.19 -38.76 92.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.633 0.651 . . . . 0.0 110.538 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -75.09 6.24 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.287 1.435 . . . . 0.0 112.274 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.42 13.5 83.33 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.324 -1.265 . . . . 0.0 114.418 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -69.43 147.62 50.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.756 1.778 . . . . 0.0 108.433 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 p -132.67 8.58 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.591 1.157 . . . . 0.0 111.336 -171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -134.02 30.47 3.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.524 1.53 . . . . 0.0 110.026 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -77.08 140.21 17.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -138.66 129.73 26.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.22 108.79 16.7 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -31.4 72.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.259 0.223 . . . . 0.0 111.315 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.95 -139.34 8.12 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.98 163.68 24.51 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -48.69 -48.07 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.363 1.465 . . . . 0.0 112.396 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -68.73 -38.05 79.9 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.709 0.404 . . . . 0.0 111.49 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -78.19 -36.71 47.04 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.643 0.777 . . . . 0.0 111.992 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.31 132.55 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.462 1.105 . . . . 0.0 108.977 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.49 -13.84 56.01 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.2 mmm -61.98 154.21 69.62 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.757 0.823 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.22 162.3 42.34 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.134 2.556 . . . . 0.0 112.003 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -133.4 159.96 38.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.2 1.0 . . . . 0.0 110.811 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.237 0.432 0 C-N-CA 125.632 1.573 . . . . 0.0 108.75 171.821 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.236 0.353 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -138.31 152.18 48.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.267 1.427 . . . . 0.0 107.744 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.47 120.53 37.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -125.46 110.25 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -68.21 133.47 48.9 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.36 6.15 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.679 0.672 . . . . 0.0 110.332 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -57.41 157.41 6.67 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.31 -0.869 . . . . 0.0 111.066 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -53.94 148.26 21.5 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 167.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.33 -26.94 63.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.171 1.914 . . . . 0.0 113.368 -166.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.32 -28.85 61.35 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.396 -0.815 . . . . 0.0 112.023 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -82.54 -33.93 28.02 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.128 0.876 . . . . 0.0 109.18 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -50.13 -50.6 48.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.774 0.83 . . . . 0.0 111.492 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -66.19 -19.83 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -63.74 -45.04 91.65 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.083 0.856 . . . . 0.0 110.324 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.79 147.82 0.82 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.002 2.521 . . . . 0.0 105.381 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.11 158.16 43.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.608 1.094 . . . . 0.0 109.28 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.71 134.69 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -58.09 143.08 44.94 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.198 0.999 . . . . 0.0 110.137 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.15 45.32 20.26 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.266 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.23 176.1 9.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.097 1.359 . . . . 0.0 110.072 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 tt -121.31 171.13 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.09 1.756 . . . . 0.0 106.406 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -124.97 131.9 53.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 mt -139.0 100.64 7.91 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.34 159.07 6.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.778 2.985 . . . . 0.0 114.078 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -55.63 -35.85 66.34 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.359 -0.838 . . . . 0.0 112.092 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.11 -2.92 29.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.692 0.797 . . . . 0.0 112.821 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.72 -17.68 2.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.0 1.32 . . . . 0.0 112.311 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.82 -37.13 77.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.027 0.931 . . . . 0.0 111.967 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.03 -31.45 68.85 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.868 0.758 . . . . 0.0 111.354 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -77.88 -14.14 59.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.581 0.752 . . . . 0.0 112.472 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -130.58 -22.06 2.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.31 -36.24 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.606 1.094 . . . . 0.0 111.066 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.1 -25.01 28.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.061 1.344 . . . . 0.0 114.143 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -122.83 -29.99 3.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.641 1.176 . . . . 0.0 110.906 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.43 72.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.782 0.833 . . . . 0.0 111.046 171.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -134.6 91.29 21.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -6.3 18.77 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.089 2.526 . . . . 0.0 115.727 -166.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -146.71 139.1 24.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.102 1.319 . . . . 0.0 109.318 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.16 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -76.15 -23.76 54.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.061 0.846 . . . . 0.0 111.673 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -69.66 144.08 53.0 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.112 -0.367 . . . . 0.0 110.736 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.59 144.72 37.3 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 109.733 -169.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.73 141.23 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -123.95 137.35 54.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.67 142.61 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -154.59 155.01 33.96 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.966 1.306 . . . . 0.0 108.135 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 53' ' ' GLN . 66.6 m -155.95 -174.03 4.78 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.25 1.82 . . . . 0.0 109.462 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.45 128.84 37.91 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.69 18.2 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.718 1.607 . . . . 0.0 114.28 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.4 11.91 11.25 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.144 -1.364 . . . . 0.0 115.061 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -67.64 -57.95 5.52 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 120.858 2.329 . . . . 0.0 113.379 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.421 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mp0 -61.26 -30.33 70.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.19 0.904 . . . . 0.0 109.716 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -74.71 -42.95 57.41 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.366 1.066 . . . . 0.0 112.196 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.49 -40.58 86.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.11 -42.24 85.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.356 1.063 . . . . 0.0 110.214 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.84 -39.62 79.86 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.732 0.696 . . . . 0.0 111.883 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.32 -38.84 66.43 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.27 1.395 . . . . 0.0 110.213 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.92 -58.59 7.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.668 0.667 . . . . 0.0 110.784 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.41 -37.1 79.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 119.611 1.096 . . . . 0.0 110.604 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.03 -37.68 75.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.234 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.8 m -62.55 -40.14 95.85 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.712 0.687 . . . . 0.0 110.356 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.19 -37.59 81.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.528 0.604 . . . . 0.0 111.182 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.4 mtp -64.46 -31.49 72.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.467 0.707 . . . . 0.0 110.945 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.26 -9.45 3.25 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.567 1.08 . . . . 0.0 113.565 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -77.21 72.75 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.095 1.447 . . . . 0.0 109.951 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 p -70.67 18.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.348 1.459 . . . . 0.0 112.895 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -132.2 24.76 4.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.316 1.846 . . . . 0.0 110.911 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -92.21 141.37 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.38 133.51 40.66 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.27 109.88 10.32 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 -30.66 70.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 111.611 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.4 -154.03 25.23 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.31 164.9 12.46 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.1 tp -46.18 -49.8 16.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 113.639 -169.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.24 -20.13 22.26 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 119.23 -0.414 . . . . 0.0 112.014 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.21 -37.62 69.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.448 0.567 . . . . 0.0 110.421 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.54 124.73 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -9.79 59.41 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mtp -61.14 154.59 60.72 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 110.608 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.4 164.23 34.97 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.961 2.44 . . . . 0.0 111.712 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -126.49 157.66 38.13 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.101 0.961 . . . . 0.0 110.044 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.238 0.473 0 C-N-CA 126.03 1.732 . . . . 0.0 107.569 172.822 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -136.29 132.02 35.17 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -94.77 115.34 27.39 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.49 107.24 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -65.97 142.54 57.82 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.1 11.6 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.809 0.731 . . . . 0.0 112.081 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -66.38 162.76 19.69 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 172.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.94 148.94 68.15 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.96 -32.94 64.87 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.896 1.73 . . . . 0.0 114.074 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.04 -30.18 67.4 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.497 -0.752 . . . . 0.0 111.408 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.04 -33.97 29.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -48.71 70.33 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.384 0.674 . . . . 0.0 111.251 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -61.99 -21.03 64.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.091 0.556 . . . . 0.0 112.35 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.98 -24.09 64.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.514 -1.231 . . . . 0.0 112.573 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 167.06 135.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.415 2.686 . . . . 0.0 106.848 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.31 162.8 38.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.847 1.203 . . . . 0.0 110.307 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.22 137.6 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -60.37 142.82 54.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.811 0.844 . . . . 0.0 109.91 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.78 44.09 39.85 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.185 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.83 179.34 6.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.111 1.364 . . . . 0.0 110.22 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -130.37 177.15 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.462 1.905 . . . . 0.0 106.48 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.37 137.33 50.89 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.349 -0.844 . . . . 0.0 108.781 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -140.79 97.38 7.23 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.19 157.2 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.527 2.818 . . . . 0.0 113.152 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -52.98 -35.88 59.67 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.618 -0.676 . . . . 0.0 112.248 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.28 -13.7 62.54 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -116.68 -36.02 4.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.189 1.395 . . . . 0.0 110.197 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.13 -33.06 45.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 C-N-CA 124.399 1.079 . . . . 0.0 111.705 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.36 -22.72 65.2 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.82 -30.94 7.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 110.534 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -84.6 -26.13 28.13 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.683 -0.636 . . . . 0.0 112.208 -169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.18 -33.65 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.568 1.076 . . . . 0.0 110.857 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.48 -9.01 10.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 -37.09 4.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.572 1.149 . . . . 0.0 109.905 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.96 -37.9 72.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.741 0.701 . . . . 0.0 112.143 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.96 73.47 33.05 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.34 -27.35 34.33 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.247 1.965 . . . . 0.0 111.976 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -76.75 102.13 6.11 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.38 -4.79 24.07 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.51 39.54 2.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.592 1.157 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.35 149.93 50.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.921 1.289 . . . . 0.0 108.159 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.01 153.67 43.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.237 0.615 . . . . 0.0 111.207 -168.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.17 137.54 51.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -110.87 126.76 55.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.3 141.89 39.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.63 169.01 24.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.55 1.14 . . . . 0.0 108.036 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -154.11 -155.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -55.43 -47.15 76.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.222 0.609 . . . . 0.0 111.213 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.86 -37.08 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.04 -23.13 0.6 Allowed Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.659 1.118 . . . . 0.0 115.615 172.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -58.58 -52.06 67.26 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.252 2.026 . . . . 0.0 112.48 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -58.99 -32.33 69.6 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.358 0.526 . . . . 0.0 110.113 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -72.92 -44.9 60.68 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 124.505 1.122 . . . . 0.0 112.59 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -45.39 93.43 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -57.23 -43.63 83.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.96 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.94 85.99 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.804 -0.56 . . . . 0.0 110.89 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -59.39 -38.15 79.78 Favored 'General case' 0 C--O 1.231 0.101 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.91 -52.63 64.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.105 0.866 . . . . 0.0 110.67 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.4 pt -68.04 -33.32 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.363 0.983 . . . . 0.0 111.335 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.51 -40.02 92.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.51 1.05 . . . . 0.0 110.289 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -64.4 -41.4 96.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.747 0.419 . . . . 0.0 109.903 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.02 -39.84 93.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.379 0.671 . . . . 0.0 111.012 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.3 mtp -68.26 -14.66 63.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.596 1.158 . . . . 0.0 111.947 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.81 28.32 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.219 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -64.22 120.05 11.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.1 p -68.66 -28.03 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -167.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.18 126.04 8.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.44 1.096 . . . . 0.0 109.665 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -144.56 149.82 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -139.64 135.08 32.89 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -79.39 110.68 14.9 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.45 70.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.814 0.446 . . . . 0.0 111.932 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.7 -141.44 9.74 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.23 168.41 24.62 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 tp -54.31 -36.07 63.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.866 1.266 . . . . 0.0 112.267 -173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.32 -9.04 58.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.049 0.94 . . . . 0.0 113.083 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.37 -31.11 2.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.459 1.027 . . . . 0.0 113.253 -168.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.43 129.94 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.93 -13.55 55.83 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.24 158.6 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.08 0.952 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.36 164.83 29.1 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.977 2.451 . . . . 0.0 111.51 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -132.83 158.16 43.19 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.054 0.942 . . . . 0.0 110.267 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 126.346 1.859 . . . . 0.0 108.216 176.602 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -139.84 149.62 43.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.672 1.589 . . . . 0.0 107.179 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -119.04 112.95 20.2 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.14 107.44 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.42 142.55 58.15 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.86 7.05 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.093 0.957 . . . . 0.0 111.766 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -63.88 165.81 8.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.661 1.119 . . . . 0.0 110.472 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.36 147.82 66.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.36 -38.15 76.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.043 1.829 . . . . 0.0 113.125 -167.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.89 -26.48 66.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.185 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.04 -34.92 32.46 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -45.61 85.66 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.994 0.518 . . . . 0.0 110.861 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -61.31 -22.34 64.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -67.26 -35.46 79.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.63 -171.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 176.78 141.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.144 2.578 . . . . 0.0 106.8 169.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.61 155.27 40.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.492 1.117 . . . . 0.0 109.723 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.11 134.09 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.059 0.943 . . . . 0.0 109.27 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.72 141.32 49.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.368 0.667 . . . . 0.0 110.177 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.87 55.42 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.674 1.13 . . . . 0.0 114.236 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.59 177.44 6.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.97 1.385 . . . . 0.0 111.509 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.02 175.7 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.647 1.979 . . . . 0.0 105.752 168.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -138.64 133.11 31.97 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.851 -1.156 . . . . 0.0 109.994 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -140.53 101.78 6.64 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.35 150.88 31.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.375 2.05 . . . . 0.0 111.821 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -46.69 -45.75 19.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.429 1.091 . . . . 0.0 112.968 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -67.73 -10.14 49.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -119.17 -13.69 9.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.707 2.003 . . . . 0.0 111.129 -170.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -49.31 -56.65 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.828 1.651 . . . . 0.0 111.326 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.65 -31.02 65.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.38 -25.11 60.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.188 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.23 -30.31 4.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.883 0.765 . . . . 0.0 112.394 -168.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.95 -34.37 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.609 1.095 . . . . 0.0 111.52 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -8.75 6.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 m -120.92 -34.37 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.797 1.239 . . . . 0.0 110.036 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -35.57 80.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.878 0.763 . . . . 0.0 111.496 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.63 79.24 41.25 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.6 18.54 0.7 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.956 3.104 . . . . 0.0 113.581 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -142.99 113.17 7.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.052 1.341 . . . . 0.0 108.173 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -20.02 57.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.86 -20.33 49.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.761 0.709 . . . . 0.0 111.7 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -75.3 148.37 39.42 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.744 0.702 . . . . 0.0 111.24 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.78 145.04 45.34 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.73 0.812 . . . . 0.0 109.858 -175.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.34 141.44 37.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -120.9 135.93 55.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -129.05 144.39 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -150.77 166.13 31.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.893 1.277 . . . . 0.0 107.829 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.7 p -169.52 -174.58 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.329 1.052 . . . . 0.0 109.242 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -65.36 125.3 24.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.68 17.7 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.491 2.317 . . . . 0.0 115.676 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.07 -8.31 8.56 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 118.563 -1.132 . . . . 0.0 115.176 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -56.66 -53.36 58.54 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.108 1.954 . . . . 0.0 111.191 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.13 -28.5 68.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.38 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 m -75.42 -46.37 33.17 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 110.792 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.8 -43.32 86.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 172.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -66.85 -41.9 86.62 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.637 0.375 . . . . 0.0 111.456 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.65 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.47 0.708 . . . . 0.0 111.134 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -57.14 -37.34 71.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.654 1.115 . . . . 0.0 110.869 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.14 -54.58 23.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.373 0.988 . . . . 0.0 109.939 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 pt -65.31 -35.18 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.418 0.554 . . . . 0.0 110.492 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.76 -35.46 72.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.656 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 m -64.28 -38.6 91.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.812 0.733 . . . . 0.0 110.599 173.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.69 -37.77 82.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.403 0.547 . . . . 0.0 110.885 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -65.94 -33.8 76.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.545 0.611 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.17 -2.53 5.48 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.164 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.45 142.2 57.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.445 1.622 . . . . 0.0 109.124 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -130.88 10.47 5.05 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.751 0.82 . . . . 0.0 111.987 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -136.49 32.71 2.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.938 1.295 . . . . 0.0 110.12 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -88.98 141.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.1 141.69 44.23 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.393 1.077 . . . . 0.0 108.139 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.25 112.33 20.19 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.67 -30.24 70.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.479 0.311 . . . . 0.0 111.698 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.46 -147.37 17.86 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.5 168.29 19.6 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -43.85 -50.33 7.96 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.549 1.539 . . . . 0.0 114.617 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -91.49 -23.89 19.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 119.295 -0.384 . . . . 0.0 111.679 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.37 -38.02 74.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.017 0.527 . . . . 0.0 110.391 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.05 113.59 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.03 58.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.6 mtp -60.67 151.31 72.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.668 0.787 . . . . 0.0 110.547 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.22 160.02 49.49 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.082 2.522 . . . . 0.0 111.141 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 156.63 45.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.963 0.905 . . . . 0.0 110.737 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.236 0.366 0 C-N-CA 126.69 1.996 . . . . 0.0 108.307 -176.414 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.236 0.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -134.35 157.14 47.14 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.31 1.444 . . . . 0.0 108.34 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -118.98 119.96 35.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -131.32 109.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.76 144.44 56.32 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.8 11.59 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.028 0.831 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -68.6 163.8 22.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.254 -0.903 . . . . 0.0 109.844 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -56.57 147.65 49.41 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.28 -39.44 57.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.818 1.678 . . . . 0.0 113.484 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.51 -25.95 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.528 -0.732 . . . . 0.0 112.011 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.74 -34.66 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -45.28 89.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.825 0.739 . . . . 0.0 110.605 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -52.06 -28.96 19.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.666 0.786 . . . . 0.0 112.754 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.8 -23.44 65.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.252 -1.356 . . . . 0.0 112.73 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 156.26 147.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.968 3.307 . . . . 0.0 110.373 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -151.73 169.44 22.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 109.168 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.13 137.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 110.06 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.34 125.94 22.92 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.176 0.991 . . . . 0.0 109.802 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.28 -1.2 89.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.215 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.57 -173.73 3.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.106 1.453 . . . . 0.0 111.025 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.87 178.52 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.791 2.036 . . . . 0.0 106.232 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -133.97 136.46 44.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.109 -0.994 . . . . 0.0 109.367 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.4 95.99 11.24 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.4 152.34 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.328 2.685 . . . . 0.0 111.946 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 tp -48.11 -40.3 23.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.763 0.825 . . . . 0.0 112.824 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.46 -34.85 77.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 111.944 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -88.14 -25.67 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.615 1.566 . . . . 0.0 111.166 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.0 t -46.62 -47.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.428 1.091 . . . . 0.0 110.336 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -56.62 -20.61 22.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.16 -1.96 5.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.137 0.975 . . . . 0.0 112.305 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -135.63 -20.39 1.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.036 0.835 . . . . 0.0 113.246 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG21 HD21 ' A' ' 61' ' ' LEU . 10.5 tp -61.75 -34.88 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.843 1.202 . . . . 0.0 112.14 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.96 68.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.376 0.534 . . . . 0.0 112.321 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 m -66.73 -35.23 79.62 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 0.0 110.462 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.56 -20.98 21.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.751 0.82 . . . . 0.0 112.227 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.1 74.61 79.13 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.34 -7.97 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.327 2.684 . . . . 0.0 113.505 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -138.56 122.76 18.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -59.28 -18.75 40.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.24 -18.83 57.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.233 0.924 . . . . 0.0 112.019 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.84 145.51 54.57 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.441 -0.787 . . . . 0.0 110.59 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -80.48 139.0 36.62 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.93 93.14 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.29 124.78 26.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.83 143.73 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.91 161.26 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.94 0.896 . . . . 0.0 108.692 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 p -164.1 179.71 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.243 1.017 . . . . 0.0 108.396 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.49 135.61 56.22 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 54.56 15.76 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.562 1.945 . . . . 0.0 116.026 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.2 -22.53 0.61 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.857 1.217 . . . . 0.0 116.029 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -53.79 -52.62 59.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.129 1.964 . . . . 0.0 113.139 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.98 -26.25 68.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.357 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -76.4 -44.93 33.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.426 1.012 . . . . 0.0 111.692 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -44.55 96.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.69 -35.5 80.76 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.376 1.07 . . . . 0.0 111.397 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.82 -42.43 70.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 110.571 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -59.98 -40.64 89.82 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 121.19 -0.944 . . . . 0.0 110.704 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.0 -44.01 77.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.694 1.134 . . . . 0.0 111.816 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 pt -67.27 -36.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 120.725 1.602 . . . . 0.0 110.15 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 33' ' ' ILE . 77.4 mt -67.86 -36.66 80.67 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.779 0.718 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.6 m -63.13 -38.65 92.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.649 0.379 . . . . 0.0 110.416 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.02 -41.06 78.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.995 0.518 . . . . 0.0 110.554 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.7 mtp -64.93 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.394 1.078 . . . . 0.0 111.116 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.36 1.2 6.18 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.355 0.979 . . . . 0.0 114.302 169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -71.58 145.75 48.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.24 1.52 . . . . 0.0 108.817 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -132.31 7.77 4.26 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -137.11 30.71 2.71 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.521 1.128 . . . . 0.0 110.457 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.0 t -87.9 136.31 23.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -144.9 131.86 20.28 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.38 112.27 10.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.85 -30.76 70.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.298 0.639 . . . . 0.0 111.649 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.62 -136.2 6.55 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.46 170.2 25.64 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.92 -41.1 64.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.836 1.254 . . . . 0.0 113.34 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -80.14 -9.04 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.71 -32.83 5.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.769 0.828 . . . . 0.0 111.817 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.6 125.04 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.97 -10.86 59.66 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mtp -63.83 155.6 76.57 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.749 0.82 . . . . 0.0 111.061 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.08 162.0 9.97 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.697 2.931 . . . . 0.0 112.961 170.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.58 160.07 36.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.02 0.928 . . . . 0.0 110.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.239 0.53 0 C-N-CA 126.422 1.889 . . . . 0.0 107.989 175.173 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.236 0.362 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -141.74 124.57 16.08 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -86.07 117.11 24.7 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.24 107.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -66.45 134.81 53.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -119.01 10.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.888 0.767 . . . . 0.0 111.189 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -61.62 161.32 10.0 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.796 0.725 . . . . 0.0 109.147 167.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.47 150.7 43.18 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.38 -31.21 43.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.267 1.312 . . . . 0.0 112.396 -168.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.73 -10.78 60.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 112.218 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.66 -32.95 10.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.636 1.107 . . . . 0.0 110.282 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -57.49 -40.4 78.54 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.721 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.24 -34.03 76.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.751 0.42 . . . . 0.0 111.264 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -72.23 -41.86 66.37 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.462 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -164.92 141.8 5.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.447 1.021 . . . . 0.0 109.507 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -155.31 164.74 38.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.06 . . . . 0.0 109.21 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.47 137.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -59.08 117.19 4.43 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 -170.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.81 90.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.314 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.2 141.86 57.91 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.703 1.752 . . . . 0.0 109.73 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.82 169.26 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.6 t-20 -131.8 128.65 39.2 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.955 -1.09 . . . . 0.0 109.845 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.71 90.45 19.59 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.2 152.84 7.57 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.452 2.768 . . . . 0.0 111.845 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -46.87 -44.17 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.86 -30.34 71.44 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.309 0.504 . . . . 0.0 112.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.67 -21.56 23.86 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.082 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.1 t -49.1 -48.41 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.619 1.167 . . . . 0.0 110.129 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.39 -16.14 21.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.39 -3.17 8.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.226 0.921 . . . . 0.0 112.249 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -142.55 -13.75 0.77 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.96 -35.11 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.167 1.348 . . . . 0.0 111.984 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.65 67.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.397 0.544 . . . . 0.0 112.419 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 m -68.9 -38.98 79.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.952 0.796 . . . . 0.0 110.127 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.33 -23.26 35.19 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.222 0.609 . . . . 0.0 112.168 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.9 75.92 78.92 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.31 -14.73 37.99 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.195 2.597 . . . . 0.0 113.663 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -145.56 138.4 26.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -57.53 -23.94 53.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -67.42 -26.22 66.31 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.281 0.946 . . . . 0.0 112.067 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -68.56 143.95 54.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.335 0.516 . . . . 0.0 110.752 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.07 145.71 35.67 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.53 136.63 48.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -123.5 121.04 34.66 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 m -114.77 141.85 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -152.04 170.84 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.98 -165.6 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -52.64 -52.29 56.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.809 0.844 . . . . 0.0 111.719 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.7 31.48 2.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.135 1.374 . . . . 0.0 111.352 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.33 -24.1 2.18 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.666 -1.075 . . . . 0.0 115.321 170.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.9 mmt-85 -66.39 -44.59 82.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.285 2.043 . . . . 0.0 113.624 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -64.16 -33.98 77.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.825 1.193 . . . . 0.0 109.283 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.69 37.61 Favored 'General case' 0 N--CA 1.46 0.07 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.5 -46.64 91.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -56.89 -44.01 81.9 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.712 0.805 . . . . 0.0 111.323 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.07 87.84 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.707 -0.62 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.11 -40.31 84.96 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.281 -0.887 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.79 -53.1 59.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.098 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -65.22 -34.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-N 120.226 1.375 . . . . 0.0 110.781 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.43 -36.22 76.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.066 0.848 . . . . 0.0 110.77 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 m -63.01 -39.16 93.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.191 0.451 . . . . 0.0 110.366 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -68.2 -42.47 79.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.352 0.661 . . . . 0.0 110.346 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.74 -30.12 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.084 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.52 6.04 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.726 -1.041 . . . . 0.0 114.181 169.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -70.69 148.12 48.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.507 1.653 . . . . 0.0 109.163 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 p -133.78 10.03 3.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.846 0.858 . . . . 0.0 112.068 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -133.75 33.08 3.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.073 1.349 . . . . 0.0 110.213 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.42 138.7 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.02 146.25 40.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.12 112.27 19.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.34 68.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.6 -150.41 22.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.47 156.09 15.83 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 168.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.5 tp -53.41 -39.37 64.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.179 . . . . 0.0 113.439 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.51 -31.82 63.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.954 0.343 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.36 -35.49 27.74 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.469 0.708 . . . . 0.0 111.345 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.73 128.9 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.899 1.279 . . . . 0.0 108.77 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -7.54 59.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.998 0.919 . . . . 0.0 113.274 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mmm -60.28 154.55 52.09 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.524 0.73 . . . . 0.0 110.5 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.53 167.31 21.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.757 2.304 . . . . 0.0 110.989 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -128.73 173.63 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.449 1.1 . . . . 0.0 110.104 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.236 0.363 0 C-N-CA 125.442 1.497 . . . . 0.0 107.05 167.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -135.79 126.68 27.59 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -90.18 121.54 32.31 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.66 111.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -71.19 125.31 26.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.01 12.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 123.082 0.553 . . . . 0.0 110.828 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -54.66 156.84 3.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.873 0.76 . . . . 0.0 111.444 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.19 143.74 24.15 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 166.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -60.17 -33.76 94.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.622 1.548 . . . . 0.0 113.849 -166.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.74 -36.99 81.56 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.566 -0.709 . . . . 0.0 111.16 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.22 -32.93 56.21 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.59 -50.5 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.598 0.759 . . . . 0.0 110.633 170.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -63.61 -24.9 67.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.48 -38.81 92.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.538 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -179.96 135.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.39 2.276 . . . . 0.0 106.307 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -145.5 162.92 36.26 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.535 1.134 . . . . 0.0 110.589 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.72 127.34 27.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.74 151.85 28.4 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 111.841 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.72 -12.85 45.69 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.585 1.088 . . . . 0.0 114.006 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 172.15 11.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.717 1.259 . . . . 0.0 111.578 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -113.39 166.83 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.337 1.855 . . . . 0.0 106.017 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -122.74 126.34 47.3 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 119.238 0.927 . . . . 0.0 109.638 172.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 29' ' ' VAL . 11.7 mt -136.23 87.52 22.87 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 143.14 41.55 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.184 2.589 . . . . 0.0 112.812 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.06 -21.33 30.71 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.379 1.072 . . . . 0.0 111.586 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.36 -32.38 70.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.023 1.329 . . . . 0.0 113.334 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -134.95 -2.77 2.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.43 1.092 . . . . 0.0 113.508 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.4 p -52.66 -38.2 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 113.957 -169.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.92 -27.15 63.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.249 0.932 . . . . 0.0 112.293 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.18 -7.97 49.92 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 112.153 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -139.18 -15.75 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.0 -40.18 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.698 1.136 . . . . 0.0 111.135 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.38 74.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.375 0.534 . . . . 0.0 111.53 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 m -68.75 -43.72 75.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.7 . . . . 0.0 109.862 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -38.22 57.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.881 0.472 . . . . 0.0 112.229 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.29 79.05 32.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.83 -30.31 17.52 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.932 1.755 . . . . 0.0 111.825 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -84.3 101.99 12.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.259 0.624 . . . . 0.0 109.757 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.71 -16.33 56.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -77.21 -20.16 55.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.037 0.835 . . . . 0.0 111.775 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.92 147.42 36.98 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 m -70.88 147.64 48.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.321 0.648 . . . . 0.0 110.599 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.84 141.56 38.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -126.9 121.19 31.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.7 m -114.23 140.1 36.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -147.01 165.12 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.342 1.057 . . . . 0.0 108.265 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 p -148.75 -147.31 0.22 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.93 76.61 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.985 0.812 . . . . 0.0 110.361 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.25 -22.37 0.44 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.01 -29.91 0.48 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.434 1.47 . . . . 0.0 116.233 171.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.99 -57.69 11.68 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.3 2.05 . . . . 0.0 112.481 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -33.52 72.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.632 0.651 . . . . 0.0 109.629 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -52.53 58.54 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.554 0.742 . . . . 0.0 111.654 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.0 91.0 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -54.93 -47.52 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.155 0.982 . . . . 0.0 110.331 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -48.28 76.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 111.08 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.21 -42.93 82.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.809 0.731 . . . . 0.0 109.926 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.27 -53.34 56.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.987 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -67.25 -34.88 71.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.779 1.172 . . . . 0.0 111.333 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.42 -35.58 75.85 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.898 1.226 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -62.05 -43.06 99.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.059 0.39 . . . . 0.0 109.958 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -65.21 -38.15 89.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.421 0.689 . . . . 0.0 111.26 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -69.84 -7.06 36.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.987 1.315 . . . . 0.0 112.309 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 4.52 47.47 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.737 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.26 143.23 52.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.432 1.616 . . . . 0.0 106.92 168.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 p -122.47 7.38 9.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.907 0.483 . . . . 0.0 112.171 -171.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -140.8 36.6 1.79 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.658 1.183 . . . . 0.0 110.148 -170.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -105.35 130.89 55.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.38 148.0 40.62 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -78.76 115.91 18.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.29 70.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.807 0.443 . . . . 0.0 111.798 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.24 5.97 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.31 168.83 30.9 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -36.49 62.47 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.721 1.608 . . . . 0.0 110.329 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -54.92 -23.07 17.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 113.599 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -131.12 -32.35 1.6 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.66 125.99 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.216 0.917 . . . . 0.0 108.628 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.97 -4.55 56.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.05 0.94 . . . . 0.0 113.287 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.12 154.49 69.51 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.923 0.889 . . . . 0.0 111.062 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.95 153.03 21.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.793 2.995 . . . . 0.0 113.631 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -127.75 156.88 41.74 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.824 0.85 . . . . 0.0 110.904 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 125.598 1.559 . . . . 0.0 108.022 168.945 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -144.34 153.45 42.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.984 1.714 . . . . 0.0 107.125 169.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -111.21 108.55 18.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.06 112.07 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -81.97 125.45 30.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.85 -0.36 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.411 HH22 ' HA ' ' A' ' 17' ' ' HIS . 3.1 ptt180 -63.28 167.63 5.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.193 1.36 . . . . 0.0 109.644 167.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.36 152.77 30.61 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.02 -27.93 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 121.807 1.671 . . . . 0.0 112.175 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.14 -0.65 12.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.613 1.165 . . . . 0.0 112.561 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -112.6 -33.2 6.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.856 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -53.53 -46.61 70.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.692 1.133 . . . . 0.0 110.407 168.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -61.84 -25.35 67.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -70.16 -50.45 40.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.635 0.652 . . . . 0.0 109.92 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -168.55 143.18 3.32 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.411 ' HA ' HH22 ' A' ' 8' ' ' ARG . 7.5 p-80 -145.5 151.43 38.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.627 1.171 . . . . 0.0 110.041 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.18 125.33 8.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -52.76 113.16 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.024 0.93 . . . . 0.0 111.133 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 2.94 80.34 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.975 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.31 141.13 58.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.555 1.678 . . . . 0.0 109.709 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.73 132.15 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.56 108.87 4.54 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.532 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.2 78.69 14.83 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 167.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.37 156.86 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.813 3.676 . . . . 0.0 113.426 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -52.57 -35.68 54.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.705 0.802 . . . . 0.0 112.617 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -70.04 -16.49 63.16 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -116.27 -28.01 6.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.224 1.41 . . . . 0.0 111.332 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.11 -41.21 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 125.103 1.361 . . . . 0.0 113.277 -167.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -59.65 -29.35 67.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.091 0.86 . . . . 0.0 112.287 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.13 -24.95 40.13 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 0.0 111.718 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.84 -17.37 4.48 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -166.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 tp -60.67 -35.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.601 1.546 . . . . 0.0 111.496 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.78 -8.92 12.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -118.96 -35.15 3.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.955 1.302 . . . . 0.0 109.562 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.71 83.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 111.068 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -140.02 76.43 27.78 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.199 1.399 . . . . 0.0 107.565 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.56 -35.77 94.67 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.433 2.088 . . . . 0.0 112.723 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -78.84 102.25 8.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.544 0.737 . . . . 0.0 110.052 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -64.07 -14.09 52.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -79.53 -16.7 55.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.371 0.987 . . . . 0.0 112.034 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.51 148.21 49.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.065 -1.022 . . . . 0.0 111.017 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -78.46 100.55 6.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.095 0.558 . . . . 0.0 109.679 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -80.81 89.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -66.57 130.08 42.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -128.85 143.25 41.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.44 166.73 29.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -158.09 -140.7 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -123.64 133.96 53.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 60.24 15.69 5.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.03 1.732 . . . . 0.0 114.968 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.7 -31.11 1.25 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.234 1.397 . . . . 0.0 115.672 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -53.03 -49.33 66.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.293 1.547 . . . . 0.0 113.934 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.52 -33.34 73.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.743 1.156 . . . . 0.0 110.98 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -74.7 -40.21 61.48 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.591 1.087 . . . . 0.0 112.79 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.27 -44.86 96.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -59.99 -42.93 95.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.662 1.185 . . . . 0.0 111.369 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.15 90.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.757 0.708 . . . . 0.0 110.523 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -60.61 -37.9 82.94 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.96 -1.087 . . . . 0.0 110.844 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.65 -49.84 69.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.866 0.867 . . . . 0.0 110.61 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.86 -36.24 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.883 1.22 . . . . 0.0 111.009 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.05 -34.79 71.57 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.008 0.822 . . . . 0.0 110.906 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -67.87 -34.76 77.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.732 0.696 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.57 -38.31 89.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.99 0.814 . . . . 0.0 110.475 172.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -69.82 -8.98 52.87 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.383 1.073 . . . . 0.0 112.385 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.03 6.39 51.97 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.192 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.3 144.5 51.71 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.603 1.701 . . . . 0.0 108.298 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 p -126.14 4.68 7.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.126 0.57 . . . . 0.0 112.376 -171.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -139.28 31.53 2.14 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.532 1.133 . . . . 0.0 110.251 -173.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.1 133.69 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.95 122.7 15.29 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.19 110.83 11.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.58 67.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.092 0.557 . . . . 0.0 111.817 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.33 -142.92 10.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.35 162.87 19.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 168.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 tp -42.03 -48.43 4.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.995 1.318 . . . . 0.0 114.081 -168.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.57 -13.5 62.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.95 -12.26 10.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.273 1.029 . . . . 0.0 112.467 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 80' ' ' MET . 6.8 mm -64.61 134.01 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -20.07 61.43 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.415 ' H ' HG22 ' A' ' 78' ' ' ILE . 95.5 mmm -62.64 156.29 64.87 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 110.885 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.45 156.88 64.29 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.336 2.024 . . . . 0.0 110.283 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 149.12 36.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.054 0.942 . . . . 0.0 109.081 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.236 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 108.923 -173.213 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -143.29 145.69 32.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.716 1.606 . . . . 0.0 106.695 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -105.07 122.89 46.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.76 119.55 53.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -75.38 128.02 34.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.55 12.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 119.461 1.028 . . . . 0.0 111.087 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -62.66 162.71 10.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.39 -0.818 . . . . 0.0 110.571 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.6 147.74 49.24 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.309 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.81 -31.69 67.98 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.905 1.736 . . . . 0.0 112.969 -167.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.8 -28.89 66.1 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.599 -0.688 . . . . 0.0 111.828 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -80.9 -38.62 27.67 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -56.54 -41.52 76.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.738 0.415 . . . . 0.0 111.049 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -58.91 -30.03 67.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.113 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -67.14 -50.31 61.72 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.815 0.734 . . . . 0.0 110.269 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.06 156.22 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.898 1.279 . . . . 0.0 108.351 168.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -153.53 160.34 42.47 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.829 1.252 . . . . 0.0 108.807 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.88 142.61 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.718 0.807 . . . . 0.0 109.215 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.34 157.84 8.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.904 0.482 . . . . 0.0 111.664 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.36 41.17 91.47 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.676 0.655 . . . . 0.0 112.681 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.41 178.1 7.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.696 1.198 . . . . 0.0 110.996 -174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.79 169.91 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.309 2.244 . . . . 0.0 106.42 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.7 t-20 -126.2 131.15 52.04 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 110.107 172.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.37 89.03 9.61 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.51 153.89 16.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.347 2.698 . . . . 0.0 113.03 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -52.8 -34.69 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.589 0.756 . . . . 0.0 112.747 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.31 -14.39 62.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -122.84 -24.32 4.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.246 1.418 . . . . 0.0 111.345 -169.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.44 -38.69 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 124.451 1.101 . . . . 0.0 112.429 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -57.33 -27.93 62.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.751 0.705 . . . . 0.0 112.118 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -99.47 -6.18 28.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 0.0 112.11 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -137.59 -23.32 1.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -167.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.58 -35.82 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 121.131 1.787 . . . . 0.0 110.903 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.3 -30.67 69.64 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.335 0.516 . . . . 0.0 111.814 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -79.28 -45.36 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.908 0.883 . . . . 0.0 109.764 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.36 66.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.241 0.617 . . . . 0.0 112.495 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.41 76.56 36.85 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.019 1.728 . . . . 0.0 106.508 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 -20.65 30.74 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.75 101.75 2.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 109.331 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.12 -9.93 35.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.737 0.815 . . . . 0.0 112.7 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.44 12.81 24.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.701 1.2 . . . . 0.0 111.19 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.62 148.74 51.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 169.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -78.89 83.46 5.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.34 109.07 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -98.5 127.69 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.1 141.58 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 123.118 0.567 . . . . 0.0 109.488 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -149.05 172.47 14.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.9 p -157.8 -162.61 1.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -46.26 91.18 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.05 -0.407 . . . . 0.0 112.082 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 18.54 3.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.209 1.404 . . . . 0.0 112.762 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.69 -17.53 44.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.987 -1.071 . . . . 0.0 114.874 172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -67.62 -50.65 57.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.7 1.75 . . . . 0.0 111.903 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.97 -33.28 71.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 110.076 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -76.5 -40.84 48.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.78 0.718 . . . . 0.0 112.808 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.55 -43.35 99.14 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -58.87 -47.16 85.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.133 1.373 . . . . 0.0 110.793 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.24 86.25 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.661 -0.649 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.38 -34.05 68.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.527 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.6 -54.73 31.26 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.319 0.963 . . . . 0.0 109.83 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -68.31 -30.93 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 121.538 -0.726 . . . . 0.0 111.616 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.9 -40.47 95.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.446 1.021 . . . . 0.0 110.101 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -66.22 -41.32 90.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.561 0.344 . . . . 0.0 110.242 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -65.24 -36.44 84.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.625 0.648 . . . . 0.0 111.109 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.5 mtm -73.39 -2.81 23.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.168 0.987 . . . . 0.0 112.266 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.36 17.2 59.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.354 -1.248 . . . . 0.0 114.261 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -63.99 129.98 42.23 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.692 1.746 . . . . 0.0 107.077 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 p -65.21 -33.55 76.27 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.717 0.407 . . . . 0.0 111.904 -168.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.36 154.34 33.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 109.319 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -148.13 146.51 17.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -129.46 122.12 28.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.43 104.91 7.19 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.15 69.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.917 0.487 . . . . 0.0 111.811 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.95 -148.29 19.4 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.64 165.1 21.62 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -49.5 -49.28 46.45 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.677 1.191 . . . . 0.0 112.41 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.7 -36.24 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.674 0.39 . . . . 0.0 111.38 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.91 -37.31 62.11 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.458 0.703 . . . . 0.0 111.751 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.16 125.27 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -19.85 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 61.4 mtm -63.91 155.25 78.57 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.384 0.674 . . . . 0.0 111.165 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.78 165.8 28.42 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.612 2.874 . . . . 0.0 112.563 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -126.84 156.59 41.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.588 1.155 . . . . 0.0 110.151 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.236 0.387 0 C-N-CA 126.476 1.91 . . . . 0.0 108.345 175.077 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.236 0.368 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -139.48 137.29 35.41 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -89.87 118.72 29.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.38 104.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -168.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.46 145.07 56.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.86 15.44 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.335 -0.853 . . . . 0.0 112.496 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.89 160.98 5.28 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.432 -0.793 . . . . 0.0 110.545 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -54.6 146.92 32.48 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.86 -31.4 91.6 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.191 1.927 . . . . 0.0 113.778 -166.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.59 -29.75 63.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.657 -0.652 . . . . 0.0 111.999 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -84.29 -31.69 24.76 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.04 0.836 . . . . 0.0 109.127 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -49.27 64.97 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.767 0.827 . . . . 0.0 111.204 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.15 -18.65 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.882 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -69.32 -31.53 70.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.806 -171.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 176.23 133.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.833 2.453 . . . . 0.0 105.973 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -147.68 161.97 40.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.911 1.232 . . . . 0.0 109.782 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.86 136.33 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.54 142.86 54.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.581 0.752 . . . . 0.0 109.812 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 46.02 42.1 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.004 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.55 178.76 6.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.129 1.371 . . . . 0.0 110.277 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.94 176.22 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.561 1.944 . . . . 0.0 106.924 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.19 139.71 50.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.927 0.891 . . . . 0.0 109.181 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -139.92 85.2 14.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.21 145.86 84.72 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.189 1.926 . . . . 0.0 112.772 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.6 tp -54.69 -25.39 26.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.015 0.526 . . . . 0.0 111.509 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.7 -22.71 65.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.232 1.013 . . . . 0.0 113.511 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -131.24 -10.05 3.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.484 1.038 . . . . 0.0 112.83 -169.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -46.26 -42.57 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.59 1.956 . . . . 0.0 113.387 -169.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.29 -25.18 61.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.285 0.948 . . . . 0.0 112.98 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -114.87 5.84 15.26 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.017 1.327 . . . . 0.0 110.983 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -136.85 -25.2 1.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.14 -167.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -34.66 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 120.261 1.391 . . . . 0.0 112.086 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.89 67.14 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.553 0.615 . . . . 0.0 112.104 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -66.19 -35.98 81.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.659 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 -25.28 20.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.302 0.641 . . . . 0.0 112.096 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.02 78.05 41.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.57 -8.48 20.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.142 2.561 . . . . 0.0 113.652 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.94 134.77 30.44 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.204 1.001 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.29 -16.46 64.29 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -19.67 60.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.737 1.153 . . . . 0.0 112.334 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 146.54 44.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.034 0.834 . . . . 0.0 110.809 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -78.37 138.13 38.37 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.007 -0.433 . . . . 0.0 110.092 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.1 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -84.16 93.21 8.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -83.85 142.8 12.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -150.47 165.24 33.81 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.668 0.787 . . . . 0.0 109.473 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.8 p -158.86 -160.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -57.58 -51.5 69.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.301 0.5 . . . . 0.0 111.157 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.18 23.52 2.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.574 1.149 . . . . 0.0 112.319 -169.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.92 -3.65 64.18 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.364 -1.242 . . . . 0.0 114.96 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -68.6 -53.59 21.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.707 2.254 . . . . 0.0 111.108 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -61.13 -31.85 71.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -66.7 -48.23 69.9 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.268 1.027 . . . . 0.0 112.452 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.61 91.45 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -55.67 -46.37 77.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.332 1.053 . . . . 0.0 110.927 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.25 80.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.079 0.552 . . . . 0.0 111.214 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.82 -39.76 90.19 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 120.03 1.286 . . . . 0.0 110.516 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -58.05 -53.08 62.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.32 0.964 . . . . 0.0 110.483 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.76 -39.69 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 118.495 0.589 . . . . 0.0 110.492 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.55 -35.86 70.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.175 0.898 . . . . 0.0 110.857 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -63.92 -41.49 97.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.57 -39.25 88.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.168 0.587 . . . . 0.0 111.008 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.0 mtp -66.34 -18.39 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.52 1.128 . . . . 0.0 111.765 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.92 8.0 24.6 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.717 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -71.68 97.85 1.82 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.508 1.654 . . . . 0.0 107.627 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -79.02 6.32 9.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.541 1.136 . . . . 0.0 113.185 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -136.33 31.2 2.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.471 1.108 . . . . 0.0 111.504 -169.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.9 140.93 15.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 170.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.19 145.01 28.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -85.38 114.59 22.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -33.82 76.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.433 0.293 . . . . 0.0 111.482 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.75 -156.42 26.68 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.33 160.88 18.27 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -43.01 -56.06 3.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.182 1.793 . . . . 0.0 113.431 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.82 -16.39 32.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.667 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.33 -34.64 65.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.588 0.631 . . . . 0.0 110.919 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.8 126.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 55.55 3.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.471 1.508 . . . . 0.0 111.161 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.2 mtp -136.51 160.62 66.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 125.455 1.502 . . . . 0.0 108.67 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 163.2 34.73 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.546 2.164 . . . . 0.0 111.284 173.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -131.91 156.53 45.96 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.13 0.972 . . . . 0.0 109.646 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.237 0.424 0 C-N-CA 126.246 1.819 . . . . 0.0 107.986 177.46 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -144.17 129.27 18.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.582 1.153 . . . . 0.0 108.192 171.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.65 117.51 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.39 105.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -68.37 149.25 49.6 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.46 12.98 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.591 0.756 . . . . 0.0 111.58 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -53.72 156.39 2.74 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 121.649 -0.657 . . . . 0.0 111.16 171.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.26 149.25 38.07 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 167.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.81 -34.44 95.74 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.331 2.02 . . . . 0.0 114.048 -166.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.11 -27.37 61.66 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.301 -0.875 . . . . 0.0 111.815 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -82.36 -34.48 28.41 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.29 -48.81 73.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.08 0.952 . . . . 0.0 110.726 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.86 2.62 3.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -75.02 -61.3 1.93 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.952 1.251 . . . . 0.0 108.716 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.61 149.26 8.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.277 1.831 . . . . 0.0 107.006 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -151.01 166.82 29.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.873 0.76 . . . . 0.0 110.401 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -60.03 137.18 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.127 0.971 . . . . 0.0 109.497 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.76 135.0 56.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.117 0.567 . . . . 0.0 109.593 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.71 2.96 53.27 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 118.833 -0.982 . . . . 0.0 114.744 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.91 -178.75 3.89 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.207 1.503 . . . . 0.0 111.101 174.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.04 171.2 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.424 1.89 . . . . 0.0 106.699 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -132.56 139.69 47.96 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.134 0.879 . . . . 0.0 110.924 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mt -142.37 82.14 13.21 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.26 143.87 62.52 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.49 2.126 . . . . 0.0 112.78 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.16 -30.02 47.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.74 -13.93 61.44 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -129.5 -14.86 4.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.608 1.163 . . . . 0.0 112.107 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.77 -39.51 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.913 1.685 . . . . 0.0 113.196 -169.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 -20.63 62.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.236 0.925 . . . . 0.0 112.653 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -111.81 7.13 20.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 111.115 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -137.58 -30.41 0.83 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -167.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.48 -38.56 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.747 1.158 . . . . 0.0 110.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.15 90.4 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.315 0.507 . . . . 0.0 111.562 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 -38.54 55.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.236 0.615 . . . . 0.0 111.068 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.51 72.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.393 0.542 . . . . 0.0 111.749 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.43 79.25 20.96 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.289 1.436 . . . . 0.0 107.644 -172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.82 -36.05 97.64 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.335 2.023 . . . . 0.0 112.856 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -83.77 104.38 13.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.608 0.763 . . . . 0.0 110.515 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.03 -14.45 60.46 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.46 -14.14 59.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.492 1.042 . . . . 0.0 111.971 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.6 143.84 57.5 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.171 -0.955 . . . . 0.0 110.991 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -81.99 97.58 8.18 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.3 94.69 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.05 79.43 5.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.66 139.27 19.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -147.89 165.59 30.18 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.015 0.926 . . . . 0.0 109.462 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.5 p -169.0 -160.46 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.211 1.004 . . . . 0.0 109.145 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.53 128.34 34.01 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.45 13.83 0.5 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.536 1.934 . . . . 0.0 115.433 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.1 3.78 46.39 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.194 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.0 -39.63 61.11 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.353 2.076 . . . . 0.0 112.806 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.82 -30.56 69.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.603 1.092 . . . . 0.0 109.221 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -69.14 -48.41 62.47 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.03 0.932 . . . . 0.0 111.727 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.7 -43.57 98.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -57.95 -47.86 81.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.575 0.75 . . . . 0.0 111.241 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.53 88.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.171 0.588 . . . . 0.0 111.354 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -57.52 -35.93 70.9 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.213 -0.929 . . . . 0.0 111.445 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.94 -55.03 33.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.235 0.925 . . . . 0.0 110.428 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt -68.95 -34.73 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 O-C-N 121.766 -0.584 . . . . 0.0 111.069 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.1 mt -69.33 -37.03 77.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.307 0.958 . . . . 0.0 110.605 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -64.26 -39.96 95.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.472 0.578 . . . . 0.0 109.942 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.69 -39.87 94.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.468 0.577 . . . . 0.0 110.901 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.01 -16.92 64.26 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.255 1.022 . . . . 0.0 111.985 174.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.36 27.82 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.847 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -73.13 106.15 4.87 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.564 1.682 . . . . 0.0 107.586 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.09 3.26 43.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 113.058 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -137.95 31.49 2.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.208 1.003 . . . . 0.0 111.382 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.25 130.53 36.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 172.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -142.34 129.24 20.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -75.1 111.46 10.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.88 71.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.826 0.451 . . . . 0.0 111.542 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.52 -153.98 25.36 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.74 165.53 12.34 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 170.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -45.15 -50.32 11.37 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.37 1.468 . . . . 0.0 113.222 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -77.56 -36.76 51.84 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.672 0.389 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.46 -36.25 73.81 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.541 0.736 . . . . 0.0 111.713 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.64 129.18 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.373 1.069 . . . . 0.0 108.497 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 -10.57 59.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.2 mmm -61.26 154.23 63.7 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.663 0.785 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.82 161.01 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.749 2.299 . . . . 0.0 111.09 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -129.26 167.15 18.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.609 1.164 . . . . 0.0 109.18 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 125.517 1.527 . . . . 0.0 106.905 170.213 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -138.92 147.38 42.22 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.651 1.58 . . . . 0.0 106.802 169.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.55 125.45 48.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.61 108.95 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -74.79 119.13 18.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.6 m -105.29 14.23 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 122.946 0.498 . . . . 0.0 111.305 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -55.67 157.24 4.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 118.641 0.655 . . . . 0.0 110.644 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.3 145.69 25.24 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 166.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.62 -30.89 70.55 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.72 1.613 . . . . 0.0 112.825 -166.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -71.26 -21.79 62.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.341 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.67 -34.36 16.29 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.737 1.153 . . . . 0.0 109.347 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -51.87 -46.19 64.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.96 0.504 . . . . 0.0 110.941 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.38 -21.22 66.15 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -73.62 -49.89 23.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.574 1.079 . . . . 0.0 110.508 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -162.66 132.43 4.44 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -151.11 160.78 43.68 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.485 1.493 . . . . 0.0 111.73 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.4 107.06 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -44.05 134.85 4.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.839 1.255 . . . . 0.0 111.753 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.12 -17.94 55.44 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.62 -1.1 . . . . 0.0 112.869 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.45 129.57 40.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.392 1.596 . . . . 0.0 109.259 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.66 156.38 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -111.46 121.29 44.79 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.596 -0.69 . . . . 0.0 109.66 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.2 mt -135.11 84.27 37.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.51 151.46 7.19 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.102 2.535 . . . . 0.0 111.658 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.1 tp -44.95 -44.0 9.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.89 -41.88 97.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.522 0.601 . . . . 0.0 111.336 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -75.07 -22.6 58.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.825 1.65 . . . . 0.0 111.249 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.84 -44.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.539 1.063 . . . . 0.0 109.713 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -61.81 -15.59 43.03 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.24 -20.28 9.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 111.696 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -129.5 -12.38 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.94 -39.24 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 121.362 1.892 . . . . 0.0 111.206 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.79 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.305 0.502 . . . . 0.0 111.787 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 m -68.3 -44.97 74.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.678 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 -39.41 68.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.236 0.614 . . . . 0.0 112.015 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.77 87.64 12.74 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.134 1.889 . . . . 0.0 111.974 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.0 152.68 44.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.364 1.066 . . . . 0.0 109.989 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.73 35.27 4.2 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.569 0.622 . . . . 0.0 112.113 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -142.78 -34.67 0.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.81 150.72 44.09 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.747 0.819 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 m -62.23 132.47 52.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 110.528 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -132.43 139.27 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.56 138.52 53.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.31 141.93 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -147.05 163.51 36.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.3 p -159.82 -154.26 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.277 0.231 . . . . 0.0 111.01 174.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.48 130.21 38.21 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 170.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 55.12 17.68 2.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.298 1.839 . . . . 0.0 114.558 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.13 -13.03 1.04 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.876 1.227 . . . . 0.0 115.188 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -64.55 -44.9 89.31 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 120.056 1.928 . . . . 0.0 111.985 -171.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.44 -30.36 71.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.798 0.726 . . . . 0.0 110.007 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -75.12 -43.41 52.9 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.615 1.098 . . . . 0.0 112.195 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -49.35 78.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -58.26 -40.76 82.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.069 . . . . 0.0 111.977 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.91 -44.17 77.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.483 0.583 . . . . 0.0 109.97 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.06 -35.77 79.61 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.787 1.176 . . . . 0.0 110.498 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.71 -52.97 63.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.557 1.071 . . . . 0.0 110.379 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.0 pt -68.07 -39.43 81.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 119.442 1.019 . . . . 0.0 110.525 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.1 -40.42 94.54 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.394 0.543 . . . . 0.0 110.91 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.87 -39.55 94.8 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.609 0.64 . . . . 0.0 110.136 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.27 -33.93 73.98 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.806 -0.559 . . . . 0.0 111.019 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.6 mtp -73.96 -1.0 17.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.804 1.242 . . . . 0.0 112.08 173.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.35 90.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.848 -1.157 . . . . 0.0 113.136 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.48 55.02 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.364 1.466 . . . . 0.0 108.686 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -67.75 -25.09 65.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.171 1.388 . . . . 0.0 111.869 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.548 ' CD2' ' H ' ' A' ' 68' ' ' HIS . 18.8 p80 -77.5 33.67 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.23 2.612 . . . . 0.0 112.736 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.5 t -120.99 140.41 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.08 1.752 . . . . 0.0 106.427 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.43 141.68 41.64 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.48 114.37 19.33 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.37 -29.97 67.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.904 0.482 . . . . 0.0 112.005 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.28 -139.46 8.12 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.75 169.7 24.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.35 -53.95 7.88 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.391 1.477 . . . . 0.0 112.427 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.79 -37.83 67.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.481 0.313 . . . . 0.0 111.272 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.64 -37.37 68.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.339 0.655 . . . . 0.0 111.787 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.05 131.86 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.288 1.035 . . . . 0.0 108.574 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.52 -8.37 59.55 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.87 151.31 74.02 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.7 0.682 . . . . 0.0 110.676 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 163.83 11.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.123 2.549 . . . . 0.0 111.877 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -136.3 166.54 23.21 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.235 0.309 0 C-N-CA 125.819 1.647 . . . . 0.0 106.556 168.108 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -133.88 128.2 34.11 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -88.74 122.61 32.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mt -128.55 115.18 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -69.54 129.01 38.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.68 7.59 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.626 0.648 . . . . 0.0 111.615 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -65.59 162.82 17.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.046 0.839 . . . . 0.0 110.206 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.88 146.76 35.89 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.4 -38.6 73.28 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.968 1.778 . . . . 0.0 113.303 -167.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.09 -27.9 68.41 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.557 -0.714 . . . . 0.0 112.045 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -82.74 -33.05 27.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -46.42 79.92 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.178 0.591 . . . . 0.0 110.671 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -61.32 -22.75 65.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -66.19 -44.27 84.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.449 0.568 . . . . 0.0 111.022 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.37 137.9 0.3 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.741 2.017 . . . . 0.0 106.912 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -149.3 164.0 36.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.471 1.109 . . . . 0.0 110.256 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.13 134.86 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.577 0.751 . . . . 0.0 109.798 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -55.14 130.66 42.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.0 88.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.333 171.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.13 -178.74 4.0 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.762 1.281 . . . . 0.0 111.623 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.0 tt -125.88 172.22 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 127.418 2.287 . . . . 0.0 106.531 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -129.8 124.21 32.8 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.484 1.038 . . . . 0.0 110.483 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.2 mt -134.76 87.5 30.61 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 170.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.83 153.94 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.673 2.916 . . . . 0.0 111.366 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.02 -39.0 18.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.655 0.782 . . . . 0.0 112.333 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -65.0 -21.48 66.86 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.129 0.971 . . . . 0.0 113.275 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' A' ' 32' ' ' ARG . 26.7 mt-10 -111.1 -13.73 14.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.4 1.48 . . . . 0.0 111.752 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -48.78 -52.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.809 1.186 . . . . 0.0 110.489 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -64.26 -10.59 24.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.72 -10.58 12.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.031 0.933 . . . . 0.0 112.141 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.407 HH12 ' CD ' ' A' ' 28' ' ' GLU . 29.8 ttp180 -141.14 -14.91 0.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.98 -36.62 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 120.531 1.514 . . . . 0.0 111.751 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.99 69.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.487 0.585 . . . . 0.0 112.124 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.0 m -68.53 -39.63 81.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.636 0.653 . . . . 0.0 110.06 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.48 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.938 0.495 . . . . 0.0 112.151 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.34 81.18 44.13 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.6 -0.74 10.78 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.213 2.609 . . . . 0.0 114.451 -169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -142.33 137.08 30.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.789 1.177 . . . . 0.0 110.06 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 60.0 mttp -62.0 -25.89 67.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.537 1.135 . . . . 0.0 113.513 -173.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -13.81 53.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.63 0.65 . . . . 0.0 112.324 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.82 145.88 44.63 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.145 0.884 . . . . 0.0 110.826 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.4 146.51 32.78 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.751 0.42 . . . . 0.0 109.999 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.24 139.14 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.57 95.62 4.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.22 143.11 12.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -147.83 160.39 42.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 p -162.21 -166.37 1.39 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.45 135.69 33.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 56.41 17.12 2.75 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.252 1.821 . . . . 0.0 115.391 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.17 -26.27 1.02 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.853 1.216 . . . . 0.0 115.378 170.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -54.49 -51.5 64.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.737 1.769 . . . . 0.0 112.625 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.57 -29.72 70.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.887 0.767 . . . . 0.0 110.471 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 m -74.46 -43.87 54.18 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.965 0.802 . . . . 0.0 112.138 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 -46.11 94.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.56 -45.04 85.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.83 1.252 . . . . 0.0 110.981 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.42 86.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.622 0.647 . . . . 0.0 110.955 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.04 -40.34 84.73 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.446 -0.784 . . . . 0.0 110.113 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.64 -54.18 43.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.977 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -66.08 -32.93 60.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.881 1.219 . . . . 0.0 111.015 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.12 -34.78 71.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.157 0.89 . . . . 0.0 110.938 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.8 m -63.77 -38.91 92.86 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.261 0.482 . . . . 0.0 110.166 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.02 -40.95 82.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.054 0.542 . . . . 0.0 110.8 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.12 -30.14 71.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.042 0.937 . . . . 0.0 111.004 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.26 0.44 7.46 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.182 -1.343 . . . . 0.0 114.528 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 40' ' ' LYS . 90.4 m-85 -65.82 151.02 47.6 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.874 1.837 . . . . 0.0 109.217 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -131.42 4.98 4.36 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.32 0.648 . . . . 0.0 112.421 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -136.25 30.3 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.471 1.108 . . . . 0.0 110.823 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.07 136.48 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.25 149.99 42.04 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -85.36 117.13 24.1 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.73 -32.47 74.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.627 0.371 . . . . 0.0 111.503 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.91 -163.92 28.86 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.596 1.57 . . . . 0.0 109.686 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.25 154.28 21.77 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.9 -44.54 63.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.791 0.836 . . . . 0.0 112.422 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.44 -37.26 82.72 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.751 0.42 . . . . 0.0 111.472 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.21 -35.14 61.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.283 0.633 . . . . 0.0 111.497 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.94 128.17 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 108.651 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.53 -8.5 59.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.6 mmm -61.18 153.86 65.03 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.903 0.881 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.86 162.39 42.32 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.058 2.505 . . . . 0.0 111.153 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -129.42 158.71 38.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.767 0.827 . . . . 0.0 110.935 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.238 0.471 0 C-N-CA 126.552 1.941 . . . . 0.0 107.869 172.429 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -147.84 154.88 41.01 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.52 1.528 . . . . 0.0 107.733 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -99.98 112.16 24.45 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.74 102.95 14.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.11 144.84 55.86 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.49 9.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.499 -0.751 . . . . 0.0 111.583 -172.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -61.28 157.78 15.65 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.89 145.92 40.18 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.14 -32.08 90.87 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.944 1.763 . . . . 0.0 113.708 -165.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.43 -15.43 56.81 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.494 -0.754 . . . . 0.0 112.498 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -88.1 -31.45 19.21 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.757 1.162 . . . . 0.0 108.859 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -50.61 72.72 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.393 0.677 . . . . 0.0 111.385 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -62.26 -23.9 66.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -169.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -63.99 -37.98 89.41 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.664 -0.684 . . . . 0.0 111.725 -172.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -174.49 135.99 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.325 1.45 . . . . 0.0 107.438 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -152.56 157.89 41.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.001 1.273 . . . . 0.0 111.026 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.54 123.11 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.77 158.7 6.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.154 0.982 . . . . 0.0 111.366 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.5 39.22 42.58 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.56 174.28 10.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.292 1.437 . . . . 0.0 110.039 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.62 164.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -121.66 135.4 54.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.01 92.92 10.65 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.53 149.89 37.23 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.963 2.442 . . . . 0.0 113.158 -171.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 tp -56.37 -28.8 60.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.229 0.612 . . . . 0.0 112.364 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -70.18 -22.35 62.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 112.763 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -116.86 -24.76 7.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.145 1.378 . . . . 0.0 112.098 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.1 p -54.81 -35.69 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.363 1.465 . . . . 0.0 113.392 -168.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.6 -18.18 58.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.658 0.663 . . . . 0.0 112.774 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -110.18 4.17 20.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 111.414 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.92 -21.7 0.72 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -62.73 -36.6 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 110.952 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.07 94.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.283 0.492 . . . . 0.0 111.631 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -37.96 63.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.252 0.478 . . . . 0.0 111.116 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.66 -39.41 64.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.36 0.527 . . . . 0.0 111.951 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.01 81.68 15.8 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.93 -26.48 26.74 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.878 1.718 . . . . 0.0 112.242 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -84.36 103.28 13.4 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.422 0.689 . . . . 0.0 110.195 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.41 -14.4 60.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.55 -17.9 62.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.326 0.966 . . . . 0.0 111.769 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.45 141.89 58.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.874 0.761 . . . . 0.0 111.557 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -83.49 82.12 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.53 100.17 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.74 130.57 38.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.59 138.61 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.54 153.3 32.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.584 1.154 . . . . 0.0 108.488 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -154.58 -174.35 4.94 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.862 1.665 . . . . 0.0 109.691 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.78 125.39 23.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.01 17.49 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.912 1.685 . . . . 0.0 114.172 -170.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.35 10.64 23.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 117.668 -1.629 . . . . 0.0 115.632 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -70.35 -44.1 68.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 121.768 2.784 . . . . 0.0 113.781 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.18 -30.53 69.65 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.899 1.227 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -41.27 48.6 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.772 0.829 . . . . 0.0 112.069 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -41.98 97.8 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.43 -45.96 84.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.586 0.754 . . . . 0.0 110.896 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.36 75.43 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.588 -0.695 . . . . 0.0 112.719 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.85 -36.98 68.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.682 1.128 . . . . 0.0 110.463 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.33 -55.41 18.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.135 0.425 . . . . 0.0 110.571 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -66.88 -35.13 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.21 0.914 . . . . 0.0 110.592 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.79 -36.09 62.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.757 -0.589 . . . . 0.0 110.863 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 p -66.66 -35.92 81.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.107 0.867 . . . . 0.0 110.328 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.58 -36.48 82.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.128 0.876 . . . . 0.0 111.472 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.5 mmm -66.44 -16.57 64.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.901 0.88 . . . . 0.0 111.847 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.04 4.99 27.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.32 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -74.89 93.22 2.63 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.409 1.604 . . . . 0.0 107.692 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -75.65 4.7 7.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.371 1.069 . . . . 0.0 113.585 -172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -138.52 24.75 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.316 0.962 . . . . 0.0 112.646 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.76 140.71 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -143.79 138.64 28.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.43 105.57 9.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.7 68.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.318 0.647 . . . . 0.0 111.977 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.12 -150.13 21.55 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.24 168.12 22.7 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 169.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.3 tp -50.16 -46.06 53.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 113.217 -169.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.25 -28.63 34.69 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.782 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -76.05 -38.34 57.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.323 0.649 . . . . 0.0 111.121 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -66.48 123.94 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.08 -7.66 58.99 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -62.06 156.57 57.57 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.94 0.896 . . . . 0.0 110.757 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.24 169.06 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.759 2.306 . . . . 0.0 110.915 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -140.0 164.7 29.32 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.45 1.1 . . . . 0.0 110.196 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 126.092 1.757 . . . . 0.0 108.209 172.576 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.236 0.374 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -142.71 129.92 20.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -90.17 115.63 27.56 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mt -125.38 108.19 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.91 138.01 55.67 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 168.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.2 6.88 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.971 0.805 . . . . 0.0 111.66 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -60.26 162.35 6.11 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.934 0.788 . . . . 0.0 110.437 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.47 149.53 60.12 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -64.23 -31.55 63.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.59 1.526 . . . . 0.0 112.636 -168.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.56 -24.63 64.64 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.337 0.655 . . . . 0.0 111.842 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -86.37 -37.14 18.74 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.165 0.893 . . . . 0.0 108.862 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -36.97 78.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.523 0.601 . . . . 0.0 110.894 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.87 -20.52 66.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.415 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.37 -54.23 7.05 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.515 1.052 . . . . 0.0 108.701 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -164.79 153.29 12.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 110.41 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -163.17 176.12 10.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.933 1.693 . . . . 0.0 109.099 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.37 145.0 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.189 -0.944 . . . . 0.0 108.579 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -63.31 146.06 54.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.033 0.933 . . . . 0.0 110.187 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.65 46.51 75.36 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.26 177.16 8.19 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.259 1.424 . . . . 0.0 110.174 -175.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 tt -126.26 176.58 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.012 1.725 . . . . 0.0 107.173 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 6.2 t-20 -132.65 134.23 44.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.366 -0.833 . . . . 0.0 109.45 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.18 89.37 14.42 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.29 151.98 21.03 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.139 2.559 . . . . 0.0 112.896 -172.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.6 tp -51.48 -34.06 33.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.651 0.78 . . . . 0.0 112.177 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.41 -15.95 63.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -125.21 -24.06 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.482 1.113 . . . . 0.0 111.969 -169.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.1 -34.88 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.639 1.176 . . . . 0.0 113.116 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -56.45 -25.38 50.44 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.008 0.822 . . . . 0.0 112.799 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.56 -0.69 20.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.178 0.991 . . . . 0.0 111.659 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -136.67 -24.44 1.17 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -167.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.3 -35.68 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.089 1.768 . . . . 0.0 110.295 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -17.6 41.9 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.269 1.027 . . . . 0.0 113.638 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -117.94 -30.16 5.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.57 1.148 . . . . 0.0 110.969 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.88 85.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.797 0.726 . . . . 0.0 110.914 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.69 77.13 22.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -25.77 38.62 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.215 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -77.04 102.05 6.31 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.36 0.664 . . . . 0.0 110.052 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.46 -13.3 60.6 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.28 -14.85 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.225 0.921 . . . . 0.0 111.735 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.67 147.54 53.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.195 -0.941 . . . . 0.0 111.486 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -77.53 78.71 4.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.949 0.9 . . . . 0.0 109.344 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.09 100.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -92.45 128.73 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.7 m -122.19 142.8 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.265 0.626 . . . . 0.0 109.571 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.92 167.35 30.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.013 1.325 . . . . 0.0 107.588 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.09 -171.14 2.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.53 -47.59 63.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 112.052 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.32 26.11 2.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 112.41 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.17 -18.15 1.25 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.742 1.163 . . . . 0.0 115.523 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -67.41 -40.45 85.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 120.424 2.112 . . . . 0.0 113.028 -173.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -65.75 -30.3 70.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.714 1.143 . . . . 0.0 109.275 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -73.39 -45.55 54.09 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 124.258 1.023 . . . . 0.0 112.293 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.74 97.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -58.25 -46.33 86.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.88 0.872 . . . . 0.0 111.167 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -37.41 87.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.303 0.641 . . . . 0.0 111.575 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.03 -36.35 74.84 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.986 0.812 . . . . 0.0 111.028 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.53 -54.93 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.853 0.752 . . . . 0.0 110.011 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.3 pt -66.18 -34.79 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.469 0.577 . . . . 0.0 111.195 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.41 -39.79 92.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 0.0 110.339 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -64.53 -42.44 95.74 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.01 -35.93 81.89 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.548 0.613 . . . . 0.0 111.317 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.59 -10.5 59.44 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.254 1.021 . . . . 0.0 111.994 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.89 11.0 47.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.56 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -71.83 135.17 46.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.352 1.576 . . . . 0.0 107.364 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -118.37 4.6 11.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.648 0.779 . . . . 0.0 112.378 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -136.98 29.39 2.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.711 1.204 . . . . 0.0 110.075 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.66 142.32 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -144.03 128.32 17.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.46 110.32 14.65 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.72 71.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.454 0.301 . . . . 0.0 111.248 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.59 -157.95 27.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.29 159.59 14.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 167.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.26 -44.83 65.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.262 1.025 . . . . 0.0 111.791 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -68.74 -11.28 60.11 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.73 -30.19 5.51 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.307 1.043 . . . . 0.0 111.867 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 131.21 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.032 0.933 . . . . 0.0 108.619 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.73 56.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.4 mmm -61.18 154.2 63.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.916 0.886 . . . . 0.0 110.667 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.92 163.46 35.51 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 111.534 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -123.92 165.83 16.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.341 1.056 . . . . 0.0 109.641 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 125.872 1.669 . . . . 0.0 106.518 171.037 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.293 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -137.61 147.31 44.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.318 1.447 . . . . 0.0 107.482 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.09 110.07 21.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.24 107.0 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.1 138.25 49.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.27 8.66 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.084 0.856 . . . . 0.0 111.783 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -62.45 159.02 16.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.899 0.772 . . . . 0.0 110.683 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.5 m -54.67 147.89 28.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.726 0.81 . . . . 0.0 109.337 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.37 -33.0 71.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.867 1.711 . . . . 0.0 112.291 -169.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 -23.82 64.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.17 -34.1 16.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.177 0.898 . . . . 0.0 108.652 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -57.31 -41.11 79.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.416 0.687 . . . . 0.0 110.831 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -62.08 -28.24 69.47 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.695 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.88 -50.51 23.37 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.413 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -167.03 152.33 7.56 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.369 0.986 . . . . 0.0 110.204 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -153.64 167.51 29.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.503 1.521 . . . . 0.0 109.683 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 t -65.85 139.85 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.3 161.76 18.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.089 0.556 . . . . 0.0 112.003 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.99 38.61 84.78 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.886 0.755 . . . . 0.0 111.825 172.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.95 179.37 7.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.299 1.039 . . . . 0.0 111.924 -169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.44 175.9 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.745 2.018 . . . . 0.0 105.994 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.25 133.08 45.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.167 -0.958 . . . . 0.0 108.67 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 29' ' ' VAL . 12.4 mt -136.47 84.04 29.52 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -55.59 146.88 62.11 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.087 2.525 . . . . 0.0 113.026 -172.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -48.72 -34.46 12.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.888 0.875 . . . . 0.0 112.389 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -55.09 -28.48 52.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.631 1.172 . . . . 0.0 112.957 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -140.04 2.81 1.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.093 0.957 . . . . 0.0 113.016 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.6 p -54.36 -39.66 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.7 -29.11 66.39 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.979 0.809 . . . . 0.0 112.122 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.32 -16.78 57.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 111.641 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -125.62 -36.91 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.173 -0.918 . . . . 0.0 113.04 -169.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.67 -36.49 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 120.047 1.294 . . . . 0.0 111.34 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.8 -7.68 5.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.721 1.209 . . . . 0.0 114.103 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.7 m -125.98 -32.59 2.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.787 1.235 . . . . 0.0 109.927 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.92 82.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.687 0.795 . . . . 0.0 111.053 172.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.42 75.66 32.5 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.6 -35.74 16.37 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 111.976 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.69 113.86 11.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.091 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -65.42 -20.95 66.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -21.71 58.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.356 0.662 . . . . 0.0 111.804 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.29 146.51 43.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.558 1.072 . . . . 0.0 110.67 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -75.26 146.57 40.98 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.011 -0.431 . . . . 0.0 110.184 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.7 98.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.74 123.11 23.49 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 m -126.55 140.77 47.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 123.537 0.735 . . . . 0.0 109.097 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -164.14 157.68 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.4 -170.7 1.72 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.644 0.778 . . . . 0.0 109.774 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -68.22 132.41 47.09 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.2 16.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.771 2.028 . . . . 0.0 115.51 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.1 -14.2 0.44 Allowed Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.723 1.154 . . . . 0.0 115.385 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mmt-85 -63.86 -40.09 95.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.352 2.076 . . . . 0.0 112.785 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -27.41 68.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.393 0.542 . . . . 0.0 110.609 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.0 m -79.41 -43.61 23.04 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.862 0.756 . . . . 0.0 111.031 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.28 -43.19 93.74 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -65.73 -42.56 90.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.105 0.562 . . . . 0.0 111.292 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.12 91.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.121 0.568 . . . . 0.0 111.157 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -55.1 -39.02 68.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.352 0.978 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.72 -53.73 30.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.809 0.731 . . . . 0.0 110.204 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 pt -68.14 -33.74 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.793 -0.567 . . . . 0.0 110.964 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.07 -35.89 74.55 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.897 0.772 . . . . 0.0 110.171 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -62.44 -39.63 93.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 110.208 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.43 -38.88 91.2 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.477 0.58 . . . . 0.0 110.748 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.0 mtp -70.43 -9.93 57.76 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.205 1.002 . . . . 0.0 112.41 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 1.74 46.24 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.058 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.29 145.98 54.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.495 1.648 . . . . 0.0 109.153 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 p -131.19 7.88 4.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.992 0.917 . . . . 0.0 111.824 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -137.06 31.05 2.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.848 1.259 . . . . 0.0 110.444 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -75.2 141.54 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -142.12 124.77 15.88 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.49 108.72 8.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -28.96 68.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.62 0.368 . . . . 0.0 111.355 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.76 -144.07 12.22 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.46 175.48 21.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.84 -52.46 8.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.195 1.398 . . . . 0.0 113.064 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.24 -36.35 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.29 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.71 -38.58 62.3 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 111.615 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.8 128.32 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.1 54.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.46 156.42 70.59 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.717 0.807 . . . . 0.0 111.277 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.42 161.64 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.077 3.185 . . . . 0.0 113.722 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -135.48 159.36 41.85 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.672 1.189 . . . . 0.0 109.966 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.235 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.924 176.86 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -143.11 153.36 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -108.47 117.75 34.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.4 113.11 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -172.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.87 132.62 45.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 165.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.261 4.3 p -127.27 9.52 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.791 0.837 . . . . 0.0 111.145 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -64.57 161.39 17.58 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.961 -1.087 . . . . 0.0 110.121 170.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.48 151.86 58.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.46 -37.32 72.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.94 1.76 . . . . 0.0 112.038 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.3 -6.58 30.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -105.29 -31.23 9.18 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.139 0.881 . . . . 0.0 110.269 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.32 -41.01 88.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.702 1.137 . . . . 0.0 110.266 169.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -64.19 -8.24 11.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.9 0.88 . . . . 0.0 112.644 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.0 -59.9 1.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.3 169.97 16.8 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.836 1.198 . . . . 0.0 111.556 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -154.28 172.91 16.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 108.69 168.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.4 144.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -61.66 159.88 12.58 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.823 -0.548 . . . . 0.0 111.699 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.36 41.93 99.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.435 0.54 . . . . 0.0 112.573 171.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.97 177.69 7.66 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.969 1.308 . . . . 0.0 110.769 -172.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.8 tt -131.97 140.85 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.367 1.467 . . . . 0.0 108.571 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -82.62 121.28 26.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.059 0.944 . . . . 0.0 110.28 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -144.26 75.05 15.54 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -53.71 150.66 28.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.58 2.854 . . . . 0.0 112.147 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.63 -27.14 67.56 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.568 -0.708 . . . . 0.0 111.829 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.11 -10.47 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -129.33 -21.33 3.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.304 1.442 . . . . 0.0 112.082 -168.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.52 -41.38 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.917 1.287 . . . . 0.0 112.706 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.19 -23.4 62.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.792 0.724 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -110.29 2.89 19.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.917 1.287 . . . . 0.0 111.267 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -133.63 -37.4 0.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.536 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.59 -36.83 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.392 1.451 . . . . 0.0 111.395 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.71 -10.53 19.92 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 m -116.18 -35.75 4.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.13 0.972 . . . . 0.0 109.867 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.67 85.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.388 0.675 . . . . 0.0 111.968 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.6 76.6 47.89 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.51 10.45 1.87 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.723 2.949 . . . . 0.0 114.202 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.52 133.74 29.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.53 1.059 . . . . 0.0 108.996 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.64 -15.11 62.23 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -17.54 59.65 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.932 1.242 . . . . 0.0 112.611 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.41 144.47 55.81 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.44 0.564 . . . . 0.0 111.506 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 m -79.65 87.91 5.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.52 82.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.446 1.098 . . . . 0.0 108.37 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.7 132.43 46.14 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.76 143.75 39.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.601 0.761 . . . . 0.0 109.526 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.29 160.02 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.363 0.665 . . . . 0.0 110.664 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.8 p -168.9 -178.94 3.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.771 1.628 . . . . 0.0 108.489 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -58.82 127.53 32.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.642 -0.661 . . . . 0.0 109.483 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.56 16.9 0.7 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.552 1.941 . . . . 0.0 115.311 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.04 1.1 6.24 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 119.628 1.104 . . . . 0.0 115.209 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.6 mmt-85 -69.32 -39.79 78.0 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 120.131 1.965 . . . . 0.0 112.503 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -69.0 -30.17 68.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.319 0.963 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -70.13 -47.65 60.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.341 1.057 . . . . 0.0 111.646 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.16 99.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -57.5 -49.42 76.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.184 0.994 . . . . 0.0 110.948 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.6 81.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.941 0.496 . . . . 0.0 111.903 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.24 -35.39 69.65 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.178 0.899 . . . . 0.0 111.379 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -53.8 46.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.152 0.887 . . . . 0.0 110.254 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 pt -69.44 -33.16 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.805 -0.559 . . . . 0.0 111.083 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.75 -40.22 88.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.125 0.875 . . . . 0.0 110.153 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -63.66 -38.65 91.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.019 0.372 . . . . 0.0 110.348 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.65 -41.27 88.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.131 0.572 . . . . 0.0 110.908 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -64.25 -33.16 75.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.664 0.786 . . . . 0.0 110.965 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 -1.31 5.27 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.419 -1.212 . . . . 0.0 114.189 169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -68.0 125.38 26.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.542 1.671 . . . . 0.0 108.036 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -114.06 9.25 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.91 0.884 . . . . 0.0 112.305 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -133.32 29.01 4.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.654 1.181 . . . . 0.0 110.134 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.41 140.9 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.65 143.29 25.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 115.13 17.17 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.98 74.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.567 0.347 . . . . 0.0 111.015 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.52 -170.86 32.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.737 1.637 . . . . 0.0 109.242 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.52 155.96 38.3 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 168.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.8 -49.84 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.494 1.117 . . . . 0.0 111.642 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -76.97 -33.56 57.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.974 0.509 . . . . 0.0 111.525 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.92 -34.96 76.24 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.526 0.73 . . . . 0.0 111.674 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.2 mt -58.08 126.17 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.4 59.58 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 ttt -59.88 141.35 89.55 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.613 1.165 . . . . 0.0 110.655 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' MET . 31.9 Cg_exo -62.23 161.58 26.35 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.679 2.919 . . . . 0.0 114.398 -169.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -110.9 161.79 15.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.071 0.948 . . . . 0.0 109.733 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.238 0.484 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 168.243 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.326 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -143.47 157.97 44.02 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.332 1.453 . . . . 0.0 108.71 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.405 ' C ' HD12 ' A' ' 5' ' ' ILE . 69.8 m95 -99.04 128.03 45.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.8 mp -121.67 116.04 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 104.376 -2.454 . . . . 0.0 104.376 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -77.37 129.56 35.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.21 -1.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.829 1.652 . . . . 0.0 109.696 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.41 161.58 11.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.891 1.223 . . . . 0.0 109.515 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -55.81 148.89 34.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.82 0.448 . . . . 0.0 109.803 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.77 -31.19 39.95 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.48 1.453 . . . . 0.0 111.823 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -69.16 -17.61 63.83 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.841 . . . . 0.0 111.725 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -89.77 -40.16 12.66 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 109.416 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -54.0 -43.45 70.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.477 1.035 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.47 -32.71 72.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.908 0.483 . . . . 0.0 111.683 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -83.96 -32.23 25.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.229 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -166.4 127.04 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.379 1.072 . . . . 0.0 108.833 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -158.44 164.49 36.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.106 0.866 . . . . 0.0 110.604 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.88 137.01 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -52.51 119.93 5.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 110.834 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.22 1.59 86.22 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.568 -1.129 . . . . 0.0 114.887 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.29 41.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.599 1.699 . . . . 0.0 111.746 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.86 155.64 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -99.11 105.03 17.08 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 mm -138.17 77.03 37.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.6 159.98 5.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.985 3.124 . . . . 0.0 113.102 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -53.09 -42.65 66.11 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.082 0.553 . . . . 0.0 112.105 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -61.1 -29.83 69.99 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.515 0.726 . . . . 0.0 111.743 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -91.9 -31.44 15.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.868 1.267 . . . . 0.0 110.618 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -44.96 -51.64 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.766 1.167 . . . . 0.0 110.95 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -57.57 -23.34 50.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.38 -2.18 6.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.835 0.854 . . . . 0.0 112.336 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -135.48 -20.73 1.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.494 -169.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.5 -29.27 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.803 1.638 . . . . 0.0 112.401 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.29 61.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.915 0.78 . . . . 0.0 112.717 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -36.12 82.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.851 0.75 . . . . 0.0 110.377 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.65 -27.09 16.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.411 1.084 . . . . 0.0 111.739 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.41 76.6 49.15 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 -14.12 30.48 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.906 2.404 . . . . 0.0 114.063 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.8 152.39 38.69 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -56.31 -27.35 55.34 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.633 1.573 . . . . 0.0 114.222 -171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.14 -32.29 73.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.327 0.651 . . . . 0.0 112.703 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.36 136.06 52.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.036 0.446 . . . . 0.0 109.896 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -84.71 138.24 32.76 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.2 96.21 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 89.58 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.7 m -81.71 138.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -149.49 171.85 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.084 0.954 . . . . 0.0 108.467 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 p -151.97 -153.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 170.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.418 ' C ' HD22 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.1 -47.99 74.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.498 1.045 . . . . 0.0 111.028 -178.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.32 -18.88 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.34 -27.26 1.69 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.542 1.064 . . . . 0.0 114.583 172.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -56.85 -58.32 8.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.363 1.581 . . . . 0.0 113.789 -170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.21 -37.52 77.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.203 0.911 . . . . 0.0 110.976 -175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.73 -41.22 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.027 0.531 . . . . 0.0 112.094 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.61 95.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.31 -43.85 79.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.654 1.182 . . . . 0.0 110.567 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.13 70.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.477 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -59.37 -32.29 70.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.209 1.368 . . . . 0.0 111.462 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.1 -53.45 30.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.041 0.837 . . . . 0.0 109.712 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.66 -35.94 76.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.498 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.65 -37.07 84.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.363 0.983 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 m -63.96 -42.07 97.38 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.177 0.444 . . . . 0.0 110.043 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.49 -38.94 91.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.987 0.515 . . . . 0.0 110.836 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 85.1 mtp -70.48 -11.21 60.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.145 1.378 . . . . 0.0 111.945 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.03 48.87 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.822 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -73.89 151.18 40.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.352 1.576 . . . . 0.0 109.336 171.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -139.1 9.13 2.53 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.301 1.041 . . . . 0.0 111.781 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -134.79 38.87 3.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.392 1.477 . . . . 0.0 109.522 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -109.95 138.23 38.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.2 145.21 28.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -79.76 106.03 11.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.91 -28.18 67.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.28 -144.72 11.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.43 165.71 25.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.79 -47.04 51.46 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.333 1.453 . . . . 0.0 110.992 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.65 -2.15 16.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.029 0.932 . . . . 0.0 113.123 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.69 -30.54 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.509 1.124 . . . . 0.0 112.596 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.89 134.54 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.267 1.027 . . . . 0.0 108.512 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.3 -16.56 54.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.6 mtp -63.68 158.81 57.57 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.416 0.686 . . . . 0.0 111.776 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.93 161.13 8.86 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.611 2.874 . . . . 0.0 113.189 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.43 163.8 23.28 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.614 1.166 . . . . 0.0 108.797 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.1 m . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 171.039 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.236 0.392 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.51 152.89 41.24 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.068 1.747 . . . . 0.0 106.799 169.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -114.3 112.7 23.51 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.75 111.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -69.46 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 166.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.81 7.43 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.785 0.721 . . . . 0.0 111.406 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.413 HH22 ' HA ' ' A' ' 17' ' ' HIS . 2.6 ptp180 -64.6 162.15 16.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.038 -1.039 . . . . 0.0 110.462 170.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 m -54.69 144.99 42.67 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.51 -33.67 77.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.104 1.203 . . . . 0.0 111.524 -168.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.84 -29.98 70.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.24 -37.86 16.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -55.66 -44.68 77.48 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.952 0.501 . . . . 0.0 110.224 176.214 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -60.48 -25.8 66.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.62 0.768 . . . . 0.0 112.506 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -71.06 -49.1 48.3 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.563 0.62 . . . . 0.0 110.424 -173.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -166.0 133.4 2.79 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.413 ' HA ' HH22 ' A' ' 8' ' ' ARG . 12.5 p-80 -146.46 162.04 39.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.488 1.04 . . . . 0.0 111.36 178.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.03 135.99 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -60.33 144.9 49.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 110.074 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.18 20.28 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.96 174.57 10.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.042 1.337 . . . . 0.0 110.36 -177.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.05 169.97 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.557 1.943 . . . . 0.0 106.688 170.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.8 t-20 -127.67 127.91 44.54 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.186 172.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -136.99 92.38 14.24 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 171.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.8 153.05 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.538 2.825 . . . . 0.0 111.984 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -46.09 -47.83 17.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.548 1.139 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -57.26 -31.35 65.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.697 1.199 . . . . 0.0 112.289 177.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -101.54 -9.34 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.342 1.857 . . . . 0.0 111.943 -169.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -51.43 -53.37 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.036 1.289 . . . . 0.0 110.127 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -61.41 -22.11 64.71 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -82.83 -21.36 34.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.557 -176.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -136.22 -28.02 1.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.99 -36.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 121.195 1.816 . . . . 0.0 111.361 -169.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -6.36 4.44 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 m -126.31 -33.52 2.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.894 -178.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.09 78.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.702 0.801 . . . . 0.0 111.098 172.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 t -139.57 75.73 31.52 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.38 -23.59 32.37 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.238 1.959 . . . . 0.0 112.202 -175.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.96 104.99 3.13 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.757 0.823 . . . . 0.0 109.826 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -63.58 -13.05 38.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.26 11.95 34.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.196 0.998 . . . . 0.0 111.369 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.73 146.99 53.22 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.071 -1.018 . . . . 0.0 109.265 168.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -80.24 77.84 6.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.67 111.88 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -92.26 136.74 32.94 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.12 143.78 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.73 168.27 24.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 p -156.33 -159.32 0.88 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -63.64 -49.79 71.87 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.625 -0.672 . . . . 0.0 110.898 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.67 35.09 1.43 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.679 1.191 . . . . 0.0 112.5 -168.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 -20.63 1.63 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.962 1.268 . . . . 0.0 115.986 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -64.11 -52.19 60.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.352 2.076 . . . . 0.0 111.831 -174.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -59.16 -30.65 68.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.906 177.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 -47.16 59.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.726 1.148 . . . . 0.0 112.768 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.28 -42.64 97.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.59 -34.72 76.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.414 1.085 . . . . 0.0 111.573 174.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -37.87 64.44 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 176.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -58.88 -39.51 81.64 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.277 -0.889 . . . . 0.0 111.247 -178.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.98 -43.93 81.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.595 1.089 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.2 pt -69.81 -32.8 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.312 1.414 . . . . 0.0 111.01 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -37.95 85.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.246 0.93 . . . . 0.0 110.268 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.3 m -64.21 -40.24 95.65 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.94 -38.41 90.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.172 0.589 . . . . 0.0 110.715 176.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -71.24 -3.62 21.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.72 1.208 . . . . 0.0 112.464 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.76 14.85 64.44 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.304 -1.275 . . . . 0.0 113.883 169.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -62.55 129.19 39.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.613 1.707 . . . . 0.0 107.534 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -66.71 -29.41 69.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.54 0.336 . . . . 0.0 111.665 -169.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.95 158.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 108.741 178.232 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -149.19 147.36 16.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 175.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -131.99 124.94 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -77.02 112.19 13.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.07 72.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.761 0.424 . . . . 0.0 111.741 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.95 -149.45 21.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -177.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.87 163.11 16.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -50.15 -44.36 52.48 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.132 1.373 . . . . 0.0 111.732 -173.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -75.31 -5.87 46.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.954 0.902 . . . . 0.0 113.057 -175.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.52 -30.56 3.62 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.222 1.009 . . . . 0.0 112.266 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.32 130.5 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.59 -16.32 51.96 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mtp -62.05 156.5 57.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.998 0.919 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 165.16 30.72 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.154 2.57 . . . . 0.0 111.748 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.2 162.34 26.4 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.258 1.023 . . . . 0.0 109.907 -176.418 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.536 0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 107.604 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.61 163.57 39.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.12 142.68 42.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 108.34 171.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.15 119.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.406 HD12 HG13 ' A' ' 44' ' ' VAL . 8.6 mt -125.5 109.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.93 132.52 45.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 167.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.56 10.83 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.528 0.731 . . . . 0.0 111.695 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' HD23 ' A' ' 75' ' ' LEU . 4.0 ptp180 -67.83 170.58 7.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.26 1.391 . . . . 0.0 108.708 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.78 150.41 48.07 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.28 -0.887 . . . . 0.0 110.921 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.79 -34.33 61.84 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.479 2.119 . . . . 0.0 112.76 -167.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.68 -27.48 68.38 Favored 'General case' 0 C--O 1.227 -0.131 0 O-C-N 121.301 -0.875 . . . . 0.0 111.224 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -88.35 -30.74 19.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.417 -0.802 . . . . 0.0 112.949 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -53.71 -47.37 70.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 170.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.76 -20.07 66.16 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.081 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.2 -49.32 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -178.88 134.43 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -148.11 160.78 42.53 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.566 1.146 . . . . 0.0 110.067 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.98 131.15 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -56.6 140.76 45.66 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.192 2.197 . . . . 0.0 109.967 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.36 83.91 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.8 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 172.8 7.8 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.527 1.164 . . . . 0.0 109.639 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 tt -112.87 170.87 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 2.9 t-20 -124.12 127.67 48.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.24 86.86 19.06 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.82 149.34 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.704 2.269 . . . . 0.0 111.959 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.8 tp -46.84 -37.64 9.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.99 0.916 . . . . 0.0 112.68 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -62.23 -28.19 69.52 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -113.21 -16.94 12.47 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.426 1.891 . . . . 0.0 108.665 -166.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -41.71 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.675 0.79 . . . . 0.0 110.477 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -57.44 -34.23 68.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.161 0.984 . . . . 0.0 113.578 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.54 -6.87 58.15 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -148.68 -25.11 0.32 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -153.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.85 -35.98 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.93 66.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.707 0.803 . . . . 0.0 112.342 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 -39.36 14.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.798 0.839 . . . . 0.0 109.805 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.47 60.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.782 0.833 . . . . 0.0 112.265 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 t -139.95 75.3 30.2 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.303 1.841 . . . . 0.0 106.867 -173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.92 -17.62 36.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.824 2.35 . . . . 0.0 112.882 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -113.21 123.49 50.31 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 5.1 mtpt -71.08 -26.73 63.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 125.201 1.401 . . . . 0.0 113.239 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.55 -14.55 62.13 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 126.07 2.106 . . . . 0.0 108.634 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.78 146.37 52.97 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.748 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -81.55 117.89 22.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.68 1.228 . . . . 0.0 110.845 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 5' ' ' ILE . 6.7 t -104.85 110.67 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 O-C-N 120.771 -1.205 . . . . 0.0 107.756 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -95.55 119.45 34.07 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.65 141.12 29.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -149.35 171.93 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 31.5 p -165.86 -170.99 1.91 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.734 1.214 . . . . 0.0 108.606 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.07 104.93 1.24 Allowed 'General case' 0 C--O 1.26 1.645 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 85.5 5.67 0.48 Allowed 'General case' 0 C--N 1.404 2.953 1 O-C-N 129.974 4.546 . . . . 0.0 111.282 156.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.92 63.15 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.171 0.891 . . . . 0.0 112.731 162.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -52.16 43.76 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 121.646 -0.914 . . . . 0.0 113.351 -165.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -61.16 -29.48 69.82 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.88 -45.92 55.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.582 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.64 95.92 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.55 -45.75 91.49 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.406 1.482 . . . . 0.0 111.788 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.34 88.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 69' ' ' VAL . 61.0 tttt -58.6 -42.2 87.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.604 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.57 -56.34 23.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.529 1.059 . . . . 0.0 110.091 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.1 pt -66.77 -31.96 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.155 -0.34 . . . . 0.0 110.359 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -71.59 -41.73 68.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.138 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.8 m -57.18 -41.29 79.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.943 0.792 . . . . 0.0 109.54 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -67.11 -39.04 86.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.611 0.641 . . . . 0.0 110.646 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.94 -10.18 51.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.846 -1.159 . . . . 0.0 111.281 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.92 13.19 47.34 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.608 1.575 . . . . 0.0 113.345 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 80.9 m-85 -70.22 130.12 41.19 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.709 1.754 . . . . 0.0 107.492 166.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 -2.07 18.3 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.06 0.544 . . . . 0.0 111.61 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -131.76 34.35 3.89 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 110.241 -169.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 37.2 t -85.67 139.12 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -141.12 129.14 21.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.39 1.076 . . . . 0.0 108.464 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.06 109.4 10.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.76 69.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.272 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.07 -153.01 25.01 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 162.39 12.63 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 166.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.512 HD23 ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -37.3 -51.49 1.06 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.846 2.058 . . . . 0.0 110.823 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -68.58 -40.72 80.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.4 -33.38 32.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.943 -1.935 . . . . 0.0 107.176 -168.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.39 123.76 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -8.78 58.68 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mtp -66.47 152.76 94.28 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.473 0.709 . . . . 0.0 110.925 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.58 162.08 22.32 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.168 2.579 . . . . 0.0 112.191 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.486 ' HE2' HD13 ' A' ' 75' ' ' LEU . 9.9 mptt -130.46 156.39 44.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.096 0.958 . . . . 0.0 108.659 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.47 162.45 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -95.97 157.92 15.68 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.347 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 165.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -149.14 162.81 39.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.899 1.28 . . . . 0.0 108.115 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.59 140.45 27.41 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 108.953 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -80.26 102.96 9.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 168.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -112.27 94.69 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -65.84 156.2 34.0 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.53 16.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.325 1.05 . . . . 0.0 111.688 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -54.97 159.71 2.26 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.871 1.268 . . . . 0.0 111.795 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.13 145.96 32.38 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.64 -37.75 86.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.648 2.232 . . . . 0.0 113.996 -166.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.16 -17.58 64.59 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -88.54 -10.35 49.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.838 0.745 . . . . 0.0 110.959 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -72.52 -20.61 61.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.531 1.514 . . . . 0.0 110.962 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.05 -12.48 60.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.773 0.829 . . . . 0.0 111.213 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -114.79 -172.49 2.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.724 1.61 . . . . 0.0 108.567 -167.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.58 117.53 4.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.203 1.001 . . . . 0.0 111.345 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -147.66 160.9 42.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.693 1.197 . . . . 0.0 109.456 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.48 139.17 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.617 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -50.84 120.13 4.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.934 1.294 . . . . 0.0 110.101 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.82 4.25 81.79 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.666 -1.075 . . . . 0.0 114.536 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 151.11 47.93 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.475 1.638 . . . . 0.0 110.654 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.63 159.5 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -125.61 133.0 52.39 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 169.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 29' ' ' VAL . 8.7 mt -136.67 88.74 18.93 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.24 144.61 29.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.029 2.486 . . . . 0.0 113.378 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.6 tp -52.23 -32.17 35.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.636 0.774 . . . . 0.0 112.561 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -68.21 -15.48 63.59 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -131.42 -14.96 3.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.317 1.447 . . . . 0.0 112.087 -169.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 24' ' ' ILE . 11.0 p -50.81 -43.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 125.675 1.59 . . . . 0.0 114.038 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.86 -21.91 66.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.423 1.011 . . . . 0.0 112.362 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.35 -18.05 40.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.746 0.818 . . . . 0.0 112.033 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -135.22 -16.78 1.86 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -166.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.29 -34.24 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.552 1.069 . . . . 0.0 111.166 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.36 77.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.469 0.577 . . . . 0.0 111.719 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -68.66 -42.82 77.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.343 0.657 . . . . 0.0 109.663 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.31 -29.02 61.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.85 81.67 45.81 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.79 -5.76 17.56 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.369 2.712 . . . . 0.0 114.541 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -142.44 136.32 29.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.58 1.082 . . . . 0.0 109.044 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.66 -22.32 66.63 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -19.4 60.28 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.261 0.937 . . . . 0.0 112.162 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.1 143.91 50.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.972 0.805 . . . . 0.0 110.674 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.84 152.94 33.17 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -138.37 137.77 43.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.22 103.35 12.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.03 141.26 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -154.32 173.74 15.78 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.43 -177.0 5.68 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -48.02 -43.93 30.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 0.0 112.132 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 16.97 5.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.195 0.998 . . . . 0.0 112.907 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.39 -31.4 0.99 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.11 1.338 . . . . 0.0 114.927 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.8 -43.28 99.23 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.395 1.597 . . . . 0.0 113.54 -173.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.48 -36.68 83.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.027 1.285 . . . . 0.0 109.453 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.44 -36.6 60.7 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.642 -0.695 . . . . 0.0 112.844 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.54 97.67 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 171.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -48.79 79.37 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 175.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -39.75 94.19 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.196 0.599 . . . . 0.0 111.589 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.2 -42.25 76.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.271 0.941 . . . . 0.0 110.066 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.14 -53.13 54.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.87 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.96 -35.69 75.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 CA-C-N 119.413 1.006 . . . . 0.0 110.996 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.0 -34.46 68.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.964 0.802 . . . . 0.0 110.534 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.4 m -63.63 -40.84 97.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.448 0.567 . . . . 0.0 110.093 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.05 -37.66 88.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.581 0.628 . . . . 0.0 110.76 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.69 -3.01 16.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.899 1.28 . . . . 0.0 112.317 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.03 4.45 60.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.495 -1.169 . . . . 0.0 113.928 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -75.1 86.26 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.591 1.695 . . . . 0.0 108.221 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 p -71.27 9.69 0.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.319 1.447 . . . . 0.0 113.904 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -136.34 27.98 3.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 111.717 -170.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.33 137.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -136.75 144.09 43.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -85.16 110.77 19.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.99 73.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.744 0.418 . . . . 0.0 111.73 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.79 -154.39 25.52 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.16 162.25 12.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.8 tp -43.48 -48.56 7.3 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 114.503 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.83 -18.49 60.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.58 -22.46 21.24 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.884 0.874 . . . . 0.0 111.958 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 mm -63.32 132.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.81 58.77 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.5 mmm -66.36 156.22 85.96 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.198 0.999 . . . . 0.0 111.612 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.24 161.67 16.02 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.497 2.798 . . . . 0.0 112.088 168.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -130.0 160.37 33.86 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.951 0.9 . . . . 0.0 110.446 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m -141.19 178.59 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 127.504 2.321 . . . . 0.0 107.772 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -132.26 173.1 11.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.121 1.368 . . . . 0.0 108.625 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 174.541 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.27 157.55 44.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.768 0.827 . . . . 0.0 109.582 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -139.98 122.03 15.7 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 169.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -78.92 118.94 21.41 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.45 104.23 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.89 124.69 24.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.17 6.48 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.009 0.924 . . . . 0.0 111.076 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -63.76 160.32 17.46 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.005 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 148.01 51.94 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.47 -32.94 70.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.922 1.748 . . . . 0.0 113.161 -167.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.06 -27.72 64.87 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.568 -0.707 . . . . 0.0 111.844 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -84.23 -34.87 23.79 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -55.28 -46.24 76.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.196 0.598 . . . . 0.0 110.616 178.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.05 -22.6 66.97 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -65.23 -45.02 86.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.765 0.712 . . . . 0.0 110.706 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -172.63 138.2 0.85 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.887 1.675 . . . . 0.0 106.988 171.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -147.18 160.54 42.33 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.294 1.038 . . . . 0.0 110.752 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.41 127.69 22.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -61.54 145.61 51.43 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.884 0.374 . . . . 0.0 110.929 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.1 -7.37 52.44 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.214 0.911 . . . . 0.0 114.094 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.62 7.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.012 1.406 . . . . 0.0 111.332 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.76 166.52 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.051 1.741 . . . . 0.0 106.409 168.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.8 t-20 -123.74 128.83 50.15 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 109.187 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 29' ' ' VAL . 9.7 mt -139.12 84.43 16.84 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.1 153.77 11.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.397 2.731 . . . . 0.0 112.815 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -51.59 -35.98 43.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.768 0.827 . . . . 0.0 112.613 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.56 -22.61 66.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.428 0.691 . . . . 0.0 112.46 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -114.66 -27.68 7.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.112 1.365 . . . . 0.0 111.772 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 p -56.7 -38.92 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 124.4 1.08 . . . . 0.0 112.898 -168.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -63.11 -19.46 64.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.238 0.926 . . . . 0.0 112.446 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -103.86 -5.4 22.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.642 1.177 . . . . 0.0 111.918 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -134.95 -21.25 1.67 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -60.43 -38.67 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 120.012 1.278 . . . . 0.0 111.524 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.6 75.14 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.969 0.804 . . . . 0.0 111.868 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 m -71.67 -45.12 62.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.635 0.774 . . . . 0.0 109.633 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.55 -30.71 66.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.17 0.588 . . . . 0.0 112.402 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.0 t -136.06 86.26 26.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.17 -1.78 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.205 2.604 . . . . 0.0 113.661 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -138.28 114.88 10.54 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.615 1.166 . . . . 0.0 108.692 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.62 -15.51 51.99 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.115 0.966 . . . . 0.0 112.871 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -66.22 -22.77 66.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.02 142.64 53.6 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.04 0.536 . . . . 0.0 111.182 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -78.2 97.87 5.66 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.55 88.19 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -82.21 89.78 6.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.14 139.97 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.857 0.463 . . . . 0.0 109.832 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -149.61 168.15 24.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.211 1.005 . . . . 0.0 108.514 169.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.39 -154.29 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -59.27 -47.71 84.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.9 0.773 . . . . 0.0 110.728 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.74 -23.22 0.72 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -25.83 1.46 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.739 1.154 . . . . 0.0 114.81 172.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -64.56 -45.49 86.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.639 1.72 . . . . 0.0 112.927 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.5 -31.29 72.44 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.75 1.159 . . . . 0.0 109.438 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -65.01 -49.53 69.86 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.899 0.88 . . . . 0.0 111.02 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.77 -42.09 95.36 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.07 -42.7 95.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.475 0.71 . . . . 0.0 110.664 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.53 92.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.017 0.527 . . . . 0.0 110.368 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.5 -37.83 73.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.985 0.811 . . . . 0.0 111.144 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -62.13 -53.09 60.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.957 0.799 . . . . 0.0 110.72 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt -69.4 -30.38 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.295 0.952 . . . . 0.0 111.566 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.21 -37.01 82.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 119.471 1.032 . . . . 0.0 110.143 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -66.29 -38.4 87.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.019 0.372 . . . . 0.0 110.199 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.19 -38.76 92.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.633 0.651 . . . . 0.0 110.538 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -75.09 6.24 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.287 1.435 . . . . 0.0 112.274 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.42 13.5 83.33 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.324 -1.265 . . . . 0.0 114.418 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -69.43 147.62 50.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.756 1.778 . . . . 0.0 108.433 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 p -132.67 8.58 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.591 1.157 . . . . 0.0 111.336 -171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -134.02 30.47 3.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.524 1.53 . . . . 0.0 110.026 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -77.08 140.21 17.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -138.66 129.73 26.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.22 108.79 16.7 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -31.4 72.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.259 0.223 . . . . 0.0 111.315 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.95 -139.34 8.12 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.98 163.68 24.51 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -48.69 -48.07 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.363 1.465 . . . . 0.0 112.396 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -68.73 -38.05 79.9 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.709 0.404 . . . . 0.0 111.49 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -78.19 -36.71 47.04 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.643 0.777 . . . . 0.0 111.992 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.31 132.55 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.462 1.105 . . . . 0.0 108.977 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.49 -13.84 56.01 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.2 mmm -61.98 154.21 69.62 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.757 0.823 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.22 162.3 42.34 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.134 2.556 . . . . 0.0 112.003 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -133.4 159.96 38.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.2 1.0 . . . . 0.0 110.811 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.53 161.95 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.632 1.573 . . . . 0.0 108.75 171.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.35 156.44 29.17 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 170.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.093 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.33 149.37 28.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.141 1.376 . . . . 0.0 107.456 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -138.31 152.18 48.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.267 1.427 . . . . 0.0 107.744 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.47 120.53 37.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -125.46 110.25 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -68.21 133.47 48.9 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.36 6.15 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.679 0.672 . . . . 0.0 110.332 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -57.41 157.41 6.67 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.31 -0.869 . . . . 0.0 111.066 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -53.94 148.26 21.5 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 167.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.33 -26.94 63.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.171 1.914 . . . . 0.0 113.368 -166.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.32 -28.85 61.35 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.396 -0.815 . . . . 0.0 112.023 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -82.54 -33.93 28.02 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.128 0.876 . . . . 0.0 109.18 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -50.13 -50.6 48.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.774 0.83 . . . . 0.0 111.492 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -66.19 -19.83 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -63.74 -45.04 91.65 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.083 0.856 . . . . 0.0 110.324 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.79 147.82 0.82 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.002 2.521 . . . . 0.0 105.381 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.11 158.16 43.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.608 1.094 . . . . 0.0 109.28 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.71 134.69 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -58.09 143.08 44.94 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.198 0.999 . . . . 0.0 110.137 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.15 45.32 20.26 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.266 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.23 176.1 9.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.097 1.359 . . . . 0.0 110.072 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 tt -121.31 171.13 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.09 1.756 . . . . 0.0 106.406 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -124.97 131.9 53.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 mt -139.0 100.64 7.91 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.34 159.07 6.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.778 2.985 . . . . 0.0 114.078 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -55.63 -35.85 66.34 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.359 -0.838 . . . . 0.0 112.092 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.11 -2.92 29.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.692 0.797 . . . . 0.0 112.821 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.72 -17.68 2.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.0 1.32 . . . . 0.0 112.311 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.82 -37.13 77.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.027 0.931 . . . . 0.0 111.967 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.03 -31.45 68.85 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.868 0.758 . . . . 0.0 111.354 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -77.88 -14.14 59.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.581 0.752 . . . . 0.0 112.472 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -130.58 -22.06 2.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.31 -36.24 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.606 1.094 . . . . 0.0 111.066 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.1 -25.01 28.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.061 1.344 . . . . 0.0 114.143 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -122.83 -29.99 3.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.641 1.176 . . . . 0.0 110.906 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.43 72.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.782 0.833 . . . . 0.0 111.046 171.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -134.6 91.29 21.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -6.3 18.77 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.089 2.526 . . . . 0.0 115.727 -166.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -146.71 139.1 24.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.102 1.319 . . . . 0.0 109.318 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.16 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -76.15 -23.76 54.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.061 0.846 . . . . 0.0 111.673 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -69.66 144.08 53.0 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.112 -0.367 . . . . 0.0 110.736 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.59 144.72 37.3 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 109.733 -169.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.73 141.23 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -123.95 137.35 54.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.67 142.61 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -154.59 155.01 33.96 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.966 1.306 . . . . 0.0 108.135 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 53' ' ' GLN . 66.6 m -155.95 -174.03 4.78 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.25 1.82 . . . . 0.0 109.462 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.45 128.84 37.91 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.69 18.2 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.718 1.607 . . . . 0.0 114.28 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.4 11.91 11.25 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.144 -1.364 . . . . 0.0 115.061 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -67.64 -57.95 5.52 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 120.858 2.329 . . . . 0.0 113.379 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.421 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mp0 -61.26 -30.33 70.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.19 0.904 . . . . 0.0 109.716 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -74.71 -42.95 57.41 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.366 1.066 . . . . 0.0 112.196 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.49 -40.58 86.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.11 -42.24 85.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.356 1.063 . . . . 0.0 110.214 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.84 -39.62 79.86 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.732 0.696 . . . . 0.0 111.883 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.32 -38.84 66.43 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.27 1.395 . . . . 0.0 110.213 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.92 -58.59 7.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.668 0.667 . . . . 0.0 110.784 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.41 -37.1 79.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 119.611 1.096 . . . . 0.0 110.604 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.03 -37.68 75.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.234 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.8 m -62.55 -40.14 95.85 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.712 0.687 . . . . 0.0 110.356 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.19 -37.59 81.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.528 0.604 . . . . 0.0 111.182 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.4 mtp -64.46 -31.49 72.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.467 0.707 . . . . 0.0 110.945 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.26 -9.45 3.25 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.567 1.08 . . . . 0.0 113.565 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -77.21 72.75 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.095 1.447 . . . . 0.0 109.951 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 p -70.67 18.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.348 1.459 . . . . 0.0 112.895 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -132.2 24.76 4.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.316 1.846 . . . . 0.0 110.911 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -92.21 141.37 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.38 133.51 40.66 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.27 109.88 10.32 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 -30.66 70.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 111.611 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.4 -154.03 25.23 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.31 164.9 12.46 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.1 tp -46.18 -49.8 16.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 113.639 -169.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.24 -20.13 22.26 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 119.23 -0.414 . . . . 0.0 112.014 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.21 -37.62 69.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.448 0.567 . . . . 0.0 110.421 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.54 124.73 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -9.79 59.41 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mtp -61.14 154.59 60.72 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 110.608 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.4 164.23 34.97 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.961 2.44 . . . . 0.0 111.712 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -126.49 157.66 38.13 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.101 0.961 . . . . 0.0 110.044 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.05 158.58 36.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.03 1.732 . . . . 0.0 107.569 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -110.79 161.4 15.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.898 0.879 . . . . 0.0 110.382 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 175.278 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.12 172.45 15.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.08 -1.013 . . . . 0.0 109.54 170.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -136.29 132.02 35.17 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -94.77 115.34 27.39 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.49 107.24 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -65.97 142.54 57.82 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.1 11.6 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.809 0.731 . . . . 0.0 112.081 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -66.38 162.76 19.69 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 172.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.94 148.94 68.15 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.96 -32.94 64.87 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.896 1.73 . . . . 0.0 114.074 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.04 -30.18 67.4 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.497 -0.752 . . . . 0.0 111.408 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.04 -33.97 29.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -48.71 70.33 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.384 0.674 . . . . 0.0 111.251 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -61.99 -21.03 64.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.091 0.556 . . . . 0.0 112.35 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.98 -24.09 64.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.514 -1.231 . . . . 0.0 112.573 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 167.06 135.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.415 2.686 . . . . 0.0 106.848 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.31 162.8 38.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.847 1.203 . . . . 0.0 110.307 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.22 137.6 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -60.37 142.82 54.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.811 0.844 . . . . 0.0 109.91 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.78 44.09 39.85 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.185 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.83 179.34 6.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.111 1.364 . . . . 0.0 110.22 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -130.37 177.15 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.462 1.905 . . . . 0.0 106.48 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.37 137.33 50.89 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.349 -0.844 . . . . 0.0 108.781 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -140.79 97.38 7.23 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.19 157.2 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.527 2.818 . . . . 0.0 113.152 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -52.98 -35.88 59.67 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.618 -0.676 . . . . 0.0 112.248 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.28 -13.7 62.54 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -116.68 -36.02 4.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.189 1.395 . . . . 0.0 110.197 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.13 -33.06 45.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 C-N-CA 124.399 1.079 . . . . 0.0 111.705 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.36 -22.72 65.2 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.82 -30.94 7.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 110.534 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -84.6 -26.13 28.13 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.683 -0.636 . . . . 0.0 112.208 -169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.18 -33.65 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.568 1.076 . . . . 0.0 110.857 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.48 -9.01 10.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 -37.09 4.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.572 1.149 . . . . 0.0 109.905 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.96 -37.9 72.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.741 0.701 . . . . 0.0 112.143 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.96 73.47 33.05 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.34 -27.35 34.33 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.247 1.965 . . . . 0.0 111.976 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -76.75 102.13 6.11 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.38 -4.79 24.07 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -111.51 39.54 2.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.592 1.157 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.35 149.93 50.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.921 1.289 . . . . 0.0 108.159 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.01 153.67 43.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.237 0.615 . . . . 0.0 111.207 -168.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.17 137.54 51.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -110.87 126.76 55.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.3 141.89 39.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.63 169.01 24.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.55 1.14 . . . . 0.0 108.036 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -154.11 -155.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -55.43 -47.15 76.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.222 0.609 . . . . 0.0 111.213 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.86 -37.08 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.04 -23.13 0.6 Allowed Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.659 1.118 . . . . 0.0 115.615 172.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -58.58 -52.06 67.26 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.252 2.026 . . . . 0.0 112.48 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -58.99 -32.33 69.6 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.358 0.526 . . . . 0.0 110.113 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -72.92 -44.9 60.68 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 124.505 1.122 . . . . 0.0 112.59 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -45.39 93.43 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -57.23 -43.63 83.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.96 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.94 85.99 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.804 -0.56 . . . . 0.0 110.89 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -59.39 -38.15 79.78 Favored 'General case' 0 C--O 1.231 0.101 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.91 -52.63 64.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.105 0.866 . . . . 0.0 110.67 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.4 pt -68.04 -33.32 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.363 0.983 . . . . 0.0 111.335 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.51 -40.02 92.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.51 1.05 . . . . 0.0 110.289 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -64.4 -41.4 96.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.747 0.419 . . . . 0.0 109.903 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.02 -39.84 93.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.379 0.671 . . . . 0.0 111.012 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.3 mtp -68.26 -14.66 63.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.596 1.158 . . . . 0.0 111.947 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.81 28.32 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.219 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -64.22 120.05 11.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.1 p -68.66 -28.03 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -167.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.18 126.04 8.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.44 1.096 . . . . 0.0 109.665 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -144.56 149.82 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -139.64 135.08 32.89 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -79.39 110.68 14.9 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.45 70.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.814 0.446 . . . . 0.0 111.932 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.7 -141.44 9.74 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.23 168.41 24.62 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 tp -54.31 -36.07 63.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.866 1.266 . . . . 0.0 112.267 -173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.32 -9.04 58.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.049 0.94 . . . . 0.0 113.083 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.37 -31.11 2.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.459 1.027 . . . . 0.0 113.253 -168.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.43 129.94 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.93 -13.55 55.83 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.24 158.6 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.08 0.952 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.36 164.83 29.1 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.977 2.451 . . . . 0.0 111.51 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -132.83 158.16 43.19 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.054 0.942 . . . . 0.0 110.267 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.74 157.78 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.346 1.859 . . . . 0.0 108.216 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -66.08 161.64 21.29 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.381 -0.825 . . . . 0.0 110.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 170.864 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.56 151.83 31.14 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.396 1.478 . . . . 0.0 107.305 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -139.84 149.62 43.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.672 1.589 . . . . 0.0 107.179 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -119.04 112.95 20.2 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.14 107.44 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.42 142.55 58.15 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.86 7.05 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.093 0.957 . . . . 0.0 111.766 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -63.88 165.81 8.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.661 1.119 . . . . 0.0 110.472 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.36 147.82 66.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.36 -38.15 76.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.043 1.829 . . . . 0.0 113.125 -167.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.89 -26.48 66.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.185 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.04 -34.92 32.46 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -45.61 85.66 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.994 0.518 . . . . 0.0 110.861 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -61.31 -22.34 64.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -67.26 -35.46 79.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.63 -171.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 176.78 141.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.144 2.578 . . . . 0.0 106.8 169.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.61 155.27 40.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.492 1.117 . . . . 0.0 109.723 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.11 134.09 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.059 0.943 . . . . 0.0 109.27 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.72 141.32 49.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.368 0.667 . . . . 0.0 110.177 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.87 55.42 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.674 1.13 . . . . 0.0 114.236 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.59 177.44 6.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.97 1.385 . . . . 0.0 111.509 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.02 175.7 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.647 1.979 . . . . 0.0 105.752 168.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -138.64 133.11 31.97 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.851 -1.156 . . . . 0.0 109.994 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -140.53 101.78 6.64 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.35 150.88 31.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.375 2.05 . . . . 0.0 111.821 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -46.69 -45.75 19.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.429 1.091 . . . . 0.0 112.968 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -67.73 -10.14 49.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -119.17 -13.69 9.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.707 2.003 . . . . 0.0 111.129 -170.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -49.31 -56.65 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.828 1.651 . . . . 0.0 111.326 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.65 -31.02 65.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.38 -25.11 60.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.188 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.23 -30.31 4.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.883 0.765 . . . . 0.0 112.394 -168.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.95 -34.37 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.609 1.095 . . . . 0.0 111.52 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -8.75 6.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 m -120.92 -34.37 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.797 1.239 . . . . 0.0 110.036 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -35.57 80.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.878 0.763 . . . . 0.0 111.496 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.63 79.24 41.25 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.6 18.54 0.7 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.956 3.104 . . . . 0.0 113.581 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -142.99 113.17 7.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.052 1.341 . . . . 0.0 108.173 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -20.02 57.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.86 -20.33 49.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.761 0.709 . . . . 0.0 111.7 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -75.3 148.37 39.42 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.744 0.702 . . . . 0.0 111.24 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.78 145.04 45.34 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.73 0.812 . . . . 0.0 109.858 -175.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.34 141.44 37.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -120.9 135.93 55.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -129.05 144.39 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -150.77 166.13 31.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.893 1.277 . . . . 0.0 107.829 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.7 p -169.52 -174.58 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.329 1.052 . . . . 0.0 109.242 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -65.36 125.3 24.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.68 17.7 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.491 2.317 . . . . 0.0 115.676 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.07 -8.31 8.56 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 118.563 -1.132 . . . . 0.0 115.176 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -56.66 -53.36 58.54 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.108 1.954 . . . . 0.0 111.191 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.13 -28.5 68.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.38 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 m -75.42 -46.37 33.17 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 110.792 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.8 -43.32 86.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 172.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -66.85 -41.9 86.62 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.637 0.375 . . . . 0.0 111.456 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.65 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.47 0.708 . . . . 0.0 111.134 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -57.14 -37.34 71.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.654 1.115 . . . . 0.0 110.869 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.14 -54.58 23.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.373 0.988 . . . . 0.0 109.939 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 pt -65.31 -35.18 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.418 0.554 . . . . 0.0 110.492 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.76 -35.46 72.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.656 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 m -64.28 -38.6 91.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.812 0.733 . . . . 0.0 110.599 173.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.69 -37.77 82.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.403 0.547 . . . . 0.0 110.885 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -65.94 -33.8 76.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.545 0.611 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.17 -2.53 5.48 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.164 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.45 142.2 57.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.445 1.622 . . . . 0.0 109.124 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -130.88 10.47 5.05 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.751 0.82 . . . . 0.0 111.987 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -136.49 32.71 2.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.938 1.295 . . . . 0.0 110.12 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -88.98 141.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.1 141.69 44.23 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.393 1.077 . . . . 0.0 108.139 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.25 112.33 20.19 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.67 -30.24 70.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.479 0.311 . . . . 0.0 111.698 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.46 -147.37 17.86 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.5 168.29 19.6 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -43.85 -50.33 7.96 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.549 1.539 . . . . 0.0 114.617 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -91.49 -23.89 19.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 119.295 -0.384 . . . . 0.0 111.679 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.37 -38.02 74.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.017 0.527 . . . . 0.0 110.391 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.05 113.59 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.03 58.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.6 mtp -60.67 151.31 72.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.668 0.787 . . . . 0.0 110.547 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.22 160.02 49.49 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.082 2.522 . . . . 0.0 111.141 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 156.63 45.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.963 0.905 . . . . 0.0 110.737 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.6 159.43 24.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.69 1.996 . . . . 0.0 108.307 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -129.06 170.85 12.99 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.336 1.054 . . . . 0.0 111.272 -169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.528 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -147.51 149.33 32.42 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.77 1.228 . . . . 0.0 108.665 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -134.35 157.14 47.14 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.31 1.444 . . . . 0.0 108.34 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -118.98 119.96 35.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -131.32 109.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.76 144.44 56.32 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.8 11.59 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.028 0.831 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -68.6 163.8 22.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.254 -0.903 . . . . 0.0 109.844 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -56.57 147.65 49.41 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.28 -39.44 57.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.818 1.678 . . . . 0.0 113.484 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.51 -25.95 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.528 -0.732 . . . . 0.0 112.011 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.74 -34.66 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -45.28 89.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.825 0.739 . . . . 0.0 110.605 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -52.06 -28.96 19.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.666 0.786 . . . . 0.0 112.754 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.8 -23.44 65.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.252 -1.356 . . . . 0.0 112.73 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 156.26 147.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.968 3.307 . . . . 0.0 110.373 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -151.73 169.44 22.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 109.168 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.13 137.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 110.06 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.34 125.94 22.92 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.176 0.991 . . . . 0.0 109.802 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.28 -1.2 89.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.215 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.57 -173.73 3.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.106 1.453 . . . . 0.0 111.025 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.87 178.52 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.791 2.036 . . . . 0.0 106.232 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -133.97 136.46 44.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.109 -0.994 . . . . 0.0 109.367 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.4 95.99 11.24 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.4 152.34 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.328 2.685 . . . . 0.0 111.946 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 tp -48.11 -40.3 23.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.763 0.825 . . . . 0.0 112.824 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.46 -34.85 77.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 111.944 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -88.14 -25.67 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.615 1.566 . . . . 0.0 111.166 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.0 t -46.62 -47.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.428 1.091 . . . . 0.0 110.336 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -56.62 -20.61 22.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.16 -1.96 5.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.137 0.975 . . . . 0.0 112.305 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -135.63 -20.39 1.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.036 0.835 . . . . 0.0 113.246 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG21 HD21 ' A' ' 61' ' ' LEU . 10.5 tp -61.75 -34.88 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.843 1.202 . . . . 0.0 112.14 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.96 68.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.376 0.534 . . . . 0.0 112.321 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 m -66.73 -35.23 79.62 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 0.0 110.462 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.56 -20.98 21.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.751 0.82 . . . . 0.0 112.227 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.1 74.61 79.13 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.34 -7.97 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.327 2.684 . . . . 0.0 113.505 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -138.56 122.76 18.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -59.28 -18.75 40.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.24 -18.83 57.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.233 0.924 . . . . 0.0 112.019 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.84 145.51 54.57 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.441 -0.787 . . . . 0.0 110.59 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -80.48 139.0 36.62 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.93 93.14 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.29 124.78 26.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.83 143.73 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.91 161.26 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.94 0.896 . . . . 0.0 108.692 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 p -164.1 179.71 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.243 1.017 . . . . 0.0 108.396 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.49 135.61 56.22 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 54.56 15.76 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.562 1.945 . . . . 0.0 116.026 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.2 -22.53 0.61 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.857 1.217 . . . . 0.0 116.029 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -53.79 -52.62 59.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.129 1.964 . . . . 0.0 113.139 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.98 -26.25 68.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.357 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -76.4 -44.93 33.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.426 1.012 . . . . 0.0 111.692 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -44.55 96.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.69 -35.5 80.76 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.376 1.07 . . . . 0.0 111.397 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.82 -42.43 70.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 110.571 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -59.98 -40.64 89.82 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 121.19 -0.944 . . . . 0.0 110.704 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.0 -44.01 77.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.694 1.134 . . . . 0.0 111.816 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 pt -67.27 -36.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 120.725 1.602 . . . . 0.0 110.15 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 33' ' ' ILE . 77.4 mt -67.86 -36.66 80.67 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.779 0.718 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.6 m -63.13 -38.65 92.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.649 0.379 . . . . 0.0 110.416 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.02 -41.06 78.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.995 0.518 . . . . 0.0 110.554 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.7 mtp -64.93 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.394 1.078 . . . . 0.0 111.116 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.36 1.2 6.18 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.355 0.979 . . . . 0.0 114.302 169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -71.58 145.75 48.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.24 1.52 . . . . 0.0 108.817 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -132.31 7.77 4.26 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -137.11 30.71 2.71 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.521 1.128 . . . . 0.0 110.457 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.0 t -87.9 136.31 23.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -144.9 131.86 20.28 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.38 112.27 10.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.85 -30.76 70.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.298 0.639 . . . . 0.0 111.649 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.62 -136.2 6.55 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.46 170.2 25.64 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.92 -41.1 64.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.836 1.254 . . . . 0.0 113.34 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -80.14 -9.04 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.71 -32.83 5.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.769 0.828 . . . . 0.0 111.817 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.6 125.04 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.97 -10.86 59.66 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mtp -63.83 155.6 76.57 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.749 0.82 . . . . 0.0 111.061 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.08 162.0 9.97 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.697 2.931 . . . . 0.0 112.961 170.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.58 160.07 36.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.02 0.928 . . . . 0.0 110.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.61 152.93 21.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 126.422 1.889 . . . . 0.0 107.989 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -64.33 154.45 35.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 176.839 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.06 154.6 44.13 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.062 1.745 . . . . 0.0 107.191 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -141.74 124.57 16.08 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -86.07 117.11 24.7 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.24 107.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -66.45 134.81 53.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -119.01 10.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.888 0.767 . . . . 0.0 111.189 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -61.62 161.32 10.0 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.796 0.725 . . . . 0.0 109.147 167.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.47 150.7 43.18 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.38 -31.21 43.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.267 1.312 . . . . 0.0 112.396 -168.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.73 -10.78 60.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 112.218 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.66 -32.95 10.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.636 1.107 . . . . 0.0 110.282 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -57.49 -40.4 78.54 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.721 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.24 -34.03 76.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.751 0.42 . . . . 0.0 111.264 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -72.23 -41.86 66.37 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.462 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -164.92 141.8 5.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.447 1.021 . . . . 0.0 109.507 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -155.31 164.74 38.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.06 . . . . 0.0 109.21 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.47 137.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -59.08 117.19 4.43 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 -170.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.81 90.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.314 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.2 141.86 57.91 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.703 1.752 . . . . 0.0 109.73 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.82 169.26 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.6 t-20 -131.8 128.65 39.2 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.955 -1.09 . . . . 0.0 109.845 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.71 90.45 19.59 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.2 152.84 7.57 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.452 2.768 . . . . 0.0 111.845 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -46.87 -44.17 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.86 -30.34 71.44 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.309 0.504 . . . . 0.0 112.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.67 -21.56 23.86 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.082 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.1 t -49.1 -48.41 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.619 1.167 . . . . 0.0 110.129 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.39 -16.14 21.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.39 -3.17 8.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.226 0.921 . . . . 0.0 112.249 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -142.55 -13.75 0.77 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.96 -35.11 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.167 1.348 . . . . 0.0 111.984 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.65 67.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.397 0.544 . . . . 0.0 112.419 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 m -68.9 -38.98 79.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.952 0.796 . . . . 0.0 110.127 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.33 -23.26 35.19 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.222 0.609 . . . . 0.0 112.168 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.9 75.92 78.92 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.31 -14.73 37.99 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.195 2.597 . . . . 0.0 113.663 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -145.56 138.4 26.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -57.53 -23.94 53.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -67.42 -26.22 66.31 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.281 0.946 . . . . 0.0 112.067 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -68.56 143.95 54.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.335 0.516 . . . . 0.0 110.752 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.07 145.71 35.67 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.53 136.63 48.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -123.5 121.04 34.66 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 m -114.77 141.85 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -152.04 170.84 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.98 -165.6 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -52.64 -52.29 56.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.809 0.844 . . . . 0.0 111.719 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.7 31.48 2.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.135 1.374 . . . . 0.0 111.352 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.33 -24.1 2.18 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.666 -1.075 . . . . 0.0 115.321 170.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.9 mmt-85 -66.39 -44.59 82.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.285 2.043 . . . . 0.0 113.624 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -64.16 -33.98 77.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.825 1.193 . . . . 0.0 109.283 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.69 37.61 Favored 'General case' 0 N--CA 1.46 0.07 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.5 -46.64 91.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -56.89 -44.01 81.9 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.712 0.805 . . . . 0.0 111.323 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.07 87.84 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.707 -0.62 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.11 -40.31 84.96 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.281 -0.887 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.79 -53.1 59.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.098 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -65.22 -34.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-N 120.226 1.375 . . . . 0.0 110.781 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.43 -36.22 76.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.066 0.848 . . . . 0.0 110.77 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 m -63.01 -39.16 93.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.191 0.451 . . . . 0.0 110.366 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -68.2 -42.47 79.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.352 0.661 . . . . 0.0 110.346 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.74 -30.12 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.084 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.52 6.04 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.726 -1.041 . . . . 0.0 114.181 169.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -70.69 148.12 48.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.507 1.653 . . . . 0.0 109.163 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 p -133.78 10.03 3.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.846 0.858 . . . . 0.0 112.068 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -133.75 33.08 3.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.073 1.349 . . . . 0.0 110.213 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.42 138.7 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.02 146.25 40.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.12 112.27 19.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.34 68.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.6 -150.41 22.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.47 156.09 15.83 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 168.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.5 tp -53.41 -39.37 64.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.179 . . . . 0.0 113.439 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.51 -31.82 63.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.954 0.343 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.36 -35.49 27.74 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.469 0.708 . . . . 0.0 111.345 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.73 128.9 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.899 1.279 . . . . 0.0 108.77 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -7.54 59.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.998 0.919 . . . . 0.0 113.274 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mmm -60.28 154.55 52.09 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.524 0.73 . . . . 0.0 110.5 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.53 167.31 21.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.757 2.304 . . . . 0.0 110.989 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -128.73 173.63 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.449 1.1 . . . . 0.0 110.104 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.66 164.22 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.442 1.497 . . . . 0.0 107.05 167.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -146.13 156.5 43.48 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.943 1.697 . . . . 0.0 108.168 -169.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 176.134 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.27 165.47 30.0 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -135.79 126.68 27.59 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -90.18 121.54 32.31 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.66 111.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -71.19 125.31 26.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.01 12.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 123.082 0.553 . . . . 0.0 110.828 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -54.66 156.84 3.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.873 0.76 . . . . 0.0 111.444 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.19 143.74 24.15 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 166.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -60.17 -33.76 94.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.622 1.548 . . . . 0.0 113.849 -166.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.74 -36.99 81.56 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.566 -0.709 . . . . 0.0 111.16 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.22 -32.93 56.21 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.59 -50.5 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.598 0.759 . . . . 0.0 110.633 170.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -63.61 -24.9 67.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.48 -38.81 92.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.538 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -179.96 135.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.39 2.276 . . . . 0.0 106.307 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -145.5 162.92 36.26 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.535 1.134 . . . . 0.0 110.589 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.72 127.34 27.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.74 151.85 28.4 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 111.841 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.72 -12.85 45.69 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.585 1.088 . . . . 0.0 114.006 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 172.15 11.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.717 1.259 . . . . 0.0 111.578 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -113.39 166.83 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.337 1.855 . . . . 0.0 106.017 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -122.74 126.34 47.3 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 119.238 0.927 . . . . 0.0 109.638 172.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 29' ' ' VAL . 11.7 mt -136.23 87.52 22.87 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 143.14 41.55 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.184 2.589 . . . . 0.0 112.812 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.06 -21.33 30.71 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.379 1.072 . . . . 0.0 111.586 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.36 -32.38 70.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.023 1.329 . . . . 0.0 113.334 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -134.95 -2.77 2.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.43 1.092 . . . . 0.0 113.508 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.4 p -52.66 -38.2 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 113.957 -169.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.92 -27.15 63.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.249 0.932 . . . . 0.0 112.293 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.18 -7.97 49.92 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 112.153 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -139.18 -15.75 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.0 -40.18 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.698 1.136 . . . . 0.0 111.135 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.38 74.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.375 0.534 . . . . 0.0 111.53 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 m -68.75 -43.72 75.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.7 . . . . 0.0 109.862 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -38.22 57.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.881 0.472 . . . . 0.0 112.229 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.29 79.05 32.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.83 -30.31 17.52 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.932 1.755 . . . . 0.0 111.825 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -84.3 101.99 12.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.259 0.624 . . . . 0.0 109.757 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.71 -16.33 56.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -77.21 -20.16 55.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.037 0.835 . . . . 0.0 111.775 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.92 147.42 36.98 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 m -70.88 147.64 48.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.321 0.648 . . . . 0.0 110.599 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.84 141.56 38.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -126.9 121.19 31.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.7 m -114.23 140.1 36.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -147.01 165.12 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.342 1.057 . . . . 0.0 108.265 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 p -148.75 -147.31 0.22 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.93 76.61 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.985 0.812 . . . . 0.0 110.361 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.25 -22.37 0.44 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.01 -29.91 0.48 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.434 1.47 . . . . 0.0 116.233 171.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.99 -57.69 11.68 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.3 2.05 . . . . 0.0 112.481 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -33.52 72.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.632 0.651 . . . . 0.0 109.629 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -52.53 58.54 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.554 0.742 . . . . 0.0 111.654 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.0 91.0 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -54.93 -47.52 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.155 0.982 . . . . 0.0 110.331 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -48.28 76.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 111.08 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.21 -42.93 82.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.809 0.731 . . . . 0.0 109.926 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.27 -53.34 56.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.987 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -67.25 -34.88 71.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.779 1.172 . . . . 0.0 111.333 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.42 -35.58 75.85 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.898 1.226 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -62.05 -43.06 99.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.059 0.39 . . . . 0.0 109.958 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -65.21 -38.15 89.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.421 0.689 . . . . 0.0 111.26 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -69.84 -7.06 36.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.987 1.315 . . . . 0.0 112.309 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 4.52 47.47 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.737 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.26 143.23 52.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.432 1.616 . . . . 0.0 106.92 168.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 p -122.47 7.38 9.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.907 0.483 . . . . 0.0 112.171 -171.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -140.8 36.6 1.79 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.658 1.183 . . . . 0.0 110.148 -170.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -105.35 130.89 55.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.38 148.0 40.62 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -78.76 115.91 18.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.29 70.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.807 0.443 . . . . 0.0 111.798 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.24 5.97 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.31 168.83 30.9 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -36.49 62.47 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.721 1.608 . . . . 0.0 110.329 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -54.92 -23.07 17.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 113.599 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -131.12 -32.35 1.6 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.66 125.99 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.216 0.917 . . . . 0.0 108.628 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.97 -4.55 56.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.05 0.94 . . . . 0.0 113.287 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.12 154.49 69.51 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.923 0.889 . . . . 0.0 111.062 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.95 153.03 21.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.793 2.995 . . . . 0.0 113.631 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -127.75 156.88 41.74 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.824 0.85 . . . . 0.0 110.904 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 164.94 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.598 1.559 . . . . 0.0 108.022 168.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -137.61 168.54 19.47 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.576 1.15 . . . . 0.0 110.157 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.748 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.98 161.49 38.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.371 1.068 . . . . 0.0 109.546 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -144.34 153.45 42.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.984 1.714 . . . . 0.0 107.125 169.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -111.21 108.55 18.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.06 112.07 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -81.97 125.45 30.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.85 -0.36 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.411 HH22 ' HA ' ' A' ' 17' ' ' HIS . 3.1 ptt180 -63.28 167.63 5.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.193 1.36 . . . . 0.0 109.644 167.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.36 152.77 30.61 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.02 -27.93 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 121.807 1.671 . . . . 0.0 112.175 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.14 -0.65 12.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.613 1.165 . . . . 0.0 112.561 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -112.6 -33.2 6.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.856 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -53.53 -46.61 70.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.692 1.133 . . . . 0.0 110.407 168.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -61.84 -25.35 67.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -70.16 -50.45 40.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.635 0.652 . . . . 0.0 109.92 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -168.55 143.18 3.32 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.411 ' HA ' HH22 ' A' ' 8' ' ' ARG . 7.5 p-80 -145.5 151.43 38.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.627 1.171 . . . . 0.0 110.041 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.18 125.33 8.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -52.76 113.16 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.024 0.93 . . . . 0.0 111.133 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 2.94 80.34 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.975 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.31 141.13 58.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.555 1.678 . . . . 0.0 109.709 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.73 132.15 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.56 108.87 4.54 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.532 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.2 78.69 14.83 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 167.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.37 156.86 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.813 3.676 . . . . 0.0 113.426 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -52.57 -35.68 54.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.705 0.802 . . . . 0.0 112.617 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -70.04 -16.49 63.16 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -116.27 -28.01 6.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.224 1.41 . . . . 0.0 111.332 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.11 -41.21 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 125.103 1.361 . . . . 0.0 113.277 -167.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -59.65 -29.35 67.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.091 0.86 . . . . 0.0 112.287 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.13 -24.95 40.13 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 0.0 111.718 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.84 -17.37 4.48 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -166.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 tp -60.67 -35.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.601 1.546 . . . . 0.0 111.496 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.78 -8.92 12.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -118.96 -35.15 3.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.955 1.302 . . . . 0.0 109.562 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.71 83.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 111.068 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -140.02 76.43 27.78 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.199 1.399 . . . . 0.0 107.565 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.56 -35.77 94.67 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.433 2.088 . . . . 0.0 112.723 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -78.84 102.25 8.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.544 0.737 . . . . 0.0 110.052 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -64.07 -14.09 52.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -79.53 -16.7 55.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.371 0.987 . . . . 0.0 112.034 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.51 148.21 49.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.065 -1.022 . . . . 0.0 111.017 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -78.46 100.55 6.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.095 0.558 . . . . 0.0 109.679 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -80.81 89.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -66.57 130.08 42.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -128.85 143.25 41.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.44 166.73 29.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -158.09 -140.7 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -123.64 133.96 53.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 60.24 15.69 5.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.03 1.732 . . . . 0.0 114.968 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.7 -31.11 1.25 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.234 1.397 . . . . 0.0 115.672 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -53.03 -49.33 66.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.293 1.547 . . . . 0.0 113.934 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.52 -33.34 73.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.743 1.156 . . . . 0.0 110.98 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -74.7 -40.21 61.48 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.591 1.087 . . . . 0.0 112.79 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.27 -44.86 96.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -59.99 -42.93 95.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.662 1.185 . . . . 0.0 111.369 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.15 90.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.757 0.708 . . . . 0.0 110.523 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -60.61 -37.9 82.94 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.96 -1.087 . . . . 0.0 110.844 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.65 -49.84 69.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.866 0.867 . . . . 0.0 110.61 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.86 -36.24 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.883 1.22 . . . . 0.0 111.009 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.05 -34.79 71.57 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.008 0.822 . . . . 0.0 110.906 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -67.87 -34.76 77.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.732 0.696 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.57 -38.31 89.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.99 0.814 . . . . 0.0 110.475 172.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -69.82 -8.98 52.87 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.383 1.073 . . . . 0.0 112.385 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.03 6.39 51.97 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.192 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.3 144.5 51.71 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.603 1.701 . . . . 0.0 108.298 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 p -126.14 4.68 7.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.126 0.57 . . . . 0.0 112.376 -171.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -139.28 31.53 2.14 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.532 1.133 . . . . 0.0 110.251 -173.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.1 133.69 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.95 122.7 15.29 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.19 110.83 11.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.58 67.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.092 0.557 . . . . 0.0 111.817 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.33 -142.92 10.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.35 162.87 19.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 168.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 tp -42.03 -48.43 4.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.995 1.318 . . . . 0.0 114.081 -168.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.57 -13.5 62.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.95 -12.26 10.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.273 1.029 . . . . 0.0 112.467 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 80' ' ' MET . 6.8 mm -64.61 134.01 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -20.07 61.43 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.415 ' H ' HG22 ' A' ' 78' ' ' ILE . 95.5 mmm -62.64 156.29 64.87 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 110.885 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.45 156.88 64.29 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.336 2.024 . . . . 0.0 110.283 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 149.12 36.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.054 0.942 . . . . 0.0 109.081 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.9 m -147.24 162.83 7.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 108.923 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.5 148.47 15.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.359 0.664 . . . . 0.0 110.219 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 175.221 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -154.43 162.47 41.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.153 0.981 . . . . 0.0 109.466 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -143.29 145.69 32.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.716 1.606 . . . . 0.0 106.695 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -105.07 122.89 46.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.76 119.55 53.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -75.38 128.02 34.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.55 12.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 119.461 1.028 . . . . 0.0 111.087 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -62.66 162.71 10.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.39 -0.818 . . . . 0.0 110.571 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.6 147.74 49.24 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.309 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.81 -31.69 67.98 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.905 1.736 . . . . 0.0 112.969 -167.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.8 -28.89 66.1 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.599 -0.688 . . . . 0.0 111.828 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -80.9 -38.62 27.67 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -56.54 -41.52 76.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.738 0.415 . . . . 0.0 111.049 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -58.91 -30.03 67.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.113 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -67.14 -50.31 61.72 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.815 0.734 . . . . 0.0 110.269 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.06 156.22 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.898 1.279 . . . . 0.0 108.351 168.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -153.53 160.34 42.47 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.829 1.252 . . . . 0.0 108.807 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.88 142.61 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.718 0.807 . . . . 0.0 109.215 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.34 157.84 8.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.904 0.482 . . . . 0.0 111.664 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.36 41.17 91.47 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.676 0.655 . . . . 0.0 112.681 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.41 178.1 7.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.696 1.198 . . . . 0.0 110.996 -174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.79 169.91 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.309 2.244 . . . . 0.0 106.42 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.7 t-20 -126.2 131.15 52.04 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 110.107 172.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.37 89.03 9.61 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.51 153.89 16.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.347 2.698 . . . . 0.0 113.03 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -52.8 -34.69 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.589 0.756 . . . . 0.0 112.747 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.31 -14.39 62.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -122.84 -24.32 4.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.246 1.418 . . . . 0.0 111.345 -169.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.44 -38.69 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 124.451 1.101 . . . . 0.0 112.429 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -57.33 -27.93 62.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.751 0.705 . . . . 0.0 112.118 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -99.47 -6.18 28.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 0.0 112.11 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -137.59 -23.32 1.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -167.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.58 -35.82 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 121.131 1.787 . . . . 0.0 110.903 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.3 -30.67 69.64 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.335 0.516 . . . . 0.0 111.814 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -79.28 -45.36 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.908 0.883 . . . . 0.0 109.764 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.36 66.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.241 0.617 . . . . 0.0 112.495 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.41 76.56 36.85 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.019 1.728 . . . . 0.0 106.508 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 -20.65 30.74 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.75 101.75 2.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 109.331 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.12 -9.93 35.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.737 0.815 . . . . 0.0 112.7 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.44 12.81 24.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.701 1.2 . . . . 0.0 111.19 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.62 148.74 51.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 169.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -78.89 83.46 5.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.34 109.07 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -98.5 127.69 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.1 141.58 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 123.118 0.567 . . . . 0.0 109.488 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -149.05 172.47 14.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.9 p -157.8 -162.61 1.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -46.26 91.18 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.05 -0.407 . . . . 0.0 112.082 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 18.54 3.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.209 1.404 . . . . 0.0 112.762 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.69 -17.53 44.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.987 -1.071 . . . . 0.0 114.874 172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -67.62 -50.65 57.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.7 1.75 . . . . 0.0 111.903 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.97 -33.28 71.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 110.076 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -76.5 -40.84 48.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.78 0.718 . . . . 0.0 112.808 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.55 -43.35 99.14 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -58.87 -47.16 85.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.133 1.373 . . . . 0.0 110.793 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.24 86.25 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.661 -0.649 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.38 -34.05 68.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.527 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.6 -54.73 31.26 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.319 0.963 . . . . 0.0 109.83 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -68.31 -30.93 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 121.538 -0.726 . . . . 0.0 111.616 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.9 -40.47 95.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.446 1.021 . . . . 0.0 110.101 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -66.22 -41.32 90.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.561 0.344 . . . . 0.0 110.242 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -65.24 -36.44 84.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.625 0.648 . . . . 0.0 111.109 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.5 mtm -73.39 -2.81 23.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.168 0.987 . . . . 0.0 112.266 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.36 17.2 59.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.354 -1.248 . . . . 0.0 114.261 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -63.99 129.98 42.23 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.692 1.746 . . . . 0.0 107.077 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 p -65.21 -33.55 76.27 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.717 0.407 . . . . 0.0 111.904 -168.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.36 154.34 33.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 109.319 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -148.13 146.51 17.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -129.46 122.12 28.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.43 104.91 7.19 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.15 69.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.917 0.487 . . . . 0.0 111.811 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.95 -148.29 19.4 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.64 165.1 21.62 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -49.5 -49.28 46.45 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.677 1.191 . . . . 0.0 112.41 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.7 -36.24 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.674 0.39 . . . . 0.0 111.38 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.91 -37.31 62.11 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.458 0.703 . . . . 0.0 111.751 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.16 125.27 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -19.85 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 61.4 mtm -63.91 155.25 78.57 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.384 0.674 . . . . 0.0 111.165 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.78 165.8 28.42 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.612 2.874 . . . . 0.0 112.563 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -126.84 156.59 41.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.588 1.155 . . . . 0.0 110.151 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -143.54 160.74 16.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.476 1.91 . . . . 0.0 108.345 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -57.65 149.55 21.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.798 -0.564 . . . . 0.0 109.511 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 173.241 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.84 161.05 40.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.382 1.073 . . . . 0.0 109.662 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -139.48 137.29 35.41 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -89.87 118.72 29.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.38 104.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -168.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.46 145.07 56.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.86 15.44 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.335 -0.853 . . . . 0.0 112.496 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.89 160.98 5.28 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.432 -0.793 . . . . 0.0 110.545 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -54.6 146.92 32.48 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.86 -31.4 91.6 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.191 1.927 . . . . 0.0 113.778 -166.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.59 -29.75 63.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.657 -0.652 . . . . 0.0 111.999 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -84.29 -31.69 24.76 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.04 0.836 . . . . 0.0 109.127 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -49.27 64.97 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.767 0.827 . . . . 0.0 111.204 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.15 -18.65 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.882 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -69.32 -31.53 70.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.806 -171.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 176.23 133.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.833 2.453 . . . . 0.0 105.973 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -147.68 161.97 40.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.911 1.232 . . . . 0.0 109.782 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.86 136.33 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.54 142.86 54.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.581 0.752 . . . . 0.0 109.812 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 46.02 42.1 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.004 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.55 178.76 6.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.129 1.371 . . . . 0.0 110.277 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.94 176.22 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.561 1.944 . . . . 0.0 106.924 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.19 139.71 50.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.927 0.891 . . . . 0.0 109.181 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -139.92 85.2 14.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.21 145.86 84.72 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.189 1.926 . . . . 0.0 112.772 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.6 tp -54.69 -25.39 26.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.015 0.526 . . . . 0.0 111.509 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.7 -22.71 65.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.232 1.013 . . . . 0.0 113.511 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -131.24 -10.05 3.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.484 1.038 . . . . 0.0 112.83 -169.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -46.26 -42.57 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.59 1.956 . . . . 0.0 113.387 -169.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.29 -25.18 61.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.285 0.948 . . . . 0.0 112.98 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -114.87 5.84 15.26 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.017 1.327 . . . . 0.0 110.983 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -136.85 -25.2 1.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.14 -167.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -34.66 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 120.261 1.391 . . . . 0.0 112.086 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.89 67.14 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.553 0.615 . . . . 0.0 112.104 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -66.19 -35.98 81.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.659 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 -25.28 20.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.302 0.641 . . . . 0.0 112.096 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.02 78.05 41.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.57 -8.48 20.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.142 2.561 . . . . 0.0 113.652 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.94 134.77 30.44 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.204 1.001 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.29 -16.46 64.29 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -19.67 60.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.737 1.153 . . . . 0.0 112.334 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 146.54 44.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.034 0.834 . . . . 0.0 110.809 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -78.37 138.13 38.37 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.007 -0.433 . . . . 0.0 110.092 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.1 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -84.16 93.21 8.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -83.85 142.8 12.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -150.47 165.24 33.81 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.668 0.787 . . . . 0.0 109.473 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.8 p -158.86 -160.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -57.58 -51.5 69.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.301 0.5 . . . . 0.0 111.157 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.18 23.52 2.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.574 1.149 . . . . 0.0 112.319 -169.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.92 -3.65 64.18 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.364 -1.242 . . . . 0.0 114.96 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -68.6 -53.59 21.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.707 2.254 . . . . 0.0 111.108 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -61.13 -31.85 71.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -66.7 -48.23 69.9 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.268 1.027 . . . . 0.0 112.452 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.61 91.45 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -55.67 -46.37 77.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.332 1.053 . . . . 0.0 110.927 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.25 80.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.079 0.552 . . . . 0.0 111.214 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.82 -39.76 90.19 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 120.03 1.286 . . . . 0.0 110.516 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -58.05 -53.08 62.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.32 0.964 . . . . 0.0 110.483 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.76 -39.69 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 118.495 0.589 . . . . 0.0 110.492 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.55 -35.86 70.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.175 0.898 . . . . 0.0 110.857 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -63.92 -41.49 97.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.57 -39.25 88.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.168 0.587 . . . . 0.0 111.008 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.0 mtp -66.34 -18.39 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.52 1.128 . . . . 0.0 111.765 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.92 8.0 24.6 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.717 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -71.68 97.85 1.82 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.508 1.654 . . . . 0.0 107.627 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -79.02 6.32 9.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.541 1.136 . . . . 0.0 113.185 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -136.33 31.2 2.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.471 1.108 . . . . 0.0 111.504 -169.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.9 140.93 15.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 170.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.19 145.01 28.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -85.38 114.59 22.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -33.82 76.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.433 0.293 . . . . 0.0 111.482 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.75 -156.42 26.68 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.33 160.88 18.27 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -43.01 -56.06 3.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.182 1.793 . . . . 0.0 113.431 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.82 -16.39 32.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.667 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.33 -34.64 65.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.588 0.631 . . . . 0.0 110.919 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.8 126.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 55.55 3.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.471 1.508 . . . . 0.0 111.161 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.2 mtp -136.51 160.62 66.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 125.455 1.502 . . . . 0.0 108.67 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 163.2 34.73 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.546 2.164 . . . . 0.0 111.284 173.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -131.91 156.53 45.96 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.13 0.972 . . . . 0.0 109.646 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.12 160.3 20.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.246 1.819 . . . . 0.0 107.986 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -138.08 166.87 23.03 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.942 0.897 . . . . 0.0 110.931 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -174.391 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -155.41 161.01 41.09 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.948 0.899 . . . . 0.0 109.61 -171.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -144.17 129.27 18.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.582 1.153 . . . . 0.0 108.192 171.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.65 117.51 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.39 105.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -68.37 149.25 49.6 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.46 12.98 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.591 0.756 . . . . 0.0 111.58 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -53.72 156.39 2.74 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 121.649 -0.657 . . . . 0.0 111.16 171.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.26 149.25 38.07 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 167.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.81 -34.44 95.74 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.331 2.02 . . . . 0.0 114.048 -166.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.11 -27.37 61.66 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.301 -0.875 . . . . 0.0 111.815 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -82.36 -34.48 28.41 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.29 -48.81 73.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.08 0.952 . . . . 0.0 110.726 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.86 2.62 3.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -75.02 -61.3 1.93 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.952 1.251 . . . . 0.0 108.716 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.61 149.26 8.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.277 1.831 . . . . 0.0 107.006 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -151.01 166.82 29.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.873 0.76 . . . . 0.0 110.401 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -60.03 137.18 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.127 0.971 . . . . 0.0 109.497 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.76 135.0 56.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.117 0.567 . . . . 0.0 109.593 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.71 2.96 53.27 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 118.833 -0.982 . . . . 0.0 114.744 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.91 -178.75 3.89 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.207 1.503 . . . . 0.0 111.101 174.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.04 171.2 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.424 1.89 . . . . 0.0 106.699 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -132.56 139.69 47.96 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.134 0.879 . . . . 0.0 110.924 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mt -142.37 82.14 13.21 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.26 143.87 62.52 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.49 2.126 . . . . 0.0 112.78 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.16 -30.02 47.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.74 -13.93 61.44 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -129.5 -14.86 4.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.608 1.163 . . . . 0.0 112.107 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.77 -39.51 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.913 1.685 . . . . 0.0 113.196 -169.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 -20.63 62.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.236 0.925 . . . . 0.0 112.653 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -111.81 7.13 20.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 111.115 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -137.58 -30.41 0.83 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -167.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.48 -38.56 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.747 1.158 . . . . 0.0 110.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.15 90.4 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.315 0.507 . . . . 0.0 111.562 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 -38.54 55.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.236 0.615 . . . . 0.0 111.068 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.51 72.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.393 0.542 . . . . 0.0 111.749 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.43 79.25 20.96 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.289 1.436 . . . . 0.0 107.644 -172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.82 -36.05 97.64 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.335 2.023 . . . . 0.0 112.856 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -83.77 104.38 13.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.608 0.763 . . . . 0.0 110.515 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.03 -14.45 60.46 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.46 -14.14 59.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.492 1.042 . . . . 0.0 111.971 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.6 143.84 57.5 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.171 -0.955 . . . . 0.0 110.991 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -81.99 97.58 8.18 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.3 94.69 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.05 79.43 5.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.66 139.27 19.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -147.89 165.59 30.18 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.015 0.926 . . . . 0.0 109.462 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.5 p -169.0 -160.46 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.211 1.004 . . . . 0.0 109.145 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.53 128.34 34.01 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.45 13.83 0.5 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.536 1.934 . . . . 0.0 115.433 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.1 3.78 46.39 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.194 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.0 -39.63 61.11 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.353 2.076 . . . . 0.0 112.806 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.82 -30.56 69.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.603 1.092 . . . . 0.0 109.221 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -69.14 -48.41 62.47 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.03 0.932 . . . . 0.0 111.727 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.7 -43.57 98.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -57.95 -47.86 81.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.575 0.75 . . . . 0.0 111.241 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.53 88.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.171 0.588 . . . . 0.0 111.354 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -57.52 -35.93 70.9 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.213 -0.929 . . . . 0.0 111.445 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.94 -55.03 33.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.235 0.925 . . . . 0.0 110.428 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt -68.95 -34.73 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 O-C-N 121.766 -0.584 . . . . 0.0 111.069 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.1 mt -69.33 -37.03 77.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.307 0.958 . . . . 0.0 110.605 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -64.26 -39.96 95.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.472 0.578 . . . . 0.0 109.942 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.69 -39.87 94.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.468 0.577 . . . . 0.0 110.901 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.01 -16.92 64.26 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.255 1.022 . . . . 0.0 111.985 174.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.36 27.82 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.847 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -73.13 106.15 4.87 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.564 1.682 . . . . 0.0 107.586 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.09 3.26 43.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 113.058 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -137.95 31.49 2.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.208 1.003 . . . . 0.0 111.382 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.25 130.53 36.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 172.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -142.34 129.24 20.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -75.1 111.46 10.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.88 71.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.826 0.451 . . . . 0.0 111.542 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.52 -153.98 25.36 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.74 165.53 12.34 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 170.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -45.15 -50.32 11.37 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.37 1.468 . . . . 0.0 113.222 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -77.56 -36.76 51.84 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.672 0.389 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.46 -36.25 73.81 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.541 0.736 . . . . 0.0 111.713 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.64 129.18 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.373 1.069 . . . . 0.0 108.497 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 -10.57 59.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.2 mmm -61.26 154.23 63.7 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.663 0.785 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.82 161.01 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.749 2.299 . . . . 0.0 111.09 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -129.26 167.15 18.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.609 1.164 . . . . 0.0 109.18 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.2 151.27 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.517 1.527 . . . . 0.0 106.905 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -67.96 148.28 51.29 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -169.794 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -155.8 155.48 33.09 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.708 1.203 . . . . 0.0 108.208 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -138.92 147.38 42.22 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.651 1.58 . . . . 0.0 106.802 169.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.55 125.45 48.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.61 108.95 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -74.79 119.13 18.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.6 m -105.29 14.23 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 122.946 0.498 . . . . 0.0 111.305 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -55.67 157.24 4.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 118.641 0.655 . . . . 0.0 110.644 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.3 145.69 25.24 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 166.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.62 -30.89 70.55 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.72 1.613 . . . . 0.0 112.825 -166.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -71.26 -21.79 62.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.341 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.67 -34.36 16.29 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.737 1.153 . . . . 0.0 109.347 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -51.87 -46.19 64.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.96 0.504 . . . . 0.0 110.941 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.38 -21.22 66.15 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -73.62 -49.89 23.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.574 1.079 . . . . 0.0 110.508 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -162.66 132.43 4.44 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -151.11 160.78 43.68 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.485 1.493 . . . . 0.0 111.73 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.4 107.06 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -44.05 134.85 4.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.839 1.255 . . . . 0.0 111.753 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.12 -17.94 55.44 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.62 -1.1 . . . . 0.0 112.869 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.45 129.57 40.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.392 1.596 . . . . 0.0 109.259 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.66 156.38 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -111.46 121.29 44.79 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.596 -0.69 . . . . 0.0 109.66 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.2 mt -135.11 84.27 37.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.51 151.46 7.19 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.102 2.535 . . . . 0.0 111.658 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.1 tp -44.95 -44.0 9.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.89 -41.88 97.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.522 0.601 . . . . 0.0 111.336 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -75.07 -22.6 58.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.825 1.65 . . . . 0.0 111.249 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.84 -44.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.539 1.063 . . . . 0.0 109.713 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -61.81 -15.59 43.03 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.24 -20.28 9.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 111.696 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -129.5 -12.38 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.94 -39.24 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 121.362 1.892 . . . . 0.0 111.206 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.79 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.305 0.502 . . . . 0.0 111.787 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 m -68.3 -44.97 74.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.678 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 -39.41 68.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.236 0.614 . . . . 0.0 112.015 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.77 87.64 12.74 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.134 1.889 . . . . 0.0 111.974 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.0 152.68 44.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.364 1.066 . . . . 0.0 109.989 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.73 35.27 4.2 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.569 0.622 . . . . 0.0 112.113 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -142.78 -34.67 0.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.81 150.72 44.09 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.747 0.819 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 m -62.23 132.47 52.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 110.528 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -132.43 139.27 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.56 138.52 53.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.31 141.93 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -147.05 163.51 36.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.3 p -159.82 -154.26 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.277 0.231 . . . . 0.0 111.01 174.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.48 130.21 38.21 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 170.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 55.12 17.68 2.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.298 1.839 . . . . 0.0 114.558 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.13 -13.03 1.04 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.876 1.227 . . . . 0.0 115.188 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -64.55 -44.9 89.31 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 120.056 1.928 . . . . 0.0 111.985 -171.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.44 -30.36 71.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.798 0.726 . . . . 0.0 110.007 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -75.12 -43.41 52.9 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.615 1.098 . . . . 0.0 112.195 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -49.35 78.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -58.26 -40.76 82.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.069 . . . . 0.0 111.977 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.91 -44.17 77.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.483 0.583 . . . . 0.0 109.97 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.06 -35.77 79.61 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.787 1.176 . . . . 0.0 110.498 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.71 -52.97 63.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.557 1.071 . . . . 0.0 110.379 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.0 pt -68.07 -39.43 81.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 119.442 1.019 . . . . 0.0 110.525 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.1 -40.42 94.54 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.394 0.543 . . . . 0.0 110.91 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.87 -39.55 94.8 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.609 0.64 . . . . 0.0 110.136 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.27 -33.93 73.98 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.806 -0.559 . . . . 0.0 111.019 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.6 mtp -73.96 -1.0 17.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.804 1.242 . . . . 0.0 112.08 173.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.35 90.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.848 -1.157 . . . . 0.0 113.136 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.48 55.02 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.364 1.466 . . . . 0.0 108.686 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -67.75 -25.09 65.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.171 1.388 . . . . 0.0 111.869 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.548 ' CD2' ' H ' ' A' ' 68' ' ' HIS . 18.8 p80 -77.5 33.67 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.23 2.612 . . . . 0.0 112.736 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.5 t -120.99 140.41 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.08 1.752 . . . . 0.0 106.427 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.43 141.68 41.64 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.48 114.37 19.33 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.37 -29.97 67.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.904 0.482 . . . . 0.0 112.005 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.28 -139.46 8.12 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.75 169.7 24.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.35 -53.95 7.88 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.391 1.477 . . . . 0.0 112.427 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.79 -37.83 67.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.481 0.313 . . . . 0.0 111.272 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.64 -37.37 68.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.339 0.655 . . . . 0.0 111.787 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.05 131.86 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.288 1.035 . . . . 0.0 108.574 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.52 -8.37 59.55 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.87 151.31 74.02 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.7 0.682 . . . . 0.0 110.676 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 163.83 11.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.123 2.549 . . . . 0.0 111.877 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -136.3 166.54 23.21 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.14 155.85 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.819 1.647 . . . . 0.0 106.556 168.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -138.66 153.47 48.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.081 0.952 . . . . 0.0 109.899 -167.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.972 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.381 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.85 148.25 28.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -133.88 128.2 34.11 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -88.74 122.61 32.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mt -128.55 115.18 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -69.54 129.01 38.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.68 7.59 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.626 0.648 . . . . 0.0 111.615 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -65.59 162.82 17.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.046 0.839 . . . . 0.0 110.206 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.88 146.76 35.89 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.4 -38.6 73.28 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.968 1.778 . . . . 0.0 113.303 -167.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.09 -27.9 68.41 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.557 -0.714 . . . . 0.0 112.045 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -82.74 -33.05 27.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -46.42 79.92 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.178 0.591 . . . . 0.0 110.671 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -61.32 -22.75 65.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -66.19 -44.27 84.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.449 0.568 . . . . 0.0 111.022 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.37 137.9 0.3 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.741 2.017 . . . . 0.0 106.912 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -149.3 164.0 36.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.471 1.109 . . . . 0.0 110.256 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.13 134.86 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.577 0.751 . . . . 0.0 109.798 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -55.14 130.66 42.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.0 88.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.333 171.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.13 -178.74 4.0 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.762 1.281 . . . . 0.0 111.623 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.0 tt -125.88 172.22 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 127.418 2.287 . . . . 0.0 106.531 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -129.8 124.21 32.8 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.484 1.038 . . . . 0.0 110.483 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.2 mt -134.76 87.5 30.61 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 170.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.83 153.94 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.673 2.916 . . . . 0.0 111.366 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.02 -39.0 18.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.655 0.782 . . . . 0.0 112.333 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -65.0 -21.48 66.86 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.129 0.971 . . . . 0.0 113.275 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' A' ' 32' ' ' ARG . 26.7 mt-10 -111.1 -13.73 14.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.4 1.48 . . . . 0.0 111.752 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -48.78 -52.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.809 1.186 . . . . 0.0 110.489 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -64.26 -10.59 24.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.72 -10.58 12.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.031 0.933 . . . . 0.0 112.141 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.407 HH12 ' CD ' ' A' ' 28' ' ' GLU . 29.8 ttp180 -141.14 -14.91 0.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.98 -36.62 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 120.531 1.514 . . . . 0.0 111.751 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.99 69.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.487 0.585 . . . . 0.0 112.124 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.0 m -68.53 -39.63 81.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.636 0.653 . . . . 0.0 110.06 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.48 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.938 0.495 . . . . 0.0 112.151 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.34 81.18 44.13 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.6 -0.74 10.78 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.213 2.609 . . . . 0.0 114.451 -169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -142.33 137.08 30.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.789 1.177 . . . . 0.0 110.06 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 60.0 mttp -62.0 -25.89 67.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.537 1.135 . . . . 0.0 113.513 -173.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -13.81 53.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.63 0.65 . . . . 0.0 112.324 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.82 145.88 44.63 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.145 0.884 . . . . 0.0 110.826 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.4 146.51 32.78 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.751 0.42 . . . . 0.0 109.999 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.24 139.14 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.57 95.62 4.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.22 143.11 12.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -147.83 160.39 42.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 p -162.21 -166.37 1.39 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.45 135.69 33.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 56.41 17.12 2.75 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.252 1.821 . . . . 0.0 115.391 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.17 -26.27 1.02 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.853 1.216 . . . . 0.0 115.378 170.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -54.49 -51.5 64.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.737 1.769 . . . . 0.0 112.625 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.57 -29.72 70.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.887 0.767 . . . . 0.0 110.471 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 m -74.46 -43.87 54.18 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.965 0.802 . . . . 0.0 112.138 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 -46.11 94.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.56 -45.04 85.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.83 1.252 . . . . 0.0 110.981 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.42 86.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.622 0.647 . . . . 0.0 110.955 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.04 -40.34 84.73 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.446 -0.784 . . . . 0.0 110.113 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.64 -54.18 43.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.977 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -66.08 -32.93 60.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.881 1.219 . . . . 0.0 111.015 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.12 -34.78 71.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.157 0.89 . . . . 0.0 110.938 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.8 m -63.77 -38.91 92.86 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.261 0.482 . . . . 0.0 110.166 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.02 -40.95 82.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.054 0.542 . . . . 0.0 110.8 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.12 -30.14 71.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.042 0.937 . . . . 0.0 111.004 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.26 0.44 7.46 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.182 -1.343 . . . . 0.0 114.528 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 40' ' ' LYS . 90.4 m-85 -65.82 151.02 47.6 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.874 1.837 . . . . 0.0 109.217 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -131.42 4.98 4.36 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.32 0.648 . . . . 0.0 112.421 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -136.25 30.3 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.471 1.108 . . . . 0.0 110.823 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.07 136.48 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.25 149.99 42.04 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -85.36 117.13 24.1 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.73 -32.47 74.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.627 0.371 . . . . 0.0 111.503 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.91 -163.92 28.86 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.596 1.57 . . . . 0.0 109.686 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.25 154.28 21.77 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.9 -44.54 63.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.791 0.836 . . . . 0.0 112.422 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.44 -37.26 82.72 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.751 0.42 . . . . 0.0 111.472 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.21 -35.14 61.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.283 0.633 . . . . 0.0 111.497 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.94 128.17 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 108.651 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.53 -8.5 59.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.6 mmm -61.18 153.86 65.03 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.903 0.881 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.86 162.39 42.32 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.058 2.505 . . . . 0.0 111.153 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -129.42 158.71 38.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.767 0.827 . . . . 0.0 110.935 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.68 163.5 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.552 1.941 . . . . 0.0 107.869 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -115.11 163.61 15.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.821 0.848 . . . . 0.0 110.389 -171.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 172.468 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -154.72 157.97 38.86 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.201 1.001 . . . . 0.0 109.33 -171.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -147.84 154.88 41.01 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.52 1.528 . . . . 0.0 107.733 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -99.98 112.16 24.45 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.74 102.95 14.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.11 144.84 55.86 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.49 9.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.499 -0.751 . . . . 0.0 111.583 -172.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -61.28 157.78 15.65 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.89 145.92 40.18 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.14 -32.08 90.87 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.944 1.763 . . . . 0.0 113.708 -165.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.43 -15.43 56.81 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.494 -0.754 . . . . 0.0 112.498 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -88.1 -31.45 19.21 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.757 1.162 . . . . 0.0 108.859 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -50.61 72.72 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.393 0.677 . . . . 0.0 111.385 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -62.26 -23.9 66.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -169.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -63.99 -37.98 89.41 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.664 -0.684 . . . . 0.0 111.725 -172.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -174.49 135.99 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.325 1.45 . . . . 0.0 107.438 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -152.56 157.89 41.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.001 1.273 . . . . 0.0 111.026 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.54 123.11 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.77 158.7 6.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.154 0.982 . . . . 0.0 111.366 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.5 39.22 42.58 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.56 174.28 10.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.292 1.437 . . . . 0.0 110.039 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.62 164.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -121.66 135.4 54.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.01 92.92 10.65 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.53 149.89 37.23 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.963 2.442 . . . . 0.0 113.158 -171.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 tp -56.37 -28.8 60.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.229 0.612 . . . . 0.0 112.364 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -70.18 -22.35 62.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 112.763 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -116.86 -24.76 7.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.145 1.378 . . . . 0.0 112.098 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.1 p -54.81 -35.69 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.363 1.465 . . . . 0.0 113.392 -168.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.6 -18.18 58.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.658 0.663 . . . . 0.0 112.774 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -110.18 4.17 20.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 111.414 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.92 -21.7 0.72 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -62.73 -36.6 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 110.952 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.07 94.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.283 0.492 . . . . 0.0 111.631 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -37.96 63.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.252 0.478 . . . . 0.0 111.116 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.66 -39.41 64.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.36 0.527 . . . . 0.0 111.951 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.01 81.68 15.8 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.93 -26.48 26.74 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.878 1.718 . . . . 0.0 112.242 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -84.36 103.28 13.4 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.422 0.689 . . . . 0.0 110.195 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.41 -14.4 60.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.55 -17.9 62.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.326 0.966 . . . . 0.0 111.769 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.45 141.89 58.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.874 0.761 . . . . 0.0 111.557 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -83.49 82.12 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.53 100.17 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.74 130.57 38.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.59 138.61 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.54 153.3 32.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.584 1.154 . . . . 0.0 108.488 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -154.58 -174.35 4.94 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.862 1.665 . . . . 0.0 109.691 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.78 125.39 23.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.01 17.49 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.912 1.685 . . . . 0.0 114.172 -170.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.35 10.64 23.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 117.668 -1.629 . . . . 0.0 115.632 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -70.35 -44.1 68.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 121.768 2.784 . . . . 0.0 113.781 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.18 -30.53 69.65 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.899 1.227 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -41.27 48.6 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.772 0.829 . . . . 0.0 112.069 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -41.98 97.8 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.43 -45.96 84.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.586 0.754 . . . . 0.0 110.896 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.36 75.43 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.588 -0.695 . . . . 0.0 112.719 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.85 -36.98 68.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.682 1.128 . . . . 0.0 110.463 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.33 -55.41 18.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.135 0.425 . . . . 0.0 110.571 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -66.88 -35.13 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.21 0.914 . . . . 0.0 110.592 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.79 -36.09 62.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.757 -0.589 . . . . 0.0 110.863 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 p -66.66 -35.92 81.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.107 0.867 . . . . 0.0 110.328 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.58 -36.48 82.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.128 0.876 . . . . 0.0 111.472 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.5 mmm -66.44 -16.57 64.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.901 0.88 . . . . 0.0 111.847 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.04 4.99 27.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.32 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -74.89 93.22 2.63 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.409 1.604 . . . . 0.0 107.692 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -75.65 4.7 7.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.371 1.069 . . . . 0.0 113.585 -172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -138.52 24.75 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.316 0.962 . . . . 0.0 112.646 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.76 140.71 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -143.79 138.64 28.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.43 105.57 9.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.7 68.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.318 0.647 . . . . 0.0 111.977 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.12 -150.13 21.55 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.24 168.12 22.7 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 169.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.3 tp -50.16 -46.06 53.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 113.217 -169.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.25 -28.63 34.69 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.782 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -76.05 -38.34 57.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.323 0.649 . . . . 0.0 111.121 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -66.48 123.94 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.08 -7.66 58.99 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -62.06 156.57 57.57 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.94 0.896 . . . . 0.0 110.757 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.24 169.06 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.759 2.306 . . . . 0.0 110.915 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -140.0 164.7 29.32 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.45 1.1 . . . . 0.0 110.196 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.65 158.87 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.092 1.757 . . . . 0.0 108.209 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.96 155.04 40.34 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.289 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 175.149 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.91 161.64 38.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.893 1.277 . . . . 0.0 108.618 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -142.71 129.92 20.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -90.17 115.63 27.56 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mt -125.38 108.19 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.91 138.01 55.67 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 168.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.2 6.88 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.971 0.805 . . . . 0.0 111.66 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -60.26 162.35 6.11 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.934 0.788 . . . . 0.0 110.437 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.47 149.53 60.12 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -64.23 -31.55 63.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.59 1.526 . . . . 0.0 112.636 -168.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.56 -24.63 64.64 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.337 0.655 . . . . 0.0 111.842 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -86.37 -37.14 18.74 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.165 0.893 . . . . 0.0 108.862 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -36.97 78.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.523 0.601 . . . . 0.0 110.894 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.87 -20.52 66.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.415 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.37 -54.23 7.05 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.515 1.052 . . . . 0.0 108.701 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -164.79 153.29 12.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 110.41 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -163.17 176.12 10.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.933 1.693 . . . . 0.0 109.099 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.37 145.0 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.189 -0.944 . . . . 0.0 108.579 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -63.31 146.06 54.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.033 0.933 . . . . 0.0 110.187 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.65 46.51 75.36 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.26 177.16 8.19 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.259 1.424 . . . . 0.0 110.174 -175.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 tt -126.26 176.58 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.012 1.725 . . . . 0.0 107.173 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 6.2 t-20 -132.65 134.23 44.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.366 -0.833 . . . . 0.0 109.45 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.18 89.37 14.42 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.29 151.98 21.03 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.139 2.559 . . . . 0.0 112.896 -172.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.6 tp -51.48 -34.06 33.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.651 0.78 . . . . 0.0 112.177 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.41 -15.95 63.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -125.21 -24.06 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.482 1.113 . . . . 0.0 111.969 -169.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.1 -34.88 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.639 1.176 . . . . 0.0 113.116 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -56.45 -25.38 50.44 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.008 0.822 . . . . 0.0 112.799 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.56 -0.69 20.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.178 0.991 . . . . 0.0 111.659 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -136.67 -24.44 1.17 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -167.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.3 -35.68 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.089 1.768 . . . . 0.0 110.295 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -17.6 41.9 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.269 1.027 . . . . 0.0 113.638 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -117.94 -30.16 5.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.57 1.148 . . . . 0.0 110.969 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.88 85.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.797 0.726 . . . . 0.0 110.914 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.69 77.13 22.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -25.77 38.62 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.215 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -77.04 102.05 6.31 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.36 0.664 . . . . 0.0 110.052 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.46 -13.3 60.6 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.28 -14.85 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.225 0.921 . . . . 0.0 111.735 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.67 147.54 53.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.195 -0.941 . . . . 0.0 111.486 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -77.53 78.71 4.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.949 0.9 . . . . 0.0 109.344 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.09 100.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -92.45 128.73 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.7 m -122.19 142.8 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.265 0.626 . . . . 0.0 109.571 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.92 167.35 30.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.013 1.325 . . . . 0.0 107.588 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.09 -171.14 2.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -51.53 -47.59 63.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 112.052 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.32 26.11 2.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 112.41 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.17 -18.15 1.25 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.742 1.163 . . . . 0.0 115.523 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -67.41 -40.45 85.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 120.424 2.112 . . . . 0.0 113.028 -173.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -65.75 -30.3 70.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.714 1.143 . . . . 0.0 109.275 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -73.39 -45.55 54.09 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 124.258 1.023 . . . . 0.0 112.293 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.74 97.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -58.25 -46.33 86.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.88 0.872 . . . . 0.0 111.167 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -37.41 87.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.303 0.641 . . . . 0.0 111.575 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.03 -36.35 74.84 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.986 0.812 . . . . 0.0 111.028 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.53 -54.93 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.853 0.752 . . . . 0.0 110.011 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.3 pt -66.18 -34.79 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.469 0.577 . . . . 0.0 111.195 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.41 -39.79 92.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 0.0 110.339 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -64.53 -42.44 95.74 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.01 -35.93 81.89 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.548 0.613 . . . . 0.0 111.317 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.59 -10.5 59.44 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.254 1.021 . . . . 0.0 111.994 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.89 11.0 47.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.56 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -71.83 135.17 46.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.352 1.576 . . . . 0.0 107.364 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -118.37 4.6 11.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.648 0.779 . . . . 0.0 112.378 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -136.98 29.39 2.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.711 1.204 . . . . 0.0 110.075 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.66 142.32 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -144.03 128.32 17.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.46 110.32 14.65 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.72 71.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.454 0.301 . . . . 0.0 111.248 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.59 -157.95 27.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.29 159.59 14.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 167.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.26 -44.83 65.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.262 1.025 . . . . 0.0 111.791 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -68.74 -11.28 60.11 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.73 -30.19 5.51 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.307 1.043 . . . . 0.0 111.867 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 131.21 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.032 0.933 . . . . 0.0 108.619 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.73 56.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.4 mmm -61.18 154.2 63.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.916 0.886 . . . . 0.0 110.667 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.92 163.46 35.51 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 111.534 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -123.92 165.83 16.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.341 1.056 . . . . 0.0 109.641 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.7 148.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.872 1.669 . . . . 0.0 106.518 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -149.23 151.14 33.75 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.308 1.043 . . . . 0.0 108.803 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 176.41 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.15 169.71 18.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.33 1.052 . . . . 0.0 109.916 175.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -137.61 147.31 44.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.318 1.447 . . . . 0.0 107.482 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.09 110.07 21.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.24 107.0 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.1 138.25 49.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.27 8.66 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.084 0.856 . . . . 0.0 111.783 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -62.45 159.02 16.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.899 0.772 . . . . 0.0 110.683 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.5 m -54.67 147.89 28.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.726 0.81 . . . . 0.0 109.337 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.37 -33.0 71.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.867 1.711 . . . . 0.0 112.291 -169.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 -23.82 64.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.17 -34.1 16.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.177 0.898 . . . . 0.0 108.652 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -57.31 -41.11 79.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.416 0.687 . . . . 0.0 110.831 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -62.08 -28.24 69.47 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.695 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.88 -50.51 23.37 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.413 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -167.03 152.33 7.56 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.369 0.986 . . . . 0.0 110.204 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -153.64 167.51 29.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.503 1.521 . . . . 0.0 109.683 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 t -65.85 139.85 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.3 161.76 18.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.089 0.556 . . . . 0.0 112.003 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.99 38.61 84.78 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.886 0.755 . . . . 0.0 111.825 172.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.95 179.37 7.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.299 1.039 . . . . 0.0 111.924 -169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.44 175.9 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.745 2.018 . . . . 0.0 105.994 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.25 133.08 45.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.167 -0.958 . . . . 0.0 108.67 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 29' ' ' VAL . 12.4 mt -136.47 84.04 29.52 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -55.59 146.88 62.11 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.087 2.525 . . . . 0.0 113.026 -172.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -48.72 -34.46 12.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.888 0.875 . . . . 0.0 112.389 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -55.09 -28.48 52.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.631 1.172 . . . . 0.0 112.957 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -140.04 2.81 1.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.093 0.957 . . . . 0.0 113.016 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.6 p -54.36 -39.66 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.7 -29.11 66.39 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.979 0.809 . . . . 0.0 112.122 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.32 -16.78 57.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 111.641 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -125.62 -36.91 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.173 -0.918 . . . . 0.0 113.04 -169.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.67 -36.49 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 120.047 1.294 . . . . 0.0 111.34 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.8 -7.68 5.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.721 1.209 . . . . 0.0 114.103 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.7 m -125.98 -32.59 2.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.787 1.235 . . . . 0.0 109.927 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.92 82.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.687 0.795 . . . . 0.0 111.053 172.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.42 75.66 32.5 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.6 -35.74 16.37 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 111.976 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.69 113.86 11.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.091 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -65.42 -20.95 66.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -21.71 58.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.356 0.662 . . . . 0.0 111.804 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.29 146.51 43.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.558 1.072 . . . . 0.0 110.67 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -75.26 146.57 40.98 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.011 -0.431 . . . . 0.0 110.184 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.7 98.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.74 123.11 23.49 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 m -126.55 140.77 47.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 123.537 0.735 . . . . 0.0 109.097 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -164.14 157.68 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.4 -170.7 1.72 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.644 0.778 . . . . 0.0 109.774 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -68.22 132.41 47.09 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.2 16.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.771 2.028 . . . . 0.0 115.51 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.1 -14.2 0.44 Allowed Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.723 1.154 . . . . 0.0 115.385 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mmt-85 -63.86 -40.09 95.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.352 2.076 . . . . 0.0 112.785 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -27.41 68.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.393 0.542 . . . . 0.0 110.609 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.0 m -79.41 -43.61 23.04 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.862 0.756 . . . . 0.0 111.031 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.28 -43.19 93.74 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -65.73 -42.56 90.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.105 0.562 . . . . 0.0 111.292 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.12 91.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.121 0.568 . . . . 0.0 111.157 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -55.1 -39.02 68.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.352 0.978 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.72 -53.73 30.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.809 0.731 . . . . 0.0 110.204 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 pt -68.14 -33.74 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.793 -0.567 . . . . 0.0 110.964 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.07 -35.89 74.55 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.897 0.772 . . . . 0.0 110.171 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -62.44 -39.63 93.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 110.208 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.43 -38.88 91.2 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.477 0.58 . . . . 0.0 110.748 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.0 mtp -70.43 -9.93 57.76 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.205 1.002 . . . . 0.0 112.41 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 1.74 46.24 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.058 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.29 145.98 54.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.495 1.648 . . . . 0.0 109.153 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 p -131.19 7.88 4.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.992 0.917 . . . . 0.0 111.824 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -137.06 31.05 2.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.848 1.259 . . . . 0.0 110.444 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -75.2 141.54 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -142.12 124.77 15.88 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.49 108.72 8.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -28.96 68.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.62 0.368 . . . . 0.0 111.355 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.76 -144.07 12.22 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.46 175.48 21.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.84 -52.46 8.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.195 1.398 . . . . 0.0 113.064 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.24 -36.35 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.29 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.71 -38.58 62.3 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 111.615 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.8 128.32 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.1 54.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.46 156.42 70.59 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.717 0.807 . . . . 0.0 111.277 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.42 161.64 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.077 3.185 . . . . 0.0 113.722 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -135.48 159.36 41.85 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.672 1.189 . . . . 0.0 109.966 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.45 164.75 11.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.924 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.7 161.73 25.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.355 1.462 . . . . 0.0 110.125 -169.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 174.849 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.72 160.05 40.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.78 0.832 . . . . 0.0 109.576 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -143.11 153.36 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -108.47 117.75 34.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.4 113.11 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -172.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.87 132.62 45.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 165.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.261 4.3 p -127.27 9.52 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.791 0.837 . . . . 0.0 111.145 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -64.57 161.39 17.58 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.961 -1.087 . . . . 0.0 110.121 170.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.48 151.86 58.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.46 -37.32 72.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.94 1.76 . . . . 0.0 112.038 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.3 -6.58 30.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -105.29 -31.23 9.18 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.139 0.881 . . . . 0.0 110.269 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.32 -41.01 88.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.702 1.137 . . . . 0.0 110.266 169.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -64.19 -8.24 11.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.9 0.88 . . . . 0.0 112.644 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.0 -59.9 1.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.3 169.97 16.8 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.836 1.198 . . . . 0.0 111.556 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -154.28 172.91 16.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 108.69 168.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.4 144.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -61.66 159.88 12.58 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.823 -0.548 . . . . 0.0 111.699 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.36 41.93 99.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.435 0.54 . . . . 0.0 112.573 171.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.97 177.69 7.66 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.969 1.308 . . . . 0.0 110.769 -172.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.8 tt -131.97 140.85 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.367 1.467 . . . . 0.0 108.571 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -82.62 121.28 26.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.059 0.944 . . . . 0.0 110.28 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -144.26 75.05 15.54 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -53.71 150.66 28.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.58 2.854 . . . . 0.0 112.147 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.63 -27.14 67.56 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.568 -0.708 . . . . 0.0 111.829 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.11 -10.47 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -129.33 -21.33 3.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.304 1.442 . . . . 0.0 112.082 -168.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.52 -41.38 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.917 1.287 . . . . 0.0 112.706 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.19 -23.4 62.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.792 0.724 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -110.29 2.89 19.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.917 1.287 . . . . 0.0 111.267 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -133.63 -37.4 0.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.536 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.59 -36.83 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.392 1.451 . . . . 0.0 111.395 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.71 -10.53 19.92 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 m -116.18 -35.75 4.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.13 0.972 . . . . 0.0 109.867 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.67 85.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.388 0.675 . . . . 0.0 111.968 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.6 76.6 47.89 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.51 10.45 1.87 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.723 2.949 . . . . 0.0 114.202 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.52 133.74 29.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.53 1.059 . . . . 0.0 108.996 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.64 -15.11 62.23 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -17.54 59.65 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.932 1.242 . . . . 0.0 112.611 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.41 144.47 55.81 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.44 0.564 . . . . 0.0 111.506 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 m -79.65 87.91 5.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.52 82.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.446 1.098 . . . . 0.0 108.37 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.7 132.43 46.14 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.76 143.75 39.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.601 0.761 . . . . 0.0 109.526 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.29 160.02 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.363 0.665 . . . . 0.0 110.664 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.8 p -168.9 -178.94 3.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.771 1.628 . . . . 0.0 108.489 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -58.82 127.53 32.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.642 -0.661 . . . . 0.0 109.483 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.56 16.9 0.7 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.552 1.941 . . . . 0.0 115.311 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.04 1.1 6.24 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 119.628 1.104 . . . . 0.0 115.209 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.6 mmt-85 -69.32 -39.79 78.0 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 120.131 1.965 . . . . 0.0 112.503 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -69.0 -30.17 68.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.319 0.963 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -70.13 -47.65 60.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.341 1.057 . . . . 0.0 111.646 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.16 99.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -57.5 -49.42 76.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.184 0.994 . . . . 0.0 110.948 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.6 81.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.941 0.496 . . . . 0.0 111.903 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.24 -35.39 69.65 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.178 0.899 . . . . 0.0 111.379 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -53.8 46.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.152 0.887 . . . . 0.0 110.254 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 pt -69.44 -33.16 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.805 -0.559 . . . . 0.0 111.083 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.75 -40.22 88.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.125 0.875 . . . . 0.0 110.153 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -63.66 -38.65 91.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.019 0.372 . . . . 0.0 110.348 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.65 -41.27 88.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.131 0.572 . . . . 0.0 110.908 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -64.25 -33.16 75.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.664 0.786 . . . . 0.0 110.965 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 -1.31 5.27 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.419 -1.212 . . . . 0.0 114.189 169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -68.0 125.38 26.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.542 1.671 . . . . 0.0 108.036 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -114.06 9.25 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.91 0.884 . . . . 0.0 112.305 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -133.32 29.01 4.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.654 1.181 . . . . 0.0 110.134 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.41 140.9 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.65 143.29 25.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 115.13 17.17 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.98 74.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.567 0.347 . . . . 0.0 111.015 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.52 -170.86 32.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.737 1.637 . . . . 0.0 109.242 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.52 155.96 38.3 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 168.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.8 -49.84 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.494 1.117 . . . . 0.0 111.642 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -76.97 -33.56 57.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.974 0.509 . . . . 0.0 111.525 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.92 -34.96 76.24 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.526 0.73 . . . . 0.0 111.674 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.2 mt -58.08 126.17 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.4 59.58 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 ttt -59.88 141.35 89.55 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.613 1.165 . . . . 0.0 110.655 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' MET . 31.9 Cg_exo -62.23 161.58 26.35 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.679 2.919 . . . . 0.0 114.398 -169.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -110.9 161.79 15.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.071 0.948 . . . . 0.0 109.733 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.61 138.84 42.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -65.42 154.46 38.39 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 173.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.02 158.32 44.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.464 0.706 . . . . 0.0 110.084 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -143.47 157.97 44.02 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.332 1.453 . . . . 0.0 108.71 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.405 ' C ' HD12 ' A' ' 5' ' ' ILE . 69.8 m95 -99.04 128.03 45.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.8 mp -121.67 116.04 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 104.376 -2.454 . . . . 0.0 104.376 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -77.37 129.56 35.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.21 -1.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.829 1.652 . . . . 0.0 109.696 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.41 161.58 11.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.891 1.223 . . . . 0.0 109.515 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -55.81 148.89 34.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.82 0.448 . . . . 0.0 109.803 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.77 -31.19 39.95 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.48 1.453 . . . . 0.0 111.823 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -69.16 -17.61 63.83 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.841 . . . . 0.0 111.725 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -89.77 -40.16 12.66 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 109.416 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -54.0 -43.45 70.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.477 1.035 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.47 -32.71 72.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.908 0.483 . . . . 0.0 111.683 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -83.96 -32.23 25.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.229 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -166.4 127.04 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.379 1.072 . . . . 0.0 108.833 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -158.44 164.49 36.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.106 0.866 . . . . 0.0 110.604 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.88 137.01 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -52.51 119.93 5.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 110.834 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.22 1.59 86.22 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.568 -1.129 . . . . 0.0 114.887 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.29 41.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.599 1.699 . . . . 0.0 111.746 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.86 155.64 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -99.11 105.03 17.08 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 mm -138.17 77.03 37.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.6 159.98 5.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.985 3.124 . . . . 0.0 113.102 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -53.09 -42.65 66.11 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.082 0.553 . . . . 0.0 112.105 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -61.1 -29.83 69.99 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.515 0.726 . . . . 0.0 111.743 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -91.9 -31.44 15.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.868 1.267 . . . . 0.0 110.618 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -44.96 -51.64 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.766 1.167 . . . . 0.0 110.95 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -57.57 -23.34 50.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.38 -2.18 6.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.835 0.854 . . . . 0.0 112.336 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -135.48 -20.73 1.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.494 -169.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.5 -29.27 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.803 1.638 . . . . 0.0 112.401 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.29 61.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.915 0.78 . . . . 0.0 112.717 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -36.12 82.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.851 0.75 . . . . 0.0 110.377 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.65 -27.09 16.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.411 1.084 . . . . 0.0 111.739 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.41 76.6 49.15 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 -14.12 30.48 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.906 2.404 . . . . 0.0 114.063 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.8 152.39 38.69 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -56.31 -27.35 55.34 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.633 1.573 . . . . 0.0 114.222 -171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.14 -32.29 73.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.327 0.651 . . . . 0.0 112.703 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.36 136.06 52.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.036 0.446 . . . . 0.0 109.896 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -84.71 138.24 32.76 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.2 96.21 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 89.58 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.7 m -81.71 138.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -149.49 171.85 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.084 0.954 . . . . 0.0 108.467 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 p -151.97 -153.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 170.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' C ' HD22 ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.1 -47.99 74.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.498 1.045 . . . . 0.0 111.028 -178.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.32 -18.88 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.34 -27.26 1.69 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.542 1.064 . . . . 0.0 114.583 172.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -56.85 -58.32 8.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.363 1.581 . . . . 0.0 113.789 -170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.21 -37.52 77.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.203 0.911 . . . . 0.0 110.976 -175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.73 -41.22 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.027 0.531 . . . . 0.0 112.094 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.61 95.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.31 -43.85 79.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.654 1.182 . . . . 0.0 110.567 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.13 70.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.477 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -59.37 -32.29 70.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.209 1.368 . . . . 0.0 111.462 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.1 -53.45 30.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.041 0.837 . . . . 0.0 109.712 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.66 -35.94 76.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.498 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.65 -37.07 84.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.363 0.983 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 m -63.96 -42.07 97.38 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.177 0.444 . . . . 0.0 110.043 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.49 -38.94 91.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.987 0.515 . . . . 0.0 110.836 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 85.1 mtp -70.48 -11.21 60.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.145 1.378 . . . . 0.0 111.945 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.03 48.87 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.822 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -73.89 151.18 40.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.352 1.576 . . . . 0.0 109.336 171.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -139.1 9.13 2.53 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.301 1.041 . . . . 0.0 111.781 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -134.79 38.87 3.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.392 1.477 . . . . 0.0 109.522 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -109.95 138.23 38.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.2 145.21 28.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -79.76 106.03 11.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.91 -28.18 67.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.28 -144.72 11.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.43 165.71 25.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.79 -47.04 51.46 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.333 1.453 . . . . 0.0 110.992 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.65 -2.15 16.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.029 0.932 . . . . 0.0 113.123 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.69 -30.54 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.509 1.124 . . . . 0.0 112.596 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.89 134.54 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.267 1.027 . . . . 0.0 108.512 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.3 -16.56 54.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.6 mtp -63.68 158.81 57.57 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.416 0.686 . . . . 0.0 111.776 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.93 161.13 8.86 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.611 2.874 . . . . 0.0 113.189 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.43 163.8 23.28 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.614 1.166 . . . . 0.0 108.797 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.79 155.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -140.98 168.83 18.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.755 0.822 . . . . 0.0 110.168 -170.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 178.448 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 163.61 33.43 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.364 1.066 . . . . 0.0 109.279 176.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.51 152.89 41.24 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.068 1.747 . . . . 0.0 106.799 169.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -114.3 112.7 23.51 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.75 111.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -69.46 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 166.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.81 7.43 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.785 0.721 . . . . 0.0 111.406 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.413 HH22 ' HA ' ' A' ' 17' ' ' HIS . 2.6 ptp180 -64.6 162.15 16.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.038 -1.039 . . . . 0.0 110.462 170.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 m -54.69 144.99 42.67 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.51 -33.67 77.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.104 1.203 . . . . 0.0 111.524 -168.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.84 -29.98 70.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.24 -37.86 16.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -55.66 -44.68 77.48 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.952 0.501 . . . . 0.0 110.224 176.214 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -60.48 -25.8 66.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.62 0.768 . . . . 0.0 112.506 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -71.06 -49.1 48.3 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.563 0.62 . . . . 0.0 110.424 -173.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -166.0 133.4 2.79 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.413 ' HA ' HH22 ' A' ' 8' ' ' ARG . 12.5 p-80 -146.46 162.04 39.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.488 1.04 . . . . 0.0 111.36 178.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.03 135.99 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -60.33 144.9 49.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 110.074 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.18 20.28 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.96 174.57 10.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.042 1.337 . . . . 0.0 110.36 -177.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.05 169.97 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.557 1.943 . . . . 0.0 106.688 170.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.8 t-20 -127.67 127.91 44.54 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.186 172.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -136.99 92.38 14.24 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 171.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.8 153.05 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.538 2.825 . . . . 0.0 111.984 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -46.09 -47.83 17.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.548 1.139 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -57.26 -31.35 65.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.697 1.199 . . . . 0.0 112.289 177.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -101.54 -9.34 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.342 1.857 . . . . 0.0 111.943 -169.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -51.43 -53.37 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.036 1.289 . . . . 0.0 110.127 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -61.41 -22.11 64.71 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -82.83 -21.36 34.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.557 -176.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -136.22 -28.02 1.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.99 -36.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 121.195 1.816 . . . . 0.0 111.361 -169.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -6.36 4.44 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 m -126.31 -33.52 2.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.894 -178.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.09 78.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.702 0.801 . . . . 0.0 111.098 172.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 t -139.57 75.73 31.52 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.38 -23.59 32.37 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.238 1.959 . . . . 0.0 112.202 -175.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.96 104.99 3.13 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.757 0.823 . . . . 0.0 109.826 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -63.58 -13.05 38.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.26 11.95 34.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.196 0.998 . . . . 0.0 111.369 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.73 146.99 53.22 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.071 -1.018 . . . . 0.0 109.265 168.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -80.24 77.84 6.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.67 111.88 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -92.26 136.74 32.94 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.12 143.78 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.73 168.27 24.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 p -156.33 -159.32 0.88 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -63.64 -49.79 71.87 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.625 -0.672 . . . . 0.0 110.898 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.67 35.09 1.43 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.679 1.191 . . . . 0.0 112.5 -168.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 -20.63 1.63 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.962 1.268 . . . . 0.0 115.986 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -64.11 -52.19 60.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.352 2.076 . . . . 0.0 111.831 -174.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -59.16 -30.65 68.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.906 177.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 -47.16 59.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.726 1.148 . . . . 0.0 112.768 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.28 -42.64 97.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.59 -34.72 76.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.414 1.085 . . . . 0.0 111.573 174.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -37.87 64.44 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 176.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -58.88 -39.51 81.64 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.277 -0.889 . . . . 0.0 111.247 -178.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.98 -43.93 81.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.595 1.089 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.2 pt -69.81 -32.8 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.312 1.414 . . . . 0.0 111.01 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -37.95 85.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.246 0.93 . . . . 0.0 110.268 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.3 m -64.21 -40.24 95.65 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.94 -38.41 90.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.172 0.589 . . . . 0.0 110.715 176.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -71.24 -3.62 21.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.72 1.208 . . . . 0.0 112.464 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.76 14.85 64.44 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.304 -1.275 . . . . 0.0 113.883 169.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -62.55 129.19 39.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.613 1.707 . . . . 0.0 107.534 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -66.71 -29.41 69.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.54 0.336 . . . . 0.0 111.665 -169.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.95 158.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 108.741 178.232 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -149.19 147.36 16.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 175.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -131.99 124.94 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -77.02 112.19 13.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.07 72.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.761 0.424 . . . . 0.0 111.741 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.95 -149.45 21.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -177.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.87 163.11 16.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -50.15 -44.36 52.48 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.132 1.373 . . . . 0.0 111.732 -173.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -75.31 -5.87 46.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.954 0.902 . . . . 0.0 113.057 -175.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.52 -30.56 3.62 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.222 1.009 . . . . 0.0 112.266 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.32 130.5 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.59 -16.32 51.96 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mtp -62.05 156.5 57.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.998 0.919 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 165.16 30.72 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.154 2.57 . . . . 0.0 111.748 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.2 162.34 26.4 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.258 1.023 . . . . 0.0 109.907 -176.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 m -137.04 164.25 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 107.604 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -135.11 162.16 33.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.19 0.996 . . . . 0.0 110.045 -171.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 169.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.12 142.68 42.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 108.34 171.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.15 119.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.406 HD12 HG13 ' A' ' 44' ' ' VAL . 8.6 mt -125.5 109.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.93 132.52 45.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 167.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.56 10.83 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.528 0.731 . . . . 0.0 111.695 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' HD23 ' A' ' 75' ' ' LEU . 4.0 ptp180 -67.83 170.58 7.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.26 1.391 . . . . 0.0 108.708 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.78 150.41 48.07 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.28 -0.887 . . . . 0.0 110.921 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.79 -34.33 61.84 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.479 2.119 . . . . 0.0 112.76 -167.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.68 -27.48 68.38 Favored 'General case' 0 C--O 1.227 -0.131 0 O-C-N 121.301 -0.875 . . . . 0.0 111.224 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -88.35 -30.74 19.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.417 -0.802 . . . . 0.0 112.949 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -53.71 -47.37 70.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 170.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.76 -20.07 66.16 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.081 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.2 -49.32 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -178.88 134.43 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -148.11 160.78 42.53 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.566 1.146 . . . . 0.0 110.067 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.98 131.15 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -56.6 140.76 45.66 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.192 2.197 . . . . 0.0 109.967 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.36 83.91 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.8 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 172.8 7.8 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.527 1.164 . . . . 0.0 109.639 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 tt -112.87 170.87 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 2.9 t-20 -124.12 127.67 48.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.24 86.86 19.06 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.82 149.34 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.704 2.269 . . . . 0.0 111.959 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.8 tp -46.84 -37.64 9.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.99 0.916 . . . . 0.0 112.68 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -62.23 -28.19 69.52 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -113.21 -16.94 12.47 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.426 1.891 . . . . 0.0 108.665 -166.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -41.71 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.675 0.79 . . . . 0.0 110.477 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -57.44 -34.23 68.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.161 0.984 . . . . 0.0 113.578 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.54 -6.87 58.15 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -148.68 -25.11 0.32 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -153.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.85 -35.98 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.93 66.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.707 0.803 . . . . 0.0 112.342 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 -39.36 14.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.798 0.839 . . . . 0.0 109.805 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.47 60.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.782 0.833 . . . . 0.0 112.265 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 t -139.95 75.3 30.2 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.303 1.841 . . . . 0.0 106.867 -173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.92 -17.62 36.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.824 2.35 . . . . 0.0 112.882 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -113.21 123.49 50.31 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 5.1 mtpt -71.08 -26.73 63.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 125.201 1.401 . . . . 0.0 113.239 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.55 -14.55 62.13 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 126.07 2.106 . . . . 0.0 108.634 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.78 146.37 52.97 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.748 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -81.55 117.89 22.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.68 1.228 . . . . 0.0 110.845 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 5' ' ' ILE . 6.7 t -104.85 110.67 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 O-C-N 120.771 -1.205 . . . . 0.0 107.756 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -95.55 119.45 34.07 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.65 141.12 29.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -149.35 171.93 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 31.5 p -165.86 -170.99 1.91 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.734 1.214 . . . . 0.0 108.606 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.07 104.93 1.24 Allowed 'General case' 0 C--O 1.26 1.645 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 85.5 5.67 0.48 Allowed 'General case' 0 C--N 1.404 2.953 1 O-C-N 129.974 4.546 . . . . 0.0 111.282 156.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.92 63.15 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.171 0.891 . . . . 0.0 112.731 162.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -52.16 43.76 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 121.646 -0.914 . . . . 0.0 113.351 -165.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -61.16 -29.48 69.82 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.88 -45.92 55.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.582 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.64 95.92 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.55 -45.75 91.49 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.406 1.482 . . . . 0.0 111.788 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.34 88.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 69' ' ' VAL . 61.0 tttt -58.6 -42.2 87.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.604 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.57 -56.34 23.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.529 1.059 . . . . 0.0 110.091 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.1 pt -66.77 -31.96 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.155 -0.34 . . . . 0.0 110.359 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -71.59 -41.73 68.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.138 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.8 m -57.18 -41.29 79.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.943 0.792 . . . . 0.0 109.54 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -67.11 -39.04 86.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.611 0.641 . . . . 0.0 110.646 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.94 -10.18 51.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.846 -1.159 . . . . 0.0 111.281 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.92 13.19 47.34 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.608 1.575 . . . . 0.0 113.345 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 80.9 m-85 -70.22 130.12 41.19 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.709 1.754 . . . . 0.0 107.492 166.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 -2.07 18.3 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.06 0.544 . . . . 0.0 111.61 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -131.76 34.35 3.89 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 110.241 -169.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 37.2 t -85.67 139.12 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -141.12 129.14 21.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.39 1.076 . . . . 0.0 108.464 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.06 109.4 10.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.76 69.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.272 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.07 -153.01 25.01 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 162.39 12.63 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 166.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.512 HD23 ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -37.3 -51.49 1.06 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.846 2.058 . . . . 0.0 110.823 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -68.58 -40.72 80.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.4 -33.38 32.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.943 -1.935 . . . . 0.0 107.176 -168.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.39 123.76 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -8.78 58.68 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mtp -66.47 152.76 94.28 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.473 0.709 . . . . 0.0 110.925 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.58 162.08 22.32 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.168 2.579 . . . . 0.0 112.191 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.486 ' HE2' HD13 ' A' ' 75' ' ' LEU . 9.9 mptt -130.46 156.39 44.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.096 0.958 . . . . 0.0 108.659 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--N 1.324 -0.51 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.83 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 C--O 1.236 0.386 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.59 140.45 27.41 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 108.953 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -80.26 102.96 9.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 168.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -112.27 94.69 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -65.84 156.2 34.0 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.53 16.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.325 1.05 . . . . 0.0 111.688 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -54.97 159.71 2.26 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.871 1.268 . . . . 0.0 111.795 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.13 145.96 32.38 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.64 -37.75 86.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.648 2.232 . . . . 0.0 113.996 -166.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.16 -17.58 64.59 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -88.54 -10.35 49.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.838 0.745 . . . . 0.0 110.959 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -72.52 -20.61 61.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.531 1.514 . . . . 0.0 110.962 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.05 -12.48 60.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.773 0.829 . . . . 0.0 111.213 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -114.79 -172.49 2.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.724 1.61 . . . . 0.0 108.567 -167.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.58 117.53 4.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.203 1.001 . . . . 0.0 111.345 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -147.66 160.9 42.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.693 1.197 . . . . 0.0 109.456 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.48 139.17 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.617 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -50.84 120.13 4.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.934 1.294 . . . . 0.0 110.101 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.82 4.25 81.79 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.666 -1.075 . . . . 0.0 114.536 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 151.11 47.93 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.475 1.638 . . . . 0.0 110.654 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.63 159.5 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -125.61 133.0 52.39 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 169.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 29' ' ' VAL . 8.7 mt -136.67 88.74 18.93 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.24 144.61 29.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.029 2.486 . . . . 0.0 113.378 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.6 tp -52.23 -32.17 35.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.636 0.774 . . . . 0.0 112.561 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -68.21 -15.48 63.59 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -131.42 -14.96 3.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.317 1.447 . . . . 0.0 112.087 -169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 24' ' ' ILE . 11.0 p -50.81 -43.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 125.675 1.59 . . . . 0.0 114.038 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.86 -21.91 66.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.423 1.011 . . . . 0.0 112.362 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.35 -18.05 40.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.746 0.818 . . . . 0.0 112.033 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -135.22 -16.78 1.86 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -166.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.29 -34.24 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.552 1.069 . . . . 0.0 111.166 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.36 77.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.469 0.577 . . . . 0.0 111.719 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -68.66 -42.82 77.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.343 0.657 . . . . 0.0 109.663 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.31 -29.02 61.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.85 81.67 45.81 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.79 -5.76 17.56 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.369 2.712 . . . . 0.0 114.541 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -142.44 136.32 29.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.58 1.082 . . . . 0.0 109.044 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.66 -22.32 66.63 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -19.4 60.28 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.261 0.937 . . . . 0.0 112.162 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.1 143.91 50.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.972 0.805 . . . . 0.0 110.674 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.84 152.94 33.17 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -138.37 137.77 43.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.22 103.35 12.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.03 141.26 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -154.32 173.74 15.78 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.43 -177.0 5.68 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.02 -43.93 30.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 0.0 112.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 16.97 5.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.195 0.998 . . . . 0.0 112.907 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.39 -31.4 0.99 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.11 1.338 . . . . 0.0 114.927 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.8 -43.28 99.23 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.395 1.597 . . . . 0.0 113.54 -173.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.48 -36.68 83.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.027 1.285 . . . . 0.0 109.453 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.44 -36.6 60.7 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.642 -0.695 . . . . 0.0 112.844 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.54 97.67 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 171.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -48.79 79.37 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 175.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -39.75 94.19 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.196 0.599 . . . . 0.0 111.589 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.2 -42.25 76.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.271 0.941 . . . . 0.0 110.066 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.14 -53.13 54.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.87 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.96 -35.69 75.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 CA-C-N 119.413 1.006 . . . . 0.0 110.996 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.0 -34.46 68.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.964 0.802 . . . . 0.0 110.534 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.4 m -63.63 -40.84 97.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.448 0.567 . . . . 0.0 110.093 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.05 -37.66 88.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.581 0.628 . . . . 0.0 110.76 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.69 -3.01 16.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.899 1.28 . . . . 0.0 112.317 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.03 4.45 60.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.495 -1.169 . . . . 0.0 113.928 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -75.1 86.26 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.591 1.695 . . . . 0.0 108.221 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 p -71.27 9.69 0.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.319 1.447 . . . . 0.0 113.904 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -136.34 27.98 3.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 111.717 -170.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.33 137.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -136.75 144.09 43.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -85.16 110.77 19.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.99 73.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.744 0.418 . . . . 0.0 111.73 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.79 -154.39 25.52 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.16 162.25 12.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.8 tp -43.48 -48.56 7.3 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 114.503 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.83 -18.49 60.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.58 -22.46 21.24 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.884 0.874 . . . . 0.0 111.958 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 mm -63.32 132.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.81 58.77 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.5 mmm -66.36 156.22 85.96 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.198 0.999 . . . . 0.0 111.612 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.24 161.67 16.02 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.497 2.798 . . . . 0.0 112.088 168.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -130.0 160.37 33.86 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.951 0.9 . . . . 0.0 110.446 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.538 0.491 0 C-N-CA 127.504 2.321 . . . . 0.0 107.772 179.003 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--O 1.237 0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -139.98 122.03 15.7 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 169.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -78.92 118.94 21.41 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.45 104.23 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.89 124.69 24.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.17 6.48 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.009 0.924 . . . . 0.0 111.076 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -63.76 160.32 17.46 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.005 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 148.01 51.94 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.47 -32.94 70.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.922 1.748 . . . . 0.0 113.161 -167.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.06 -27.72 64.87 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.568 -0.707 . . . . 0.0 111.844 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -84.23 -34.87 23.79 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -55.28 -46.24 76.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.196 0.598 . . . . 0.0 110.616 178.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.05 -22.6 66.97 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -65.23 -45.02 86.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.765 0.712 . . . . 0.0 110.706 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -172.63 138.2 0.85 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.887 1.675 . . . . 0.0 106.988 171.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -147.18 160.54 42.33 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.294 1.038 . . . . 0.0 110.752 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.41 127.69 22.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -61.54 145.61 51.43 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.884 0.374 . . . . 0.0 110.929 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.1 -7.37 52.44 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.214 0.911 . . . . 0.0 114.094 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.62 7.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.012 1.406 . . . . 0.0 111.332 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.76 166.52 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.051 1.741 . . . . 0.0 106.409 168.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.8 t-20 -123.74 128.83 50.15 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 109.187 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 29' ' ' VAL . 9.7 mt -139.12 84.43 16.84 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.1 153.77 11.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.397 2.731 . . . . 0.0 112.815 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -51.59 -35.98 43.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.768 0.827 . . . . 0.0 112.613 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.56 -22.61 66.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.428 0.691 . . . . 0.0 112.46 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -114.66 -27.68 7.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.112 1.365 . . . . 0.0 111.772 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 p -56.7 -38.92 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 124.4 1.08 . . . . 0.0 112.898 -168.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -63.11 -19.46 64.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.238 0.926 . . . . 0.0 112.446 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -103.86 -5.4 22.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.642 1.177 . . . . 0.0 111.918 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -134.95 -21.25 1.67 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -60.43 -38.67 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 120.012 1.278 . . . . 0.0 111.524 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.6 75.14 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.969 0.804 . . . . 0.0 111.868 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 m -71.67 -45.12 62.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.635 0.774 . . . . 0.0 109.633 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.55 -30.71 66.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.17 0.588 . . . . 0.0 112.402 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.0 t -136.06 86.26 26.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.17 -1.78 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.205 2.604 . . . . 0.0 113.661 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -138.28 114.88 10.54 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.615 1.166 . . . . 0.0 108.692 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.62 -15.51 51.99 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.115 0.966 . . . . 0.0 112.871 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -66.22 -22.77 66.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.02 142.64 53.6 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.04 0.536 . . . . 0.0 111.182 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -78.2 97.87 5.66 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.55 88.19 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -82.21 89.78 6.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.14 139.97 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.857 0.463 . . . . 0.0 109.832 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -149.61 168.15 24.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.211 1.005 . . . . 0.0 108.514 169.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.39 -154.29 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -47.71 84.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.9 0.773 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.74 -23.22 0.72 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -25.83 1.46 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.739 1.154 . . . . 0.0 114.81 172.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -64.56 -45.49 86.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.639 1.72 . . . . 0.0 112.927 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.5 -31.29 72.44 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.75 1.159 . . . . 0.0 109.438 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -65.01 -49.53 69.86 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.899 0.88 . . . . 0.0 111.02 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.77 -42.09 95.36 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.07 -42.7 95.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.475 0.71 . . . . 0.0 110.664 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.53 92.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.017 0.527 . . . . 0.0 110.368 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.5 -37.83 73.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.985 0.811 . . . . 0.0 111.144 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -62.13 -53.09 60.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.957 0.799 . . . . 0.0 110.72 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt -69.4 -30.38 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.295 0.952 . . . . 0.0 111.566 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.21 -37.01 82.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 119.471 1.032 . . . . 0.0 110.143 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -66.29 -38.4 87.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.019 0.372 . . . . 0.0 110.199 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.19 -38.76 92.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.633 0.651 . . . . 0.0 110.538 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -75.09 6.24 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.287 1.435 . . . . 0.0 112.274 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.42 13.5 83.33 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.324 -1.265 . . . . 0.0 114.418 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -69.43 147.62 50.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.756 1.778 . . . . 0.0 108.433 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 p -132.67 8.58 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.591 1.157 . . . . 0.0 111.336 -171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -134.02 30.47 3.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.524 1.53 . . . . 0.0 110.026 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -77.08 140.21 17.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -138.66 129.73 26.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.22 108.79 16.7 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -31.4 72.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.259 0.223 . . . . 0.0 111.315 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.95 -139.34 8.12 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.98 163.68 24.51 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -48.69 -48.07 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.363 1.465 . . . . 0.0 112.396 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -68.73 -38.05 79.9 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.709 0.404 . . . . 0.0 111.49 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -78.19 -36.71 47.04 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.643 0.777 . . . . 0.0 111.992 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.31 132.55 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.462 1.105 . . . . 0.0 108.977 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.49 -13.84 56.01 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.2 mmm -61.98 154.21 69.62 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.757 0.823 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.22 162.3 42.34 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.134 2.556 . . . . 0.0 112.003 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -133.4 159.96 38.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.2 1.0 . . . . 0.0 110.811 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.237 0.432 0 C-N-CA 125.632 1.573 . . . . 0.0 108.75 171.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.236 0.353 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -138.31 152.18 48.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.267 1.427 . . . . 0.0 107.744 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.47 120.53 37.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -125.46 110.25 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -68.21 133.47 48.9 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.36 6.15 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.679 0.672 . . . . 0.0 110.332 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -57.41 157.41 6.67 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.31 -0.869 . . . . 0.0 111.066 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -53.94 148.26 21.5 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 167.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.33 -26.94 63.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.171 1.914 . . . . 0.0 113.368 -166.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.32 -28.85 61.35 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.396 -0.815 . . . . 0.0 112.023 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -82.54 -33.93 28.02 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.128 0.876 . . . . 0.0 109.18 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -50.13 -50.6 48.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.774 0.83 . . . . 0.0 111.492 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -66.19 -19.83 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -63.74 -45.04 91.65 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.083 0.856 . . . . 0.0 110.324 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.79 147.82 0.82 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.002 2.521 . . . . 0.0 105.381 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.11 158.16 43.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.608 1.094 . . . . 0.0 109.28 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.71 134.69 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -58.09 143.08 44.94 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.198 0.999 . . . . 0.0 110.137 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.15 45.32 20.26 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.266 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.23 176.1 9.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.097 1.359 . . . . 0.0 110.072 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 tt -121.31 171.13 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.09 1.756 . . . . 0.0 106.406 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -124.97 131.9 53.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 mt -139.0 100.64 7.91 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.34 159.07 6.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.778 2.985 . . . . 0.0 114.078 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -55.63 -35.85 66.34 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.359 -0.838 . . . . 0.0 112.092 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.11 -2.92 29.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.692 0.797 . . . . 0.0 112.821 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.72 -17.68 2.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.0 1.32 . . . . 0.0 112.311 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.82 -37.13 77.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.027 0.931 . . . . 0.0 111.967 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.03 -31.45 68.85 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.868 0.758 . . . . 0.0 111.354 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -77.88 -14.14 59.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.581 0.752 . . . . 0.0 112.472 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -130.58 -22.06 2.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.31 -36.24 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.606 1.094 . . . . 0.0 111.066 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.1 -25.01 28.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.061 1.344 . . . . 0.0 114.143 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -122.83 -29.99 3.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.641 1.176 . . . . 0.0 110.906 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.43 72.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.782 0.833 . . . . 0.0 111.046 171.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -134.6 91.29 21.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -6.3 18.77 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.089 2.526 . . . . 0.0 115.727 -166.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -146.71 139.1 24.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.102 1.319 . . . . 0.0 109.318 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.16 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -76.15 -23.76 54.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.061 0.846 . . . . 0.0 111.673 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -69.66 144.08 53.0 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.112 -0.367 . . . . 0.0 110.736 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.59 144.72 37.3 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 109.733 -169.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.73 141.23 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -123.95 137.35 54.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.67 142.61 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -154.59 155.01 33.96 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.966 1.306 . . . . 0.0 108.135 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 53' ' ' GLN . 66.6 m -155.95 -174.03 4.78 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.25 1.82 . . . . 0.0 109.462 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.45 128.84 37.91 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.69 18.2 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.718 1.607 . . . . 0.0 114.28 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.4 11.91 11.25 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.144 -1.364 . . . . 0.0 115.061 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -67.64 -57.95 5.52 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 120.858 2.329 . . . . 0.0 113.379 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.421 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mp0 -61.26 -30.33 70.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.19 0.904 . . . . 0.0 109.716 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -74.71 -42.95 57.41 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.366 1.066 . . . . 0.0 112.196 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.49 -40.58 86.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.11 -42.24 85.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.356 1.063 . . . . 0.0 110.214 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.84 -39.62 79.86 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.732 0.696 . . . . 0.0 111.883 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.32 -38.84 66.43 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.27 1.395 . . . . 0.0 110.213 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.92 -58.59 7.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.668 0.667 . . . . 0.0 110.784 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.41 -37.1 79.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 119.611 1.096 . . . . 0.0 110.604 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.03 -37.68 75.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.234 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.8 m -62.55 -40.14 95.85 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.712 0.687 . . . . 0.0 110.356 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.19 -37.59 81.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.528 0.604 . . . . 0.0 111.182 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.4 mtp -64.46 -31.49 72.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.467 0.707 . . . . 0.0 110.945 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.26 -9.45 3.25 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.567 1.08 . . . . 0.0 113.565 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -77.21 72.75 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.095 1.447 . . . . 0.0 109.951 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 p -70.67 18.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.348 1.459 . . . . 0.0 112.895 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -132.2 24.76 4.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.316 1.846 . . . . 0.0 110.911 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -92.21 141.37 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.38 133.51 40.66 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.27 109.88 10.32 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 -30.66 70.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 111.611 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.4 -154.03 25.23 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.31 164.9 12.46 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.1 tp -46.18 -49.8 16.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 113.639 -169.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.24 -20.13 22.26 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 119.23 -0.414 . . . . 0.0 112.014 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.21 -37.62 69.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.448 0.567 . . . . 0.0 110.421 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.54 124.73 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -9.79 59.41 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mtp -61.14 154.59 60.72 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 110.608 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.4 164.23 34.97 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.961 2.44 . . . . 0.0 111.712 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -126.49 157.66 38.13 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.101 0.961 . . . . 0.0 110.044 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.238 0.473 0 C-N-CA 126.03 1.732 . . . . 0.0 107.569 172.822 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -136.29 132.02 35.17 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -94.77 115.34 27.39 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.49 107.24 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -65.97 142.54 57.82 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.1 11.6 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.809 0.731 . . . . 0.0 112.081 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -66.38 162.76 19.69 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 172.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.94 148.94 68.15 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.96 -32.94 64.87 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.896 1.73 . . . . 0.0 114.074 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.04 -30.18 67.4 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.497 -0.752 . . . . 0.0 111.408 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.04 -33.97 29.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -48.71 70.33 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.384 0.674 . . . . 0.0 111.251 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -61.99 -21.03 64.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.091 0.556 . . . . 0.0 112.35 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.98 -24.09 64.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.514 -1.231 . . . . 0.0 112.573 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 167.06 135.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.415 2.686 . . . . 0.0 106.848 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.31 162.8 38.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.847 1.203 . . . . 0.0 110.307 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.22 137.6 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -60.37 142.82 54.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.811 0.844 . . . . 0.0 109.91 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.78 44.09 39.85 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.185 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.83 179.34 6.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.111 1.364 . . . . 0.0 110.22 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -130.37 177.15 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.462 1.905 . . . . 0.0 106.48 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.37 137.33 50.89 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.349 -0.844 . . . . 0.0 108.781 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -140.79 97.38 7.23 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.19 157.2 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.527 2.818 . . . . 0.0 113.152 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -52.98 -35.88 59.67 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.618 -0.676 . . . . 0.0 112.248 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.28 -13.7 62.54 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -116.68 -36.02 4.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.189 1.395 . . . . 0.0 110.197 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.13 -33.06 45.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 C-N-CA 124.399 1.079 . . . . 0.0 111.705 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.36 -22.72 65.2 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.82 -30.94 7.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 110.534 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -84.6 -26.13 28.13 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.683 -0.636 . . . . 0.0 112.208 -169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.18 -33.65 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.568 1.076 . . . . 0.0 110.857 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.48 -9.01 10.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 -37.09 4.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.572 1.149 . . . . 0.0 109.905 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.96 -37.9 72.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.741 0.701 . . . . 0.0 112.143 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.96 73.47 33.05 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.34 -27.35 34.33 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.247 1.965 . . . . 0.0 111.976 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -76.75 102.13 6.11 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.38 -4.79 24.07 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -111.51 39.54 2.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.592 1.157 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.35 149.93 50.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.921 1.289 . . . . 0.0 108.159 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.01 153.67 43.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.237 0.615 . . . . 0.0 111.207 -168.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.17 137.54 51.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -110.87 126.76 55.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.3 141.89 39.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.63 169.01 24.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.55 1.14 . . . . 0.0 108.036 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -154.11 -155.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.43 -47.15 76.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.222 0.609 . . . . 0.0 111.213 177.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.86 -37.08 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.04 -23.13 0.6 Allowed Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.659 1.118 . . . . 0.0 115.615 172.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -58.58 -52.06 67.26 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.252 2.026 . . . . 0.0 112.48 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -58.99 -32.33 69.6 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.358 0.526 . . . . 0.0 110.113 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -72.92 -44.9 60.68 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 124.505 1.122 . . . . 0.0 112.59 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -45.39 93.43 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -57.23 -43.63 83.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.96 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.94 85.99 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.804 -0.56 . . . . 0.0 110.89 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -59.39 -38.15 79.78 Favored 'General case' 0 C--O 1.231 0.101 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.91 -52.63 64.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.105 0.866 . . . . 0.0 110.67 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.4 pt -68.04 -33.32 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.363 0.983 . . . . 0.0 111.335 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.51 -40.02 92.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.51 1.05 . . . . 0.0 110.289 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -64.4 -41.4 96.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.747 0.419 . . . . 0.0 109.903 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.02 -39.84 93.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.379 0.671 . . . . 0.0 111.012 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.3 mtp -68.26 -14.66 63.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.596 1.158 . . . . 0.0 111.947 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.81 28.32 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.219 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -64.22 120.05 11.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.1 p -68.66 -28.03 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -167.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.18 126.04 8.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.44 1.096 . . . . 0.0 109.665 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -144.56 149.82 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -139.64 135.08 32.89 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -79.39 110.68 14.9 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.45 70.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.814 0.446 . . . . 0.0 111.932 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.7 -141.44 9.74 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.23 168.41 24.62 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 tp -54.31 -36.07 63.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.866 1.266 . . . . 0.0 112.267 -173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.32 -9.04 58.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.049 0.94 . . . . 0.0 113.083 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.37 -31.11 2.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.459 1.027 . . . . 0.0 113.253 -168.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.43 129.94 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.93 -13.55 55.83 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.24 158.6 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.08 0.952 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.36 164.83 29.1 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.977 2.451 . . . . 0.0 111.51 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -132.83 158.16 43.19 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.054 0.942 . . . . 0.0 110.267 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 126.346 1.859 . . . . 0.0 108.216 176.602 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -139.84 149.62 43.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.672 1.589 . . . . 0.0 107.179 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -119.04 112.95 20.2 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.14 107.44 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.42 142.55 58.15 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.86 7.05 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.093 0.957 . . . . 0.0 111.766 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -63.88 165.81 8.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.661 1.119 . . . . 0.0 110.472 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.36 147.82 66.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.36 -38.15 76.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.043 1.829 . . . . 0.0 113.125 -167.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.89 -26.48 66.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.185 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.04 -34.92 32.46 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -45.61 85.66 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.994 0.518 . . . . 0.0 110.861 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -61.31 -22.34 64.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -67.26 -35.46 79.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.63 -171.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 176.78 141.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.144 2.578 . . . . 0.0 106.8 169.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.61 155.27 40.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.492 1.117 . . . . 0.0 109.723 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.11 134.09 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.059 0.943 . . . . 0.0 109.27 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.72 141.32 49.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.368 0.667 . . . . 0.0 110.177 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.87 55.42 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.674 1.13 . . . . 0.0 114.236 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.59 177.44 6.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.97 1.385 . . . . 0.0 111.509 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.02 175.7 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.647 1.979 . . . . 0.0 105.752 168.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -138.64 133.11 31.97 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.851 -1.156 . . . . 0.0 109.994 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -140.53 101.78 6.64 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.35 150.88 31.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.375 2.05 . . . . 0.0 111.821 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -46.69 -45.75 19.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.429 1.091 . . . . 0.0 112.968 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -67.73 -10.14 49.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -119.17 -13.69 9.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.707 2.003 . . . . 0.0 111.129 -170.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -49.31 -56.65 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.828 1.651 . . . . 0.0 111.326 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.65 -31.02 65.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.38 -25.11 60.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.188 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.23 -30.31 4.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.883 0.765 . . . . 0.0 112.394 -168.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.95 -34.37 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.609 1.095 . . . . 0.0 111.52 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -8.75 6.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 m -120.92 -34.37 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.797 1.239 . . . . 0.0 110.036 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -35.57 80.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.878 0.763 . . . . 0.0 111.496 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.63 79.24 41.25 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.6 18.54 0.7 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.956 3.104 . . . . 0.0 113.581 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -142.99 113.17 7.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.052 1.341 . . . . 0.0 108.173 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -20.02 57.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.86 -20.33 49.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.761 0.709 . . . . 0.0 111.7 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -75.3 148.37 39.42 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.744 0.702 . . . . 0.0 111.24 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.78 145.04 45.34 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.73 0.812 . . . . 0.0 109.858 -175.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.34 141.44 37.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -120.9 135.93 55.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -129.05 144.39 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -150.77 166.13 31.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.893 1.277 . . . . 0.0 107.829 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.7 p -169.52 -174.58 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.329 1.052 . . . . 0.0 109.242 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -65.36 125.3 24.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.68 17.7 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.491 2.317 . . . . 0.0 115.676 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.07 -8.31 8.56 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 118.563 -1.132 . . . . 0.0 115.176 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -56.66 -53.36 58.54 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.108 1.954 . . . . 0.0 111.191 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.13 -28.5 68.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.38 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 m -75.42 -46.37 33.17 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 110.792 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.8 -43.32 86.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 172.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -66.85 -41.9 86.62 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.637 0.375 . . . . 0.0 111.456 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.65 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.47 0.708 . . . . 0.0 111.134 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -57.14 -37.34 71.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.654 1.115 . . . . 0.0 110.869 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.14 -54.58 23.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.373 0.988 . . . . 0.0 109.939 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 pt -65.31 -35.18 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.418 0.554 . . . . 0.0 110.492 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.76 -35.46 72.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.656 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 m -64.28 -38.6 91.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.812 0.733 . . . . 0.0 110.599 173.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.69 -37.77 82.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.403 0.547 . . . . 0.0 110.885 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -65.94 -33.8 76.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.545 0.611 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.17 -2.53 5.48 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.164 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.45 142.2 57.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.445 1.622 . . . . 0.0 109.124 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -130.88 10.47 5.05 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.751 0.82 . . . . 0.0 111.987 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -136.49 32.71 2.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.938 1.295 . . . . 0.0 110.12 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -88.98 141.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.1 141.69 44.23 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.393 1.077 . . . . 0.0 108.139 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.25 112.33 20.19 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.67 -30.24 70.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.479 0.311 . . . . 0.0 111.698 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.46 -147.37 17.86 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.5 168.29 19.6 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -43.85 -50.33 7.96 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.549 1.539 . . . . 0.0 114.617 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -91.49 -23.89 19.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 119.295 -0.384 . . . . 0.0 111.679 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.37 -38.02 74.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.017 0.527 . . . . 0.0 110.391 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.05 113.59 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.03 58.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.6 mtp -60.67 151.31 72.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.668 0.787 . . . . 0.0 110.547 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.22 160.02 49.49 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.082 2.522 . . . . 0.0 111.141 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 156.63 45.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.963 0.905 . . . . 0.0 110.737 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.236 0.366 0 C-N-CA 126.69 1.996 . . . . 0.0 108.307 -176.414 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.236 0.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -134.35 157.14 47.14 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.31 1.444 . . . . 0.0 108.34 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -118.98 119.96 35.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -131.32 109.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.76 144.44 56.32 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.8 11.59 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.028 0.831 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -68.6 163.8 22.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.254 -0.903 . . . . 0.0 109.844 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -56.57 147.65 49.41 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.28 -39.44 57.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.818 1.678 . . . . 0.0 113.484 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.51 -25.95 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.528 -0.732 . . . . 0.0 112.011 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.74 -34.66 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -45.28 89.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.825 0.739 . . . . 0.0 110.605 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -52.06 -28.96 19.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.666 0.786 . . . . 0.0 112.754 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.8 -23.44 65.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.252 -1.356 . . . . 0.0 112.73 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 156.26 147.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.968 3.307 . . . . 0.0 110.373 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -151.73 169.44 22.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 109.168 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.13 137.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 110.06 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.34 125.94 22.92 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.176 0.991 . . . . 0.0 109.802 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.28 -1.2 89.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.215 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.57 -173.73 3.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.106 1.453 . . . . 0.0 111.025 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.87 178.52 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.791 2.036 . . . . 0.0 106.232 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -133.97 136.46 44.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.109 -0.994 . . . . 0.0 109.367 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.4 95.99 11.24 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.4 152.34 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.328 2.685 . . . . 0.0 111.946 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 tp -48.11 -40.3 23.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.763 0.825 . . . . 0.0 112.824 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.46 -34.85 77.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 111.944 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -88.14 -25.67 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.615 1.566 . . . . 0.0 111.166 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.0 t -46.62 -47.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.428 1.091 . . . . 0.0 110.336 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -56.62 -20.61 22.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.16 -1.96 5.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.137 0.975 . . . . 0.0 112.305 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -135.63 -20.39 1.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.036 0.835 . . . . 0.0 113.246 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG21 HD21 ' A' ' 61' ' ' LEU . 10.5 tp -61.75 -34.88 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.843 1.202 . . . . 0.0 112.14 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.96 68.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.376 0.534 . . . . 0.0 112.321 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 m -66.73 -35.23 79.62 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 0.0 110.462 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.56 -20.98 21.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.751 0.82 . . . . 0.0 112.227 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.1 74.61 79.13 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.34 -7.97 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.327 2.684 . . . . 0.0 113.505 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -138.56 122.76 18.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -59.28 -18.75 40.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.24 -18.83 57.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.233 0.924 . . . . 0.0 112.019 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.84 145.51 54.57 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.441 -0.787 . . . . 0.0 110.59 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -80.48 139.0 36.62 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.93 93.14 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.29 124.78 26.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.83 143.73 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.91 161.26 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.94 0.896 . . . . 0.0 108.692 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 p -164.1 179.71 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.243 1.017 . . . . 0.0 108.396 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.49 135.61 56.22 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 54.56 15.76 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.562 1.945 . . . . 0.0 116.026 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.2 -22.53 0.61 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.857 1.217 . . . . 0.0 116.029 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -53.79 -52.62 59.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.129 1.964 . . . . 0.0 113.139 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.98 -26.25 68.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.357 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -76.4 -44.93 33.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.426 1.012 . . . . 0.0 111.692 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -44.55 96.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.69 -35.5 80.76 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.376 1.07 . . . . 0.0 111.397 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.82 -42.43 70.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 110.571 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -59.98 -40.64 89.82 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 121.19 -0.944 . . . . 0.0 110.704 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.0 -44.01 77.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.694 1.134 . . . . 0.0 111.816 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 pt -67.27 -36.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 120.725 1.602 . . . . 0.0 110.15 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 33' ' ' ILE . 77.4 mt -67.86 -36.66 80.67 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.779 0.718 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.6 m -63.13 -38.65 92.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.649 0.379 . . . . 0.0 110.416 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.02 -41.06 78.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.995 0.518 . . . . 0.0 110.554 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.7 mtp -64.93 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.394 1.078 . . . . 0.0 111.116 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.36 1.2 6.18 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.355 0.979 . . . . 0.0 114.302 169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -71.58 145.75 48.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.24 1.52 . . . . 0.0 108.817 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -132.31 7.77 4.26 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -137.11 30.71 2.71 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.521 1.128 . . . . 0.0 110.457 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.0 t -87.9 136.31 23.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -144.9 131.86 20.28 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.38 112.27 10.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.85 -30.76 70.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.298 0.639 . . . . 0.0 111.649 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.62 -136.2 6.55 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.46 170.2 25.64 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.92 -41.1 64.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.836 1.254 . . . . 0.0 113.34 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -80.14 -9.04 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.71 -32.83 5.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.769 0.828 . . . . 0.0 111.817 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.6 125.04 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.97 -10.86 59.66 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mtp -63.83 155.6 76.57 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.749 0.82 . . . . 0.0 111.061 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.08 162.0 9.97 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.697 2.931 . . . . 0.0 112.961 170.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.58 160.07 36.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.02 0.928 . . . . 0.0 110.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.239 0.53 0 C-N-CA 126.422 1.889 . . . . 0.0 107.989 175.173 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.236 0.362 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -141.74 124.57 16.08 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -86.07 117.11 24.7 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.24 107.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -66.45 134.81 53.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -119.01 10.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.888 0.767 . . . . 0.0 111.189 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -61.62 161.32 10.0 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.796 0.725 . . . . 0.0 109.147 167.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.47 150.7 43.18 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.38 -31.21 43.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.267 1.312 . . . . 0.0 112.396 -168.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.73 -10.78 60.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 112.218 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.66 -32.95 10.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.636 1.107 . . . . 0.0 110.282 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -57.49 -40.4 78.54 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.721 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.24 -34.03 76.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.751 0.42 . . . . 0.0 111.264 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -72.23 -41.86 66.37 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.462 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -164.92 141.8 5.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.447 1.021 . . . . 0.0 109.507 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -155.31 164.74 38.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.06 . . . . 0.0 109.21 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.47 137.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -59.08 117.19 4.43 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 -170.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.81 90.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.314 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.2 141.86 57.91 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.703 1.752 . . . . 0.0 109.73 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.82 169.26 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.6 t-20 -131.8 128.65 39.2 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.955 -1.09 . . . . 0.0 109.845 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.71 90.45 19.59 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.2 152.84 7.57 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.452 2.768 . . . . 0.0 111.845 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -46.87 -44.17 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.86 -30.34 71.44 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.309 0.504 . . . . 0.0 112.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.67 -21.56 23.86 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.082 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.1 t -49.1 -48.41 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.619 1.167 . . . . 0.0 110.129 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.39 -16.14 21.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.39 -3.17 8.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.226 0.921 . . . . 0.0 112.249 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -142.55 -13.75 0.77 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.96 -35.11 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.167 1.348 . . . . 0.0 111.984 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.65 67.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.397 0.544 . . . . 0.0 112.419 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 m -68.9 -38.98 79.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.952 0.796 . . . . 0.0 110.127 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.33 -23.26 35.19 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.222 0.609 . . . . 0.0 112.168 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.9 75.92 78.92 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.31 -14.73 37.99 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.195 2.597 . . . . 0.0 113.663 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -145.56 138.4 26.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -57.53 -23.94 53.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -67.42 -26.22 66.31 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.281 0.946 . . . . 0.0 112.067 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -68.56 143.95 54.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.335 0.516 . . . . 0.0 110.752 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.07 145.71 35.67 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.53 136.63 48.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -123.5 121.04 34.66 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 m -114.77 141.85 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -152.04 170.84 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.98 -165.6 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -52.64 -52.29 56.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.809 0.844 . . . . 0.0 111.719 -177.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.7 31.48 2.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.135 1.374 . . . . 0.0 111.352 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.33 -24.1 2.18 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.666 -1.075 . . . . 0.0 115.321 170.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.9 mmt-85 -66.39 -44.59 82.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.285 2.043 . . . . 0.0 113.624 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -64.16 -33.98 77.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.825 1.193 . . . . 0.0 109.283 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.69 37.61 Favored 'General case' 0 N--CA 1.46 0.07 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.5 -46.64 91.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -56.89 -44.01 81.9 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.712 0.805 . . . . 0.0 111.323 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.07 87.84 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.707 -0.62 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.11 -40.31 84.96 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.281 -0.887 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.79 -53.1 59.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.098 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -65.22 -34.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-N 120.226 1.375 . . . . 0.0 110.781 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.43 -36.22 76.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.066 0.848 . . . . 0.0 110.77 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 m -63.01 -39.16 93.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.191 0.451 . . . . 0.0 110.366 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -68.2 -42.47 79.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.352 0.661 . . . . 0.0 110.346 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.74 -30.12 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.084 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.52 6.04 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.726 -1.041 . . . . 0.0 114.181 169.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -70.69 148.12 48.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.507 1.653 . . . . 0.0 109.163 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 p -133.78 10.03 3.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.846 0.858 . . . . 0.0 112.068 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -133.75 33.08 3.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.073 1.349 . . . . 0.0 110.213 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.42 138.7 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.02 146.25 40.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.12 112.27 19.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.34 68.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.6 -150.41 22.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.47 156.09 15.83 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 168.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.5 tp -53.41 -39.37 64.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.179 . . . . 0.0 113.439 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.51 -31.82 63.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.954 0.343 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.36 -35.49 27.74 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.469 0.708 . . . . 0.0 111.345 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.73 128.9 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.899 1.279 . . . . 0.0 108.77 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -7.54 59.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.998 0.919 . . . . 0.0 113.274 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mmm -60.28 154.55 52.09 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.524 0.73 . . . . 0.0 110.5 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.53 167.31 21.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.757 2.304 . . . . 0.0 110.989 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -128.73 173.63 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.449 1.1 . . . . 0.0 110.104 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.236 0.363 0 C-N-CA 125.442 1.497 . . . . 0.0 107.05 167.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -135.79 126.68 27.59 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -90.18 121.54 32.31 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.66 111.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -71.19 125.31 26.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.01 12.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 123.082 0.553 . . . . 0.0 110.828 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -54.66 156.84 3.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.873 0.76 . . . . 0.0 111.444 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.19 143.74 24.15 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 166.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -60.17 -33.76 94.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.622 1.548 . . . . 0.0 113.849 -166.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.74 -36.99 81.56 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.566 -0.709 . . . . 0.0 111.16 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.22 -32.93 56.21 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.59 -50.5 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.598 0.759 . . . . 0.0 110.633 170.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -63.61 -24.9 67.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.48 -38.81 92.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.538 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -179.96 135.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.39 2.276 . . . . 0.0 106.307 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -145.5 162.92 36.26 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.535 1.134 . . . . 0.0 110.589 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.72 127.34 27.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.74 151.85 28.4 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 111.841 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.72 -12.85 45.69 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.585 1.088 . . . . 0.0 114.006 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 172.15 11.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.717 1.259 . . . . 0.0 111.578 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -113.39 166.83 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.337 1.855 . . . . 0.0 106.017 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -122.74 126.34 47.3 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 119.238 0.927 . . . . 0.0 109.638 172.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 29' ' ' VAL . 11.7 mt -136.23 87.52 22.87 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 143.14 41.55 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.184 2.589 . . . . 0.0 112.812 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.06 -21.33 30.71 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.379 1.072 . . . . 0.0 111.586 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.36 -32.38 70.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.023 1.329 . . . . 0.0 113.334 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -134.95 -2.77 2.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.43 1.092 . . . . 0.0 113.508 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.4 p -52.66 -38.2 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 113.957 -169.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.92 -27.15 63.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.249 0.932 . . . . 0.0 112.293 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.18 -7.97 49.92 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 112.153 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -139.18 -15.75 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.0 -40.18 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.698 1.136 . . . . 0.0 111.135 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.38 74.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.375 0.534 . . . . 0.0 111.53 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 m -68.75 -43.72 75.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.7 . . . . 0.0 109.862 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -38.22 57.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.881 0.472 . . . . 0.0 112.229 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.29 79.05 32.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.83 -30.31 17.52 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.932 1.755 . . . . 0.0 111.825 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -84.3 101.99 12.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.259 0.624 . . . . 0.0 109.757 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.71 -16.33 56.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -77.21 -20.16 55.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.037 0.835 . . . . 0.0 111.775 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.92 147.42 36.98 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 m -70.88 147.64 48.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.321 0.648 . . . . 0.0 110.599 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.84 141.56 38.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -126.9 121.19 31.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.7 m -114.23 140.1 36.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -147.01 165.12 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.342 1.057 . . . . 0.0 108.265 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 p -148.75 -147.31 0.22 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.93 76.61 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.985 0.812 . . . . 0.0 110.361 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.25 -22.37 0.44 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.01 -29.91 0.48 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.434 1.47 . . . . 0.0 116.233 171.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.99 -57.69 11.68 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.3 2.05 . . . . 0.0 112.481 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -33.52 72.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.632 0.651 . . . . 0.0 109.629 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -52.53 58.54 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.554 0.742 . . . . 0.0 111.654 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.0 91.0 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -54.93 -47.52 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.155 0.982 . . . . 0.0 110.331 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -48.28 76.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 111.08 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.21 -42.93 82.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.809 0.731 . . . . 0.0 109.926 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.27 -53.34 56.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.987 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -67.25 -34.88 71.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.779 1.172 . . . . 0.0 111.333 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.42 -35.58 75.85 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.898 1.226 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -62.05 -43.06 99.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.059 0.39 . . . . 0.0 109.958 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -65.21 -38.15 89.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.421 0.689 . . . . 0.0 111.26 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -69.84 -7.06 36.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.987 1.315 . . . . 0.0 112.309 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 4.52 47.47 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.737 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.26 143.23 52.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.432 1.616 . . . . 0.0 106.92 168.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 p -122.47 7.38 9.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.907 0.483 . . . . 0.0 112.171 -171.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -140.8 36.6 1.79 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.658 1.183 . . . . 0.0 110.148 -170.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -105.35 130.89 55.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.38 148.0 40.62 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -78.76 115.91 18.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.29 70.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.807 0.443 . . . . 0.0 111.798 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.24 5.97 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.31 168.83 30.9 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -36.49 62.47 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.721 1.608 . . . . 0.0 110.329 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -54.92 -23.07 17.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 113.599 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -131.12 -32.35 1.6 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.66 125.99 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.216 0.917 . . . . 0.0 108.628 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.97 -4.55 56.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.05 0.94 . . . . 0.0 113.287 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.12 154.49 69.51 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.923 0.889 . . . . 0.0 111.062 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.95 153.03 21.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.793 2.995 . . . . 0.0 113.631 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -127.75 156.88 41.74 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.824 0.85 . . . . 0.0 110.904 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 125.598 1.559 . . . . 0.0 108.022 168.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -144.34 153.45 42.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.984 1.714 . . . . 0.0 107.125 169.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -111.21 108.55 18.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.06 112.07 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -81.97 125.45 30.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.85 -0.36 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.411 HH22 ' HA ' ' A' ' 17' ' ' HIS . 3.1 ptt180 -63.28 167.63 5.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.193 1.36 . . . . 0.0 109.644 167.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.36 152.77 30.61 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.02 -27.93 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 121.807 1.671 . . . . 0.0 112.175 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.14 -0.65 12.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.613 1.165 . . . . 0.0 112.561 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -112.6 -33.2 6.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.856 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -53.53 -46.61 70.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.692 1.133 . . . . 0.0 110.407 168.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -61.84 -25.35 67.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -70.16 -50.45 40.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.635 0.652 . . . . 0.0 109.92 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -168.55 143.18 3.32 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.411 ' HA ' HH22 ' A' ' 8' ' ' ARG . 7.5 p-80 -145.5 151.43 38.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.627 1.171 . . . . 0.0 110.041 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.18 125.33 8.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -52.76 113.16 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.024 0.93 . . . . 0.0 111.133 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 2.94 80.34 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.975 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.31 141.13 58.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.555 1.678 . . . . 0.0 109.709 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.73 132.15 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.56 108.87 4.54 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.532 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.2 78.69 14.83 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 167.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.37 156.86 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.813 3.676 . . . . 0.0 113.426 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -52.57 -35.68 54.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.705 0.802 . . . . 0.0 112.617 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -70.04 -16.49 63.16 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -116.27 -28.01 6.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.224 1.41 . . . . 0.0 111.332 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.11 -41.21 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 125.103 1.361 . . . . 0.0 113.277 -167.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -59.65 -29.35 67.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.091 0.86 . . . . 0.0 112.287 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.13 -24.95 40.13 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 0.0 111.718 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.84 -17.37 4.48 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -166.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 tp -60.67 -35.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.601 1.546 . . . . 0.0 111.496 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.78 -8.92 12.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -118.96 -35.15 3.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.955 1.302 . . . . 0.0 109.562 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.71 83.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 111.068 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -140.02 76.43 27.78 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.199 1.399 . . . . 0.0 107.565 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.56 -35.77 94.67 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.433 2.088 . . . . 0.0 112.723 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -78.84 102.25 8.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.544 0.737 . . . . 0.0 110.052 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -64.07 -14.09 52.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -79.53 -16.7 55.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.371 0.987 . . . . 0.0 112.034 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.51 148.21 49.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.065 -1.022 . . . . 0.0 111.017 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -78.46 100.55 6.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.095 0.558 . . . . 0.0 109.679 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -80.81 89.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -66.57 130.08 42.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -128.85 143.25 41.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.44 166.73 29.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -158.09 -140.7 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -123.64 133.96 53.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 60.24 15.69 5.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.03 1.732 . . . . 0.0 114.968 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.7 -31.11 1.25 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.234 1.397 . . . . 0.0 115.672 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -53.03 -49.33 66.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.293 1.547 . . . . 0.0 113.934 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.52 -33.34 73.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.743 1.156 . . . . 0.0 110.98 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -74.7 -40.21 61.48 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.591 1.087 . . . . 0.0 112.79 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.27 -44.86 96.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -59.99 -42.93 95.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.662 1.185 . . . . 0.0 111.369 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.15 90.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.757 0.708 . . . . 0.0 110.523 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -60.61 -37.9 82.94 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.96 -1.087 . . . . 0.0 110.844 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.65 -49.84 69.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.866 0.867 . . . . 0.0 110.61 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.86 -36.24 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.883 1.22 . . . . 0.0 111.009 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.05 -34.79 71.57 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.008 0.822 . . . . 0.0 110.906 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -67.87 -34.76 77.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.732 0.696 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.57 -38.31 89.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.99 0.814 . . . . 0.0 110.475 172.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -69.82 -8.98 52.87 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.383 1.073 . . . . 0.0 112.385 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.03 6.39 51.97 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.192 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.3 144.5 51.71 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.603 1.701 . . . . 0.0 108.298 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 p -126.14 4.68 7.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.126 0.57 . . . . 0.0 112.376 -171.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -139.28 31.53 2.14 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.532 1.133 . . . . 0.0 110.251 -173.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.1 133.69 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.95 122.7 15.29 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.19 110.83 11.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.58 67.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.092 0.557 . . . . 0.0 111.817 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.33 -142.92 10.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.35 162.87 19.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 168.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 tp -42.03 -48.43 4.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.995 1.318 . . . . 0.0 114.081 -168.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.57 -13.5 62.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.95 -12.26 10.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.273 1.029 . . . . 0.0 112.467 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 80' ' ' MET . 6.8 mm -64.61 134.01 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -20.07 61.43 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.415 ' H ' HG22 ' A' ' 78' ' ' ILE . 95.5 mmm -62.64 156.29 64.87 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 110.885 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.45 156.88 64.29 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.336 2.024 . . . . 0.0 110.283 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 149.12 36.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.054 0.942 . . . . 0.0 109.081 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.236 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 108.923 -173.213 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -143.29 145.69 32.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.716 1.606 . . . . 0.0 106.695 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -105.07 122.89 46.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.76 119.55 53.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -75.38 128.02 34.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.55 12.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 119.461 1.028 . . . . 0.0 111.087 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -62.66 162.71 10.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.39 -0.818 . . . . 0.0 110.571 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.6 147.74 49.24 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.309 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.81 -31.69 67.98 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.905 1.736 . . . . 0.0 112.969 -167.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.8 -28.89 66.1 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.599 -0.688 . . . . 0.0 111.828 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -80.9 -38.62 27.67 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -56.54 -41.52 76.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.738 0.415 . . . . 0.0 111.049 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -58.91 -30.03 67.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.113 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -67.14 -50.31 61.72 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.815 0.734 . . . . 0.0 110.269 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.06 156.22 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.898 1.279 . . . . 0.0 108.351 168.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -153.53 160.34 42.47 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.829 1.252 . . . . 0.0 108.807 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.88 142.61 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.718 0.807 . . . . 0.0 109.215 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.34 157.84 8.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.904 0.482 . . . . 0.0 111.664 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.36 41.17 91.47 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.676 0.655 . . . . 0.0 112.681 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.41 178.1 7.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.696 1.198 . . . . 0.0 110.996 -174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.79 169.91 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.309 2.244 . . . . 0.0 106.42 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.7 t-20 -126.2 131.15 52.04 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 110.107 172.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.37 89.03 9.61 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.51 153.89 16.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.347 2.698 . . . . 0.0 113.03 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -52.8 -34.69 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.589 0.756 . . . . 0.0 112.747 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.31 -14.39 62.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -122.84 -24.32 4.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.246 1.418 . . . . 0.0 111.345 -169.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.44 -38.69 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 124.451 1.101 . . . . 0.0 112.429 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -57.33 -27.93 62.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.751 0.705 . . . . 0.0 112.118 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -99.47 -6.18 28.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 0.0 112.11 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -137.59 -23.32 1.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -167.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.58 -35.82 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 121.131 1.787 . . . . 0.0 110.903 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.3 -30.67 69.64 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.335 0.516 . . . . 0.0 111.814 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -79.28 -45.36 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.908 0.883 . . . . 0.0 109.764 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.36 66.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.241 0.617 . . . . 0.0 112.495 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.41 76.56 36.85 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.019 1.728 . . . . 0.0 106.508 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 -20.65 30.74 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.75 101.75 2.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 109.331 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.12 -9.93 35.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.737 0.815 . . . . 0.0 112.7 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -109.44 12.81 24.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.701 1.2 . . . . 0.0 111.19 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.62 148.74 51.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 169.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -78.89 83.46 5.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.34 109.07 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -98.5 127.69 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.1 141.58 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 123.118 0.567 . . . . 0.0 109.488 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -149.05 172.47 14.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.9 p -157.8 -162.61 1.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -46.26 91.18 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.05 -0.407 . . . . 0.0 112.082 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 18.54 3.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.209 1.404 . . . . 0.0 112.762 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.69 -17.53 44.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.987 -1.071 . . . . 0.0 114.874 172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -67.62 -50.65 57.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.7 1.75 . . . . 0.0 111.903 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.97 -33.28 71.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 110.076 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -76.5 -40.84 48.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.78 0.718 . . . . 0.0 112.808 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.55 -43.35 99.14 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -58.87 -47.16 85.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.133 1.373 . . . . 0.0 110.793 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.24 86.25 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.661 -0.649 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.38 -34.05 68.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.527 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.6 -54.73 31.26 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.319 0.963 . . . . 0.0 109.83 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -68.31 -30.93 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 121.538 -0.726 . . . . 0.0 111.616 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.9 -40.47 95.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.446 1.021 . . . . 0.0 110.101 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -66.22 -41.32 90.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.561 0.344 . . . . 0.0 110.242 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -65.24 -36.44 84.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.625 0.648 . . . . 0.0 111.109 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.5 mtm -73.39 -2.81 23.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.168 0.987 . . . . 0.0 112.266 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.36 17.2 59.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.354 -1.248 . . . . 0.0 114.261 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -63.99 129.98 42.23 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.692 1.746 . . . . 0.0 107.077 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 p -65.21 -33.55 76.27 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.717 0.407 . . . . 0.0 111.904 -168.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.36 154.34 33.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 109.319 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -148.13 146.51 17.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -129.46 122.12 28.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.43 104.91 7.19 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.15 69.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.917 0.487 . . . . 0.0 111.811 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.95 -148.29 19.4 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.64 165.1 21.62 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -49.5 -49.28 46.45 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.677 1.191 . . . . 0.0 112.41 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.7 -36.24 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.674 0.39 . . . . 0.0 111.38 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.91 -37.31 62.11 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.458 0.703 . . . . 0.0 111.751 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.16 125.27 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -19.85 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 61.4 mtm -63.91 155.25 78.57 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.384 0.674 . . . . 0.0 111.165 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.78 165.8 28.42 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.612 2.874 . . . . 0.0 112.563 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -126.84 156.59 41.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.588 1.155 . . . . 0.0 110.151 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.236 0.387 0 C-N-CA 126.476 1.91 . . . . 0.0 108.345 175.077 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.236 0.368 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -139.48 137.29 35.41 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -89.87 118.72 29.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.38 104.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -168.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.46 145.07 56.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.86 15.44 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.335 -0.853 . . . . 0.0 112.496 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.89 160.98 5.28 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.432 -0.793 . . . . 0.0 110.545 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -54.6 146.92 32.48 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.86 -31.4 91.6 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.191 1.927 . . . . 0.0 113.778 -166.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.59 -29.75 63.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.657 -0.652 . . . . 0.0 111.999 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -84.29 -31.69 24.76 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.04 0.836 . . . . 0.0 109.127 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -49.27 64.97 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.767 0.827 . . . . 0.0 111.204 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.15 -18.65 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.882 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -69.32 -31.53 70.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.806 -171.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 176.23 133.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.833 2.453 . . . . 0.0 105.973 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -147.68 161.97 40.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.911 1.232 . . . . 0.0 109.782 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.86 136.33 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.54 142.86 54.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.581 0.752 . . . . 0.0 109.812 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 46.02 42.1 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.004 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.55 178.76 6.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.129 1.371 . . . . 0.0 110.277 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.94 176.22 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.561 1.944 . . . . 0.0 106.924 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.19 139.71 50.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.927 0.891 . . . . 0.0 109.181 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -139.92 85.2 14.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.21 145.86 84.72 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.189 1.926 . . . . 0.0 112.772 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.6 tp -54.69 -25.39 26.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.015 0.526 . . . . 0.0 111.509 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.7 -22.71 65.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.232 1.013 . . . . 0.0 113.511 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -131.24 -10.05 3.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.484 1.038 . . . . 0.0 112.83 -169.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -46.26 -42.57 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.59 1.956 . . . . 0.0 113.387 -169.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.29 -25.18 61.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.285 0.948 . . . . 0.0 112.98 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -114.87 5.84 15.26 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.017 1.327 . . . . 0.0 110.983 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -136.85 -25.2 1.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.14 -167.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -34.66 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 120.261 1.391 . . . . 0.0 112.086 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.89 67.14 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.553 0.615 . . . . 0.0 112.104 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -66.19 -35.98 81.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.659 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 -25.28 20.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.302 0.641 . . . . 0.0 112.096 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.02 78.05 41.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.57 -8.48 20.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.142 2.561 . . . . 0.0 113.652 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.94 134.77 30.44 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.204 1.001 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.29 -16.46 64.29 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -19.67 60.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.737 1.153 . . . . 0.0 112.334 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 146.54 44.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.034 0.834 . . . . 0.0 110.809 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -78.37 138.13 38.37 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.007 -0.433 . . . . 0.0 110.092 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.1 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -84.16 93.21 8.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -83.85 142.8 12.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -150.47 165.24 33.81 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.668 0.787 . . . . 0.0 109.473 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.8 p -158.86 -160.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -57.58 -51.5 69.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.301 0.5 . . . . 0.0 111.157 -177.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.18 23.52 2.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.574 1.149 . . . . 0.0 112.319 -169.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.92 -3.65 64.18 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.364 -1.242 . . . . 0.0 114.96 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -68.6 -53.59 21.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.707 2.254 . . . . 0.0 111.108 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -61.13 -31.85 71.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -66.7 -48.23 69.9 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.268 1.027 . . . . 0.0 112.452 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.61 91.45 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -55.67 -46.37 77.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.332 1.053 . . . . 0.0 110.927 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.25 80.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.079 0.552 . . . . 0.0 111.214 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.82 -39.76 90.19 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 120.03 1.286 . . . . 0.0 110.516 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -58.05 -53.08 62.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.32 0.964 . . . . 0.0 110.483 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.76 -39.69 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 118.495 0.589 . . . . 0.0 110.492 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.55 -35.86 70.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.175 0.898 . . . . 0.0 110.857 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -63.92 -41.49 97.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.57 -39.25 88.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.168 0.587 . . . . 0.0 111.008 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.0 mtp -66.34 -18.39 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.52 1.128 . . . . 0.0 111.765 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.92 8.0 24.6 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.717 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -71.68 97.85 1.82 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.508 1.654 . . . . 0.0 107.627 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -79.02 6.32 9.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.541 1.136 . . . . 0.0 113.185 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -136.33 31.2 2.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.471 1.108 . . . . 0.0 111.504 -169.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.9 140.93 15.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 170.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.19 145.01 28.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -85.38 114.59 22.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -33.82 76.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.433 0.293 . . . . 0.0 111.482 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.75 -156.42 26.68 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.33 160.88 18.27 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -43.01 -56.06 3.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.182 1.793 . . . . 0.0 113.431 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.82 -16.39 32.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.667 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.33 -34.64 65.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.588 0.631 . . . . 0.0 110.919 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.8 126.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 55.55 3.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.471 1.508 . . . . 0.0 111.161 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.2 mtp -136.51 160.62 66.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 125.455 1.502 . . . . 0.0 108.67 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 163.2 34.73 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.546 2.164 . . . . 0.0 111.284 173.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -131.91 156.53 45.96 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.13 0.972 . . . . 0.0 109.646 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.237 0.424 0 C-N-CA 126.246 1.819 . . . . 0.0 107.986 177.46 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -144.17 129.27 18.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.582 1.153 . . . . 0.0 108.192 171.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.65 117.51 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.39 105.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -68.37 149.25 49.6 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.46 12.98 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.591 0.756 . . . . 0.0 111.58 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -53.72 156.39 2.74 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 121.649 -0.657 . . . . 0.0 111.16 171.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.26 149.25 38.07 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 167.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.81 -34.44 95.74 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.331 2.02 . . . . 0.0 114.048 -166.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.11 -27.37 61.66 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.301 -0.875 . . . . 0.0 111.815 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -82.36 -34.48 28.41 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.29 -48.81 73.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.08 0.952 . . . . 0.0 110.726 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.86 2.62 3.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -75.02 -61.3 1.93 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.952 1.251 . . . . 0.0 108.716 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.61 149.26 8.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.277 1.831 . . . . 0.0 107.006 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -151.01 166.82 29.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.873 0.76 . . . . 0.0 110.401 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -60.03 137.18 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.127 0.971 . . . . 0.0 109.497 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.76 135.0 56.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.117 0.567 . . . . 0.0 109.593 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.71 2.96 53.27 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 118.833 -0.982 . . . . 0.0 114.744 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.91 -178.75 3.89 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.207 1.503 . . . . 0.0 111.101 174.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.04 171.2 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.424 1.89 . . . . 0.0 106.699 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -132.56 139.69 47.96 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.134 0.879 . . . . 0.0 110.924 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mt -142.37 82.14 13.21 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.26 143.87 62.52 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.49 2.126 . . . . 0.0 112.78 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.16 -30.02 47.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.74 -13.93 61.44 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -129.5 -14.86 4.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.608 1.163 . . . . 0.0 112.107 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.77 -39.51 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.913 1.685 . . . . 0.0 113.196 -169.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 -20.63 62.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.236 0.925 . . . . 0.0 112.653 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -111.81 7.13 20.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 111.115 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -137.58 -30.41 0.83 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -167.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.48 -38.56 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.747 1.158 . . . . 0.0 110.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.15 90.4 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.315 0.507 . . . . 0.0 111.562 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 -38.54 55.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.236 0.615 . . . . 0.0 111.068 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.51 72.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.393 0.542 . . . . 0.0 111.749 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.43 79.25 20.96 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.289 1.436 . . . . 0.0 107.644 -172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.82 -36.05 97.64 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.335 2.023 . . . . 0.0 112.856 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -83.77 104.38 13.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.608 0.763 . . . . 0.0 110.515 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.03 -14.45 60.46 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.46 -14.14 59.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.492 1.042 . . . . 0.0 111.971 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.6 143.84 57.5 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.171 -0.955 . . . . 0.0 110.991 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -81.99 97.58 8.18 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.3 94.69 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.05 79.43 5.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.66 139.27 19.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -147.89 165.59 30.18 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.015 0.926 . . . . 0.0 109.462 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.5 p -169.0 -160.46 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.211 1.004 . . . . 0.0 109.145 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.53 128.34 34.01 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.45 13.83 0.5 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.536 1.934 . . . . 0.0 115.433 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.1 3.78 46.39 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.194 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.0 -39.63 61.11 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.353 2.076 . . . . 0.0 112.806 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.82 -30.56 69.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.603 1.092 . . . . 0.0 109.221 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -69.14 -48.41 62.47 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.03 0.932 . . . . 0.0 111.727 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.7 -43.57 98.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -57.95 -47.86 81.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.575 0.75 . . . . 0.0 111.241 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.53 88.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.171 0.588 . . . . 0.0 111.354 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -57.52 -35.93 70.9 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.213 -0.929 . . . . 0.0 111.445 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.94 -55.03 33.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.235 0.925 . . . . 0.0 110.428 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt -68.95 -34.73 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 O-C-N 121.766 -0.584 . . . . 0.0 111.069 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.1 mt -69.33 -37.03 77.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.307 0.958 . . . . 0.0 110.605 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -64.26 -39.96 95.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.472 0.578 . . . . 0.0 109.942 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.69 -39.87 94.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.468 0.577 . . . . 0.0 110.901 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.01 -16.92 64.26 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.255 1.022 . . . . 0.0 111.985 174.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.36 27.82 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.847 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -73.13 106.15 4.87 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.564 1.682 . . . . 0.0 107.586 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.09 3.26 43.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 113.058 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -137.95 31.49 2.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.208 1.003 . . . . 0.0 111.382 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.25 130.53 36.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 172.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -142.34 129.24 20.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -75.1 111.46 10.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.88 71.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.826 0.451 . . . . 0.0 111.542 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.52 -153.98 25.36 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.74 165.53 12.34 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 170.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -45.15 -50.32 11.37 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.37 1.468 . . . . 0.0 113.222 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -77.56 -36.76 51.84 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.672 0.389 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.46 -36.25 73.81 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.541 0.736 . . . . 0.0 111.713 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.64 129.18 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.373 1.069 . . . . 0.0 108.497 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 -10.57 59.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.2 mmm -61.26 154.23 63.7 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.663 0.785 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.82 161.01 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.749 2.299 . . . . 0.0 111.09 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -129.26 167.15 18.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.609 1.164 . . . . 0.0 109.18 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 125.517 1.527 . . . . 0.0 106.905 170.213 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -138.92 147.38 42.22 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.651 1.58 . . . . 0.0 106.802 169.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.55 125.45 48.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.61 108.95 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -74.79 119.13 18.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.6 m -105.29 14.23 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 122.946 0.498 . . . . 0.0 111.305 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -55.67 157.24 4.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 118.641 0.655 . . . . 0.0 110.644 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.3 145.69 25.24 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 166.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.62 -30.89 70.55 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.72 1.613 . . . . 0.0 112.825 -166.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -71.26 -21.79 62.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.341 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.67 -34.36 16.29 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.737 1.153 . . . . 0.0 109.347 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -51.87 -46.19 64.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.96 0.504 . . . . 0.0 110.941 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.38 -21.22 66.15 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -73.62 -49.89 23.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.574 1.079 . . . . 0.0 110.508 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -162.66 132.43 4.44 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -151.11 160.78 43.68 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.485 1.493 . . . . 0.0 111.73 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.4 107.06 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -44.05 134.85 4.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.839 1.255 . . . . 0.0 111.753 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.12 -17.94 55.44 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.62 -1.1 . . . . 0.0 112.869 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.45 129.57 40.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.392 1.596 . . . . 0.0 109.259 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.66 156.38 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -111.46 121.29 44.79 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.596 -0.69 . . . . 0.0 109.66 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.2 mt -135.11 84.27 37.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.51 151.46 7.19 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.102 2.535 . . . . 0.0 111.658 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.1 tp -44.95 -44.0 9.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.89 -41.88 97.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.522 0.601 . . . . 0.0 111.336 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -75.07 -22.6 58.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.825 1.65 . . . . 0.0 111.249 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.84 -44.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.539 1.063 . . . . 0.0 109.713 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -61.81 -15.59 43.03 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.24 -20.28 9.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 111.696 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -129.5 -12.38 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.94 -39.24 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 121.362 1.892 . . . . 0.0 111.206 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.79 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.305 0.502 . . . . 0.0 111.787 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 m -68.3 -44.97 74.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.678 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 -39.41 68.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.236 0.614 . . . . 0.0 112.015 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.77 87.64 12.74 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.134 1.889 . . . . 0.0 111.974 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.0 152.68 44.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.364 1.066 . . . . 0.0 109.989 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.73 35.27 4.2 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.569 0.622 . . . . 0.0 112.113 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -142.78 -34.67 0.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.81 150.72 44.09 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.747 0.819 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 m -62.23 132.47 52.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 110.528 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -132.43 139.27 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.56 138.52 53.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.31 141.93 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -147.05 163.51 36.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.3 p -159.82 -154.26 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.277 0.231 . . . . 0.0 111.01 174.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.48 130.21 38.21 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 170.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 55.12 17.68 2.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.298 1.839 . . . . 0.0 114.558 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.13 -13.03 1.04 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.876 1.227 . . . . 0.0 115.188 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -64.55 -44.9 89.31 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 120.056 1.928 . . . . 0.0 111.985 -171.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.44 -30.36 71.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.798 0.726 . . . . 0.0 110.007 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -75.12 -43.41 52.9 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.615 1.098 . . . . 0.0 112.195 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -49.35 78.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -58.26 -40.76 82.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.069 . . . . 0.0 111.977 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.91 -44.17 77.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.483 0.583 . . . . 0.0 109.97 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.06 -35.77 79.61 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.787 1.176 . . . . 0.0 110.498 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.71 -52.97 63.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.557 1.071 . . . . 0.0 110.379 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.0 pt -68.07 -39.43 81.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 119.442 1.019 . . . . 0.0 110.525 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.1 -40.42 94.54 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.394 0.543 . . . . 0.0 110.91 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.87 -39.55 94.8 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.609 0.64 . . . . 0.0 110.136 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.27 -33.93 73.98 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.806 -0.559 . . . . 0.0 111.019 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.6 mtp -73.96 -1.0 17.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.804 1.242 . . . . 0.0 112.08 173.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.35 90.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.848 -1.157 . . . . 0.0 113.136 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.48 55.02 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.364 1.466 . . . . 0.0 108.686 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -67.75 -25.09 65.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.171 1.388 . . . . 0.0 111.869 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.548 ' CD2' ' H ' ' A' ' 68' ' ' HIS . 18.8 p80 -77.5 33.67 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.23 2.612 . . . . 0.0 112.736 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.5 t -120.99 140.41 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.08 1.752 . . . . 0.0 106.427 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.43 141.68 41.64 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.48 114.37 19.33 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.37 -29.97 67.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.904 0.482 . . . . 0.0 112.005 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.28 -139.46 8.12 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.75 169.7 24.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.35 -53.95 7.88 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.391 1.477 . . . . 0.0 112.427 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.79 -37.83 67.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.481 0.313 . . . . 0.0 111.272 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.64 -37.37 68.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.339 0.655 . . . . 0.0 111.787 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.05 131.86 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.288 1.035 . . . . 0.0 108.574 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.52 -8.37 59.55 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.87 151.31 74.02 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.7 0.682 . . . . 0.0 110.676 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 163.83 11.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.123 2.549 . . . . 0.0 111.877 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -136.3 166.54 23.21 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.235 0.309 0 C-N-CA 125.819 1.647 . . . . 0.0 106.556 168.108 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -133.88 128.2 34.11 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -88.74 122.61 32.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mt -128.55 115.18 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -69.54 129.01 38.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.68 7.59 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.626 0.648 . . . . 0.0 111.615 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -65.59 162.82 17.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.046 0.839 . . . . 0.0 110.206 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.88 146.76 35.89 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.4 -38.6 73.28 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.968 1.778 . . . . 0.0 113.303 -167.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.09 -27.9 68.41 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.557 -0.714 . . . . 0.0 112.045 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -82.74 -33.05 27.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -46.42 79.92 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.178 0.591 . . . . 0.0 110.671 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -61.32 -22.75 65.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -66.19 -44.27 84.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.449 0.568 . . . . 0.0 111.022 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.37 137.9 0.3 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.741 2.017 . . . . 0.0 106.912 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -149.3 164.0 36.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.471 1.109 . . . . 0.0 110.256 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.13 134.86 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.577 0.751 . . . . 0.0 109.798 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -55.14 130.66 42.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.0 88.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.333 171.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.13 -178.74 4.0 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.762 1.281 . . . . 0.0 111.623 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.0 tt -125.88 172.22 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 127.418 2.287 . . . . 0.0 106.531 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -129.8 124.21 32.8 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.484 1.038 . . . . 0.0 110.483 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.2 mt -134.76 87.5 30.61 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 170.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.83 153.94 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.673 2.916 . . . . 0.0 111.366 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.02 -39.0 18.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.655 0.782 . . . . 0.0 112.333 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -65.0 -21.48 66.86 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.129 0.971 . . . . 0.0 113.275 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' A' ' 32' ' ' ARG . 26.7 mt-10 -111.1 -13.73 14.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.4 1.48 . . . . 0.0 111.752 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -48.78 -52.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.809 1.186 . . . . 0.0 110.489 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -64.26 -10.59 24.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.72 -10.58 12.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.031 0.933 . . . . 0.0 112.141 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.407 HH12 ' CD ' ' A' ' 28' ' ' GLU . 29.8 ttp180 -141.14 -14.91 0.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.98 -36.62 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 120.531 1.514 . . . . 0.0 111.751 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.99 69.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.487 0.585 . . . . 0.0 112.124 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.0 m -68.53 -39.63 81.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.636 0.653 . . . . 0.0 110.06 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.48 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.938 0.495 . . . . 0.0 112.151 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.34 81.18 44.13 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.6 -0.74 10.78 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.213 2.609 . . . . 0.0 114.451 -169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -142.33 137.08 30.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.789 1.177 . . . . 0.0 110.06 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 60.0 mttp -62.0 -25.89 67.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.537 1.135 . . . . 0.0 113.513 -173.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -13.81 53.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.63 0.65 . . . . 0.0 112.324 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.82 145.88 44.63 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.145 0.884 . . . . 0.0 110.826 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.4 146.51 32.78 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.751 0.42 . . . . 0.0 109.999 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.24 139.14 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.57 95.62 4.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.22 143.11 12.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -147.83 160.39 42.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 p -162.21 -166.37 1.39 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.45 135.69 33.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 56.41 17.12 2.75 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.252 1.821 . . . . 0.0 115.391 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.17 -26.27 1.02 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.853 1.216 . . . . 0.0 115.378 170.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -54.49 -51.5 64.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.737 1.769 . . . . 0.0 112.625 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.57 -29.72 70.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.887 0.767 . . . . 0.0 110.471 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 m -74.46 -43.87 54.18 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.965 0.802 . . . . 0.0 112.138 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 -46.11 94.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.56 -45.04 85.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.83 1.252 . . . . 0.0 110.981 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.42 86.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.622 0.647 . . . . 0.0 110.955 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.04 -40.34 84.73 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.446 -0.784 . . . . 0.0 110.113 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.64 -54.18 43.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.977 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -66.08 -32.93 60.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.881 1.219 . . . . 0.0 111.015 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.12 -34.78 71.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.157 0.89 . . . . 0.0 110.938 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.8 m -63.77 -38.91 92.86 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.261 0.482 . . . . 0.0 110.166 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.02 -40.95 82.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.054 0.542 . . . . 0.0 110.8 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.12 -30.14 71.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.042 0.937 . . . . 0.0 111.004 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.26 0.44 7.46 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.182 -1.343 . . . . 0.0 114.528 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 40' ' ' LYS . 90.4 m-85 -65.82 151.02 47.6 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.874 1.837 . . . . 0.0 109.217 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -131.42 4.98 4.36 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.32 0.648 . . . . 0.0 112.421 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -136.25 30.3 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.471 1.108 . . . . 0.0 110.823 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.07 136.48 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.25 149.99 42.04 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -85.36 117.13 24.1 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.73 -32.47 74.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.627 0.371 . . . . 0.0 111.503 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.91 -163.92 28.86 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.596 1.57 . . . . 0.0 109.686 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.25 154.28 21.77 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.9 -44.54 63.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.791 0.836 . . . . 0.0 112.422 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.44 -37.26 82.72 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.751 0.42 . . . . 0.0 111.472 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.21 -35.14 61.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.283 0.633 . . . . 0.0 111.497 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.94 128.17 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 108.651 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.53 -8.5 59.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.6 mmm -61.18 153.86 65.03 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.903 0.881 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.86 162.39 42.32 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.058 2.505 . . . . 0.0 111.153 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -129.42 158.71 38.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.767 0.827 . . . . 0.0 110.935 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.238 0.471 0 C-N-CA 126.552 1.941 . . . . 0.0 107.869 172.429 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -147.84 154.88 41.01 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.52 1.528 . . . . 0.0 107.733 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -99.98 112.16 24.45 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.74 102.95 14.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.11 144.84 55.86 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.49 9.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.499 -0.751 . . . . 0.0 111.583 -172.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -61.28 157.78 15.65 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.89 145.92 40.18 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.14 -32.08 90.87 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.944 1.763 . . . . 0.0 113.708 -165.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.43 -15.43 56.81 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.494 -0.754 . . . . 0.0 112.498 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -88.1 -31.45 19.21 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.757 1.162 . . . . 0.0 108.859 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -50.61 72.72 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.393 0.677 . . . . 0.0 111.385 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -62.26 -23.9 66.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -169.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -63.99 -37.98 89.41 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.664 -0.684 . . . . 0.0 111.725 -172.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -174.49 135.99 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.325 1.45 . . . . 0.0 107.438 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -152.56 157.89 41.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.001 1.273 . . . . 0.0 111.026 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.54 123.11 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.77 158.7 6.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.154 0.982 . . . . 0.0 111.366 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.5 39.22 42.58 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.56 174.28 10.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.292 1.437 . . . . 0.0 110.039 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.62 164.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -121.66 135.4 54.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.01 92.92 10.65 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.53 149.89 37.23 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.963 2.442 . . . . 0.0 113.158 -171.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 tp -56.37 -28.8 60.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.229 0.612 . . . . 0.0 112.364 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -70.18 -22.35 62.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 112.763 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -116.86 -24.76 7.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.145 1.378 . . . . 0.0 112.098 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.1 p -54.81 -35.69 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.363 1.465 . . . . 0.0 113.392 -168.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.6 -18.18 58.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.658 0.663 . . . . 0.0 112.774 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -110.18 4.17 20.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 111.414 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.92 -21.7 0.72 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -62.73 -36.6 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 110.952 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.07 94.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.283 0.492 . . . . 0.0 111.631 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -37.96 63.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.252 0.478 . . . . 0.0 111.116 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.66 -39.41 64.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.36 0.527 . . . . 0.0 111.951 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.01 81.68 15.8 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.93 -26.48 26.74 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.878 1.718 . . . . 0.0 112.242 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -84.36 103.28 13.4 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.422 0.689 . . . . 0.0 110.195 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.41 -14.4 60.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.55 -17.9 62.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.326 0.966 . . . . 0.0 111.769 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.45 141.89 58.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.874 0.761 . . . . 0.0 111.557 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -83.49 82.12 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.53 100.17 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.74 130.57 38.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.59 138.61 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.54 153.3 32.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.584 1.154 . . . . 0.0 108.488 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -154.58 -174.35 4.94 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.862 1.665 . . . . 0.0 109.691 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.78 125.39 23.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.01 17.49 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.912 1.685 . . . . 0.0 114.172 -170.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.35 10.64 23.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 117.668 -1.629 . . . . 0.0 115.632 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -70.35 -44.1 68.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 121.768 2.784 . . . . 0.0 113.781 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.18 -30.53 69.65 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.899 1.227 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -41.27 48.6 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.772 0.829 . . . . 0.0 112.069 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -41.98 97.8 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.43 -45.96 84.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.586 0.754 . . . . 0.0 110.896 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.36 75.43 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.588 -0.695 . . . . 0.0 112.719 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.85 -36.98 68.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.682 1.128 . . . . 0.0 110.463 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.33 -55.41 18.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.135 0.425 . . . . 0.0 110.571 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -66.88 -35.13 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.21 0.914 . . . . 0.0 110.592 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.79 -36.09 62.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.757 -0.589 . . . . 0.0 110.863 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 p -66.66 -35.92 81.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.107 0.867 . . . . 0.0 110.328 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.58 -36.48 82.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.128 0.876 . . . . 0.0 111.472 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.5 mmm -66.44 -16.57 64.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.901 0.88 . . . . 0.0 111.847 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.04 4.99 27.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.32 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -74.89 93.22 2.63 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.409 1.604 . . . . 0.0 107.692 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -75.65 4.7 7.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.371 1.069 . . . . 0.0 113.585 -172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -138.52 24.75 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.316 0.962 . . . . 0.0 112.646 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.76 140.71 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -143.79 138.64 28.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.43 105.57 9.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.7 68.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.318 0.647 . . . . 0.0 111.977 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.12 -150.13 21.55 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.24 168.12 22.7 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 169.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.3 tp -50.16 -46.06 53.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 113.217 -169.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.25 -28.63 34.69 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.782 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -76.05 -38.34 57.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.323 0.649 . . . . 0.0 111.121 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -66.48 123.94 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.08 -7.66 58.99 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -62.06 156.57 57.57 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.94 0.896 . . . . 0.0 110.757 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.24 169.06 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.759 2.306 . . . . 0.0 110.915 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -140.0 164.7 29.32 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.45 1.1 . . . . 0.0 110.196 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 126.092 1.757 . . . . 0.0 108.209 172.576 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.236 0.374 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -142.71 129.92 20.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -90.17 115.63 27.56 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mt -125.38 108.19 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.91 138.01 55.67 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 168.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.2 6.88 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.971 0.805 . . . . 0.0 111.66 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -60.26 162.35 6.11 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.934 0.788 . . . . 0.0 110.437 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.47 149.53 60.12 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -64.23 -31.55 63.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.59 1.526 . . . . 0.0 112.636 -168.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.56 -24.63 64.64 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.337 0.655 . . . . 0.0 111.842 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -86.37 -37.14 18.74 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.165 0.893 . . . . 0.0 108.862 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -36.97 78.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.523 0.601 . . . . 0.0 110.894 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.87 -20.52 66.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.415 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.37 -54.23 7.05 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.515 1.052 . . . . 0.0 108.701 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -164.79 153.29 12.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 110.41 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -163.17 176.12 10.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.933 1.693 . . . . 0.0 109.099 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.37 145.0 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.189 -0.944 . . . . 0.0 108.579 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -63.31 146.06 54.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.033 0.933 . . . . 0.0 110.187 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.65 46.51 75.36 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.26 177.16 8.19 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.259 1.424 . . . . 0.0 110.174 -175.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 tt -126.26 176.58 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.012 1.725 . . . . 0.0 107.173 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 6.2 t-20 -132.65 134.23 44.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.366 -0.833 . . . . 0.0 109.45 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.18 89.37 14.42 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.29 151.98 21.03 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.139 2.559 . . . . 0.0 112.896 -172.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.6 tp -51.48 -34.06 33.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.651 0.78 . . . . 0.0 112.177 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.41 -15.95 63.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -125.21 -24.06 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.482 1.113 . . . . 0.0 111.969 -169.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.1 -34.88 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.639 1.176 . . . . 0.0 113.116 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -56.45 -25.38 50.44 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.008 0.822 . . . . 0.0 112.799 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.56 -0.69 20.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.178 0.991 . . . . 0.0 111.659 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -136.67 -24.44 1.17 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -167.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.3 -35.68 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.089 1.768 . . . . 0.0 110.295 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -17.6 41.9 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.269 1.027 . . . . 0.0 113.638 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -117.94 -30.16 5.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.57 1.148 . . . . 0.0 110.969 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.88 85.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.797 0.726 . . . . 0.0 110.914 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.69 77.13 22.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -25.77 38.62 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.215 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -77.04 102.05 6.31 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.36 0.664 . . . . 0.0 110.052 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.46 -13.3 60.6 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.28 -14.85 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.225 0.921 . . . . 0.0 111.735 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.67 147.54 53.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.195 -0.941 . . . . 0.0 111.486 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -77.53 78.71 4.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.949 0.9 . . . . 0.0 109.344 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.09 100.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -92.45 128.73 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.7 m -122.19 142.8 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.265 0.626 . . . . 0.0 109.571 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.92 167.35 30.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.013 1.325 . . . . 0.0 107.588 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.09 -171.14 2.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.415 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -51.53 -47.59 63.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 112.052 -178.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.32 26.11 2.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 112.41 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.17 -18.15 1.25 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.742 1.163 . . . . 0.0 115.523 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -67.41 -40.45 85.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 120.424 2.112 . . . . 0.0 113.028 -173.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -65.75 -30.3 70.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.714 1.143 . . . . 0.0 109.275 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -73.39 -45.55 54.09 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 124.258 1.023 . . . . 0.0 112.293 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.74 97.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -58.25 -46.33 86.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.88 0.872 . . . . 0.0 111.167 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -37.41 87.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.303 0.641 . . . . 0.0 111.575 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.03 -36.35 74.84 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.986 0.812 . . . . 0.0 111.028 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.53 -54.93 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.853 0.752 . . . . 0.0 110.011 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.3 pt -66.18 -34.79 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.469 0.577 . . . . 0.0 111.195 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.41 -39.79 92.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 0.0 110.339 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -64.53 -42.44 95.74 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.01 -35.93 81.89 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.548 0.613 . . . . 0.0 111.317 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.59 -10.5 59.44 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.254 1.021 . . . . 0.0 111.994 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.89 11.0 47.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.56 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -71.83 135.17 46.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.352 1.576 . . . . 0.0 107.364 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -118.37 4.6 11.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.648 0.779 . . . . 0.0 112.378 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -136.98 29.39 2.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.711 1.204 . . . . 0.0 110.075 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.66 142.32 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -144.03 128.32 17.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.46 110.32 14.65 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.72 71.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.454 0.301 . . . . 0.0 111.248 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.59 -157.95 27.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.29 159.59 14.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 167.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.26 -44.83 65.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.262 1.025 . . . . 0.0 111.791 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -68.74 -11.28 60.11 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.73 -30.19 5.51 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.307 1.043 . . . . 0.0 111.867 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 131.21 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.032 0.933 . . . . 0.0 108.619 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.73 56.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.4 mmm -61.18 154.2 63.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.916 0.886 . . . . 0.0 110.667 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.92 163.46 35.51 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 111.534 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -123.92 165.83 16.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.341 1.056 . . . . 0.0 109.641 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 125.872 1.669 . . . . 0.0 106.518 171.037 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.293 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -137.61 147.31 44.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.318 1.447 . . . . 0.0 107.482 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.09 110.07 21.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.24 107.0 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.1 138.25 49.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.27 8.66 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.084 0.856 . . . . 0.0 111.783 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -62.45 159.02 16.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.899 0.772 . . . . 0.0 110.683 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.5 m -54.67 147.89 28.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.726 0.81 . . . . 0.0 109.337 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.37 -33.0 71.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.867 1.711 . . . . 0.0 112.291 -169.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 -23.82 64.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.17 -34.1 16.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.177 0.898 . . . . 0.0 108.652 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -57.31 -41.11 79.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.416 0.687 . . . . 0.0 110.831 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -62.08 -28.24 69.47 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.695 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.88 -50.51 23.37 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.413 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -167.03 152.33 7.56 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.369 0.986 . . . . 0.0 110.204 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -153.64 167.51 29.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.503 1.521 . . . . 0.0 109.683 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 t -65.85 139.85 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.3 161.76 18.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.089 0.556 . . . . 0.0 112.003 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.99 38.61 84.78 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.886 0.755 . . . . 0.0 111.825 172.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.95 179.37 7.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.299 1.039 . . . . 0.0 111.924 -169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.44 175.9 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.745 2.018 . . . . 0.0 105.994 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.25 133.08 45.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.167 -0.958 . . . . 0.0 108.67 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 29' ' ' VAL . 12.4 mt -136.47 84.04 29.52 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -55.59 146.88 62.11 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.087 2.525 . . . . 0.0 113.026 -172.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -48.72 -34.46 12.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.888 0.875 . . . . 0.0 112.389 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -55.09 -28.48 52.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.631 1.172 . . . . 0.0 112.957 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -140.04 2.81 1.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.093 0.957 . . . . 0.0 113.016 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.6 p -54.36 -39.66 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.7 -29.11 66.39 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.979 0.809 . . . . 0.0 112.122 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.32 -16.78 57.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 111.641 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -125.62 -36.91 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.173 -0.918 . . . . 0.0 113.04 -169.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.67 -36.49 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 120.047 1.294 . . . . 0.0 111.34 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.8 -7.68 5.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.721 1.209 . . . . 0.0 114.103 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.7 m -125.98 -32.59 2.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.787 1.235 . . . . 0.0 109.927 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.92 82.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.687 0.795 . . . . 0.0 111.053 172.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.42 75.66 32.5 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.6 -35.74 16.37 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 111.976 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.69 113.86 11.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.091 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -65.42 -20.95 66.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -21.71 58.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.356 0.662 . . . . 0.0 111.804 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.29 146.51 43.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.558 1.072 . . . . 0.0 110.67 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -75.26 146.57 40.98 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.011 -0.431 . . . . 0.0 110.184 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.7 98.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.74 123.11 23.49 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 m -126.55 140.77 47.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 123.537 0.735 . . . . 0.0 109.097 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -164.14 157.68 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.4 -170.7 1.72 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.644 0.778 . . . . 0.0 109.774 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -68.22 132.41 47.09 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.2 16.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.771 2.028 . . . . 0.0 115.51 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.1 -14.2 0.44 Allowed Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.723 1.154 . . . . 0.0 115.385 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mmt-85 -63.86 -40.09 95.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.352 2.076 . . . . 0.0 112.785 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -27.41 68.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.393 0.542 . . . . 0.0 110.609 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.0 m -79.41 -43.61 23.04 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.862 0.756 . . . . 0.0 111.031 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.28 -43.19 93.74 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -65.73 -42.56 90.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.105 0.562 . . . . 0.0 111.292 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.12 91.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.121 0.568 . . . . 0.0 111.157 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -55.1 -39.02 68.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.352 0.978 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.72 -53.73 30.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.809 0.731 . . . . 0.0 110.204 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 pt -68.14 -33.74 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.793 -0.567 . . . . 0.0 110.964 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.07 -35.89 74.55 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.897 0.772 . . . . 0.0 110.171 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -62.44 -39.63 93.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 110.208 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.43 -38.88 91.2 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.477 0.58 . . . . 0.0 110.748 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.0 mtp -70.43 -9.93 57.76 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.205 1.002 . . . . 0.0 112.41 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 1.74 46.24 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.058 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.29 145.98 54.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.495 1.648 . . . . 0.0 109.153 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 p -131.19 7.88 4.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.992 0.917 . . . . 0.0 111.824 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -137.06 31.05 2.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.848 1.259 . . . . 0.0 110.444 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -75.2 141.54 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -142.12 124.77 15.88 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.49 108.72 8.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -28.96 68.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.62 0.368 . . . . 0.0 111.355 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.76 -144.07 12.22 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.46 175.48 21.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.84 -52.46 8.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.195 1.398 . . . . 0.0 113.064 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.24 -36.35 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.29 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.71 -38.58 62.3 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 111.615 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.8 128.32 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.1 54.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.46 156.42 70.59 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.717 0.807 . . . . 0.0 111.277 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.42 161.64 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.077 3.185 . . . . 0.0 113.722 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -135.48 159.36 41.85 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.672 1.189 . . . . 0.0 109.966 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.235 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.924 176.86 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -143.11 153.36 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -108.47 117.75 34.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.4 113.11 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -172.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.87 132.62 45.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 165.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.261 4.3 p -127.27 9.52 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.791 0.837 . . . . 0.0 111.145 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -64.57 161.39 17.58 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.961 -1.087 . . . . 0.0 110.121 170.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.48 151.86 58.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.46 -37.32 72.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.94 1.76 . . . . 0.0 112.038 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.3 -6.58 30.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -105.29 -31.23 9.18 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.139 0.881 . . . . 0.0 110.269 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.32 -41.01 88.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.702 1.137 . . . . 0.0 110.266 169.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -64.19 -8.24 11.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.9 0.88 . . . . 0.0 112.644 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.0 -59.9 1.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.3 169.97 16.8 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.836 1.198 . . . . 0.0 111.556 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -154.28 172.91 16.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 108.69 168.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.4 144.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -61.66 159.88 12.58 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.823 -0.548 . . . . 0.0 111.699 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.36 41.93 99.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.435 0.54 . . . . 0.0 112.573 171.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.97 177.69 7.66 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.969 1.308 . . . . 0.0 110.769 -172.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.8 tt -131.97 140.85 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.367 1.467 . . . . 0.0 108.571 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -82.62 121.28 26.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.059 0.944 . . . . 0.0 110.28 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -144.26 75.05 15.54 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -53.71 150.66 28.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.58 2.854 . . . . 0.0 112.147 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.63 -27.14 67.56 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.568 -0.708 . . . . 0.0 111.829 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.11 -10.47 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -129.33 -21.33 3.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.304 1.442 . . . . 0.0 112.082 -168.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.52 -41.38 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.917 1.287 . . . . 0.0 112.706 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.19 -23.4 62.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.792 0.724 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -110.29 2.89 19.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.917 1.287 . . . . 0.0 111.267 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -133.63 -37.4 0.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.536 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.59 -36.83 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.392 1.451 . . . . 0.0 111.395 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.71 -10.53 19.92 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 m -116.18 -35.75 4.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.13 0.972 . . . . 0.0 109.867 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.67 85.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.388 0.675 . . . . 0.0 111.968 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.6 76.6 47.89 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.51 10.45 1.87 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.723 2.949 . . . . 0.0 114.202 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.52 133.74 29.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.53 1.059 . . . . 0.0 108.996 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.64 -15.11 62.23 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -17.54 59.65 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.932 1.242 . . . . 0.0 112.611 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.41 144.47 55.81 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.44 0.564 . . . . 0.0 111.506 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 m -79.65 87.91 5.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.52 82.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.446 1.098 . . . . 0.0 108.37 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.7 132.43 46.14 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.76 143.75 39.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.601 0.761 . . . . 0.0 109.526 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.29 160.02 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.363 0.665 . . . . 0.0 110.664 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.8 p -168.9 -178.94 3.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.771 1.628 . . . . 0.0 108.489 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -58.82 127.53 32.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.642 -0.661 . . . . 0.0 109.483 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.56 16.9 0.7 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.552 1.941 . . . . 0.0 115.311 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.04 1.1 6.24 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 119.628 1.104 . . . . 0.0 115.209 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.6 mmt-85 -69.32 -39.79 78.0 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 120.131 1.965 . . . . 0.0 112.503 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -69.0 -30.17 68.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.319 0.963 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -70.13 -47.65 60.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.341 1.057 . . . . 0.0 111.646 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.16 99.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -57.5 -49.42 76.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.184 0.994 . . . . 0.0 110.948 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.6 81.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.941 0.496 . . . . 0.0 111.903 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.24 -35.39 69.65 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.178 0.899 . . . . 0.0 111.379 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -53.8 46.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.152 0.887 . . . . 0.0 110.254 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 pt -69.44 -33.16 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.805 -0.559 . . . . 0.0 111.083 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.75 -40.22 88.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.125 0.875 . . . . 0.0 110.153 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -63.66 -38.65 91.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.019 0.372 . . . . 0.0 110.348 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.65 -41.27 88.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.131 0.572 . . . . 0.0 110.908 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -64.25 -33.16 75.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.664 0.786 . . . . 0.0 110.965 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 -1.31 5.27 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.419 -1.212 . . . . 0.0 114.189 169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -68.0 125.38 26.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.542 1.671 . . . . 0.0 108.036 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -114.06 9.25 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.91 0.884 . . . . 0.0 112.305 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -133.32 29.01 4.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.654 1.181 . . . . 0.0 110.134 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.41 140.9 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.65 143.29 25.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 115.13 17.17 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.98 74.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.567 0.347 . . . . 0.0 111.015 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.52 -170.86 32.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.737 1.637 . . . . 0.0 109.242 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.52 155.96 38.3 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 168.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.8 -49.84 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.494 1.117 . . . . 0.0 111.642 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -76.97 -33.56 57.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.974 0.509 . . . . 0.0 111.525 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.92 -34.96 76.24 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.526 0.73 . . . . 0.0 111.674 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.2 mt -58.08 126.17 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.4 59.58 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 ttt -59.88 141.35 89.55 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.613 1.165 . . . . 0.0 110.655 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' MET . 31.9 Cg_exo -62.23 161.58 26.35 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.679 2.919 . . . . 0.0 114.398 -169.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -110.9 161.79 15.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.071 0.948 . . . . 0.0 109.733 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.238 0.484 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 168.243 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.326 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -143.47 157.97 44.02 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.332 1.453 . . . . 0.0 108.71 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.405 ' C ' HD12 ' A' ' 5' ' ' ILE . 69.8 m95 -99.04 128.03 45.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.8 mp -121.67 116.04 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 104.376 -2.454 . . . . 0.0 104.376 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -77.37 129.56 35.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.21 -1.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.829 1.652 . . . . 0.0 109.696 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.41 161.58 11.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.891 1.223 . . . . 0.0 109.515 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -55.81 148.89 34.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.82 0.448 . . . . 0.0 109.803 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.77 -31.19 39.95 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.48 1.453 . . . . 0.0 111.823 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -69.16 -17.61 63.83 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.841 . . . . 0.0 111.725 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -89.77 -40.16 12.66 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 109.416 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -54.0 -43.45 70.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.477 1.035 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.47 -32.71 72.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.908 0.483 . . . . 0.0 111.683 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -83.96 -32.23 25.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.229 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -166.4 127.04 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.379 1.072 . . . . 0.0 108.833 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -158.44 164.49 36.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.106 0.866 . . . . 0.0 110.604 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.88 137.01 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -52.51 119.93 5.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 110.834 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.22 1.59 86.22 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.568 -1.129 . . . . 0.0 114.887 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.29 41.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.599 1.699 . . . . 0.0 111.746 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.86 155.64 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -99.11 105.03 17.08 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 mm -138.17 77.03 37.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.6 159.98 5.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.985 3.124 . . . . 0.0 113.102 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -53.09 -42.65 66.11 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.082 0.553 . . . . 0.0 112.105 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -61.1 -29.83 69.99 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.515 0.726 . . . . 0.0 111.743 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -91.9 -31.44 15.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.868 1.267 . . . . 0.0 110.618 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -44.96 -51.64 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.766 1.167 . . . . 0.0 110.95 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -57.57 -23.34 50.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.38 -2.18 6.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.835 0.854 . . . . 0.0 112.336 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -135.48 -20.73 1.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.494 -169.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.5 -29.27 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.803 1.638 . . . . 0.0 112.401 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.29 61.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.915 0.78 . . . . 0.0 112.717 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -36.12 82.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.851 0.75 . . . . 0.0 110.377 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.65 -27.09 16.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.411 1.084 . . . . 0.0 111.739 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.41 76.6 49.15 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 -14.12 30.48 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.906 2.404 . . . . 0.0 114.063 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.8 152.39 38.69 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -56.31 -27.35 55.34 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.633 1.573 . . . . 0.0 114.222 -171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.14 -32.29 73.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.327 0.651 . . . . 0.0 112.703 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.36 136.06 52.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.036 0.446 . . . . 0.0 109.896 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -84.71 138.24 32.76 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.2 96.21 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 89.58 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.7 m -81.71 138.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -149.49 171.85 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.084 0.954 . . . . 0.0 108.467 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 p -151.97 -153.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 170.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.418 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.1 -47.99 74.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.498 1.045 . . . . 0.0 111.028 -178.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.32 -18.88 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.34 -27.26 1.69 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.542 1.064 . . . . 0.0 114.583 172.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -56.85 -58.32 8.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.363 1.581 . . . . 0.0 113.789 -170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.52 77.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.203 0.911 . . . . 0.0 110.976 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.73 -41.22 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.027 0.531 . . . . 0.0 112.094 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.61 95.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.31 -43.85 79.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.654 1.182 . . . . 0.0 110.567 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.13 70.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.477 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -59.37 -32.29 70.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.209 1.368 . . . . 0.0 111.462 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.1 -53.45 30.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.041 0.837 . . . . 0.0 109.712 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.66 -35.94 76.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.498 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.65 -37.07 84.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.363 0.983 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 m -63.96 -42.07 97.38 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.177 0.444 . . . . 0.0 110.043 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.49 -38.94 91.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.987 0.515 . . . . 0.0 110.836 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 85.1 mtp -70.48 -11.21 60.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.145 1.378 . . . . 0.0 111.945 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.03 48.87 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.822 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -73.89 151.18 40.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.352 1.576 . . . . 0.0 109.336 171.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -139.1 9.13 2.53 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.301 1.041 . . . . 0.0 111.781 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -134.79 38.87 3.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.392 1.477 . . . . 0.0 109.522 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -109.95 138.23 38.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.2 145.21 28.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -79.76 106.03 11.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.91 -28.18 67.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.28 -144.72 11.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.43 165.71 25.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.79 -47.04 51.46 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.333 1.453 . . . . 0.0 110.992 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.65 -2.15 16.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.029 0.932 . . . . 0.0 113.123 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.69 -30.54 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.509 1.124 . . . . 0.0 112.596 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.89 134.54 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.267 1.027 . . . . 0.0 108.512 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.3 -16.56 54.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.6 mtp -63.68 158.81 57.57 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.416 0.686 . . . . 0.0 111.776 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.93 161.13 8.86 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.611 2.874 . . . . 0.0 113.189 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.43 163.8 23.28 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.614 1.166 . . . . 0.0 108.797 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.1 m . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 171.039 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.236 0.392 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.51 152.89 41.24 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.068 1.747 . . . . 0.0 106.799 169.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -114.3 112.7 23.51 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.75 111.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -69.46 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 166.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.81 7.43 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.785 0.721 . . . . 0.0 111.406 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.413 HH22 ' HA ' ' A' ' 17' ' ' HIS . 2.6 ptp180 -64.6 162.15 16.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.038 -1.039 . . . . 0.0 110.462 170.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 m -54.69 144.99 42.67 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.51 -33.67 77.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.104 1.203 . . . . 0.0 111.524 -168.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.84 -29.98 70.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.24 -37.86 16.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -55.66 -44.68 77.48 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.952 0.501 . . . . 0.0 110.224 176.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -60.48 -25.8 66.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.62 0.768 . . . . 0.0 112.506 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -71.06 -49.1 48.3 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.563 0.62 . . . . 0.0 110.424 -173.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -166.0 133.4 2.79 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.413 ' HA ' HH22 ' A' ' 8' ' ' ARG . 12.5 p-80 -146.46 162.04 39.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.488 1.04 . . . . 0.0 111.36 178.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.03 135.99 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -60.33 144.9 49.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 110.074 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.18 20.28 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.96 174.57 10.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.042 1.337 . . . . 0.0 110.36 -177.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.05 169.97 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.557 1.943 . . . . 0.0 106.688 170.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.8 t-20 -127.67 127.91 44.54 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.186 172.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -136.99 92.38 14.24 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 171.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.8 153.05 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.538 2.825 . . . . 0.0 111.984 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -46.09 -47.83 17.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.548 1.139 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -57.26 -31.35 65.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.697 1.199 . . . . 0.0 112.289 177.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -101.54 -9.34 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.342 1.857 . . . . 0.0 111.943 -169.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -51.43 -53.37 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.036 1.289 . . . . 0.0 110.127 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -61.41 -22.11 64.71 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -82.83 -21.36 34.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.557 -176.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -136.22 -28.02 1.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.99 -36.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 121.195 1.816 . . . . 0.0 111.361 -169.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -6.36 4.44 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 m -126.31 -33.52 2.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.894 -178.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.09 78.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.702 0.801 . . . . 0.0 111.098 172.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 t -139.57 75.73 31.52 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.38 -23.59 32.37 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.238 1.959 . . . . 0.0 112.202 -175.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.96 104.99 3.13 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.757 0.823 . . . . 0.0 109.826 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -63.58 -13.05 38.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.26 11.95 34.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.196 0.998 . . . . 0.0 111.369 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.73 146.99 53.22 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.071 -1.018 . . . . 0.0 109.265 168.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -80.24 77.84 6.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.67 111.88 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -92.26 136.74 32.94 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.12 143.78 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.73 168.27 24.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 p -156.33 -159.32 0.88 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.435 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -63.64 -49.79 71.87 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.625 -0.672 . . . . 0.0 110.898 179.426 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.67 35.09 1.43 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.679 1.191 . . . . 0.0 112.5 -168.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 -20.63 1.63 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.962 1.268 . . . . 0.0 115.986 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -64.11 -52.19 60.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.352 2.076 . . . . 0.0 111.831 -174.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -59.16 -30.65 68.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.906 177.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 -47.16 59.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.726 1.148 . . . . 0.0 112.768 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.28 -42.64 97.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.59 -34.72 76.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.414 1.085 . . . . 0.0 111.573 174.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -37.87 64.44 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 176.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -58.88 -39.51 81.64 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.277 -0.889 . . . . 0.0 111.247 -178.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.98 -43.93 81.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.595 1.089 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.2 pt -69.81 -32.8 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.312 1.414 . . . . 0.0 111.01 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -37.95 85.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.246 0.93 . . . . 0.0 110.268 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.3 m -64.21 -40.24 95.65 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.94 -38.41 90.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.172 0.589 . . . . 0.0 110.715 176.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -71.24 -3.62 21.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.72 1.208 . . . . 0.0 112.464 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.76 14.85 64.44 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.304 -1.275 . . . . 0.0 113.883 169.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -62.55 129.19 39.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.613 1.707 . . . . 0.0 107.534 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -66.71 -29.41 69.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.54 0.336 . . . . 0.0 111.665 -169.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.95 158.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 108.741 178.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -149.19 147.36 16.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 175.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -131.99 124.94 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -77.02 112.19 13.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.07 72.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.761 0.424 . . . . 0.0 111.741 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.95 -149.45 21.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -177.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.87 163.11 16.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -50.15 -44.36 52.48 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.132 1.373 . . . . 0.0 111.732 -173.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -75.31 -5.87 46.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.954 0.902 . . . . 0.0 113.057 -175.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.52 -30.56 3.62 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.222 1.009 . . . . 0.0 112.266 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.32 130.5 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.59 -16.32 51.96 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mtp -62.05 156.5 57.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.998 0.919 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 165.16 30.72 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.154 2.57 . . . . 0.0 111.748 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.2 162.34 26.4 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.258 1.023 . . . . 0.0 109.907 -176.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.536 0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 107.604 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -152.61 163.57 39.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.12 142.68 42.29 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 108.34 171.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.15 119.81 37.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.406 HD12 HG13 ' A' ' 44' ' ' VAL . 8.6 mt -125.5 109.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.93 132.52 45.35 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 167.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.6 m -119.56 10.83 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.528 0.731 . . . . 0.0 111.695 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' HD23 ' A' ' 75' ' ' LEU . 4.0 ptp180 -67.83 170.58 7.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.26 1.391 . . . . 0.0 108.708 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.78 150.41 48.07 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 121.28 -0.887 . . . . 0.0 110.921 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.79 -34.33 61.84 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.479 2.119 . . . . 0.0 112.76 -167.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.68 -27.48 68.38 Favored 'General case' 0 C--O 1.227 -0.131 0 O-C-N 121.301 -0.875 . . . . 0.0 111.224 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -88.35 -30.74 19.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.417 -0.802 . . . . 0.0 112.949 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -53.71 -47.37 70.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 170.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.76 -20.07 66.16 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.081 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.2 -49.32 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -178.88 134.43 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -148.11 160.78 42.53 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.566 1.146 . . . . 0.0 110.067 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.98 131.15 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -56.6 140.76 45.66 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.192 2.197 . . . . 0.0 109.967 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.76 12.36 83.91 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.8 172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 172.8 7.8 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.527 1.164 . . . . 0.0 109.639 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 tt -112.87 170.87 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 167.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 2.9 t-20 -124.12 127.67 48.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.24 86.86 19.06 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.82 149.34 11.05 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.704 2.269 . . . . 0.0 111.959 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.8 tp -46.84 -37.64 9.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.99 0.916 . . . . 0.0 112.68 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -62.23 -28.19 69.52 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -113.21 -16.94 12.47 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.426 1.891 . . . . 0.0 108.665 -166.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -41.71 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.675 0.79 . . . . 0.0 110.477 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -57.44 -34.23 68.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.161 0.984 . . . . 0.0 113.578 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -87.54 -6.87 58.15 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.139 0.899 . . . . 0.0 109.475 -169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -148.68 -25.11 0.32 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -153.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.85 -35.98 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -25.93 66.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.707 0.803 . . . . 0.0 112.342 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.55 -39.36 14.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.798 0.839 . . . . 0.0 109.805 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.18 -31.47 60.97 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.782 0.833 . . . . 0.0 112.265 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 t -139.95 75.3 30.2 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.303 1.841 . . . . 0.0 106.867 -173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.92 -17.62 36.72 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.824 2.35 . . . . 0.0 112.882 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -113.21 123.49 50.31 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 5.1 mtpt -71.08 -26.73 63.18 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 125.201 1.401 . . . . 0.0 113.239 -174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.55 -14.55 62.13 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 126.07 2.106 . . . . 0.0 108.634 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.78 146.37 52.97 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.748 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 m -81.55 117.89 22.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.68 1.228 . . . . 0.0 110.845 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.406 HG13 HD12 ' A' ' 5' ' ' ILE . 6.7 t -104.85 110.67 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 O-C-N 120.771 -1.205 . . . . 0.0 107.756 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -95.55 119.45 34.07 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 m -112.65 141.12 29.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -149.35 171.93 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 31.5 p -165.86 -170.99 1.91 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.734 1.214 . . . . 0.0 108.606 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.07 104.93 1.24 Allowed 'General case' 0 C--O 1.26 1.645 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 85.5 5.67 0.48 Allowed 'General case' 0 C--N 1.404 2.953 1 O-C-N 129.974 4.546 . . . . 0.0 111.282 156.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.03 -14.92 63.15 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.171 0.891 . . . . 0.0 112.731 162.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -52.16 43.76 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 121.646 -0.914 . . . . 0.0 113.351 -165.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -61.16 -29.48 69.82 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -178.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.88 -45.92 55.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.141 -0.933 . . . . 0.0 112.582 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.64 95.92 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -62.55 -45.75 91.49 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.406 1.482 . . . . 0.0 111.788 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.34 88.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 69' ' ' VAL . 61.0 tttt -58.6 -42.2 87.59 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.604 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.57 -56.34 23.12 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.529 1.059 . . . . 0.0 110.091 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.1 pt -66.77 -31.96 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.155 -0.34 . . . . 0.0 110.359 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.3 mt -71.59 -41.73 68.61 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.138 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.8 m -57.18 -41.29 79.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.943 0.792 . . . . 0.0 109.54 170.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -67.11 -39.04 86.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.611 0.641 . . . . 0.0 110.646 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -67.94 -10.18 51.3 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.846 -1.159 . . . . 0.0 111.281 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.92 13.19 47.34 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.608 1.575 . . . . 0.0 113.345 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 80.9 m-85 -70.22 130.12 41.19 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.709 1.754 . . . . 0.0 107.492 166.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 -2.07 18.3 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.06 0.544 . . . . 0.0 111.61 -172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -131.76 34.35 3.89 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.685 1.594 . . . . 0.0 110.241 -169.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 37.2 t -85.67 139.12 17.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -141.12 129.14 21.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.39 1.076 . . . . 0.0 108.464 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.06 109.4 10.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.76 69.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.272 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.07 -153.01 25.01 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.17 162.39 12.63 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 166.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.512 HD23 ' NH2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -37.3 -51.49 1.06 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.846 2.058 . . . . 0.0 110.823 -175.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -68.58 -40.72 80.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.4 -33.38 32.28 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.943 -1.935 . . . . 0.0 107.176 -168.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.39 123.76 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -8.78 58.68 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mtp -66.47 152.76 94.28 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.473 0.709 . . . . 0.0 110.925 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -61.58 162.08 22.32 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.168 2.579 . . . . 0.0 112.191 172.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.486 ' HE2' HD13 ' A' ' 75' ' ' LEU . 9.9 mptt -130.46 156.39 44.84 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 124.096 0.958 . . . . 0.0 108.659 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.47 162.45 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -95.97 157.92 15.68 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.347 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 165.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -149.14 162.81 39.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.899 1.28 . . . . 0.0 108.115 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -145.59 140.45 27.41 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.352 1.061 . . . . 0.0 108.953 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -80.26 102.96 9.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 168.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt -112.27 94.69 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -65.84 156.2 34.0 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 168.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.53 16.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.325 1.05 . . . . 0.0 111.688 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -54.97 159.71 2.26 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.871 1.268 . . . . 0.0 111.795 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.13 145.96 32.38 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.64 -37.75 86.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.648 2.232 . . . . 0.0 113.996 -166.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.16 -17.58 64.59 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -88.54 -10.35 49.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.838 0.745 . . . . 0.0 110.959 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -72.52 -20.61 61.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.531 1.514 . . . . 0.0 110.962 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -67.05 -12.48 60.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.773 0.829 . . . . 0.0 111.213 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -114.79 -172.49 2.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.724 1.61 . . . . 0.0 108.567 -167.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.58 117.53 4.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.203 1.001 . . . . 0.0 111.345 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -147.66 160.9 42.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.693 1.197 . . . . 0.0 109.456 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.48 139.17 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.838 0.855 . . . . 0.0 109.617 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -50.84 120.13 4.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.934 1.294 . . . . 0.0 110.101 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.82 4.25 81.79 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.666 -1.075 . . . . 0.0 114.536 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 151.11 47.93 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.475 1.638 . . . . 0.0 110.654 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.63 159.5 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -125.61 133.0 52.39 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 169.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 29' ' ' VAL . 8.7 mt -136.67 88.74 18.93 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.24 144.61 29.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.029 2.486 . . . . 0.0 113.378 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.6 tp -52.23 -32.17 35.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.636 0.774 . . . . 0.0 112.561 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -68.21 -15.48 63.59 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -131.42 -14.96 3.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.317 1.447 . . . . 0.0 112.087 -169.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HA ' HG22 ' A' ' 24' ' ' ILE . 11.0 p -50.81 -43.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 125.675 1.59 . . . . 0.0 114.038 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -62.86 -21.91 66.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.423 1.011 . . . . 0.0 112.362 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.35 -18.05 40.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.746 0.818 . . . . 0.0 112.033 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -135.22 -16.78 1.86 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -166.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.29 -34.24 56.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.552 1.069 . . . . 0.0 111.166 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.36 77.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.469 0.577 . . . . 0.0 111.719 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 m -68.66 -42.82 77.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.343 0.657 . . . . 0.0 109.663 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.31 -29.02 61.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.85 81.67 45.81 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.79 -5.76 17.56 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.369 2.712 . . . . 0.0 114.541 -168.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -142.44 136.32 29.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.58 1.082 . . . . 0.0 109.044 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.66 -22.32 66.63 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.69 -19.4 60.28 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.261 0.937 . . . . 0.0 112.162 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.1 143.91 50.47 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.972 0.805 . . . . 0.0 110.674 -174.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.84 152.94 33.17 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -138.37 137.77 43.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.22 103.35 12.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.03 141.26 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -154.32 173.74 15.78 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.43 -177.0 5.68 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.02 -43.93 30.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 0.0 112.132 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 16.97 5.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.195 0.998 . . . . 0.0 112.907 -170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.39 -31.4 0.99 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.11 1.338 . . . . 0.0 114.927 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -62.8 -43.28 99.23 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 119.395 1.597 . . . . 0.0 113.54 -173.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.48 -36.68 83.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.027 1.285 . . . . 0.0 109.453 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.44 -36.6 60.7 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.642 -0.695 . . . . 0.0 112.844 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.54 97.67 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 171.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -48.79 79.37 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 175.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -39.75 94.19 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.196 0.599 . . . . 0.0 111.589 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.2 -42.25 76.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 119.271 0.941 . . . . 0.0 110.066 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.14 -53.13 54.28 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.87 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.96 -35.69 75.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 CA-C-N 119.413 1.006 . . . . 0.0 110.996 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.0 -34.46 68.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.964 0.802 . . . . 0.0 110.534 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.4 m -63.63 -40.84 97.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.448 0.567 . . . . 0.0 110.093 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.05 -37.66 88.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.581 0.628 . . . . 0.0 110.76 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.69 -3.01 16.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.899 1.28 . . . . 0.0 112.317 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.03 4.45 60.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.495 -1.169 . . . . 0.0 113.928 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -75.1 86.26 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.591 1.695 . . . . 0.0 108.221 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 p -71.27 9.69 0.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.319 1.447 . . . . 0.0 113.904 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -136.34 27.98 3.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 111.717 -170.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.33 137.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -136.75 144.09 43.62 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -85.16 110.77 19.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.22 -31.99 73.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.744 0.418 . . . . 0.0 111.73 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.79 -154.39 25.52 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.16 162.25 12.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.8 tp -43.48 -48.56 7.3 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.793 1.637 . . . . 0.0 114.503 -169.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.83 -18.49 60.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.58 -22.46 21.24 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.884 0.874 . . . . 0.0 111.958 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 mm -63.32 132.89 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.81 58.77 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.5 mmm -66.36 156.22 85.96 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.198 0.999 . . . . 0.0 111.612 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.24 161.67 16.02 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.497 2.798 . . . . 0.0 112.088 168.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -130.0 160.37 33.86 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.951 0.9 . . . . 0.0 110.446 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.6 m -141.19 178.59 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 127.504 2.321 . . . . 0.0 107.772 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -132.26 173.1 11.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.121 1.368 . . . . 0.0 108.625 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 174.541 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.27 157.55 44.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.768 0.827 . . . . 0.0 109.582 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -139.98 122.03 15.7 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 169.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -78.92 118.94 21.41 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -127.45 104.23 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.89 124.69 24.4 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.17 6.48 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.009 0.924 . . . . 0.0 111.076 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -63.76 160.32 17.46 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.005 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 148.01 51.94 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.47 -32.94 70.52 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.922 1.748 . . . . 0.0 113.161 -167.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -70.06 -27.72 64.87 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.568 -0.707 . . . . 0.0 111.844 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -84.23 -34.87 23.79 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -55.28 -46.24 76.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.196 0.598 . . . . 0.0 110.616 178.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.05 -22.6 66.97 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -65.23 -45.02 86.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.765 0.712 . . . . 0.0 110.706 -172.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -172.63 138.2 0.85 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.887 1.675 . . . . 0.0 106.988 171.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -147.18 160.54 42.33 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.294 1.038 . . . . 0.0 110.752 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.41 127.69 22.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -61.54 145.61 51.43 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.884 0.374 . . . . 0.0 110.929 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.1 -7.37 52.44 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.214 0.911 . . . . 0.0 114.094 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.62 7.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.012 1.406 . . . . 0.0 111.332 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.76 166.52 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.051 1.741 . . . . 0.0 106.409 168.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.8 t-20 -123.74 128.83 50.15 Favored 'General case' 0 CA--C 1.511 -0.548 0 O-C-N 121.452 -0.78 . . . . 0.0 109.187 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 29' ' ' VAL . 9.7 mt -139.12 84.43 16.84 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.1 153.77 11.86 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.397 2.731 . . . . 0.0 112.815 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -51.59 -35.98 43.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.768 0.827 . . . . 0.0 112.613 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.56 -22.61 66.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.428 0.691 . . . . 0.0 112.46 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -114.66 -27.68 7.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.112 1.365 . . . . 0.0 111.772 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 p -56.7 -38.92 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 124.4 1.08 . . . . 0.0 112.898 -168.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -63.11 -19.46 64.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.238 0.926 . . . . 0.0 112.446 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -103.86 -5.4 22.39 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.642 1.177 . . . . 0.0 111.918 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -134.95 -21.25 1.67 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -167.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -60.43 -38.67 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 120.012 1.278 . . . . 0.0 111.524 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.6 75.14 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.969 0.804 . . . . 0.0 111.868 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 m -71.67 -45.12 62.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.635 0.774 . . . . 0.0 109.633 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.55 -30.71 66.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.17 0.588 . . . . 0.0 112.402 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.0 t -136.06 86.26 26.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.17 -1.78 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.205 2.604 . . . . 0.0 113.661 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -138.28 114.88 10.54 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.615 1.166 . . . . 0.0 108.692 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.62 -15.51 51.99 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.115 0.966 . . . . 0.0 112.871 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -66.22 -22.77 66.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.02 142.64 53.6 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.04 0.536 . . . . 0.0 111.182 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -78.2 97.87 5.66 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.55 88.19 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -82.21 89.78 6.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.3 m -83.14 139.97 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.857 0.463 . . . . 0.0 109.832 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -149.61 168.15 24.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.211 1.005 . . . . 0.0 108.514 169.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.39 -154.29 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -47.71 84.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.9 0.773 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.74 -23.22 0.72 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -25.83 1.46 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.739 1.154 . . . . 0.0 114.81 172.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -64.56 -45.49 86.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.639 1.72 . . . . 0.0 112.927 -171.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.5 -31.29 72.44 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.75 1.159 . . . . 0.0 109.438 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -65.01 -49.53 69.86 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.899 0.88 . . . . 0.0 111.02 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.77 -42.09 95.36 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.07 -42.7 95.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.475 0.71 . . . . 0.0 110.664 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.53 92.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.017 0.527 . . . . 0.0 110.368 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.5 -37.83 73.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.985 0.811 . . . . 0.0 111.144 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -62.13 -53.09 60.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.957 0.799 . . . . 0.0 110.72 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt -69.4 -30.38 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.295 0.952 . . . . 0.0 111.566 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.21 -37.01 82.91 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 119.471 1.032 . . . . 0.0 110.143 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.4 m -66.29 -38.4 87.69 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.019 0.372 . . . . 0.0 110.199 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.19 -38.76 92.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.633 0.651 . . . . 0.0 110.538 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -75.09 6.24 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.287 1.435 . . . . 0.0 112.274 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.42 13.5 83.33 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.324 -1.265 . . . . 0.0 114.418 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -69.43 147.62 50.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.756 1.778 . . . . 0.0 108.433 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 p -132.67 8.58 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.591 1.157 . . . . 0.0 111.336 -171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -134.02 30.47 3.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.524 1.53 . . . . 0.0 110.026 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -77.08 140.21 17.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -138.66 129.73 26.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -83.22 108.79 16.7 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -31.4 72.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.259 0.223 . . . . 0.0 111.315 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.95 -139.34 8.12 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.98 163.68 24.51 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -48.69 -48.07 40.4 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.363 1.465 . . . . 0.0 112.396 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -68.73 -38.05 79.9 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.709 0.404 . . . . 0.0 111.49 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -78.19 -36.71 47.04 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.643 0.777 . . . . 0.0 111.992 -173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.31 132.55 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.462 1.105 . . . . 0.0 108.977 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.49 -13.84 56.01 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.2 mmm -61.98 154.21 69.62 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.757 0.823 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.22 162.3 42.34 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.134 2.556 . . . . 0.0 112.003 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -133.4 159.96 38.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.2 1.0 . . . . 0.0 110.811 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.53 161.95 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.632 1.573 . . . . 0.0 108.75 171.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.35 156.44 29.17 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 170.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.093 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.33 149.37 28.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.141 1.376 . . . . 0.0 107.456 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -138.31 152.18 48.27 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.267 1.427 . . . . 0.0 107.744 170.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.47 120.53 37.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -125.46 110.25 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -68.21 133.47 48.9 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 166.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.36 6.15 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.679 0.672 . . . . 0.0 110.332 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -57.41 157.41 6.67 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.31 -0.869 . . . . 0.0 111.066 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -53.94 148.26 21.5 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 167.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.33 -26.94 63.47 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.171 1.914 . . . . 0.0 113.368 -166.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.32 -28.85 61.35 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.396 -0.815 . . . . 0.0 112.023 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -82.54 -33.93 28.02 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.128 0.876 . . . . 0.0 109.18 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -50.13 -50.6 48.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.774 0.83 . . . . 0.0 111.492 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -66.19 -19.83 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -63.74 -45.04 91.65 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.083 0.856 . . . . 0.0 110.324 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.79 147.82 0.82 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.002 2.521 . . . . 0.0 105.381 169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.11 158.16 43.91 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.608 1.094 . . . . 0.0 109.28 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.71 134.69 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -58.09 143.08 44.94 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.198 0.999 . . . . 0.0 110.137 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.15 45.32 20.26 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.266 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.23 176.1 9.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.097 1.359 . . . . 0.0 110.072 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.3 tt -121.31 171.13 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.09 1.756 . . . . 0.0 106.406 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -124.97 131.9 53.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 mt -139.0 100.64 7.91 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 170.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.34 159.07 6.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.778 2.985 . . . . 0.0 114.078 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 tp -55.63 -35.85 66.34 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.359 -0.838 . . . . 0.0 112.092 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.11 -2.92 29.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.692 0.797 . . . . 0.0 112.821 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -132.72 -17.68 2.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.0 1.32 . . . . 0.0 112.311 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.82 -37.13 77.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.027 0.931 . . . . 0.0 111.967 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.03 -31.45 68.85 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.868 0.758 . . . . 0.0 111.354 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -77.88 -14.14 59.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.581 0.752 . . . . 0.0 112.472 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -130.58 -22.06 2.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -166.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.3 tp -55.31 -36.24 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.606 1.094 . . . . 0.0 111.066 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.1 -25.01 28.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.061 1.344 . . . . 0.0 114.143 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -122.83 -29.99 3.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.641 1.176 . . . . 0.0 110.906 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.86 -31.43 72.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.782 0.833 . . . . 0.0 111.046 171.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -134.6 91.29 21.74 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -6.3 18.77 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.089 2.526 . . . . 0.0 115.727 -166.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -146.71 139.1 24.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 120.102 1.319 . . . . 0.0 109.318 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.16 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -76.15 -23.76 54.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.061 0.846 . . . . 0.0 111.673 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -69.66 144.08 53.0 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.112 -0.367 . . . . 0.0 110.736 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.59 144.72 37.3 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.981 0.512 . . . . 0.0 109.733 -169.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.73 141.23 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -123.95 137.35 54.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.67 142.61 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -154.59 155.01 33.96 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.966 1.306 . . . . 0.0 108.135 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 53' ' ' GLN . 66.6 m -155.95 -174.03 4.78 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.25 1.82 . . . . 0.0 109.462 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.45 128.84 37.91 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.69 18.2 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.718 1.607 . . . . 0.0 114.28 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.4 11.91 11.25 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.144 -1.364 . . . . 0.0 115.061 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -67.64 -57.95 5.52 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 120.858 2.329 . . . . 0.0 113.379 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.421 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mp0 -61.26 -30.33 70.4 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.19 0.904 . . . . 0.0 109.716 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -74.71 -42.95 57.41 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.366 1.066 . . . . 0.0 112.196 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.49 -40.58 86.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -58.11 -42.24 85.29 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.356 1.063 . . . . 0.0 110.214 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.84 -39.62 79.86 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.732 0.696 . . . . 0.0 111.883 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.32 -38.84 66.43 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.27 1.395 . . . . 0.0 110.213 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.92 -58.59 7.81 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.668 0.667 . . . . 0.0 110.784 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.41 -37.1 79.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 119.611 1.096 . . . . 0.0 110.604 -174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.03 -37.68 75.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.234 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.8 m -62.55 -40.14 95.85 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.712 0.687 . . . . 0.0 110.356 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.19 -37.59 81.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.528 0.604 . . . . 0.0 111.182 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.4 mtp -64.46 -31.49 72.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.467 0.707 . . . . 0.0 110.945 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.26 -9.45 3.25 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.567 1.08 . . . . 0.0 113.565 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -77.21 72.75 3.78 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.095 1.447 . . . . 0.0 109.951 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 p -70.67 18.02 0.06 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.348 1.459 . . . . 0.0 112.895 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -132.2 24.76 4.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.316 1.846 . . . . 0.0 110.911 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -92.21 141.37 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.38 133.51 40.66 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.27 109.88 10.32 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.37 -30.66 70.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.019 0.528 . . . . 0.0 111.611 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.4 -154.03 25.23 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -117.31 164.9 12.46 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.1 tp -46.18 -49.8 16.5 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.215 1.406 . . . . 0.0 113.639 -169.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.24 -20.13 22.26 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 119.23 -0.414 . . . . 0.0 112.014 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.21 -37.62 69.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.448 0.567 . . . . 0.0 110.421 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.9 mt -66.54 124.73 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -9.79 59.41 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.8 mtp -61.14 154.59 60.72 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.0 0.92 . . . . 0.0 110.608 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.4 164.23 34.97 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.961 2.44 . . . . 0.0 111.712 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -126.49 157.66 38.13 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.101 0.961 . . . . 0.0 110.044 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.05 158.58 36.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.03 1.732 . . . . 0.0 107.569 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -110.79 161.4 15.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.898 0.879 . . . . 0.0 110.382 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 175.278 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.12 172.45 15.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.08 -1.013 . . . . 0.0 109.54 170.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -136.29 132.02 35.17 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -94.77 115.34 27.39 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.49 107.24 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -65.97 142.54 57.82 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 167.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.1 11.6 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.809 0.731 . . . . 0.0 112.081 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -66.38 162.76 19.69 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.215 -0.928 . . . . 0.0 109.661 172.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.94 148.94 68.15 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.96 -32.94 64.87 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 121.896 1.73 . . . . 0.0 114.074 -165.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.04 -30.18 67.4 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.497 -0.752 . . . . 0.0 111.408 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.04 -33.97 29.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -48.71 70.33 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.384 0.674 . . . . 0.0 111.251 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -61.99 -21.03 64.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.091 0.556 . . . . 0.0 112.35 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -68.98 -24.09 64.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.514 -1.231 . . . . 0.0 112.573 -171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 167.06 135.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.415 2.686 . . . . 0.0 106.848 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.31 162.8 38.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.847 1.203 . . . . 0.0 110.307 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.22 137.6 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -60.37 142.82 54.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.811 0.844 . . . . 0.0 109.91 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.78 44.09 39.85 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.185 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.83 179.34 6.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.111 1.364 . . . . 0.0 110.22 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.7 tt -130.37 177.15 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.462 1.905 . . . . 0.0 106.48 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.37 137.33 50.89 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.349 -0.844 . . . . 0.0 108.781 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -140.79 97.38 7.23 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.19 157.2 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.527 2.818 . . . . 0.0 113.152 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -52.98 -35.88 59.67 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.618 -0.676 . . . . 0.0 112.248 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.28 -13.7 62.54 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -116.68 -36.02 4.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.189 1.395 . . . . 0.0 110.197 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 p -58.13 -33.06 45.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 C-N-CA 124.399 1.079 . . . . 0.0 111.705 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -61.36 -22.72 65.2 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.82 -30.94 7.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 110.534 174.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -84.6 -26.13 28.13 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.683 -0.636 . . . . 0.0 112.208 -169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 tp -61.18 -33.65 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.568 1.076 . . . . 0.0 110.857 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.48 -9.01 10.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 -37.09 4.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.572 1.149 . . . . 0.0 109.905 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.96 -37.9 72.8 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.741 0.701 . . . . 0.0 112.143 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.96 73.47 33.05 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.34 -27.35 34.33 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.247 1.965 . . . . 0.0 111.976 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -76.75 102.13 6.11 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -70.38 -4.79 24.07 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -111.51 39.54 2.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.592 1.157 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.35 149.93 50.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.921 1.289 . . . . 0.0 108.159 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.01 153.67 43.39 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.237 0.615 . . . . 0.0 111.207 -168.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.17 137.54 51.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -110.87 126.76 55.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 m -121.3 141.89 39.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.63 169.01 24.31 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.55 1.14 . . . . 0.0 108.036 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -154.11 -155.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.43 -47.15 76.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.222 0.609 . . . . 0.0 111.213 177.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.86 -37.08 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.04 -23.13 0.6 Allowed Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.659 1.118 . . . . 0.0 115.615 172.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -58.58 -52.06 67.26 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.252 2.026 . . . . 0.0 112.48 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -58.99 -32.33 69.6 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.358 0.526 . . . . 0.0 110.113 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -72.92 -44.9 60.68 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 124.505 1.122 . . . . 0.0 112.59 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -45.39 93.43 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -57.23 -43.63 83.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.348 1.059 . . . . 0.0 110.96 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.94 85.99 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.804 -0.56 . . . . 0.0 110.89 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -59.39 -38.15 79.78 Favored 'General case' 0 C--O 1.231 0.101 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.91 -52.63 64.22 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.105 0.866 . . . . 0.0 110.67 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.4 pt -68.04 -33.32 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.363 0.983 . . . . 0.0 111.335 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.51 -40.02 92.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 119.51 1.05 . . . . 0.0 110.289 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -64.4 -41.4 96.67 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.747 0.419 . . . . 0.0 109.903 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.02 -39.84 93.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.379 0.671 . . . . 0.0 111.012 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.3 mtp -68.26 -14.66 63.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.596 1.158 . . . . 0.0 111.947 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.74 19.81 28.32 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.219 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -64.22 120.05 11.41 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.1 p -68.66 -28.03 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -167.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.18 126.04 8.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.44 1.096 . . . . 0.0 109.665 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -144.56 149.82 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -139.64 135.08 32.89 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -79.39 110.68 14.9 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.57 -29.45 70.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.814 0.446 . . . . 0.0 111.932 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.7 -141.44 9.74 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.23 168.41 24.62 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 tp -54.31 -36.07 63.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.866 1.266 . . . . 0.0 112.267 -173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.32 -9.04 58.21 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.049 0.94 . . . . 0.0 113.083 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.37 -31.11 2.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.459 1.027 . . . . 0.0 113.253 -168.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.43 129.94 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.93 -13.55 55.83 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.24 158.6 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.08 0.952 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.36 164.83 29.1 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.977 2.451 . . . . 0.0 111.51 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -132.83 158.16 43.19 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.054 0.942 . . . . 0.0 110.267 -176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.74 157.78 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.346 1.859 . . . . 0.0 108.216 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -66.08 161.64 21.29 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.381 -0.825 . . . . 0.0 110.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 170.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.56 151.83 31.14 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.396 1.478 . . . . 0.0 107.305 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -139.84 149.62 43.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.672 1.589 . . . . 0.0 107.179 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -119.04 112.95 20.2 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.6 mt -123.14 107.44 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -65.42 142.55 58.15 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 168.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -129.86 7.05 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.093 0.957 . . . . 0.0 111.766 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -63.88 165.81 8.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.661 1.119 . . . . 0.0 110.472 171.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.36 147.82 66.47 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.36 -38.15 76.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.043 1.829 . . . . 0.0 113.125 -167.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.89 -26.48 66.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.185 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.04 -34.92 32.46 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -45.61 85.66 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.994 0.518 . . . . 0.0 110.861 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -61.31 -22.34 64.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -67.26 -35.46 79.58 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 111.63 -171.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 176.78 141.87 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.144 2.578 . . . . 0.0 106.8 169.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -148.61 155.27 40.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.492 1.117 . . . . 0.0 109.723 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -59.11 134.09 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.059 0.943 . . . . 0.0 109.27 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.72 141.32 49.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.368 0.667 . . . . 0.0 110.177 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.87 55.42 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.674 1.13 . . . . 0.0 114.236 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.59 177.44 6.76 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.97 1.385 . . . . 0.0 111.509 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.02 175.7 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.647 1.979 . . . . 0.0 105.752 168.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -138.64 133.11 31.97 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.851 -1.156 . . . . 0.0 109.994 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -140.53 101.78 6.64 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.35 150.88 31.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.375 2.05 . . . . 0.0 111.821 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.7 tp -46.69 -45.75 19.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.429 1.091 . . . . 0.0 112.968 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -67.73 -10.14 49.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -119.17 -13.69 9.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.707 2.003 . . . . 0.0 111.129 -170.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -49.31 -56.65 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.828 1.651 . . . . 0.0 111.326 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.65 -31.02 65.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.38 -25.11 60.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 112.188 -177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -120.23 -30.31 4.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.883 0.765 . . . . 0.0 112.394 -168.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.95 -34.37 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.609 1.095 . . . . 0.0 111.52 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -8.75 6.73 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.5 m -120.92 -34.37 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.797 1.239 . . . . 0.0 110.036 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -35.57 80.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.878 0.763 . . . . 0.0 111.496 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.63 79.24 41.25 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.6 18.54 0.7 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.956 3.104 . . . . 0.0 113.581 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -142.99 113.17 7.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.052 1.341 . . . . 0.0 108.173 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -20.02 57.08 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.86 -20.33 49.83 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.761 0.709 . . . . 0.0 111.7 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -75.3 148.37 39.42 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.744 0.702 . . . . 0.0 111.24 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.78 145.04 45.34 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.73 0.812 . . . . 0.0 109.858 -175.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.34 141.44 37.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -120.9 135.93 55.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -129.05 144.39 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -150.77 166.13 31.41 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.893 1.277 . . . . 0.0 107.829 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.7 p -169.52 -174.58 1.95 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.329 1.052 . . . . 0.0 109.242 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -65.36 125.3 24.66 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.68 17.7 0.87 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.491 2.317 . . . . 0.0 115.676 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.07 -8.31 8.56 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 118.563 -1.132 . . . . 0.0 115.176 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.3 mtm-85 -56.66 -53.36 58.54 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.108 1.954 . . . . 0.0 111.191 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.13 -28.5 68.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.38 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 m -75.42 -46.37 33.17 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.95 0.9 . . . . 0.0 110.792 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.8 -43.32 86.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 172.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -66.85 -41.9 86.62 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 122.637 0.375 . . . . 0.0 111.456 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.65 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.47 0.708 . . . . 0.0 111.134 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -57.14 -37.34 71.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.654 1.115 . . . . 0.0 110.869 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.14 -54.58 23.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.373 0.988 . . . . 0.0 109.939 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 pt -65.31 -35.18 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.418 0.554 . . . . 0.0 110.492 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.76 -35.46 72.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.656 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 m -64.28 -38.6 91.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.812 0.733 . . . . 0.0 110.599 173.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.69 -37.77 82.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.403 0.547 . . . . 0.0 110.885 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -65.94 -33.8 76.65 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.545 0.611 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.17 -2.53 5.48 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.164 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.45 142.2 57.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.445 1.622 . . . . 0.0 109.124 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -130.88 10.47 5.05 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.751 0.82 . . . . 0.0 111.987 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -136.49 32.71 2.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.938 1.295 . . . . 0.0 110.12 -172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -88.98 141.96 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.1 141.69 44.23 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.393 1.077 . . . . 0.0 108.139 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.25 112.33 20.19 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.67 -30.24 70.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.479 0.311 . . . . 0.0 111.698 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.46 -147.37 17.86 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.5 168.29 19.6 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 173.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -43.85 -50.33 7.96 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.549 1.539 . . . . 0.0 114.617 -168.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -91.49 -23.89 19.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 119.295 -0.384 . . . . 0.0 111.679 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.37 -38.02 74.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.017 0.527 . . . . 0.0 110.391 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.05 113.59 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.03 58.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.6 mtp -60.67 151.31 72.19 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.668 0.787 . . . . 0.0 110.547 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.22 160.02 49.49 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.082 2.522 . . . . 0.0 111.141 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.45 156.63 45.76 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.963 0.905 . . . . 0.0 110.737 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.6 159.43 24.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.69 1.996 . . . . 0.0 108.307 -176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -129.06 170.85 12.99 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.336 1.054 . . . . 0.0 111.272 -169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.528 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -147.51 149.33 32.42 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.77 1.228 . . . . 0.0 108.665 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -134.35 157.14 47.14 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.31 1.444 . . . . 0.0 108.34 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -118.98 119.96 35.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.8 mt -131.32 109.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.76 144.44 56.32 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.8 11.59 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.028 0.831 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -68.6 163.8 22.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.254 -0.903 . . . . 0.0 109.844 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -56.57 147.65 49.41 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.28 -39.44 57.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.818 1.678 . . . . 0.0 113.484 -166.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.51 -25.95 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.528 -0.732 . . . . 0.0 112.011 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -81.74 -34.66 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -45.28 89.23 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.825 0.739 . . . . 0.0 110.605 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -52.06 -28.96 19.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.666 0.786 . . . . 0.0 112.754 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.8 -23.44 65.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 117.252 -1.356 . . . . 0.0 112.73 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 156.26 147.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 129.968 3.307 . . . . 0.0 110.373 168.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -151.73 169.44 22.18 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 109.168 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.13 137.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 110.06 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.34 125.94 22.92 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.176 0.991 . . . . 0.0 109.802 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.28 -1.2 89.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.858 -0.968 . . . . 0.0 114.215 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.57 -173.73 3.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.106 1.453 . . . . 0.0 111.025 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.87 178.52 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.791 2.036 . . . . 0.0 106.232 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -133.97 136.46 44.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.109 -0.994 . . . . 0.0 109.367 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.4 95.99 11.24 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.336 -2.838 . . . . 0.0 103.336 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.4 152.34 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.328 2.685 . . . . 0.0 111.946 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 tp -48.11 -40.3 23.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.763 0.825 . . . . 0.0 112.824 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -62.46 -34.85 77.63 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.199 0.6 . . . . 0.0 111.944 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -88.14 -25.67 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.615 1.566 . . . . 0.0 111.166 -174.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.0 t -46.62 -47.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.428 1.091 . . . . 0.0 110.336 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -56.62 -20.61 22.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.16 -1.96 5.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.137 0.975 . . . . 0.0 112.305 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -135.63 -20.39 1.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.036 0.835 . . . . 0.0 113.246 -168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG21 HD21 ' A' ' 61' ' ' LEU . 10.5 tp -61.75 -34.88 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.843 1.202 . . . . 0.0 112.14 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.96 68.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.376 0.534 . . . . 0.0 112.321 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 m -66.73 -35.23 79.62 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 0.0 110.462 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.56 -20.98 21.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.751 0.82 . . . . 0.0 112.227 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.1 74.61 79.13 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.34 -7.97 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.327 2.684 . . . . 0.0 113.505 -172.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -138.56 122.76 18.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -59.28 -18.75 40.24 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.24 -18.83 57.34 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.233 0.924 . . . . 0.0 112.019 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.84 145.51 54.57 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.441 -0.787 . . . . 0.0 110.59 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -80.48 139.0 36.62 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.93 93.14 2.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.29 124.78 26.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.83 143.73 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -153.91 161.26 42.14 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.94 0.896 . . . . 0.0 108.692 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 p -164.1 179.71 6.75 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.243 1.017 . . . . 0.0 108.396 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -64.49 135.61 56.22 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 54.56 15.76 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.562 1.945 . . . . 0.0 116.026 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.2 -22.53 0.61 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.857 1.217 . . . . 0.0 116.029 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -53.79 -52.62 59.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.129 1.964 . . . . 0.0 113.139 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.98 -26.25 68.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.357 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.2 m -76.4 -44.93 33.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.426 1.012 . . . . 0.0 111.692 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.53 -44.55 96.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.69 -35.5 80.76 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.376 1.07 . . . . 0.0 111.397 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.82 -42.43 70.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.375 0.989 . . . . 0.0 110.571 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -59.98 -40.64 89.82 Favored 'General case' 0 C--O 1.231 0.083 0 O-C-N 121.19 -0.944 . . . . 0.0 110.704 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.0 -44.01 77.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.694 1.134 . . . . 0.0 111.816 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.2 pt -67.27 -36.18 75.99 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 120.725 1.602 . . . . 0.0 110.15 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD21 HG21 ' A' ' 33' ' ' ILE . 77.4 mt -67.86 -36.66 80.67 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.779 0.718 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.6 m -63.13 -38.65 92.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.649 0.379 . . . . 0.0 110.416 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -69.02 -41.06 78.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.995 0.518 . . . . 0.0 110.554 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.7 mtp -64.93 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.394 1.078 . . . . 0.0 111.116 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.36 1.2 6.18 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.355 0.979 . . . . 0.0 114.302 169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -71.58 145.75 48.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.24 1.52 . . . . 0.0 108.817 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -132.31 7.77 4.26 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -137.11 30.71 2.71 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.521 1.128 . . . . 0.0 110.457 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.0 t -87.9 136.31 23.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -144.9 131.86 20.28 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.38 112.27 10.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.85 -30.76 70.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.298 0.639 . . . . 0.0 111.649 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.62 -136.2 6.55 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.46 170.2 25.64 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.92 -41.1 64.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.836 1.254 . . . . 0.0 113.34 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -80.14 -9.04 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.71 -32.83 5.03 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.769 0.828 . . . . 0.0 111.817 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.7 mt -65.6 125.04 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.97 -10.86 59.66 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mtp -63.83 155.6 76.57 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.749 0.82 . . . . 0.0 111.061 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.08 162.0 9.97 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.697 2.931 . . . . 0.0 112.961 170.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.58 160.07 36.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.02 0.928 . . . . 0.0 110.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.61 152.93 21.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 126.422 1.889 . . . . 0.0 107.989 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -64.33 154.45 35.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 176.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -143.06 154.6 44.13 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.062 1.745 . . . . 0.0 107.191 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -141.74 124.57 16.08 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -86.07 117.11 24.7 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.24 107.56 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -66.45 134.81 53.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 168.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -119.01 10.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.888 0.767 . . . . 0.0 111.189 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -61.62 161.32 10.0 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.796 0.725 . . . . 0.0 109.147 167.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.47 150.7 43.18 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.38 -31.21 43.53 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.267 1.312 . . . . 0.0 112.396 -168.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.73 -10.78 60.19 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 112.218 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.66 -32.95 10.49 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.636 1.107 . . . . 0.0 110.282 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -57.49 -40.4 78.54 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.721 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.24 -34.03 76.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.751 0.42 . . . . 0.0 111.264 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -72.23 -41.86 66.37 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.462 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -164.92 141.8 5.96 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.447 1.021 . . . . 0.0 109.507 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -155.31 164.74 38.35 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.06 . . . . 0.0 109.21 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.47 137.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -59.08 117.19 4.43 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 -170.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.81 90.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.585 -1.119 . . . . 0.0 114.314 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.2 141.86 57.91 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.703 1.752 . . . . 0.0 109.73 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -75.82 169.26 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.6 t-20 -131.8 128.65 39.2 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 120.955 -1.09 . . . . 0.0 109.845 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -135.71 90.45 19.59 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.2 152.84 7.57 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.452 2.768 . . . . 0.0 111.845 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -46.87 -44.17 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.86 -30.34 71.44 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.309 0.504 . . . . 0.0 112.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.67 -21.56 23.86 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.082 -174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.1 t -49.1 -48.41 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.619 1.167 . . . . 0.0 110.129 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.39 -16.14 21.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.39 -3.17 8.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.226 0.921 . . . . 0.0 112.249 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -142.55 -13.75 0.77 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.96 -35.11 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.167 1.348 . . . . 0.0 111.984 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.65 67.53 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.397 0.544 . . . . 0.0 112.419 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 m -68.9 -38.98 79.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.952 0.796 . . . . 0.0 110.127 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.33 -23.26 35.19 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.222 0.609 . . . . 0.0 112.168 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 t -129.9 75.92 78.92 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.31 -14.73 37.99 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.195 2.597 . . . . 0.0 113.663 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -145.56 138.4 26.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -57.53 -23.94 53.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -67.42 -26.22 66.31 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.281 0.946 . . . . 0.0 112.067 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -68.56 143.95 54.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.335 0.516 . . . . 0.0 110.752 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.07 145.71 35.67 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -172.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.53 136.63 48.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -123.5 121.04 34.66 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 m -114.77 141.85 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -152.04 170.84 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.98 -165.6 2.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -52.64 -52.29 56.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.809 0.844 . . . . 0.0 111.719 -177.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.7 31.48 2.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.135 1.374 . . . . 0.0 111.352 -169.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.33 -24.1 2.18 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.666 -1.075 . . . . 0.0 115.321 170.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.9 mmt-85 -66.39 -44.59 82.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.285 2.043 . . . . 0.0 113.624 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -64.16 -33.98 77.02 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.825 1.193 . . . . 0.0 109.283 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -35.69 37.61 Favored 'General case' 0 N--CA 1.46 0.07 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.5 -46.64 91.96 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 170.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -56.89 -44.01 81.9 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.712 0.805 . . . . 0.0 111.323 174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.07 87.84 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.707 -0.62 . . . . 0.0 110.83 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.11 -40.31 84.96 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.281 -0.887 . . . . 0.0 109.914 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.79 -53.1 59.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.098 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -65.22 -34.72 72.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 CA-C-N 120.226 1.375 . . . . 0.0 110.781 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.43 -36.22 76.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.066 0.848 . . . . 0.0 110.77 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 m -63.01 -39.16 93.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.191 0.451 . . . . 0.0 110.366 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -68.2 -42.47 79.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.352 0.661 . . . . 0.0 110.346 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.74 -30.12 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.084 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.52 6.04 6.87 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.726 -1.041 . . . . 0.0 114.181 169.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -70.69 148.12 48.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.507 1.653 . . . . 0.0 109.163 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 p -133.78 10.03 3.94 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.846 0.858 . . . . 0.0 112.068 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -133.75 33.08 3.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.073 1.349 . . . . 0.0 110.213 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.42 138.7 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -139.02 146.25 40.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.12 112.27 19.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.34 68.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.6 -150.41 22.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.47 156.09 15.83 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 168.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.5 tp -53.41 -39.37 64.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.179 . . . . 0.0 113.439 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.51 -31.82 63.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.954 0.343 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.36 -35.49 27.74 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.469 0.708 . . . . 0.0 111.345 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.73 128.9 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.899 1.279 . . . . 0.0 108.77 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.11 -7.54 59.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.998 0.919 . . . . 0.0 113.274 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.8 mmm -60.28 154.55 52.09 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.524 0.73 . . . . 0.0 110.5 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.53 167.31 21.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.757 2.304 . . . . 0.0 110.989 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -128.73 173.63 10.16 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.449 1.1 . . . . 0.0 110.104 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.66 164.22 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.442 1.497 . . . . 0.0 107.05 167.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -146.13 156.5 43.48 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.943 1.697 . . . . 0.0 108.168 -169.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 176.134 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -147.27 165.47 30.0 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -135.79 126.68 27.59 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -90.18 121.54 32.31 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.66 111.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -71.19 125.31 26.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 166.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.01 12.71 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 123.082 0.553 . . . . 0.0 110.828 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -54.66 156.84 3.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.873 0.76 . . . . 0.0 111.444 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.19 143.74 24.15 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 166.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -60.17 -33.76 94.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.622 1.548 . . . . 0.0 113.849 -166.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.74 -36.99 81.56 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.566 -0.709 . . . . 0.0 111.16 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -77.22 -32.93 56.21 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -51.59 -50.5 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.598 0.759 . . . . 0.0 110.633 170.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -63.61 -24.9 67.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.48 -38.81 92.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.538 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -179.96 135.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.39 2.276 . . . . 0.0 106.307 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -145.5 162.92 36.26 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.535 1.134 . . . . 0.0 110.589 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.72 127.34 27.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -60.74 151.85 28.4 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 111.841 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.72 -12.85 45.69 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.585 1.088 . . . . 0.0 114.006 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.99 172.15 11.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.717 1.259 . . . . 0.0 111.578 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.6 tt -113.39 166.83 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.337 1.855 . . . . 0.0 106.017 168.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -122.74 126.34 47.3 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 119.238 0.927 . . . . 0.0 109.638 172.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 29' ' ' VAL . 11.7 mt -136.23 87.52 22.87 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 143.14 41.55 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.184 2.589 . . . . 0.0 112.812 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.06 -21.33 30.71 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.379 1.072 . . . . 0.0 111.586 172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.36 -32.38 70.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.023 1.329 . . . . 0.0 113.334 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -134.95 -2.77 2.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.43 1.092 . . . . 0.0 113.508 -169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.4 p -52.66 -38.2 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 113.957 -169.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.92 -27.15 63.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.249 0.932 . . . . 0.0 112.293 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.18 -7.97 49.92 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.575 0.75 . . . . 0.0 112.153 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -139.18 -15.75 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.0 -40.18 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.698 1.136 . . . . 0.0 111.135 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -33.38 74.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.375 0.534 . . . . 0.0 111.53 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 m -68.75 -43.72 75.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.7 . . . . 0.0 109.862 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -38.22 57.74 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.881 0.472 . . . . 0.0 112.229 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 t -138.29 79.05 32.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.83 -30.31 17.52 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.932 1.755 . . . . 0.0 111.825 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -84.3 101.99 12.35 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.259 0.624 . . . . 0.0 109.757 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.71 -16.33 56.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -77.21 -20.16 55.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.037 0.835 . . . . 0.0 111.775 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.92 147.42 36.98 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 m -70.88 147.64 48.6 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.321 0.648 . . . . 0.0 110.599 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.84 141.56 38.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -126.9 121.19 31.07 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.7 m -114.23 140.1 36.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -147.01 165.12 30.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.342 1.057 . . . . 0.0 108.265 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 p -148.75 -147.31 0.22 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.03 -48.93 76.61 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.985 0.812 . . . . 0.0 110.361 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.25 -22.37 0.44 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.01 -29.91 0.48 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 120.434 1.47 . . . . 0.0 116.233 171.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.99 -57.69 11.68 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.3 2.05 . . . . 0.0 112.481 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.93 -33.52 72.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.632 0.651 . . . . 0.0 109.629 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -52.53 58.54 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.554 0.742 . . . . 0.0 111.654 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.0 91.0 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -54.93 -47.52 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.155 0.982 . . . . 0.0 110.331 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -48.28 76.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 111.08 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.21 -42.93 82.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 118.809 0.731 . . . . 0.0 109.926 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.27 -53.34 56.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.987 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -67.25 -34.88 71.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.779 1.172 . . . . 0.0 111.333 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.42 -35.58 75.85 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.898 1.226 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m -62.05 -43.06 99.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.059 0.39 . . . . 0.0 109.958 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -65.21 -38.15 89.53 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.421 0.689 . . . . 0.0 111.26 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.0 mtp -69.84 -7.06 36.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.987 1.315 . . . . 0.0 112.309 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.17 4.52 47.47 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.737 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.26 143.23 52.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.432 1.616 . . . . 0.0 106.92 168.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 p -122.47 7.38 9.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.907 0.483 . . . . 0.0 112.171 -171.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -140.8 36.6 1.79 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.658 1.183 . . . . 0.0 110.148 -170.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -105.35 130.89 55.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.38 148.0 40.62 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -78.76 115.91 18.76 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.29 70.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.807 0.443 . . . . 0.0 111.798 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.24 5.97 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.31 168.83 30.9 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -36.49 62.47 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.721 1.608 . . . . 0.0 110.329 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -54.92 -23.07 17.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.255 1.422 . . . . 0.0 113.599 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -131.12 -32.35 1.6 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.66 125.99 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 119.216 0.917 . . . . 0.0 108.628 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.97 -4.55 56.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.05 0.94 . . . . 0.0 113.287 -175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.12 154.49 69.51 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.923 0.889 . . . . 0.0 111.062 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.95 153.03 21.56 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.793 2.995 . . . . 0.0 113.631 176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -127.75 156.88 41.74 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.824 0.85 . . . . 0.0 110.904 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.63 164.94 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.598 1.559 . . . . 0.0 108.022 168.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -137.61 168.54 19.47 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.576 1.15 . . . . 0.0 110.157 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.748 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.98 161.49 38.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.371 1.068 . . . . 0.0 109.546 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -144.34 153.45 42.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.984 1.714 . . . . 0.0 107.125 169.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -111.21 108.55 18.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.06 112.07 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -81.97 125.45 30.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.85 -0.36 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.411 HH22 ' HA ' ' A' ' 17' ' ' HIS . 3.1 ptt180 -63.28 167.63 5.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.193 1.36 . . . . 0.0 109.644 167.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.36 152.77 30.61 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.02 -27.93 42.03 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 121.807 1.671 . . . . 0.0 112.175 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.14 -0.65 12.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.613 1.165 . . . . 0.0 112.561 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -112.6 -33.2 6.21 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.856 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -53.53 -46.61 70.21 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.692 1.133 . . . . 0.0 110.407 168.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -61.84 -25.35 67.46 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -70.16 -50.45 40.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.635 0.652 . . . . 0.0 109.92 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -168.55 143.18 3.32 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.411 ' HA ' HH22 ' A' ' 8' ' ' ARG . 7.5 p-80 -145.5 151.43 38.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.627 1.171 . . . . 0.0 110.041 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.18 125.33 8.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -52.76 113.16 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.024 0.93 . . . . 0.0 111.133 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 2.94 80.34 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.56 -1.133 . . . . 0.0 113.975 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.31 141.13 58.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.555 1.678 . . . . 0.0 109.709 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.73 132.15 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.56 108.87 4.54 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.532 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.2 78.69 14.83 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 167.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.37 156.86 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.813 3.676 . . . . 0.0 113.426 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -52.57 -35.68 54.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.705 0.802 . . . . 0.0 112.617 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -70.04 -16.49 63.16 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -116.27 -28.01 6.67 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.224 1.41 . . . . 0.0 111.332 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -53.11 -41.21 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 125.103 1.361 . . . . 0.0 113.277 -167.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -59.65 -29.35 67.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.091 0.86 . . . . 0.0 112.287 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.13 -24.95 40.13 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.222 0.609 . . . . 0.0 111.718 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.84 -17.37 4.48 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -166.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 tp -60.67 -35.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.601 1.546 . . . . 0.0 111.496 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.78 -8.92 12.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -118.96 -35.15 3.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.955 1.302 . . . . 0.0 109.562 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.87 -38.71 83.44 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 111.068 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -140.02 76.43 27.78 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.199 1.399 . . . . 0.0 107.565 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.56 -35.77 94.67 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.433 2.088 . . . . 0.0 112.723 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -78.84 102.25 8.08 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.544 0.737 . . . . 0.0 110.052 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -64.07 -14.09 52.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -79.53 -16.7 55.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.371 0.987 . . . . 0.0 112.034 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.51 148.21 49.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.065 -1.022 . . . . 0.0 111.017 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -78.46 100.55 6.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.095 0.558 . . . . 0.0 109.679 -175.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 t -80.81 89.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -66.57 130.08 42.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -128.85 143.25 41.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.44 166.73 29.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.0 p -158.09 -140.7 0.08 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -123.64 133.96 53.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 60.24 15.69 5.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.03 1.732 . . . . 0.0 114.968 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.7 -31.11 1.25 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.234 1.397 . . . . 0.0 115.672 168.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -53.03 -49.33 66.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.293 1.547 . . . . 0.0 113.934 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -61.52 -33.34 73.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.743 1.156 . . . . 0.0 110.98 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -74.7 -40.21 61.48 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.591 1.087 . . . . 0.0 112.79 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.27 -44.86 96.36 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -59.99 -42.93 95.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.662 1.185 . . . . 0.0 111.369 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.15 90.7 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.757 0.708 . . . . 0.0 110.523 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -60.61 -37.9 82.94 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.96 -1.087 . . . . 0.0 110.844 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -64.65 -49.84 69.45 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.866 0.867 . . . . 0.0 110.61 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.86 -36.24 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.883 1.22 . . . . 0.0 111.009 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.05 -34.79 71.57 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.008 0.822 . . . . 0.0 110.906 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -67.87 -34.76 77.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.732 0.696 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.57 -38.31 89.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.99 0.814 . . . . 0.0 110.475 172.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.4 mtp -69.82 -8.98 52.87 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.383 1.073 . . . . 0.0 112.385 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.03 6.39 51.97 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.192 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.3 144.5 51.71 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.603 1.701 . . . . 0.0 108.298 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 p -126.14 4.68 7.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.126 0.57 . . . . 0.0 112.376 -171.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -139.28 31.53 2.14 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.532 1.133 . . . . 0.0 110.251 -173.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.1 133.69 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.95 122.7 15.29 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.19 110.83 11.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.58 67.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.092 0.557 . . . . 0.0 111.817 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.33 -142.92 10.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.35 162.87 19.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 168.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 tp -42.03 -48.43 4.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.995 1.318 . . . . 0.0 114.081 -168.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.57 -13.5 62.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.95 -12.26 10.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.273 1.029 . . . . 0.0 112.467 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 80' ' ' MET . 6.8 mm -64.61 134.01 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -20.07 61.43 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.415 ' H ' HG22 ' A' ' 78' ' ' ILE . 95.5 mmm -62.64 156.29 64.87 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.842 1.257 . . . . 0.0 110.885 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.45 156.88 64.29 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.336 2.024 . . . . 0.0 110.283 169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 149.12 36.34 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.054 0.942 . . . . 0.0 109.081 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.9 m -147.24 162.83 7.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 108.923 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.5 148.47 15.46 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.359 0.664 . . . . 0.0 110.219 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 175.221 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -154.43 162.47 41.14 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.153 0.981 . . . . 0.0 109.466 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -143.29 145.69 32.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.716 1.606 . . . . 0.0 106.695 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -105.07 122.89 46.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.76 119.55 53.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -75.38 128.02 34.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 166.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.55 12.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 119.461 1.028 . . . . 0.0 111.087 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -62.66 162.71 10.21 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.39 -0.818 . . . . 0.0 110.571 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.6 147.74 49.24 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.309 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.81 -31.69 67.98 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.905 1.736 . . . . 0.0 112.969 -167.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.8 -28.89 66.1 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.599 -0.688 . . . . 0.0 111.828 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -80.9 -38.62 27.67 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -56.54 -41.52 76.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.738 0.415 . . . . 0.0 111.049 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -58.91 -30.03 67.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.113 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -67.14 -50.31 61.72 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.815 0.734 . . . . 0.0 110.269 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.06 156.22 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.898 1.279 . . . . 0.0 108.351 168.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -153.53 160.34 42.47 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.829 1.252 . . . . 0.0 108.807 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -59.88 142.61 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.718 0.807 . . . . 0.0 109.215 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.34 157.84 8.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.904 0.482 . . . . 0.0 111.664 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.36 41.17 91.47 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.676 0.655 . . . . 0.0 112.681 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.41 178.1 7.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.696 1.198 . . . . 0.0 110.996 -174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.7 tt -129.79 169.91 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 127.309 2.244 . . . . 0.0 106.42 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.429 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 8.7 t-20 -126.2 131.15 52.04 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 119.163 0.892 . . . . 0.0 110.107 172.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.4 mt -141.37 89.03 9.61 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.51 153.89 16.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.347 2.698 . . . . 0.0 113.03 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -52.8 -34.69 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.589 0.756 . . . . 0.0 112.747 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.31 -14.39 62.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -122.84 -24.32 4.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.246 1.418 . . . . 0.0 111.345 -169.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.5 p -57.44 -38.69 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 C-N-CA 124.451 1.101 . . . . 0.0 112.429 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -57.33 -27.93 62.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.751 0.705 . . . . 0.0 112.118 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -99.47 -6.18 28.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.105 0.962 . . . . 0.0 112.11 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -137.59 -23.32 1.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -167.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.58 -35.82 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 121.131 1.787 . . . . 0.0 110.903 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.3 -30.67 69.64 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.335 0.516 . . . . 0.0 111.814 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -79.28 -45.36 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.908 0.883 . . . . 0.0 109.764 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.36 66.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.241 0.617 . . . . 0.0 112.495 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.41 76.56 36.85 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.019 1.728 . . . . 0.0 106.508 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 -20.65 30.74 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.75 101.75 2.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 109.331 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.12 -9.93 35.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.737 0.815 . . . . 0.0 112.7 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -109.44 12.81 24.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.701 1.2 . . . . 0.0 111.19 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.62 148.74 51.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.259 -0.901 . . . . 0.0 110.06 169.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -78.89 83.46 5.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.34 109.07 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -98.5 127.69 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.2 m -128.1 141.58 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 123.118 0.567 . . . . 0.0 109.488 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -149.05 172.47 14.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.9 p -157.8 -162.61 1.19 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -46.26 91.18 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.05 -0.407 . . . . 0.0 112.082 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 18.54 3.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.209 1.404 . . . . 0.0 112.762 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.69 -17.53 44.32 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 120.987 -1.071 . . . . 0.0 114.874 172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -67.62 -50.65 57.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.7 1.75 . . . . 0.0 111.903 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.97 -33.28 71.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 110.076 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -76.5 -40.84 48.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.78 0.718 . . . . 0.0 112.808 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.55 -43.35 99.14 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -58.87 -47.16 85.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.133 1.373 . . . . 0.0 110.793 173.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.24 86.25 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.661 -0.649 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.38 -34.05 68.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.527 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.6 -54.73 31.26 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.319 0.963 . . . . 0.0 109.83 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -68.31 -30.93 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 121.538 -0.726 . . . . 0.0 111.616 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.9 -40.47 95.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.446 1.021 . . . . 0.0 110.101 174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -66.22 -41.32 90.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.561 0.344 . . . . 0.0 110.242 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -65.24 -36.44 84.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.625 0.648 . . . . 0.0 111.109 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.5 mtm -73.39 -2.81 23.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.168 0.987 . . . . 0.0 112.266 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.36 17.2 59.24 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.354 -1.248 . . . . 0.0 114.261 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -63.99 129.98 42.23 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.692 1.746 . . . . 0.0 107.077 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 p -65.21 -33.55 76.27 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.717 0.407 . . . . 0.0 111.904 -168.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.36 154.34 33.14 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 109.319 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -148.13 146.51 17.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -129.46 122.12 28.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -76.43 104.91 7.19 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.15 69.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.917 0.487 . . . . 0.0 111.811 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.95 -148.29 19.4 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.64 165.1 21.62 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 168.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -49.5 -49.28 46.45 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.677 1.191 . . . . 0.0 112.41 -169.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.7 -36.24 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.674 0.39 . . . . 0.0 111.38 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.91 -37.31 62.11 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.458 0.703 . . . . 0.0 111.751 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.6 mt -65.16 125.27 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -19.85 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 61.4 mtm -63.91 155.25 78.57 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 123.384 0.674 . . . . 0.0 111.165 -177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.78 165.8 28.42 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.612 2.874 . . . . 0.0 112.563 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -126.84 156.59 41.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.588 1.155 . . . . 0.0 110.151 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -143.54 160.74 16.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.476 1.91 . . . . 0.0 108.345 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -57.65 149.55 21.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.798 -0.564 . . . . 0.0 109.511 173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 N-CA-C 108.007 -2.037 . . . . 0.0 108.007 173.241 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -145.84 161.05 40.86 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.382 1.073 . . . . 0.0 109.662 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -139.48 137.29 35.41 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -89.87 118.72 29.66 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.38 104.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -168.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.46 145.07 56.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.86 15.44 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.335 -0.853 . . . . 0.0 112.496 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.89 160.98 5.28 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.432 -0.793 . . . . 0.0 110.545 172.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -54.6 146.92 32.48 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.86 -31.4 91.6 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.191 1.927 . . . . 0.0 113.778 -166.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.59 -29.75 63.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.657 -0.652 . . . . 0.0 111.999 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -84.29 -31.69 24.76 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.04 0.836 . . . . 0.0 109.127 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -49.27 64.97 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.767 0.827 . . . . 0.0 111.204 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -65.15 -18.65 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.882 -171.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -69.32 -31.53 70.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.806 -171.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 176.23 133.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.833 2.453 . . . . 0.0 105.973 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -147.68 161.97 40.12 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.911 1.232 . . . . 0.0 109.782 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.86 136.33 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -60.54 142.86 54.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.581 0.752 . . . . 0.0 109.812 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 46.02 42.1 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.004 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.55 178.76 6.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.129 1.371 . . . . 0.0 110.277 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.5 tt -129.94 176.22 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 126.561 1.944 . . . . 0.0 106.924 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.19 139.71 50.81 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.927 0.891 . . . . 0.0 109.181 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.3 mm -139.92 85.2 14.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.21 145.86 84.72 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.189 1.926 . . . . 0.0 112.772 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.6 tp -54.69 -25.39 26.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.015 0.526 . . . . 0.0 111.509 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.7 -22.71 65.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.232 1.013 . . . . 0.0 113.511 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -131.24 -10.05 3.73 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.484 1.038 . . . . 0.0 112.83 -169.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -46.26 -42.57 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.59 1.956 . . . . 0.0 113.387 -169.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.29 -25.18 61.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.285 0.948 . . . . 0.0 112.98 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -114.87 5.84 15.26 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.017 1.327 . . . . 0.0 110.983 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -136.85 -25.2 1.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.14 -167.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.51 -34.66 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 120.261 1.391 . . . . 0.0 112.086 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.89 67.14 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.553 0.615 . . . . 0.0 112.104 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -66.19 -35.98 81.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.383 0.673 . . . . 0.0 110.659 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.3 -25.28 20.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.302 0.641 . . . . 0.0 112.096 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.02 78.05 41.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.57 -8.48 20.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.142 2.561 . . . . 0.0 113.652 -172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.94 134.77 30.44 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.204 1.001 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.29 -16.46 64.29 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -169.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -19.67 60.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.737 1.153 . . . . 0.0 112.334 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 146.54 44.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.034 0.834 . . . . 0.0 110.809 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -78.37 138.13 38.37 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.007 -0.433 . . . . 0.0 110.092 -171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.1 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -84.16 93.21 8.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -83.85 142.8 12.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -150.47 165.24 33.81 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.668 0.787 . . . . 0.0 109.473 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.8 p -158.86 -160.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -57.58 -51.5 69.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.301 0.5 . . . . 0.0 111.157 -177.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.18 23.52 2.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.574 1.149 . . . . 0.0 112.319 -169.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.92 -3.65 64.18 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-O 118.364 -1.242 . . . . 0.0 114.96 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -68.6 -53.59 21.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.707 2.254 . . . . 0.0 111.108 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -61.13 -31.85 71.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -66.7 -48.23 69.9 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.268 1.027 . . . . 0.0 112.452 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.61 91.45 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -55.67 -46.37 77.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.332 1.053 . . . . 0.0 110.927 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.6 -38.25 80.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.079 0.552 . . . . 0.0 111.214 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -60.82 -39.76 90.19 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 120.03 1.286 . . . . 0.0 110.516 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -58.05 -53.08 62.24 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.32 0.964 . . . . 0.0 110.483 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -68.76 -39.69 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 118.495 0.589 . . . . 0.0 110.492 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.55 -35.86 70.77 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.175 0.898 . . . . 0.0 110.857 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.5 m -63.92 -41.49 97.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.57 -39.25 88.4 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.168 0.587 . . . . 0.0 111.008 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.0 mtp -66.34 -18.39 65.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.52 1.128 . . . . 0.0 111.765 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.92 8.0 24.6 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.544 -1.142 . . . . 0.0 113.717 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -71.68 97.85 1.82 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.508 1.654 . . . . 0.0 107.627 170.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -79.02 6.32 9.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.541 1.136 . . . . 0.0 113.185 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -136.33 31.2 2.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.471 1.108 . . . . 0.0 111.504 -169.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.9 140.93 15.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 170.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.19 145.01 28.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -85.38 114.59 22.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.01 -33.82 76.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.433 0.293 . . . . 0.0 111.482 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.75 -156.42 26.68 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.33 160.88 18.27 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -43.01 -56.06 3.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.182 1.793 . . . . 0.0 113.431 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.82 -16.39 32.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.667 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.33 -34.64 65.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.588 0.631 . . . . 0.0 110.919 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.8 126.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 55.55 3.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.471 1.508 . . . . 0.0 111.161 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.2 mtp -136.51 160.62 66.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 125.455 1.502 . . . . 0.0 108.67 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.98 163.2 34.73 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.546 2.164 . . . . 0.0 111.284 173.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -131.91 156.53 45.96 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.13 0.972 . . . . 0.0 109.646 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.12 160.3 20.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 126.246 1.819 . . . . 0.0 107.986 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -138.08 166.87 23.03 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.942 0.897 . . . . 0.0 110.931 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -174.391 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -155.41 161.01 41.09 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.948 0.899 . . . . 0.0 109.61 -171.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -144.17 129.27 18.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.582 1.153 . . . . 0.0 108.192 171.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -71.65 117.51 13.32 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.39 105.85 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -68.37 149.25 49.6 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.46 12.98 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.591 0.756 . . . . 0.0 111.58 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -53.72 156.39 2.74 Favored 'General case' 0 C--N 1.343 0.315 0 O-C-N 121.649 -0.657 . . . . 0.0 111.16 171.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.26 149.25 38.07 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 167.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.81 -34.44 95.74 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.331 2.02 . . . . 0.0 114.048 -166.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.11 -27.37 61.66 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.301 -0.875 . . . . 0.0 111.815 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -82.36 -34.48 28.41 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.29 -48.81 73.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.08 0.952 . . . . 0.0 110.726 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.86 2.62 3.24 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -75.02 -61.3 1.93 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.952 1.251 . . . . 0.0 108.716 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.61 149.26 8.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.277 1.831 . . . . 0.0 107.006 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -151.01 166.82 29.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.873 0.76 . . . . 0.0 110.401 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -60.03 137.18 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.127 0.971 . . . . 0.0 109.497 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.76 135.0 56.73 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.117 0.567 . . . . 0.0 109.593 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.71 2.96 53.27 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 118.833 -0.982 . . . . 0.0 114.744 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.91 -178.75 3.89 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.207 1.503 . . . . 0.0 111.101 174.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.04 171.2 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 126.424 1.89 . . . . 0.0 106.699 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -132.56 139.69 47.96 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 119.134 0.879 . . . . 0.0 110.924 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mt -142.37 82.14 13.21 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.26 143.87 62.52 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.49 2.126 . . . . 0.0 112.78 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.16 -30.02 47.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.74 -13.93 61.44 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -129.5 -14.86 4.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.608 1.163 . . . . 0.0 112.107 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.77 -39.51 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.913 1.685 . . . . 0.0 113.196 -169.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 -20.63 62.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.236 0.925 . . . . 0.0 112.653 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -111.81 7.13 20.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.972 1.309 . . . . 0.0 111.115 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -137.58 -30.41 0.83 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -167.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.48 -38.56 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.747 1.158 . . . . 0.0 110.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.15 90.4 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.315 0.507 . . . . 0.0 111.562 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 -38.54 55.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.236 0.615 . . . . 0.0 111.068 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.51 72.15 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.393 0.542 . . . . 0.0 111.749 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.43 79.25 20.96 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 125.289 1.436 . . . . 0.0 107.644 -172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.82 -36.05 97.64 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.335 2.023 . . . . 0.0 112.856 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -83.77 104.38 13.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.608 0.763 . . . . 0.0 110.515 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.03 -14.45 60.46 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.46 -14.14 59.76 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.492 1.042 . . . . 0.0 111.971 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.6 143.84 57.5 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.171 -0.955 . . . . 0.0 110.991 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -81.99 97.58 8.18 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.3 94.69 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -79.05 79.43 5.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.66 139.27 19.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -147.89 165.59 30.18 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.015 0.926 . . . . 0.0 109.462 170.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.5 p -169.0 -160.46 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.211 1.004 . . . . 0.0 109.145 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -77.53 128.34 34.01 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.45 13.83 0.5 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.536 1.934 . . . . 0.0 115.433 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.1 3.78 46.39 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.961 -0.911 . . . . 0.0 114.194 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.0 -39.63 61.11 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.353 2.076 . . . . 0.0 112.806 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.82 -30.56 69.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.603 1.092 . . . . 0.0 109.221 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -69.14 -48.41 62.47 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.03 0.932 . . . . 0.0 111.727 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.7 -43.57 98.77 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -57.95 -47.86 81.67 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.575 0.75 . . . . 0.0 111.241 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.53 88.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.171 0.588 . . . . 0.0 111.354 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -57.52 -35.93 70.9 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.213 -0.929 . . . . 0.0 111.445 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.94 -55.03 33.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.235 0.925 . . . . 0.0 110.428 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt -68.95 -34.73 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 O-C-N 121.766 -0.584 . . . . 0.0 111.069 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.1 mt -69.33 -37.03 77.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.307 0.958 . . . . 0.0 110.605 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.7 m -64.26 -39.96 95.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.472 0.578 . . . . 0.0 109.942 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.69 -39.87 94.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.468 0.577 . . . . 0.0 110.901 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.01 -16.92 64.26 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.255 1.022 . . . . 0.0 111.985 174.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.36 27.82 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.847 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -73.13 106.15 4.87 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.564 1.682 . . . . 0.0 107.586 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.09 3.26 43.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 113.058 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -137.95 31.49 2.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.208 1.003 . . . . 0.0 111.382 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.25 130.53 36.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 172.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -142.34 129.24 20.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -75.1 111.46 10.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.88 71.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.826 0.451 . . . . 0.0 111.542 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.52 -153.98 25.36 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.74 165.53 12.34 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 170.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -45.15 -50.32 11.37 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.37 1.468 . . . . 0.0 113.222 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -77.56 -36.76 51.84 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.672 0.389 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.46 -36.25 73.81 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.541 0.736 . . . . 0.0 111.713 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.64 129.18 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.373 1.069 . . . . 0.0 108.497 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 -10.57 59.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.2 mmm -61.26 154.23 63.7 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.663 0.785 . . . . 0.0 110.745 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.82 161.01 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.749 2.299 . . . . 0.0 111.09 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -129.26 167.15 18.11 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.609 1.164 . . . . 0.0 109.18 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.2 151.27 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.517 1.527 . . . . 0.0 106.905 170.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -67.96 148.28 51.29 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -169.794 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -155.8 155.48 33.09 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.708 1.203 . . . . 0.0 108.208 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -138.92 147.38 42.22 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.651 1.58 . . . . 0.0 106.802 169.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.55 125.45 48.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.61 108.95 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -74.79 119.13 18.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.6 m -105.29 14.23 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 122.946 0.498 . . . . 0.0 111.305 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -55.67 157.24 4.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 118.641 0.655 . . . . 0.0 110.644 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.3 145.69 25.24 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 166.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.62 -30.89 70.55 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.72 1.613 . . . . 0.0 112.825 -166.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -71.26 -21.79 62.06 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.341 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -89.67 -34.36 16.29 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.737 1.153 . . . . 0.0 109.347 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -51.87 -46.19 64.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.96 0.504 . . . . 0.0 110.941 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -63.38 -21.22 66.15 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -73.62 -49.89 23.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.574 1.079 . . . . 0.0 110.508 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -162.66 132.43 4.44 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -151.11 160.78 43.68 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 120.485 1.493 . . . . 0.0 111.73 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.4 107.06 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -44.05 134.85 4.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.839 1.255 . . . . 0.0 111.753 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.12 -17.94 55.44 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.62 -1.1 . . . . 0.0 112.869 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.45 129.57 40.33 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.392 1.596 . . . . 0.0 109.259 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.66 156.38 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -111.46 121.29 44.79 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.596 -0.69 . . . . 0.0 109.66 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.2 mt -135.11 84.27 37.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.51 151.46 7.19 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.102 2.535 . . . . 0.0 111.658 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.1 tp -44.95 -44.0 9.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.89 -41.88 97.61 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.522 0.601 . . . . 0.0 111.336 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -75.07 -22.6 58.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.825 1.65 . . . . 0.0 111.249 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.9 t -50.84 -44.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.539 1.063 . . . . 0.0 109.713 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -61.81 -15.59 43.03 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.24 -20.28 9.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.162 0.985 . . . . 0.0 111.696 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -129.5 -12.38 4.43 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.94 -39.24 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 121.362 1.892 . . . . 0.0 111.206 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.79 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.305 0.502 . . . . 0.0 111.787 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 m -68.3 -44.97 74.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.678 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.29 -39.41 68.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.236 0.614 . . . . 0.0 112.015 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -139.77 87.64 12.74 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -25.9 14.46 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.134 1.889 . . . . 0.0 111.974 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.0 152.68 44.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.364 1.066 . . . . 0.0 109.989 171.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.73 35.27 4.2 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.569 0.622 . . . . 0.0 112.113 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -142.78 -34.67 0.43 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.81 150.72 44.09 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.747 0.819 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 m -62.23 132.47 52.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.54 0.736 . . . . 0.0 110.528 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -132.43 139.27 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -120.56 138.52 53.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.31 141.93 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -147.05 163.51 36.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.3 p -159.82 -154.26 0.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.277 0.231 . . . . 0.0 111.01 174.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.48 130.21 38.21 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 170.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 55.12 17.68 2.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.298 1.839 . . . . 0.0 114.558 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.13 -13.03 1.04 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.876 1.227 . . . . 0.0 115.188 173.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -64.55 -44.9 89.31 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 120.056 1.928 . . . . 0.0 111.985 -171.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.44 -30.36 71.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.798 0.726 . . . . 0.0 110.007 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -75.12 -43.41 52.9 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.615 1.098 . . . . 0.0 112.195 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.35 -49.35 78.4 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -58.26 -40.76 82.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.069 . . . . 0.0 111.977 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.91 -44.17 77.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.483 0.583 . . . . 0.0 109.97 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -62.06 -35.77 79.61 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.787 1.176 . . . . 0.0 110.498 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.71 -52.97 63.42 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.557 1.071 . . . . 0.0 110.379 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.0 pt -68.07 -39.43 81.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 119.442 1.019 . . . . 0.0 110.525 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.4 mt -65.1 -40.42 94.54 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.394 0.543 . . . . 0.0 110.91 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.87 -39.55 94.8 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.609 0.64 . . . . 0.0 110.136 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -69.27 -33.93 73.98 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.806 -0.559 . . . . 0.0 111.019 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.6 mtp -73.96 -1.0 17.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.804 1.242 . . . . 0.0 112.08 173.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.35 90.54 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.848 -1.157 . . . . 0.0 113.136 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -78.48 55.02 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.364 1.466 . . . . 0.0 108.686 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -67.75 -25.09 65.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.171 1.388 . . . . 0.0 111.869 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.548 ' CD2' ' H ' ' A' ' 68' ' ' HIS . 18.8 p80 -77.5 33.67 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.23 2.612 . . . . 0.0 112.736 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.5 t -120.99 140.41 45.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 126.08 1.752 . . . . 0.0 106.427 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.43 141.68 41.64 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.48 114.37 19.33 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.37 -29.97 67.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.904 0.482 . . . . 0.0 112.005 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.28 -139.46 8.12 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.75 169.7 24.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.35 -53.95 7.88 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.391 1.477 . . . . 0.0 112.427 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.79 -37.83 67.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.481 0.313 . . . . 0.0 111.272 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.64 -37.37 68.02 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.339 0.655 . . . . 0.0 111.787 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.3 mt -65.05 131.86 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.288 1.035 . . . . 0.0 108.574 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.52 -8.37 59.55 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.87 151.31 74.02 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 118.7 0.682 . . . . 0.0 110.676 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.05 163.83 11.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.123 2.549 . . . . 0.0 111.877 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -136.3 166.54 23.21 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.14 155.85 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 125.819 1.647 . . . . 0.0 106.556 168.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -138.66 153.47 48.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.081 0.952 . . . . 0.0 109.899 -167.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.972 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.381 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.85 148.25 28.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -133.88 128.2 34.11 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -88.74 122.61 32.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mt -128.55 115.18 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -69.54 129.01 38.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.68 7.59 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.626 0.648 . . . . 0.0 111.615 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -65.59 162.82 17.45 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.046 0.839 . . . . 0.0 110.206 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -54.88 146.76 35.89 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.4 -38.6 73.28 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.968 1.778 . . . . 0.0 113.303 -167.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.09 -27.9 68.41 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.557 -0.714 . . . . 0.0 112.045 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -82.74 -33.05 27.59 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -46.42 79.92 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.178 0.591 . . . . 0.0 110.671 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -61.32 -22.75 65.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -66.19 -44.27 84.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.449 0.568 . . . . 0.0 111.022 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -176.37 137.9 0.3 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.741 2.017 . . . . 0.0 106.912 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -149.3 164.0 36.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.471 1.109 . . . . 0.0 110.256 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.13 134.86 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.577 0.751 . . . . 0.0 109.798 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 tm0? -55.14 130.66 42.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.79 -0.0 88.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.333 171.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.13 -178.74 4.0 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.762 1.281 . . . . 0.0 111.623 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.0 tt -125.88 172.22 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 127.418 2.287 . . . . 0.0 106.531 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -129.8 124.21 32.8 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.484 1.038 . . . . 0.0 110.483 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.2 mt -134.76 87.5 30.61 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 170.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.83 153.94 5.46 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.673 2.916 . . . . 0.0 111.366 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.02 -39.0 18.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.655 0.782 . . . . 0.0 112.333 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -65.0 -21.48 66.86 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.129 0.971 . . . . 0.0 113.275 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' A' ' 32' ' ' ARG . 26.7 mt-10 -111.1 -13.73 14.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.4 1.48 . . . . 0.0 111.752 -174.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t -48.78 -52.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.809 1.186 . . . . 0.0 110.489 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -64.26 -10.59 24.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -114.72 -10.58 12.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.031 0.933 . . . . 0.0 112.141 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.407 HH12 ' CD ' ' A' ' 28' ' ' GLU . 29.8 ttp180 -141.14 -14.91 0.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.98 -36.62 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 120.531 1.514 . . . . 0.0 111.751 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.78 -29.99 69.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.487 0.585 . . . . 0.0 112.124 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.0 m -68.53 -39.63 81.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.636 0.653 . . . . 0.0 110.06 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.02 -30.48 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.938 0.495 . . . . 0.0 112.151 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 t -135.34 81.18 44.13 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.6 -0.74 10.78 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.213 2.609 . . . . 0.0 114.451 -169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -142.33 137.08 30.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.789 1.177 . . . . 0.0 110.06 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 60.0 mttp -62.0 -25.89 67.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.537 1.135 . . . . 0.0 113.513 -173.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.73 -13.81 53.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.63 0.65 . . . . 0.0 112.324 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -73.82 145.88 44.63 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.145 0.884 . . . . 0.0 110.826 -175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.4 146.51 32.78 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.751 0.42 . . . . 0.0 109.999 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.24 139.14 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -120.57 95.62 4.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.22 143.11 12.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -147.83 160.39 42.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.9 p -162.21 -166.37 1.39 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.45 135.69 33.75 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 56.41 17.12 2.75 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.252 1.821 . . . . 0.0 115.391 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.17 -26.27 1.02 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.853 1.216 . . . . 0.0 115.378 170.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 -54.49 -51.5 64.89 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.737 1.769 . . . . 0.0 112.625 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.57 -29.72 70.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.887 0.767 . . . . 0.0 110.471 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 m -74.46 -43.87 54.18 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.965 0.802 . . . . 0.0 112.138 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 -46.11 94.47 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.56 -45.04 85.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.83 1.252 . . . . 0.0 110.981 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.42 86.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.622 0.647 . . . . 0.0 110.955 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.04 -40.34 84.73 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.446 -0.784 . . . . 0.0 110.113 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.64 -54.18 43.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.977 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -66.08 -32.93 60.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 119.881 1.219 . . . . 0.0 111.015 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.12 -34.78 71.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.157 0.89 . . . . 0.0 110.938 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.8 m -63.77 -38.91 92.86 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.261 0.482 . . . . 0.0 110.166 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -68.02 -40.95 82.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.054 0.542 . . . . 0.0 110.8 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.12 -30.14 71.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.042 0.937 . . . . 0.0 111.004 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.26 0.44 7.46 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.182 -1.343 . . . . 0.0 114.528 168.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 40' ' ' LYS . 90.4 m-85 -65.82 151.02 47.6 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.874 1.837 . . . . 0.0 109.217 174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -131.42 4.98 4.36 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.32 0.648 . . . . 0.0 112.421 -172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -136.25 30.3 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.471 1.108 . . . . 0.0 110.823 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.07 136.48 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -141.25 149.99 42.04 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -85.36 117.13 24.1 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.73 -32.47 74.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.627 0.371 . . . . 0.0 111.503 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.91 -163.92 28.86 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.596 1.57 . . . . 0.0 109.686 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.25 154.28 21.77 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.9 -44.54 63.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.791 0.836 . . . . 0.0 112.422 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.44 -37.26 82.72 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.751 0.42 . . . . 0.0 111.472 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.21 -35.14 61.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.283 0.633 . . . . 0.0 111.497 -176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.94 128.17 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.576 1.15 . . . . 0.0 108.651 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.53 -8.5 59.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.6 mmm -61.18 153.86 65.03 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.903 0.881 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.86 162.39 42.32 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.058 2.505 . . . . 0.0 111.153 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -129.42 158.71 38.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.767 0.827 . . . . 0.0 110.935 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.68 163.5 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 126.552 1.941 . . . . 0.0 107.869 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -115.11 163.61 15.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.821 0.848 . . . . 0.0 110.389 -171.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 172.468 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -154.72 157.97 38.86 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.201 1.001 . . . . 0.0 109.33 -171.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -147.84 154.88 41.01 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.52 1.528 . . . . 0.0 107.733 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -99.98 112.16 24.45 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.74 102.95 14.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -67.11 144.84 55.86 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.49 9.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.499 -0.751 . . . . 0.0 111.583 -172.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -61.28 157.78 15.65 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.518 -0.739 . . . . 0.0 110.63 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.7 m -54.89 145.92 40.18 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.14 -32.08 90.87 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.944 1.763 . . . . 0.0 113.708 -165.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -80.43 -15.43 56.81 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.494 -0.754 . . . . 0.0 112.498 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -88.1 -31.45 19.21 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.757 1.162 . . . . 0.0 108.859 171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.86 -50.61 72.72 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.393 0.677 . . . . 0.0 111.385 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -62.26 -23.9 66.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -169.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -63.99 -37.98 89.41 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.664 -0.684 . . . . 0.0 111.725 -172.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -174.49 135.99 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.325 1.45 . . . . 0.0 107.438 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -152.56 157.89 41.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.001 1.273 . . . . 0.0 111.026 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -67.54 123.11 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.77 158.7 6.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.154 0.982 . . . . 0.0 111.366 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.5 39.22 42.58 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.56 174.28 10.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.292 1.437 . . . . 0.0 110.039 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.62 164.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 169.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -121.66 135.4 54.97 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.01 92.92 10.65 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.53 149.89 37.23 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.963 2.442 . . . . 0.0 113.158 -171.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 tp -56.37 -28.8 60.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.229 0.612 . . . . 0.0 112.364 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -70.18 -22.35 62.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 112.763 175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -116.86 -24.76 7.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.145 1.378 . . . . 0.0 112.098 -168.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.1 p -54.81 -35.69 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.363 1.465 . . . . 0.0 113.392 -168.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -61.6 -18.18 58.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.658 0.663 . . . . 0.0 112.774 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -110.18 4.17 20.78 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.622 1.169 . . . . 0.0 111.414 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.92 -21.7 0.72 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -168.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tp -62.73 -36.6 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 110.952 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.07 94.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.283 0.492 . . . . 0.0 111.631 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -37.96 63.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.252 0.478 . . . . 0.0 111.116 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.66 -39.41 64.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.36 0.527 . . . . 0.0 111.951 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.01 81.68 15.8 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.93 -26.48 26.74 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.878 1.718 . . . . 0.0 112.242 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -84.36 103.28 13.4 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.422 0.689 . . . . 0.0 110.195 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.41 -14.4 60.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.55 -17.9 62.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.326 0.966 . . . . 0.0 111.769 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.45 141.89 58.16 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.874 0.761 . . . . 0.0 111.557 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -83.49 82.12 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.53 100.17 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.74 130.57 38.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.59 138.61 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.54 153.3 32.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.584 1.154 . . . . 0.0 108.488 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -154.58 -174.35 4.94 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.862 1.665 . . . . 0.0 109.691 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.78 125.39 23.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 48.01 17.49 0.11 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.912 1.685 . . . . 0.0 114.172 -170.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.35 10.64 23.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 117.668 -1.629 . . . . 0.0 115.632 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -70.35 -44.1 68.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 121.768 2.784 . . . . 0.0 113.781 -169.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.18 -30.53 69.65 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.899 1.227 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -41.27 48.6 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.772 0.829 . . . . 0.0 112.069 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -41.98 97.8 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.43 -45.96 84.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.586 0.754 . . . . 0.0 110.896 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.84 -33.36 75.43 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.588 -0.695 . . . . 0.0 112.719 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.85 -36.98 68.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.682 1.128 . . . . 0.0 110.463 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.33 -55.41 18.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.135 0.425 . . . . 0.0 110.571 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -66.88 -35.13 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.21 0.914 . . . . 0.0 110.592 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.79 -36.09 62.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.757 -0.589 . . . . 0.0 110.863 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.0 p -66.66 -35.92 81.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.107 0.867 . . . . 0.0 110.328 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.58 -36.48 82.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.128 0.876 . . . . 0.0 111.472 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.5 mmm -66.44 -16.57 64.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.901 0.88 . . . . 0.0 111.847 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.04 4.99 27.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.32 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -74.89 93.22 2.63 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.409 1.604 . . . . 0.0 107.692 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -75.65 4.7 7.25 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.371 1.069 . . . . 0.0 113.585 -172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -138.52 24.75 2.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.316 0.962 . . . . 0.0 112.646 -170.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.76 140.71 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -143.79 138.64 28.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.43 105.57 9.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.5 -28.7 68.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.318 0.647 . . . . 0.0 111.977 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.12 -150.13 21.55 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.24 168.12 22.7 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 169.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.3 tp -50.16 -46.06 53.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 113.217 -169.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -81.25 -28.63 34.69 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.782 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -76.05 -38.34 57.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.323 0.649 . . . . 0.0 111.121 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 89.7 mt -66.48 123.94 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.08 -7.66 58.99 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -62.06 156.57 57.57 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 123.94 0.896 . . . . 0.0 110.757 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.24 169.06 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.759 2.306 . . . . 0.0 110.915 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -140.0 164.7 29.32 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.45 1.1 . . . . 0.0 110.196 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.65 158.87 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.092 1.757 . . . . 0.0 108.209 172.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -67.96 155.04 40.34 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.479 -0.763 . . . . 0.0 109.289 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 175.149 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.91 161.64 38.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.893 1.277 . . . . 0.0 108.618 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -142.71 129.92 20.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -90.17 115.63 27.56 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mt -125.38 108.19 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -67.91 138.01 55.67 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 168.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.2 6.88 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.971 0.805 . . . . 0.0 111.66 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -60.26 162.35 6.11 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.934 0.788 . . . . 0.0 110.437 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.47 149.53 60.12 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -64.23 -31.55 63.64 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.59 1.526 . . . . 0.0 112.636 -168.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.56 -24.63 64.64 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.337 0.655 . . . . 0.0 111.842 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -86.37 -37.14 18.74 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 119.165 0.893 . . . . 0.0 108.862 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -36.97 78.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.523 0.601 . . . . 0.0 110.894 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.87 -20.52 66.26 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.521 -0.752 . . . . 0.0 112.415 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.37 -54.23 7.05 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.515 1.052 . . . . 0.0 108.701 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -164.79 153.29 12.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 110.41 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -163.17 176.12 10.32 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.933 1.693 . . . . 0.0 109.099 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.37 145.0 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.189 -0.944 . . . . 0.0 108.579 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -63.31 146.06 54.26 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.033 0.933 . . . . 0.0 110.187 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.65 46.51 75.36 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.26 177.16 8.19 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.259 1.424 . . . . 0.0 110.174 -175.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 tt -126.26 176.58 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.012 1.725 . . . . 0.0 107.173 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 6.2 t-20 -132.65 134.23 44.59 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.366 -0.833 . . . . 0.0 109.45 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.18 89.37 14.42 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.29 151.98 21.03 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.139 2.559 . . . . 0.0 112.896 -172.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.6 tp -51.48 -34.06 33.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.651 0.78 . . . . 0.0 112.177 173.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.41 -15.95 63.4 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -125.21 -24.06 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.482 1.113 . . . . 0.0 111.969 -169.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.1 -34.88 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.639 1.176 . . . . 0.0 113.116 -169.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -56.45 -25.38 50.44 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.008 0.822 . . . . 0.0 112.799 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.56 -0.69 20.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.178 0.991 . . . . 0.0 111.659 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -136.67 -24.44 1.17 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -167.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.3 -35.68 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 121.089 1.768 . . . . 0.0 110.295 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.16 -17.6 41.9 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.269 1.027 . . . . 0.0 113.638 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -117.94 -30.16 5.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.57 1.148 . . . . 0.0 110.969 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.88 85.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.797 0.726 . . . . 0.0 110.914 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.69 77.13 22.83 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -25.77 38.62 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.215 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -77.04 102.05 6.31 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.36 0.664 . . . . 0.0 110.052 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.46 -13.3 60.6 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -77.28 -14.85 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.225 0.921 . . . . 0.0 111.735 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.67 147.54 53.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.195 -0.941 . . . . 0.0 111.486 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -77.53 78.71 4.04 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.949 0.9 . . . . 0.0 109.344 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.8 t -64.09 100.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -92.45 128.73 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.7 m -122.19 142.8 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.265 0.626 . . . . 0.0 109.571 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.92 167.35 30.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.013 1.325 . . . . 0.0 107.588 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.09 -171.14 2.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.415 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -51.53 -47.59 63.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.223 1.009 . . . . 0.0 112.052 -178.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.32 26.11 2.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.412 1.085 . . . . 0.0 112.41 -169.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.17 -18.15 1.25 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.742 1.163 . . . . 0.0 115.523 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 mmt-85 -67.41 -40.45 85.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 120.424 2.112 . . . . 0.0 113.028 -173.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -65.75 -30.3 70.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.714 1.143 . . . . 0.0 109.275 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -73.39 -45.55 54.09 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 124.258 1.023 . . . . 0.0 112.293 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.74 97.41 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -58.25 -46.33 86.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.88 0.872 . . . . 0.0 111.167 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -37.41 87.15 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.303 0.641 . . . . 0.0 111.575 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.03 -36.35 74.84 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.986 0.812 . . . . 0.0 111.028 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.53 -54.93 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.853 0.752 . . . . 0.0 110.011 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.3 pt -66.18 -34.79 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.469 0.577 . . . . 0.0 111.195 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.41 -39.79 92.6 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 0.0 110.339 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -64.53 -42.44 95.74 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.01 -35.93 81.89 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.548 0.613 . . . . 0.0 111.317 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.59 -10.5 59.44 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.254 1.021 . . . . 0.0 111.994 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.89 11.0 47.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.56 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -71.83 135.17 46.53 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.352 1.576 . . . . 0.0 107.364 169.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -118.37 4.6 11.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.648 0.779 . . . . 0.0 112.378 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -136.98 29.39 2.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.711 1.204 . . . . 0.0 110.075 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.66 142.32 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -144.03 128.32 17.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.46 110.32 14.65 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.72 71.45 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.454 0.301 . . . . 0.0 111.248 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.59 -157.95 27.54 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.29 159.59 14.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 167.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.26 -44.83 65.13 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.262 1.025 . . . . 0.0 111.791 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -68.74 -11.28 60.11 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.73 -30.19 5.51 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.307 1.043 . . . . 0.0 111.867 -171.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 131.21 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.032 0.933 . . . . 0.0 108.619 172.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.05 -13.73 56.9 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.4 mmm -61.18 154.2 63.2 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.916 0.886 . . . . 0.0 110.667 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.92 163.46 35.51 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 111.534 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -123.92 165.83 16.72 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.341 1.056 . . . . 0.0 109.641 -175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.7 148.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.872 1.669 . . . . 0.0 106.518 171.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -149.23 151.14 33.75 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.308 1.043 . . . . 0.0 108.803 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 176.41 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.15 169.71 18.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.33 1.052 . . . . 0.0 109.916 175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -137.61 147.31 44.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.318 1.447 . . . . 0.0 107.482 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.09 110.07 21.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.24 107.0 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -171.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.1 138.25 49.57 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.27 8.66 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.084 0.856 . . . . 0.0 111.783 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -62.45 159.02 16.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 118.899 0.772 . . . . 0.0 110.683 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.5 m -54.67 147.89 28.67 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.726 0.81 . . . . 0.0 109.337 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.37 -33.0 71.61 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.867 1.711 . . . . 0.0 112.291 -169.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 -23.82 64.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.17 -34.1 16.8 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.177 0.898 . . . . 0.0 108.652 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -57.31 -41.11 79.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.416 0.687 . . . . 0.0 110.831 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -62.08 -28.24 69.47 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.695 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.88 -50.51 23.37 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.413 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -167.03 152.33 7.56 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.369 0.986 . . . . 0.0 110.204 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -153.64 167.51 29.34 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.503 1.521 . . . . 0.0 109.683 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 t -65.85 139.85 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.3 161.76 18.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.089 0.556 . . . . 0.0 112.003 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.99 38.61 84.78 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.886 0.755 . . . . 0.0 111.825 172.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -143.95 179.37 7.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.299 1.039 . . . . 0.0 111.924 -169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.44 175.9 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.745 2.018 . . . . 0.0 105.994 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -131.25 133.08 45.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.167 -0.958 . . . . 0.0 108.67 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 29' ' ' VAL . 12.4 mt -136.47 84.04 29.52 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -55.59 146.88 62.11 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.087 2.525 . . . . 0.0 113.026 -172.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -48.72 -34.46 12.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.888 0.875 . . . . 0.0 112.389 169.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -55.09 -28.48 52.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.631 1.172 . . . . 0.0 112.957 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -140.04 2.81 1.95 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.093 0.957 . . . . 0.0 113.016 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 24' ' ' ILE . 14.6 p -54.36 -39.66 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -169.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.7 -29.11 66.39 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.979 0.809 . . . . 0.0 112.122 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.32 -16.78 57.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 111.641 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -125.62 -36.91 2.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.173 -0.918 . . . . 0.0 113.04 -169.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.67 -36.49 71.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 120.047 1.294 . . . . 0.0 111.34 -171.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.8 -7.68 5.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.721 1.209 . . . . 0.0 114.103 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.7 m -125.98 -32.59 2.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.787 1.235 . . . . 0.0 109.927 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.01 -37.92 82.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.687 0.795 . . . . 0.0 111.053 172.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -139.42 75.66 32.5 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.6 -35.74 16.37 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.73 1.62 . . . . 0.0 111.976 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -73.69 113.86 11.3 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.091 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -65.42 -20.95 66.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -21.71 58.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.356 0.662 . . . . 0.0 111.804 175.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.29 146.51 43.1 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.558 1.072 . . . . 0.0 110.67 -174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -75.26 146.57 40.98 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.011 -0.431 . . . . 0.0 110.184 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.7 98.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -73.74 123.11 23.49 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 m -126.55 140.77 47.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 123.537 0.735 . . . . 0.0 109.097 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -164.14 157.68 18.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -166.4 -170.7 1.72 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.644 0.778 . . . . 0.0 109.774 -174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -68.22 132.41 47.09 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.2 16.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.771 2.028 . . . . 0.0 115.51 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.1 -14.2 0.44 Allowed Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.723 1.154 . . . . 0.0 115.385 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mmt-85 -63.86 -40.09 95.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.352 2.076 . . . . 0.0 112.785 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -27.41 68.29 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.393 0.542 . . . . 0.0 110.609 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.0 m -79.41 -43.61 23.04 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.862 0.756 . . . . 0.0 111.031 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.28 -43.19 93.74 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -65.73 -42.56 90.89 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.105 0.562 . . . . 0.0 111.292 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.12 91.45 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.121 0.568 . . . . 0.0 111.157 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -55.1 -39.02 68.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.352 0.978 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.72 -53.73 30.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.809 0.731 . . . . 0.0 110.204 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 pt -68.14 -33.74 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.793 -0.567 . . . . 0.0 110.964 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.07 -35.89 74.55 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.897 0.772 . . . . 0.0 110.171 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -62.44 -39.63 93.99 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 110.208 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.43 -38.88 91.2 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.477 0.58 . . . . 0.0 110.748 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.0 mtp -70.43 -9.93 57.76 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.205 1.002 . . . . 0.0 112.41 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 1.74 46.24 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.058 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -67.29 145.98 54.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.495 1.648 . . . . 0.0 109.153 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 p -131.19 7.88 4.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.992 0.917 . . . . 0.0 111.824 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -137.06 31.05 2.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.848 1.259 . . . . 0.0 110.444 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -75.2 141.54 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -142.12 124.77 15.88 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.49 108.72 8.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -28.96 68.84 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.62 0.368 . . . . 0.0 111.355 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.76 -144.07 12.22 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.46 175.48 21.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 170.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.84 -52.46 8.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.195 1.398 . . . . 0.0 113.064 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.24 -36.35 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.421 0.288 . . . . 0.0 111.29 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.71 -38.58 62.3 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.102 0.561 . . . . 0.0 111.615 -172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.8 128.32 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -14.1 54.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.46 156.42 70.59 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.717 0.807 . . . . 0.0 111.277 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.42 161.64 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.077 3.185 . . . . 0.0 113.722 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -135.48 159.36 41.85 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.672 1.189 . . . . 0.0 109.966 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.45 164.75 11.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 108.924 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.7 161.73 25.72 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.355 1.462 . . . . 0.0 110.125 -169.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 174.849 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.72 160.05 40.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.78 0.832 . . . . 0.0 109.576 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -143.11 153.36 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -108.47 117.75 34.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.4 113.11 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -172.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -70.87 132.62 45.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 165.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.261 4.3 p -127.27 9.52 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.791 0.837 . . . . 0.0 111.145 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -64.57 161.39 17.58 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.961 -1.087 . . . . 0.0 110.121 170.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.48 151.86 58.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.46 -37.32 72.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.94 1.76 . . . . 0.0 112.038 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.3 -6.58 30.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -105.29 -31.23 9.18 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.139 0.881 . . . . 0.0 110.269 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.32 -41.01 88.07 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.702 1.137 . . . . 0.0 110.266 169.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -64.19 -8.24 11.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.9 0.88 . . . . 0.0 112.644 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -93.0 -59.9 1.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.3 169.97 16.8 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.836 1.198 . . . . 0.0 111.556 171.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -154.28 172.91 16.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 108.69 168.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.4 144.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -61.66 159.88 12.58 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.823 -0.548 . . . . 0.0 111.699 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.36 41.93 99.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.435 0.54 . . . . 0.0 112.573 171.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.97 177.69 7.66 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.969 1.308 . . . . 0.0 110.769 -172.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.8 tt -131.97 140.85 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.367 1.467 . . . . 0.0 108.571 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -82.62 121.28 26.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.059 0.944 . . . . 0.0 110.28 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -144.26 75.05 15.54 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -53.71 150.66 28.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.58 2.854 . . . . 0.0 112.147 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.0 tp -60.63 -27.14 67.56 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.568 -0.708 . . . . 0.0 111.829 175.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.11 -10.47 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -129.33 -21.33 3.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.304 1.442 . . . . 0.0 112.082 -168.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.52 -41.38 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.917 1.287 . . . . 0.0 112.706 -169.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.19 -23.4 62.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.792 0.724 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -110.29 2.89 19.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.917 1.287 . . . . 0.0 111.267 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -133.63 -37.4 0.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.536 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.59 -36.83 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.392 1.451 . . . . 0.0 111.395 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.71 -10.53 19.92 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 m -116.18 -35.75 4.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.13 0.972 . . . . 0.0 109.867 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.53 -37.67 85.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.388 0.675 . . . . 0.0 111.968 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.6 76.6 47.89 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.51 10.45 1.87 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.723 2.949 . . . . 0.0 114.202 -168.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.52 133.74 29.63 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.53 1.059 . . . . 0.0 108.996 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -71.64 -15.11 62.23 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -17.54 59.65 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.932 1.242 . . . . 0.0 112.611 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.41 144.47 55.81 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.44 0.564 . . . . 0.0 111.506 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 m -79.65 87.91 5.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -74.52 82.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.446 1.098 . . . . 0.0 108.37 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.7 132.43 46.14 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 172.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.76 143.75 39.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.601 0.761 . . . . 0.0 109.526 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.29 160.02 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.363 0.665 . . . . 0.0 110.664 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.8 p -168.9 -178.94 3.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.771 1.628 . . . . 0.0 108.489 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -58.82 127.53 32.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.642 -0.661 . . . . 0.0 109.483 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 52.56 16.9 0.7 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.552 1.941 . . . . 0.0 115.311 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.04 1.1 6.24 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 119.628 1.104 . . . . 0.0 115.209 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.6 mmt-85 -69.32 -39.79 78.0 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 120.131 1.965 . . . . 0.0 112.503 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -69.0 -30.17 68.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.319 0.963 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 m -70.13 -47.65 60.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.341 1.057 . . . . 0.0 111.646 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.16 99.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -57.5 -49.42 76.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.184 0.994 . . . . 0.0 110.948 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.6 81.04 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.941 0.496 . . . . 0.0 111.903 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.24 -35.39 69.65 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.178 0.899 . . . . 0.0 111.379 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -53.8 46.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.152 0.887 . . . . 0.0 110.254 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 pt -69.44 -33.16 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.805 -0.559 . . . . 0.0 111.083 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.75 -40.22 88.21 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.125 0.875 . . . . 0.0 110.153 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.6 m -63.66 -38.65 91.92 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.019 0.372 . . . . 0.0 110.348 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.65 -41.27 88.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.131 0.572 . . . . 0.0 110.908 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.3 mtp -64.25 -33.16 75.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.664 0.786 . . . . 0.0 110.965 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 -1.31 5.27 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.419 -1.212 . . . . 0.0 114.189 169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -68.0 125.38 26.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.542 1.671 . . . . 0.0 108.036 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 p -114.06 9.25 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.91 0.884 . . . . 0.0 112.305 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -133.32 29.01 4.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.654 1.181 . . . . 0.0 110.134 -173.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.41 140.9 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.65 143.29 25.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 115.13 17.17 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.98 74.62 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.567 0.347 . . . . 0.0 111.015 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.52 -170.86 32.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.737 1.637 . . . . 0.0 109.242 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.52 155.96 38.3 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 168.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.8 -49.84 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.494 1.117 . . . . 0.0 111.642 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -76.97 -33.56 57.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.974 0.509 . . . . 0.0 111.525 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.92 -34.96 76.24 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.526 0.73 . . . . 0.0 111.674 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.2 mt -58.08 126.17 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.4 59.58 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 ttt -59.88 141.35 89.55 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.613 1.165 . . . . 0.0 110.655 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' MET . 31.9 Cg_exo -62.23 161.58 26.35 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.679 2.919 . . . . 0.0 114.398 -169.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -110.9 161.79 15.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.071 0.948 . . . . 0.0 109.733 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.61 138.84 42.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 168.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -65.42 154.46 38.39 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 173.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.02 158.32 44.05 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.464 0.706 . . . . 0.0 110.084 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -143.47 157.97 44.02 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.332 1.453 . . . . 0.0 108.71 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.405 ' C ' HD12 ' A' ' 5' ' ' ILE . 69.8 m95 -99.04 128.03 45.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 4' ' ' TRP . 1.8 mp -121.67 116.04 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 104.376 -2.454 . . . . 0.0 104.376 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -77.37 129.56 35.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.21 -1.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.829 1.652 . . . . 0.0 109.696 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.41 161.58 11.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.891 1.223 . . . . 0.0 109.515 169.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -55.81 148.89 34.99 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.82 0.448 . . . . 0.0 109.803 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.77 -31.19 39.95 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 121.48 1.453 . . . . 0.0 111.823 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -69.16 -17.61 63.83 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.804 0.841 . . . . 0.0 111.725 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -89.77 -40.16 12.66 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.653 1.115 . . . . 0.0 109.416 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -54.0 -43.45 70.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.477 1.035 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.47 -32.71 72.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.908 0.483 . . . . 0.0 111.683 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -83.96 -32.23 25.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.229 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -166.4 127.04 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.379 1.072 . . . . 0.0 108.833 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -158.44 164.49 36.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.106 0.866 . . . . 0.0 110.604 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.88 137.01 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -52.51 119.93 5.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.203 1.001 . . . . 0.0 110.834 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.22 1.59 86.22 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.568 -1.129 . . . . 0.0 114.887 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.97 154.29 41.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.599 1.699 . . . . 0.0 111.746 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mm -73.86 155.64 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -99.11 105.03 17.08 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.7 mm -138.17 77.03 37.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.6 159.98 5.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.985 3.124 . . . . 0.0 113.102 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -53.09 -42.65 66.11 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.082 0.553 . . . . 0.0 112.105 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -61.1 -29.83 69.99 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.515 0.726 . . . . 0.0 111.743 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -91.9 -31.44 15.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.868 1.267 . . . . 0.0 110.618 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -44.96 -51.64 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.766 1.167 . . . . 0.0 110.95 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -57.57 -23.34 50.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.38 -2.18 6.88 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.835 0.854 . . . . 0.0 112.336 -173.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -135.48 -20.73 1.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 117.586 -1.197 . . . . 0.0 113.494 -169.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 tp -60.5 -29.27 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 120.803 1.638 . . . . 0.0 112.401 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.29 61.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.915 0.78 . . . . 0.0 112.717 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -36.12 82.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.851 0.75 . . . . 0.0 110.377 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.65 -27.09 16.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.411 1.084 . . . . 0.0 111.739 -176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.41 76.6 49.15 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 -14.12 30.48 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.906 2.404 . . . . 0.0 114.063 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -146.8 152.39 38.69 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -56.31 -27.35 55.34 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.633 1.573 . . . . 0.0 114.222 -171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.14 -32.29 73.91 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.327 0.651 . . . . 0.0 112.703 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.36 136.06 52.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.036 0.446 . . . . 0.0 109.896 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 m -84.71 138.24 32.76 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.2 96.21 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -78.91 89.58 4.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.7 m -81.71 138.77 18.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -149.49 171.85 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.084 0.954 . . . . 0.0 108.467 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 p -151.97 -153.02 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 170.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.418 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -55.1 -47.99 74.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.498 1.045 . . . . 0.0 111.028 -178.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.32 -18.88 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.34 -27.26 1.69 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.542 1.064 . . . . 0.0 114.583 172.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -56.85 -58.32 8.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.363 1.581 . . . . 0.0 113.789 -170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.21 -37.52 77.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.203 0.911 . . . . 0.0 110.976 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.73 -41.22 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.027 0.531 . . . . 0.0 112.094 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.61 95.58 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.31 -43.85 79.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.654 1.182 . . . . 0.0 110.567 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.13 70.51 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.526 -0.749 . . . . 0.0 112.477 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -59.37 -32.29 70.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.209 1.368 . . . . 0.0 111.462 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.1 -53.45 30.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.041 0.837 . . . . 0.0 109.712 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 pt -65.66 -35.94 76.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.498 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.65 -37.07 84.05 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.363 0.983 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.5 m -63.96 -42.07 97.38 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.177 0.444 . . . . 0.0 110.043 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -65.49 -38.94 91.22 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.987 0.515 . . . . 0.0 110.836 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 85.1 mtp -70.48 -11.21 60.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.145 1.378 . . . . 0.0 111.945 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.03 48.87 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.679 -1.067 . . . . 0.0 113.822 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -73.89 151.18 40.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.352 1.576 . . . . 0.0 109.336 171.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 p -139.1 9.13 2.53 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.301 1.041 . . . . 0.0 111.781 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -134.79 38.87 3.02 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.392 1.477 . . . . 0.0 109.522 -173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -109.95 138.23 38.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.2 145.21 28.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -79.76 106.03 11.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.91 -28.18 67.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.28 -144.72 11.69 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.43 165.71 25.44 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 169.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.79 -47.04 51.46 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.333 1.453 . . . . 0.0 110.992 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -71.65 -2.15 16.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.029 0.932 . . . . 0.0 113.123 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -129.69 -30.54 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.509 1.124 . . . . 0.0 112.596 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.89 134.54 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.267 1.027 . . . . 0.0 108.512 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.3 -16.56 54.35 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.6 mtp -63.68 158.81 57.57 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.416 0.686 . . . . 0.0 111.776 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.93 161.13 8.86 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.611 2.874 . . . . 0.0 113.189 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.43 163.8 23.28 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.614 1.166 . . . . 0.0 108.797 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.79 155.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 171.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -140.98 168.83 18.86 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.755 0.822 . . . . 0.0 110.168 -170.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 178.448 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.62 163.61 33.43 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.364 1.066 . . . . 0.0 109.279 176.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -144.51 152.89 41.24 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.068 1.747 . . . . 0.0 106.799 169.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -114.3 112.7 23.51 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.75 111.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -69.46 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 166.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.81 7.43 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 118.785 0.721 . . . . 0.0 111.406 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.413 HH22 ' HA ' ' A' ' 17' ' ' HIS . 2.6 ptp180 -64.6 162.15 16.16 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.038 -1.039 . . . . 0.0 110.462 170.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 m -54.69 144.99 42.67 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.51 -33.67 77.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.104 1.203 . . . . 0.0 111.524 -168.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.84 -29.98 70.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 176.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.24 -37.86 16.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -55.66 -44.68 77.48 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.952 0.501 . . . . 0.0 110.224 176.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -60.48 -25.8 66.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.62 0.768 . . . . 0.0 112.506 -174.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -71.06 -49.1 48.3 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.563 0.62 . . . . 0.0 110.424 -173.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -166.0 133.4 2.79 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.413 ' HA ' HH22 ' A' ' 8' ' ' ARG . 12.5 p-80 -146.46 162.04 39.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.488 1.04 . . . . 0.0 111.36 178.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.03 135.99 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -60.33 144.9 49.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.942 0.897 . . . . 0.0 110.074 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.18 20.28 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.804 -0.442 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.96 174.57 10.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.042 1.337 . . . . 0.0 110.36 -177.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -123.05 169.97 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.557 1.943 . . . . 0.0 106.688 170.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 7.8 t-20 -127.67 127.91 44.54 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.351 -0.843 . . . . 0.0 109.186 172.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -136.99 92.38 14.24 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 102.426 -3.175 . . . . 0.0 102.426 171.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.8 153.05 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.538 2.825 . . . . 0.0 111.984 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.5 tp -46.09 -47.83 17.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.548 1.139 . . . . 0.0 112.519 -179.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -57.26 -31.35 65.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.697 1.199 . . . . 0.0 112.289 177.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -101.54 -9.34 21.09 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.342 1.857 . . . . 0.0 111.943 -169.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -51.43 -53.37 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 120.036 1.289 . . . . 0.0 110.127 -176.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -61.41 -22.11 64.71 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -82.83 -21.36 34.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.557 -176.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -136.22 -28.02 1.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 tp -60.99 -36.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 121.195 1.816 . . . . 0.0 111.361 -169.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -6.36 4.44 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 178.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 m -126.31 -33.52 2.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.894 -178.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.09 78.49 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.702 0.801 . . . . 0.0 111.098 172.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 t -139.57 75.73 31.52 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.38 -23.59 32.37 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.238 1.959 . . . . 0.0 112.202 -175.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.96 104.99 3.13 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.757 0.823 . . . . 0.0 109.826 177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -63.58 -13.05 38.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -104.26 11.95 34.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.196 0.998 . . . . 0.0 111.369 178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.73 146.99 53.22 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 121.071 -1.018 . . . . 0.0 109.265 168.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.0 m -80.24 77.84 6.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.67 111.88 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -92.26 136.74 32.94 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 171.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.12 143.78 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.73 168.27 24.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 p -156.33 -159.32 0.88 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.435 HD22 ' C ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -63.64 -49.79 71.87 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.625 -0.672 . . . . 0.0 110.898 179.426 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.67 35.09 1.43 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.679 1.191 . . . . 0.0 112.5 -168.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 -20.63 1.63 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.962 1.268 . . . . 0.0 115.986 170.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -64.11 -52.19 60.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 120.352 2.076 . . . . 0.0 111.831 -174.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -59.16 -30.65 68.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.906 177.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 -47.16 59.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.726 1.148 . . . . 0.0 112.768 178.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.28 -42.64 97.74 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.59 -34.72 76.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.414 1.085 . . . . 0.0 111.573 174.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.94 -37.87 64.44 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.196 -0.94 . . . . 0.0 110.832 176.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -58.88 -39.51 81.64 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.277 -0.889 . . . . 0.0 111.247 -178.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.98 -43.93 81.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.595 1.089 . . . . 0.0 111.674 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.2 pt -69.81 -32.8 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.312 1.414 . . . . 0.0 111.01 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -37.95 85.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.246 0.93 . . . . 0.0 110.268 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.3 m -64.21 -40.24 95.65 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.94 -38.41 90.86 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.172 0.589 . . . . 0.0 110.715 176.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -71.24 -3.62 21.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.72 1.208 . . . . 0.0 112.464 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.76 14.85 64.44 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.304 -1.275 . . . . 0.0 113.883 169.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -62.55 129.19 39.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.613 1.707 . . . . 0.0 107.534 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -66.71 -29.41 69.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.54 0.336 . . . . 0.0 111.665 -169.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.95 158.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.499 1.52 . . . . 0.0 108.741 178.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -149.19 147.36 16.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 175.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -131.99 124.94 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -77.02 112.19 13.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.07 72.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.761 0.424 . . . . 0.0 111.741 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.95 -149.45 21.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -177.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -122.87 163.11 16.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -50.15 -44.36 52.48 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.132 1.373 . . . . 0.0 111.732 -173.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -75.31 -5.87 46.93 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.954 0.902 . . . . 0.0 113.057 -175.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.52 -30.56 3.62 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.222 1.009 . . . . 0.0 112.266 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.32 130.5 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.59 -16.32 51.96 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 89.8 mtp -62.05 156.5 57.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 123.998 0.919 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 165.16 30.72 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.154 2.57 . . . . 0.0 111.748 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.2 162.34 26.4 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.258 1.023 . . . . 0.0 109.907 -176.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 m -137.04 164.25 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.491 1.916 . . . . 0.0 107.604 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -135.11 162.16 33.27 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.19 0.996 . . . . 0.0 110.045 -171.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 169.86 . . . . . . . . 0 0 . 1 stop_ save_